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 Complex biological systems sense, process, and respond to a range of environmental 
signals in real-time. The ability of such systems to adapt their functional response to dynamic 
external signals motivates the use of biological materials in other engineering applications. 
Recent advances in 3D printing have enabled the manufacture of complex structures from 
biological materials. We have developed a projection stereolithographic 3D printing apparatus 
capable of patterning cells and biocompatible polymers at physiologically relevant length scales, 
on the order of single cells. This enables reverse engineering in vitro model systems that recreate 
the structure and function of native tissue for applications ranging from high-throughput drug 
testing to regenerative medicine.  
While reverse engineering native tissues and organs has important implications in 
biomedical engineering, the ability to “build with biology” presents the next generation of 
engineers with both a unique design challenge and opportunity. Specifically, we now have the 
ability to forward engineer bio-hybrid machines and robots (bio-bots) that harness the adaptive 
functionalities of biological materials to achieve more complex functional behaviors than 
machines composed of synthetic materials alone. Perhaps the most intuitive demonstration of a 
“living machine” is a system that can generate force and produce motion. To that end, we have 
designed and 3D printed locomotive bio-bots, powered by external electrical and optical stimuli. 
In addition to being the first demonstrations of untethered locomotion in skeletal muscle-
powered soft robots, these bio-hybrid machines have served as meso-scale models for studying 
tissue self-assembly, maturation, damage, remodeling, and healing in vitro. 
Bio-hybrid machines that can dynamically sense and adaptively respond to a range of 
environmental signals have broad applicability in healthcare applications such as dynamic 
implants or targeted drug delivery. Advanced research in exoskeletons and hyper-natural 
functionality could even extend the useful application of such machines to national defense and 
environmental cleanup. We have developed a modular skeletal muscle bioactuator that can serve 
as a fundamental building block for such machines, setting the stage for future generations of 
bio-hybrid machines that can self-assemble, self-heal, and perhaps even self-replicate to target 
grand engineering challenges. Furthermore, we present a robust optimized protocol for 
manufacturing 3D printed muscle-powered biological machines, and a mechanism to incorporate 
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CHAPTER 1: INTRODUCTION 
 
1.1 Motivation 
The enabling technology of 3D printing has provided engineers and scientists with the 
ability to manufacture complex 3D systems with an increasingly diverse array of materials, 
including cells, proteins, and biocompatible polymers. This ability to “build with biology” 
presents the next generation of engineers with both a unique design challenge and opportunity: 
we can reverse engineer native tissues and organs for applications in regenerative medicine, or 
forward engineer bio-hybrid machines and systems capable of non-natural functional behaviors. 
This dissertation presents the development and optimization of stereolithographic 3D printing 
technologies for manufacturing biological systems at the macro- and micro-scale, and lays the 
foundation for using these technologies to manufacture modular biological actuators for 
application in bio-hybrid robots (bio-bots). Furthermore, this dissertation presents an approach 
for translating this research from the lab bench to the classroom, providing the next generation of 
engineers with the fundamental training in biofabrication that they require to target grand 
engineering challenges. By harnessing the dynamic adaptive functional capabilities of biological 
materials, and training the next generation of engineers to build with biology, we can set the 
stage for a new era of engineering design and manufacturing. 
 
1.2 Overview 
 An overview of stereolithographic 3D printing, and its applications in biomedical 
engineering, is presented in Chapter 2. Followed by this literature review of 3D printing 
processes, macro-scale and micro-scale approaches for patterning cells and biomaterials in 
complex structures are presented in Chapters 3 and 4 respectively. Chapter 5 details the 
development of skeletal muscle-powered robotic devices, capable of controllable locomotion and 
2D steering in response to electrical (5.1) and optical (5.2) signals. Chapter 6 demonstrates the 
ability of biological materials to accomplish complex functional behaviors, such as dynamic 
adaptation to environment signals and healing. Chapter 7 outlines the translation of biological 
design principles from the lab bench to the classroom (7.1), and provides a modular protocol for 
building muscle-powered machines (7.2) for a wide range of applications. Chapter 8 discusses 
future directions for this field, and the global impact of building with biology. 
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CHAPTER 2: STEREOLITHOGRAPHIC 3D PRINTERS FOR 
APPLICATIONS IN BIOPRINTING1 
 
2.1 Introduction 
Stereolithographic 3D printing is a solid freeform additive layer manufacturing 
technology that was pioneered by the 3D Systems manufacturing company in 1986. Originally 
intended for use in rapid prototyping for manufacturing sectors such as the automotive and 
aeronautic industries, stereolithography (SLA) revolutionized this field by eliminating the need 
for inefficient and expensive methods of manufacture. As the first commercially available and 
most popular form of solid freeform fabrication (SFF) technology, stereolithography has 
undergone decades of further developments in efficiency and accuracy, yielding surface finish 
quality comparable to traditional machine milling and rendering it one of the most commercially 
viable additive manufacturing technologies available at present. The many advancements in this 
field and the advantages associated with this versatile manufacturing technology thus encourage 
its widespread use and adaptation to a variety of industry sectors, most interestingly applications 
in biomedical and translational research1.  
Stereolithography demonstrates greater versatility in scale of fabricated parts (sub-micron 
to decimeter) and has the highest fabrication accuracy and resolution as compared to other 
additive layer manufacturing technologies2. Alternative additive manufacturing apparatus such as 
selective laser sintering (SLS), sheet lamination (LOM), or adhesion bonding (3DP) machines 
are restricted to fabricating parts with less complex internal geometries, because they are limited 
by unused material being trapped inside internal holes. Fused deposition modeling (FDM) 
apparatus, like SLA, are not limited by this, but do have high heat effects on the raw material 
used for fabrication3. The cost of fabricating parts via stereolithography is comparable to other 
additive manufacturing apparatus and is counterbalanced by the versatility of design, high 
resolution, and superior quality of parts fabricated via SLA4.  
																																																								
1	This section is an adaptation of the following first authored book chapter and the copyright 
owner has granted permission to reprint (Appendix A.1): 
Raman, Ritu, and Rashid Bashir. “Stereolithographic 3D Bioprinting for Biomedical 
Applications.” Essentials of 3D Biofabrication and Translation., 2015. 89–121. Print. 
 
Author contributions: R.R. wrote the chapter, R.B. edited the chapter.	
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The main limitation facing the advancement of stereolithography for translational 
biomedical applications is the scarcity of suitable biocompatible and biodegradable 
photopolymerizable liquid polymer resins. As shall be seen in this chapter, this limitation is 
being daily reduced by the development of a vast array of stereolithographic resin materials 
including families of natural and synthetic polymers, ceramics, composites, hydrogels, and even 
living cells. These resins have been altered and tuned to target a myriad array of biomedical 
applications. 
 This section outlines the use of stereolithographic manufacturing processes to fabricate a 
variety of models and structures that have translational applications in biomedical engineering. 
Section 2.2 introduces the physics and materials chemistry governing the stereolithographic 
fabrication process, with especial emphasis placed on the design challenges pertinent to 
biofabrication applications. Section 2.3 elaborates on applications of stereolithographic 
fabrication in surgical procedures, prosthesis, and implants, introducing concepts that promise to 
improve upon currently existing clinical practices that are in wide use and operation. Section 2.4 
covers the use of stereolithography to fabricate biomaterial scaffolds and tissue substitutes for 
novel and rapidly evolving applications in tissue engineering and regenerative medicine. A 
discussion of the current challenges present in the field of stereolithography, as well as the 
anticipated advancements in this field, is presented in Section 2.5. A presentation of 
stereolithographic biofabrication in the broader context of translational 3D biofabrication and a 
discussion of future research trends concludes this chapter. 
 
2.2 The Stereolithographic Process 
Stereolithographic systems rely on the process of photopolymerization, or light-initiated 
polymerization, to fabricate 3D structures. In general, stereolithographic processes can be 
separated into two broad categories: single-photon and multi-photon methods, which differ in the 
method of light excitation and absorption that trigger the polymerization process. Single-photon 
methods can be further divided into: 1) Visible radiation systems that employ light in the visible 
wavelength range; 2) “Conventional” stereolithography systems that employ ultraviolet (UV) 
radiation; 3) IR stereolithography systems that employ infrared radiation; 4) Stereo-thermal 
lithography systems that combine ultraviolet and infrared radiation to initiate polymerization5. 
All these single-photon polymerization processes can be implemented using direct-laser writing, 
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physical mask projection, or digital mask projection machines, as shall be described in later 
sections. Of the diverse array of stereolithographic systems listed above, conventional single-
photon stereolithography apparatus are by far the most popular (Figure 2.1).  
Conventional SLA machines utilize the energy from an ultraviolet light source to drive 
the conversion of ultraviolet-irradiation-sensitive liquid oligomers into cross-linked solid/gel-like 
polymeric networks. These machines, as well as SLA machines based on visible light irradiation, 
possess the advantage of providing precise spatial and temporal control of reaction kinetics as 
they are governed purely by the ease of light manipulation. Recent advances in developing 
controlled light sources, such as lasers, have thus greatly enhanced the advantages of using such 
systems. Conventional stereolithography systems have likewise seen the greatest use and 
adaption in biomedical and translational research, as they have the ability to drive polymerization 
under physiologic conditions with minimal heat production and damage to the raw material. This 
is of especial relevance in 3D fabrication of structures containing encapsulated living cells, as 
discussed in Section 2.4. 
 As with most additive layer manufacturing technologies, the first step in fabricating a 3D 
structure by stereolithography involves creating a digital model of the part, using computer aided 
design software (CAD). Lately, advanced digital scanners have also been used to convert 
complex structures into virtual 3D models. This is of especial interest in the context of 
biomedical and translational applications, as many of the scanning technologies that are used in 
this field have their basis in clinical imaging technologies such as magnetic resonance imaging 
(MRI) and computed tomography (CT). Complex structures, such as those found inside the 
human body, can thus be imaged and readily converted into 3D digital models for manufacturing 
patient-specific models, implants, and tissue engineered replacements for damaged tissue.  
In order to be prepared for 3D printing, all digital models must first be converted to a 
standard tessellation language file format (STL) that represents the surface geometry of the 3D 
model as a series of interconnecting tessellated triangles. Specialized software is then used to 
virtually slice the model into sequential layers of specified thickness, often determined by the 
user-specified part size, required resolution, and desired accuracy of the final part. The resulting 
information is then sent to the stereolithography apparatus, which builds the 3D model layer-by-
layer sequentially from the bottom up. Schematics of various forms of SLA machines are further 
described in Section 2.2.1 (Figures 2.2-2.3). 
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2.2.1 Stereolithographic Fabrication Apparatus 
2.2.1.1 Single-Photon Stereolithography 
Single-photon stereolithographic fabrication processes are so termed because the process 
of photoinitiator excitation in this process is driven by the absorption of a single photon. 
Conventional ultraviolet light-based stereolithography falls under this category of 
photopolymerization, as does visible light-based stereolithography. The two most basic and 
widely adopted apparatus for single-photon photolithography in the context of biomedical 
applications are direct laser writing and mask-based ultraviolet light-based stereolithography.     
 A direct laser writing stereolithographic apparatus uses a high-energy laser to trace lines 
across the resin surface, serially polymerizing (i.e. “rasterizing”) two-dimensional cross-sections 
of a three-dimensional design. Sequential polymerization of these two-dimensional cross-
sections layer by layer from the bottom-up, with the aid of a computer-controlled stage, drives 
formation of three-dimensional structures5. 
 Similarly, mask-based stereolithography filters a high-energy light source through a 
patterned physical or digital mask, allowing for curing of an entire two-dimensional cross-
section within a single exposure, rather than serially tracing lines as with a laser-based apparatus. 
This process is thus considered higher-throughput than laser-based processes, as complete layers 
of resin can be polymerized within a single light exposure, thereby reducing build-time. It is of 
importance to remember, however, that resolution of feature sizes obtainable via mask-based 
projection stereolithography systems is inversely proportional to the size/scale of the final 
manufactured part. Hence, fabricating large parts with very small feature sizes can be a time-
consuming process, as it will require rasterizing several 2D projections to completely polymerize 
an entire 2D cross-section of the 3D model. Novel stereolithography apparatus that employ a 
combination of a laser light source and mask-based projection system have been developed to 
target this mismatch between part size, resolution, and fabrication time, but these apparatus are 
yet to be widely employed6.  
Physical masks used in this type of mask-based projection photolithography are 
manufactured via the microfabrication approaches that were initially developed to target 
applications in semiconductor manufacturing. Greater design flexibility is enabled by the use of 
digital masks that can display a vast array of different patterns. One of the most commonly used 
digital masks used in this type of stereolithography is inspired by the digital light processing 
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(DLP) technology in projectors, projection-based television sets, digital signs, and digital cinema 
projection. The digital mask, or digital micromirror device (DMD), is comprised of an array of 
millions of microscopic mirrors that can be precisely and independently rotated into an “on” state 
or and “off” state, generating a pixelated patterned image. Patterning and projection of light 
through this digital mask enables the photopolymerization of a stereolithographic resin in 
precisely defined patterns7,8.    
 Both laser-based and mask-based stereolithography apparatus rely heavily on computer-
controlled building stages that move the 2D polymerized cross-sections by a precisely defined 
amount to ensure adherence of sequential layers to one another. Understanding of the cure depth 
relationship of the resin in use, as well as precise calibration of the light energy of the apparatus, 
is thus of great importance in manufacturing 3D parts via single-photon stereolithography 
(Figure 2.4). 
 
2.2.1.2 Multi-Photon Stereolithography 
Two-photon stereolithographic fabrication processes represent the simplest case of multi-
photon absorption, and involve the sequential or simultaneous absorption of two relatively low-
intensity photons in order to excite a photosensitive resin to a high-energy radical state. This 
method of excitation depends quadratically on the incident light intensity5, as opposed to the 
linear relationship for single-photon stereolithography, allowing for extremely rapid fabrication 
in three dimensions with submicron resolution (Figure 2.5).  
In two-photon initiated stereolithography, which was first demonstrated by Kawata and 
colleagues in 19979, femto-second light pulses from a near-infrared laser are focused into a 3D 
volume/vat of liquid resin. The polymerization process is initiated in the precisely defined focal 
volume of the laser, limiting interaction with the resin through which the laser passes to reach the 
focal volume. Shifting the focal plane of the laser enables the fabrication of complex three-
dimensional structures with high-resolution feature sizes10. Similarly, three-photon approaches to 
photopolymerization of 3D structures with submicron resolution have also been demonstrated11. 
There is great potential for using multi-photon fabrication approaches to manufacture three-
dimensional scaffolds with complex internal micro-architectures for tissue engineering 
applications12. Multi-photon methods for patterning living cells encapsulated within 
photosensitive resins have also been demonstrated13. It is to be noted that photoinitiators used for 
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conventional stereolithography are often unsuitable for applications in two-photon initiated 
stereolithography (see Section 2.1.2.2.1), as these chemicals demonstrate reduced 
photosensitivity to light in the near-infrared wavelength range5 (Figure 2.6). 
 
2.2.1.3 Interference Stereolithography 
A novel form of photolithography known as interference lithography (alternatively 
known as holography) is based on creating an interference pattern between multiple coherent 
light waves in order to create a pattern of high intensity and low intensity fringes of light14. 
Photosensitive resins exposed to this interference-derived pattern of light are thus polymerized in 
regions of high intensity fringes. This method can be used to create patterns with nanoscale 
resolution and offers the additional advantage of more rapid polymerization than attainable via 
conventional stereolithography15. However, because interference lithography is restricted in the 
number and type of patterns that can be created via light interference, it is only of interest in 
biomedical applications that require repetitive structures16. For example, tissue engineering of 
cancellous/trabecular bone requires the formation of an ossified “spongy” scaffold with a 
repetitive porous structure. This type of scaffold, and other scaffolds that require similar 
repetitive porous structures, could be rapidly and accurately fabricated via an interference 
lithography fabrication apparatus (Figure 2.7). 
 
2.2.2 Stereolithographic Resins 
A conventional stereolithography single-photon photo-fabrication apparatus uses the 
energy from ultraviolet light to selectively polymerize, or “cure”, photosensitive liquids called 
resins to form solid or gel-like structures. Photosensitive resins, which are the raw materials used 
in conventional stereolithography, are composed primarily of polymerizable oligomers, or 
“prepolymers”, and a radical photoinitiator. The polymerization process of these resins can be 
simply described in three steps: initiation, propagation, and termination. During initiation, 
components of the resin are irradiated by light and form reactive radical species. These radicals 
then propagate between polymerizable oligomers to form cross-linked networks. The formation 
of covalent bonds in these networks terminates the polymerization process (Figure 2.8). 
 Radical photoinitiators are a crucial component of stereolithographic resins. They belong 
to a family of reactive chemical compounds that decompose to form high-energy free radicals, or 
	8	
molecules with unpaired valence electrons, when exposed to light. In single-photon 
stereolithography processes, a single photon from the irradiating light source is sufficient to 
excite the photoinitiator into this high-energy state. In multi-photon stereolithography processes, 
the simultaneous or sequential absorption of two relatively low-intensity photons is required to 
excite a photosensitive resin to a high-energy radical state. In both types of processes, 
photoinitiators help to initiate the stereolithographic polymerization process by forming the 
reactive radical species that drive polymerization of oligomers in the resin material. The choice 
of photoinitiator determines the rate of polymerization, or curing, of the resin. As several 
photoinitiators are cytotoxic, the family of photoinitiators suitable for applications in biomedical 
engineering is limited, as discussed in Section 2.2.2.1. 
 The primary component of a stereolithographic resin is the polymerizable oligomer. 
Following the initiation of the polymerization process by radical photoinitiators, the functional 
groups of polymerizable oligomers form active radicals that react with one another to form cross-
linked polymerized networks. Conventional SLA processes rely heavily upon fabrication with 
acrylate and methacrylate oligomers, epoxide, and vinyl ether based resins that cure rapidly upon 
irradiation and whose chemical formulas can readily be modified to obtain materials with a 
variety of geometric and material properties. Indeed, many polymerizable oligomer systems 
currently used for stereolithographic biofabrication applications rely on biocompatible oligomers 
containing acrylate and methacrylate functional groups that form radicals in response to photo-
excitation. A detailed description of the composition and material properties of the most 
commonly used stereolithographic resins for biomedical applications is presented in Section 
2.2.2.2. 
 The process of curing photopolymerizable resins via conventional stereolithography is 
very well understood and is easily characterized via an adapted form of the Beer-Lambert 
equation, which is a relationship between the intensity of a light source and the exponential 
decay it experiences as it passes through an absorbing medium. This adapted equation, termed 
the cure-depth equation (Equation 1), demonstrates the relationship between the amount of 
ultraviolet radiation that a liquid resin is exposed to and the depth to which the resin is cured as 
an effect of radiation penetration: 





Where Cd represents the maximum cure depth of the resin, Dp represents the penetration depth at 
which ultraviolet energy intensity is reduced to 1/e of its maximum value at the surface of the 
resin (e is the mathematical constant that forms the base of the natural logarithm), Emax is the 
maximum ultraviolet energy intensity at the resin surface, and Ec is the critical energy intensity 
required to cure the resin by triggering its transition into a solid phase.  
Resins are generally characterized by their penetration depths and critical energy. The 
penetration depth corresponds to the extinction coefficient, or molar absorptivity, of the 
irradiated resin. This characteristic value can be tuned and modified by adjusting the 
concentration of photoinitiator solution present in the resin. It can also be modulated by the 
addition of visible-light or UV-absorbing dyes which compete for irradiation absorption during 
the polymerization process17. Values of Dp are tuned to prevent “over-cure”, or excessive 
exposure to ultraviolet light caused by repeated irradiation during the layer-by-layer 
manufacturing process. Prevention of over-cure is of essential importance in preserving viability 
of cells in stereolithographic bio-printing applications targeting tissue engineering, as excessive 
ultraviolet exposure has a detrimental effect on cellular viability (See Section 2.1.4). The value 
of the critical energy for a resin, Ec, is likewise dependent on the concentration of photoinitiator 
present in the solution, as well as other dissolved gases (ex. oxygen) or liquids (ex. colored dyes) 
that could compete for the absorbed light energy. The energy dose of the irradiating light source 
at the surface of the resin, corresponding to Emax, is regulated by modulating the scanning speed 
(for laser-based systems) or specifying the exposure time (for projection mask-based systems).  
Precise calibration and modulation of the light energy dose and composition of the 
photosensitive resin therefore provides a simple and reliable method of controlling the cure 
depth. Plots of cure depth vs. energy dose for a given combination of stereolithographic 
apparatus and resin are termed “working curves”. These working curves are used to select the 
conditions that provide cure depths that ensure adhesion to the fabrication support platform as 
well as to adjacent layers of the 3D fabricated part. Reduced cure depths provide more accurate 
control of thickness and provide higher quality finishes to manufactured parts. However, 
decreased cure depths correspond to increase number of layers and hence increased build-time. 
 For applications in conventional manufacturing sectors, parts manufactured via 
stereolithography are often subjected to a post-curing process, which involves uniform exposure 
to ultraviolet irradiation that helps improve the mechanical properties of the fabricated parts. 
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This step is often not required for translational biomedical applications, as many such 
applications don’t require extremely high mechanical strengths, but various post-fabrication 
steps used to clean and sterilize fabricated parts have been employed, as discussed later in this 
chapter.  
 
2.2.2.1 Radical Photoinitiators for Stereolithographic Biofabrication 
Different photoinitiators are distinguished by the wavelength range in which they present 
high-energy absorption, and are thus readily described by their unique absorption spectra. The 
choice of excitation light source wavelength and photoinitiator composition are thus inextricably 
linked to one another. A general trend in excitation wavelength is that the shorter the wavelength 
of ultraviolet light, the better the resolution of fabricated feature sizes. However, this decrease in 
excitation wavelength is paired with lower penetration depth into the sample and hence increased 
build-time18. 
A variety of photoinitiators have been developed to suit a range of photopolymerization 
applications, but most photoinitiators are cytotoxic (i.e. cause cell death), which renders them 
inappropriate for use in biomedical applications. For such translational medical applications, the 
wavelength criterion poses a further challenge for adapting stereolithographic technology, as it is 
essential in such cases to limit the oxidative damage to biological components caused by 
exposure to high-energy irradiation. These stringent limitations severely constrain the size of the 
relevant family of photoinitiators that can be used in biomedical applications. However, by 
characterizing the cytotoxicity of relevant photoinitiators and incorporating post-processing steps 
such as repeated “washes” and sterilizations, researchers have succeeded in fabricating 3D 
structures that can safely integrate with biological tissues and organs. The success of finding a 
range of photoinitiators that match the design criteria required for biomedical applications has 
demonstrated feasibility of using stereolithography for a broad range of applications including 
patient-specific prosthetics, implants, and scaffolds for tissue engineering.  
Tissue engineering applications pose the most stringent restrictions on the photoinitiator 
compositions that can be incorporated in stereolithographic resins, as they require living cells to 
come into direct and prolonged contact with these reactive compounds. Furthermore, the 
viability of living cells exposed to high-intensity irradiation is very sensitive to the wavelength of 
the light source – cells are more viable upon irradiation of wavelengths in the UV A (400-
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315nm) range than in the UV B (315-280nm) or UV C (280-100nm) range. Thus, photoinitiators 
with absorption spectra in the UV A range are most suitable for applications involving resins 
containing living cells. It is to be noted that the absorption spectra of photoinitiators can be 
modified by adjusting the concentration of photoinitiator present in the photopolymer resin, as 
increasing the photoinitiator concentration ensures that irradiation from a broader range of target 
wavelengths can be utilized.  
 The most commonly used commercially available photoinitiator for applications in tissue 
engineering by conventional stereolithography is 2-hydroxy-1-[4-hydroxyethoxy)phenyl]-2-
methyl-1-propanone, also known as Irgacure 2959. The cytotoxicity profile of this photoinitiator 
has been very well characterized by several studies. Elisseeff and colleagues published an 
extensive comparison of the cytotoxicity profile of Irgacure 2959 and other commonly used 
ultraviolet light sensitive photoinitiators on a broad range of mammalian cell types and species19. 
This study demonstrated minimal cytotoxicity of Irgacure 2959, as compared to other ultraviolet 
irradiation sensitive photoinitiators. Furthermore, this study demonstrated that resin cytotoxicity 
is highly sensitive to the concentration of photoinitiator, as expected, and that different cell types 
have varying degrees of sensitivity to identical concentrations of a given photoinitiator. The 
advantageous properties of Irgacure 2959 as demonstrated by this and other studies have, 
therefore, contributed to its popular use in conventional stereolithography based systems to 
manufacture 3D structures with encapsulated cells (Figure 2.9). 
 Advances in photoinitiator chemistry have been further driven by Anseth and colleagues, 
who have developed a photoinitiator, lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), 
that demonstrates increased sensitivity to ultraviolet light and is also sensitive to wavelengths in 
the visible light range20. By enabling the use of reduced photoinitiator concentrations and 
lowered light intensities, LAP has demonstrably superior capacity to preserve the viability of 
cells encapsulated in stereolithographic resins. As this field continues to grow and applications of 
stereolithography in regenerative medicine become more popular, it is likely that further research 
will target the discovery of photoinitiator compounds with advantageous properties similar to or 
perhaps greater than those demonstrated by Irgacure 2959 and LAP (Figure 2.10).  
 
2.2.2.2 Biocompatible Polymerizable Oligomers for Stereolithographic Biofabrication 
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Stereolithography systems for conventional manufacturing applications have, as 
mentioned in an earlier section of this chapter, primarily used reactive acrylate/methacrylate, 
epoxide, or vinyl ether-based resins, or some hybrid composition thereof5. As stereolithographic 
fabrication technology expands to target translational medical applications, the number of 
suitable resins is decreased slightly, but isn’t as restricting as the requirements posed on 
photoinitiators discussed in Section 2.2.2.1. This is because most cross-linked polymers are not 
toxic in themselves, though the unreacted monomers and residues of reactive photoinitiator 
residues may have cytotoxic effects. In many cases, post-processing steps such as washes with 
water and/or alcoholic solutions, sterilization with ultraviolet light irradiation, or treatment with 
supercritical carbon dioxide (which introduces micro-porosity into fabricated structures in 
addition to removing toxic residues21) have proven sufficient to ensure biomedical applicability 
of a resin composition. 
It is to be noted, however, that there are still many quality criteria that must be met in 
order for a stereolithographic resin to be considered suitable and desirable for biofabrication. 
Photosensitive resins for biomedical applications must, in addition to efficiently absorbing and 
curing in response to light irradiation, be biocompatible. That is, they must integrate with the 
target biological host without having a toxic effect on the living system. Biomedical applications 
also often require materials that are biodegradable (controllably disintegrate in response to host 
environmental cues leaving only non-toxic byproducts) and bioactive (actively promote 
beneficial and regenerative effects in the host biological system). 
 
2.2.2.2.1 High-Strength Resins 
For biomedical applications that require high mechanical strength, such as load-bearing 
implants, polymer-ceramic composite materials combine strong mechanical properties with 
demonstrable biocompatibility22. Formulation of these ceramic-based resin materials is primarily 
accomplished by mixing ceramic particles, most often alumina or hydroxyapatite, with a liquid 
photopolymer23–25. It is to be noted that such powder-infused resin compositions are often 
extremely viscous, and must hence be mixed with diluents as described previously. Furthermore, 
the ceramic particles in these resins must be significantly smaller than the resolved feature sizes 
and layer thickness within the fabricated part in order to maintain fabrication quality/accuracy26. 
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2.2.2.2.2 Elastomeric Resins 
An important constraint on relevant stereolithographic resins is posed by the mechanical 
properties that are required of biomedical devices. Most conventional SLA resins are glass-
like/brittle, because they are composed primarily of low molecular weight monomers that react 
to form rigid cross-linked networks. By contrast, biomedical applications require materials that 
are more elastomeric (i.e. compliant/flexible) in nature. Resins formulated for these applications 
thus comprise high molecular weight macromers with relatively low glass transition 
temperatures. Since liquid suspensions of such macromers are often very viscous, fabrication 
with such resins often requires mixing with either non-reactive or reactive diluents such as N-
methylpyrrolidone, N-vinyl-2-pyrrolidone, diethyl fumarate, or water to reduce resin viscosity 
and increase fabrication resolution and accuracy1. These diluents have demonstrably increased 
the hydrophilicity and biocompatibility of SLA fabricated structures for a variety of resin 
compositions27,28. It is to be noted that non-reactive diluents, such as N-methylpyrrolidone, are 
more applicable when the macromer contains more reactive groups such as acrylates or 
methacrylates.   
 Historically, stereolithographic systems have made extensive use of (meth)acrylate-based 
and epoxy-based resins for fabrication. Epoxy-based resins are generally cytotoxic and hence 
unsuitable for translational medical applications. On the other hand, modified polyether 
(meth)acrylate-based systems, such as those developed by Emons and colleagues, have been 
proven to be biocompatible via in vitro tests on mouse fibroblasts29. Furthermore, these 
biocompatible resins form elastomeric polymers that are more flexible than conventional SLA-
fabricated materials, displaying a broad range of tune-able material properties (hardness, 
stiffness, etc.) that can be tailored to suit various biomedical applications (Figure 2.11). 
 
2.2.2.2.3 Biodegradable Resins 
Often, in vivo applications of SLA fabricated biomedical devices require that the 
fabricated structures biodegrade in a precisely controlled and non-toxic manner, in order to 
encourage the regeneration of host tissue at the site of disease or trauma-induced damage. As a 
consequence, the field of research targeting formulations of biodegradable photosensitive resins 
has been very active in recent years.  
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Matsuda and colleagues initiated early developments in this field by developing a 
photosensitive biodegradable oligomer through ring-opening polyaddition of trimethylene 
carbonate (TMC) with ε-caprolactone (CL)30,31. Degradation behaviors of these polymers 
induced by hydrolytic surface erosion were measured in vivo via subcutaneous implantation of 
SLA fabricated microstructures in rats32. Similar work on TMC-based biodegradable polymers 
by Cho and colleagues demonstrated the use of such materials to create scaffolds for 
regeneration of cartilage and bone33.  
In early demonstrations by Dean and colleagues, SLA systems were successfully used to 
manufacture biocompatible and biodegradable structures with poly (propylene fumarate) (PPF) 
based photosensitive resins mixed with diethyl fumarate diluent (DEF)34. Further 
characterization and in vitro testing of such PPF/DEF biodegradable systems have promising 
implications for a diverse array of tissue engineering applications28,35,36.  
 More recently, Grijpma and colleagues have developed SLA-compatible poly (D,L-
lactide) (PDLLA) biodegradable resins mixed with N-vinyl-2-pyrrolidone (NVP) diluent, 
creating hydrophilic polymerized networks with good cell-adhesive properties as demonstrated 
by in vitro tests with mouse preosteoblasts27. Further developments by this group eliminated the 
need for such reactive diluents, which are non-biodegradable, by replacing them with the non-
reactive diluent ethyl lactate and further improving the biodegradability of SLA-fabricated 
structures37. 
 
2.2.2.2.4 Hydrogel Resins 
The resins presented in this section have thus far been compatible for applications that 
involve fabrication of biomedical devices/structures that come into contact with biological 
systems after post-processing steps. However, next-generation regenerative medicine 
applications that fall under the category of “tissue engineering” herald the need for 
stereolithographic resins that contain living cells. The most promising of photosensitive 
polymeric materials that support this requirement are a broad class of hydrophilic and 
biocompatible materials known as “hydrogels”. 
 Cross-linked polymeric hydrogel networks are highly porous and absorbent, facilitating 
the diffusion of biochemical signals and essential nutrients through the polymeric network. Their 
structural and functional properties, such as network porosity and hydrophilic swelling behavior, 
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can be readily tailored via chemical modifications to the monomers present in the resin. Their 
mechanical properties, which fall in the range of 1-100 kPa, are more suited to applications 
targeting engineering of soft tissues such as those present in the human body. Furthermore, 
hydrogels also have the ability to respond to changes in temperature, pH, illumination, or other 
physical and chemical stimuli. This is particularly advantageous for biomedical applications that 
rely on real-time response behavior such as dynamic medical implants or bioactuators that 
generate force in response to external stimuli. For these reasons, systems incorporating hydrogel 
polymers have seen widespread use in translational medical applications in recent years38,39.  
 In a pioneering study in this field, Boland and colleagues presented the first 
demonstration of encapsulating live cells within a photopolymerizable hydrogel via 
stereolithography. A hydrogel prepolymer solution comprising a mixture of poly (ethylene 
oxide) (PEO) and poly (ethylene glycol) dimethacrylate (PEGDMA), reminiscent of the 
(meth)acrylate based polymer chemistry discussed earlier in this chapter, was mixed with 
Irgacure 2959 photoinitiator and Chinese hamster ovary (CHO) cells and polymerized using a 
direct-laser writing single-photon stereolithography machine40. Viability of cells cultured in vitro 
within these polymerized hydrogel constructs was assessed via live/dead assay, proving that 
SLA-based technologies could be used to fabricate high-density elastomeric tissue-like 
constructs.  
Wicker and colleagues expanded upon this early work, which demonstrated fabrication of 
relatively simple geometry constructs, to viably encapsulate living cells in PEGDMA hydrogels 
with more complex 3D geometries via SLA41. The hydrogel prepolymer formulation in this case 
used a combination of two photoinitiators, Irgacure 2959 and HMPP (2-hydroxy-2-methyl-1-
phenyl-1-propanone). The soluble fraction and swelling ratios of fabricated hydrogels were 
characterized, providing an understanding of the underlying mechanisms that govern the 
geometric properties of fabricated parts as a result of polymer resin chemistry (Figure 2.12).  
 
2.2.2.2.5 Bioactive Resins 
These and other early studies with PEG-based hydrogels, while promising, were still 
limited by the fact that cells do not naturally form strong adhesive interactions with networks of 
synthetic polymers. To target this, the study by Wicker and colleagues explored the effect of 
covalently incorporating the cell-adhesive ligand RGDS (Arg-Gly-Asp-Ser tetrapeptide) within 
	16	
the fabricated hydrogel matrix to provide cell-adhesive attachment sites throughout the 
polymerized structure. Bashir and colleagues expanded upon this work by assessing the effect of 
RGDS on the long-term viability of cells encapsulated within PEG-based hydrogels of varying 
molecular weights42. Addition of these adhesive peptide sequences showed significant increases 
in cell viability, proliferation, and spreading as compared to control samples, demonstrating that 
the incorporation of bioactive moieties within polymeric networks could remove this limitation 
from SLA-fabricated hydrogel structures. West and colleagues expanded this work by using two-
photon laser scanning photolithography to precisely dictate the placement of RGDS peptides 
within 3D fabricated acrylate-modified PEG hydrogel architectures43 (Figure 2.13). 
Others have similarly investigated the effects of incorporating different types of bioactive 
compounds within polymeric matrices. Farsari and colleagues utilized a multi-photon 
photopolymerization apparatus to immobilize biotin linked to fluorescently labeled streptavidin 
to 3D fabricated structures, demonstrating the ability to bind proteins to structures via SLA11. 
Similar work by Woodbury and colleagues utilizing a scanning laser-based SLA in conjunction 
with methacrylate-based polymer resins to selectively graft peptides onto 3D fabricated 
microstructures and study post-source decay sequencing of peptides44. Bashir and colleagues 
have demonstrated spatially selective and controllable patterning of proteins on hydrogel 
polymers by combining a micro-contact printing approach with a direct-laser writing SLA setup, 
showing that cell patterning and alignment in 3D structures can be readily controlled by such a 
process45. Roy and colleagues have also demonstrated the use of SLA to spatiotemporally pattern 
scaffolds with extracellular matrix (ECM) components, such as heparan sulfate, and polymeric 
microparticles containing heparan-binding growth factors, such as basic fibroblast growth factor 
(FGF-2)46. By demonstrating controlled predesigned spatiotemporal distribution of multiple 
bioactive factors within SLA-fabricated polymeric matrices, these and other studies have set the 
stage for engineering complex tissue engineered structures through multi-lineage differentiation 
of a single encapsulated population of stem cells.   
 An alternative approach to separately incorporating bioactive moieties into polymerized 
matrices is to modify the chemistry of oligomeric monomers used in photosensitive resins. Liska 
and colleagues used a stereolithographic process to polymerize various methacrylate-based 
gelatin derivatives, demonstrating the ability to fabricate arbitrary cellular structures with a range 
of cell types47. Other modified methacrylated PEG and gelatin based systems incorporating 
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oligopeptides into hydrogel networks have shown that such polymeric scaffolds significantly 
enhance cell adhesion and growth as compared to non-modified materials48. Chen, 
Khademhosseini and colleagues have recently made extensive use of similar gelatin methacrylate 
(GelMA) hydrogel materials as a photosensitive resin for high-resolution 3D patterning using a 
projection stereolithography apparatus, demonstrating the biological functionality of such 
manufactured constructs49. 
 Methacrylate modification of naturally occurring polysaccharides, such as hyaluronic 
acid50 and chitosan51, has likewise been used in photosensitive resin compositions for 
applications in stereolithographic biofabrication targeting tissue repair and regeneration. Recent 
studies by Schober and colleagues have even demonstrated multi-photon laser-based 
photofabrication of unmodified native polymers, such as collagen and fibrinogen, and liquids, 
such as natural human blood and fetal calf serum52. 
 
2.2.2.3 Multi-Material Stereolithographic Biofabrication 
While all the polymers described in this section are useful for a variety of biomedical 
applications, true versatility of the stereolithographic process can only be attained by multi-
material fabrication of complex 3D structures. This type of multi-material SLA fabrication can 
be accomplished by selectively polymerizing portions of layers with a single resin type, washing 
away un-polymerized resin, and then adding and polymerizing a different resin, as demonstrated 
by Wicker and colleagues8. Bashir and colleagues incorporated a similar multi-step system to 
fabricate 3D cell-encapsulating multi-material hydrogel structures using a laser-based 
apparatus42. This set the stage for using multi-material SLA processes to co-culture systems of 
cells, such as neurons and skeletal muscle, to study intercellular interactions and establish a basis 
for engineering complex tissues and organs containing multiple encapsulated cell types53 (Figure 
2.14-2.15). 
 
2.2.2.4 Novel Resin Systems 
As stereolithography has grown to become a fairly well established commercial process, 
the number of photosensitive resins that rapidly solidify in response to light-excitation has 
correspondingly increased. The morphological, mechanical, and material properties of these 
polymerizable resins cover a broad range and are broadly relevant for a variety of translational 
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applications in the field of biomedical engineering. However, the numbers of 
photopolymerizable resins for stereolithography that are compatible with applications in 
bionanotechnology are still limited. A few of the most commonly used families of resins in this 
field have been elaborated upon in this section, and detailed information regarding 
photosensitive non-cytotoxic resins are listed in more extensive reviews54,55, but the rapidly 
changing nature of this field ensures that the variety of available resins will continue to increase 
and diversify in the coming years. 
 
2.2.3 Applications of Stereolithography in Biomedical Engineering 
The vast array of biomedical and translational applications of stereolithographic 
fabrication fall into a series of broad categories: Manufacturing of 1) data visualization and 
surgical planning tools to aid clinicians; 2) individualized prosthetics; 3) customized implants 
and surgical tools; 4) biomaterial scaffolds for tissue engineering; 5) high-density cellular 
constructs for tissue engineering. These applications are further elaborated upon in Sections 2.3 
and 2.4. 
 
2.3 Applications of Stereolithography in Surgical Procedures, Prostheses, and Implants 
The vast majority of currently used pre- and post-operative surgical procedures, 
prostheses, and implants could benefit greatly from the integration of patient-specific models and 
customized design parameters. While this individualized treatment model would be infeasible 
using standardized manufacturing techniques, the relative ease of generating accurate digital 
models and rapidly fabricating prototypes via medical imaging and stereolithography renders 
patient-specific treatment feasible. Use of stereolithographic manufacturing to manufacture pre-
operative planning models, external prosthetics, implantable devices, and surgical guides and 
tools are discussed in this section. 
 
2.3.1 Stereolithographic Fabrication of Pre-operative Visualization and Planning Tools to Aid 
Clinicians 
Structural models and analysis have been extensively used in the fields of architecture 
and civil engineering for decades, motivating the complex analysis of clinically relevant 3D 
models via a similar approach. Advances in clinical imaging of 3D structures via computed 
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tomography (CT) and magnetic resonance imaging (MRI) have greatly advanced the practicing 
clinician’s ability to easily visualize exterior surfaces and some internal structures. 
Manufacturing of patient-specific models and three-dimensional representations of clinical data 
via stereolithography promises to carry these advances further by building physical 
representations of a patient’s anatomy. These models can be tuned to represent both hard and soft 
tissues and colored to distinguish different internal structures or pathologies such as tumors, 
thereby augmenting the complexity of patient-specific models and predicting/controlling the 
effectiveness and aesthetic result of surgery56. Tools and models manufactured via 
stereolithography promise to aid clinicians in gaining a complex spatial understanding of patient 
anatomy, studying pathologies, making accurate diagnoses, and preoperative planning. 
 
2.3.1.1 Patient Specific Models 
Stoker and colleagues demonstrated early efforts in the construction of patient-specific 
anatomical models by using an SLA to manufacture plastic models of the internal anatomy 
within a closed skull, as imaged by computed tomography57. Providing a 3D physical 
representation of the internal anatomy of the skull has obvious applications in both physician and 
patient education, and can further aid as a model for surgical planning. Further developments in 
this field by Wittenberg and colleagues demonstrated the use of a stereolithography in 
maxillofacial operation planning by checking the “fit” of a human donor source for cranioplasty 
prior to surgical intervention58. This surgical planning step enabled by stereolithography was 
shown to demonstrable reduce operative risks and treatment time and improved post-operative 
results.  
 
2.3.1.2 Preoperative Planning Tools 
More recently, the efficacy of using CT/SLA-fabricated templates for oral implant 
surgeries have shown that such preoperative planning tools have a higher likelihood of implant 
survival and significantly lower deviation from planned implant positions59. Indeed, studies have 
shown that such stereolithographic surgical templates, in addition to allowing precise translation 
of surgical treatment plans into practice, also offer significant benefits over traditional 
procedures in more complex cases59. 
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 Implants that must function in high load-bearing environments, such as total hip 
replacements, require even more careful preoperative planning to ensure proper surgical 
placement. De Momi and colleagues utilized an SLA-fabricated preoperative planning model to 
visualize physiological movement of the hip joint during daily life activities and generate data on 
patient gait analysis60. Understanding the load-bearing capacity of this implant in the context of 
the specific patient model provided surgeons with an accurate guided approach to performing the 
actual implantation procedure (Figure 2.16). 
 
2.3.1.3 Data Visualization 
Stereolithography has also found use as an aid to generate physical representations of 
clinical data that help clinicians visualize patient-specific scenarios. Maurer and colleagues 
introduced this concept by manufacturing polyacrylic hard copies of echocardiographic patient 
data in order to enhance surgeon’s spatial perception of the anatomy and pathology of the heart61.  
By providing anatomically correct models of mitral valve anatomy and pathology in patients, this 
3D representation of data acquired via echocardiography helped improve the efficiency of 
diagnoses as well as preoperative planning for treatment of cardiovascular pathologies.  
  These and other studies first introduced stereolithographic fabrication into the field of 
medicine, by providing a customizable planning and educational tool for clinicians as well as 
patients. SLA-fabricated physical models have been used to fabricate complex external and 
internal structures within the human body and three-dimensional representations of clinical data 
sets. By providing clinicians with test-platforms and patient-specific models for preoperative 
planning, stereolithography has the potential to greatly impact the efficiency and accuracy of the 
diagnosis and treatment of a diverse set of pathologies. 
 
2.3.2 Stereolithographic Fabrication of Individualized Prosthetics 
Building upon this early work using stereolithography to fabricate patient-specific models 
and guide surgical planning, researchers began to use SLA processes to generate anatomically 
accurate 3D models that could be used directly as prosthetics. These individualized 




2.3.2.1 Cosmetic Prosthetics 
Initial studies in this field demonstrated much success in using stereolithography to 
fabricate high-quality patient specific hearing aids, setting the stage for mass customization of 
prosthetic devices63. Wilkinson and colleagues carried these developments further by utilizing a 
stereolithographic fabrication process to manufacture a customized whole-ear prosthetic from a 
wax resin64. In this study, information gathered from a digitized magnetic resonance image of a 
patient’s ear was used to create a mirror-image 3D model of the missing contralateral ear. The 
digitized data was then converted into a 3D mold with a cavity corresponding to the shape of the 
missing ear and fabricated from a photopolymerizable silicone resin via stereolithography. A 
wax resin was then injected into the silicone mold to generate a prosthetic ear of the precise 
dimensions and morphology corresponding to the patient. Other auricular prostheses and 
personalized maxillofacial prostheses manufactured via mirror-image conversion of digital 
models have seen similar success as applications of stereolithographic fabrication65. As SLA 
technology has continued to evolve and the number of available resins has increased, direct 
mold-less fabrication of customized prosthetic devices has also been enabled (Figure 2.17). 
 
2.3.2.2 Load-Bearing Prosthetics 
The manufacturing of more complex prosthetics for functional and weight bearing limbs, 
as opposed to mainly cosmetic enhancements, has likewise been enabled by new developments 
in chemically modified SLA resins with strong mechanical properties (i.e. hardness, stiffness, 
corrosion resistance etc.). Preliminary studies in this field have used SLA technologies to test 
preliminary fitting of external prosthetics on patient-specific “test sockets”. These sockets serve 
the purpose of testing the weight-distribution of the prosthetic to ensure that soft tissue is 
compressed only in pressure tolerant areas. Ensuring a good fit through such test socket 
procedures is essential to the successful integration of the prosthetic with the patient. 
Stereolithographic fabrication of test-sockets for high load-bearing structures such as trans-tibial 
prosthetics have been successfully demonstrated (Figure 2.18)66.  
 
2.3.3 Stereolithographic Fabrication of Customized Implants and Surgical Guides 
The advances in prosthetics enabled by stereolithography illustrated in the previous 
section lead naturally to the use of stereolithography to manufacture customized patient-specific 
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implants. These customized biocompatible implants, which must permanently integrate with a 
host biological system, promise to greatly improve the prospective for invasive surgical 
procedures targeting synthetic replacements of native tissue and organs.   
Since implants, unlike external prosthetics, are in direct contact with native and 
regenerated tissue in vivo, it is critical to ensure the long-term biocompatibility of implant 
materials fabricated via stereolithography. A study by Popov and colleagues demonstrated that 
removal of potentially toxic residues of photosensitive resins (monomers, low molecular weight 
oligomers, etc.) could be accomplished via treatment with supercritical carbon dioxide, 
significantly enhancing the biocompatibility of the fabricated structures when implanted in 
vivo21. Other sterilization procedures using ultraviolet radiation or washes with alcoholic 
solutions have been similarly proven successful, as discussed further in Section 2.1.4. 
 
2.3.3.1 Cosmetic Implants 
Drawing upon the early advances in using stereolithography to fabricate external 
maxillofacial prosthetics, there have been many successful attempts to manufacture patient-
specific implants for cranioplasty manufactured via stereolithography. Some approaches used CT 
data and SLA apparatus to design molds that were then used to fabricate thermally polymerized 
custom implants from acrylic materials67, or carbon-fiber reinforced polymeric composites68.  
More direct SLA-fabrication approaches have been demonstrated by Day and colleagues, who 
used a digital model obtained via contiguous helical CT scans to directly fabricate a patient-
specific mandible via stereolithography to fit a large surgical defect obtained as a result of a 
tumor69. Fitting of the manufactured implant into the defect site provided aesthetically appealing 





2.3.3.2 Load-Bearing Implants 
Customized design of load-bearing implants has been enabled by the creation of SLA-
fabricated replica models of individualized patients. Early studies in this field aimed at 
individualizing total knee replacements for patients were shown to successfully return weight-
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bearing capacity to damaged limbs in both animal and human models70,71. Such customized 
implantation procedures have great value for all patient models, but especially in complicated 
cases where more individualized morphologies must be taken into account. As with the 
prosthetic devices mentioned earlier in this section, further developments in creating SLA resins 
with strong mechanical properties (such as the polymer-ceramic composites detailed in Section 
2.1.2) promise to result in the direct fabrication of patient-specific load-bearing implants. 
 
2.3.3.3 Surgical Guides 
SLA technologies have also been used to manufacture surgical guides that ensure proper 
placement of implants within patients. These guides are critical to the operative procedure, and 
are conventionally employed to direct implant drilling and placement systems. Customized 
surgical guides manufactured via SLA can greatly augment surgical outcome by improving the 
ultimate functional performance and design aesthetics of the implanted device. Rosenstiel and 
colleagues have demonstrated the reliability of surgical guides manufactured via 
stereolithography, showing that a significantly lower mean angular deviation was obtained for 
SLA surgically guided implants as compared to implants placed without SLA surgical guides72. 
These and other similar studies have demonstrated the ability to rapidly and accurately 
manufacture patient-specific surgical guides via stereolithography, thereby ensuring a high 
quality of pre-surgical planning and surgical execution on a customized case-by-case basis 
(Figure 2.20). 
 
2.4 Applications of Stereolithography in Tissue Engineering and Regenerative Medicine 
The field of tissue engineering is centered on the aim of creating complex biological 
substitutes for native tissue using a combination of cells and instructive biomaterials. This 
emerging field promises to revolutionize modern medicine by providing an alternative to tissue 
and organ transplantation, and perhaps eliminating the need for implants and transplants 
altogether by aiding the rapid development and testing of new drugs and therapies73. The use of 
stereolithographic fabrication to fabricate biocompatible scaffolds for tissue engineering, 
followed by advances in this field pioneered by stereolithographic printing of living cells, is 
described in the following sections. As previously discussed in Section 2.2, advances in creating 
biocompatible, biodegradable, and bioactive photosensitive resins have enabled many of the 
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advances in this field. These resins are tailored to prevent inflammatory response upon 
implantation, controllably degrade into non-toxic byproducts that can achieve good renal 
clearance, and actively encourage the formation of new regenerated tissue74,75. 
 
2.4.1 Stereolithographic Fabrication Strategies for Tissue Engineering and Regenerative 
Medicine 
2.4.1.1 “Top-Down” Fabrication 
The conventional approach to tissue engineering has been the fabrication of porous 
biocompatible and biodegradable scaffold structures as platforms for cell seeding. In the early 
stages of these studies, scaffolds were often generated using conventional microfabrication 
approaches for patterning natural and synthetic materials76. Researchers have even explored 
approaches in which cadaveric tissue is de-cellularized and repopulated with living cells to yield 
functional tissue and whole organs77,78. More recently, direct-fabrication of biocompatible 
scaffolds via SLA processes has seen much success in a variety of tissue engineering 
applications (see Sections 2.4.2-2.4.5) 
 Scaffold-based approaches provide the ability to place cells within precise morphological 
designs while maintaining the cell-cell and cell-matrix interactions observed in vivo. However, 
these approaches come with the challenges of regulating the distribution of cells within the 
scaffolds, as well as the inability to engineer adequate vascular networks that can provide 
supplies of nutrients to large-scale engineered tissues. These challenges render scaffold-based 
“top down” approaches undesirable for applications in tissue engineering of complex tissues and 
organs, as they are unable to provide truly precise spatial control of cells and biochemical signals 
in three dimensions79. 
 
2.4.1.2 “Bottom-Up” Fabrication 
The rise of “bottom up” approaches in biofabrication, triggered by the advent of highly 
absorbent biocompatible stereolithographic resins, provides and attractive alternative approach to 
manufacturing complex biological substitutes for native tissue and organs. In this approach, 
engineered tissues can be directly assembled layer by layer from the bottom up by using SLA 
resins containing encapsulated cells, allowing for complex three-dimensional control over the 
morphological and functional properties of engineered tissue.  
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 The single-photon and multi-photon stereolithographic systems presented earlier in this 
chapter are ideal candidates for targeting applications in bottom-up tissue engineering. These 
systems have demonstrable high-resolution patterning capabilities and have been proven to 
viably encapsulate cells in polymeric networks while preserving viability and functionality in 
long-term studies by minimizing heat production and damage to raw material during fabrication. 
 
2.4.1.3 Macro- and Micro-scale Architecture 
High-resolution fabrication of three-dimensional porous structures with intricate internal 
geometries is a necessary requirement of both top-down and bottoms-up methods of 
manufacturing viable tissue engineered constructs. Recent studies on the effect of micro-scale 
porous internal architectures of scaffolds on the repair and regeneration rate of damaged tissue 
have demonstrated the need for creating 3D structures with controllable morphologies on both 
the macro- and micro-scales. This level of micro-environmental control has the further advantage 
of facilitating architecture for vascular networks and conduits, setting the stage for developing 
large-scale engineered tissues and organs in the future. High-resolution spatiotemporal patterning 
of bioactive moieties can also drive advances in multi-lineage differentiation of a single 
population of encapsulated patient stem cells, creating truly customized replacement tissues. 
Hence, while many of the pioneering studies in SLA-based tissue engineering utilized the direct 
laser writing strategies and conventional ultraviolet irradiation driven polymerization, the rise of 
digital mask projection micro-stereolithography apparatus promise to further improve our ability 
to fabricate biodegradable and biocompatible architectures with single micron resolution36. Two-
photon methods improve upon this even more by establishing biocompatible fabrication 
mechanisms with sub-micron resolution12. The fundamental challenge underlying all these 
fabrication strategies is based on negotiating the balance between fabricating macro-scale 
structures while incorporating micro-scale features. 
  The use of SLA fabrication strategies to target regenerative medicine applications in 
tissue engineered bone, cartilage, and cardiovascular tissue/networks are presented in the 
following sections. SLA technologies that target a range of other tissue/organ systems such as 
liver, connective tissues, and neural conduits have also been demonstrated, proving the readily 
customizable nature of this fabrication process.  
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2.4.2 Stereolithographic Fabrication for Bone Tissue Engineering 
Tissue engineered substitutes for bone are motivated by clinical need: skeletal defects, 
caused by disease or traumatic fracture, are increasingly common in a growing and ageing 
population and require treatment with bone grafts in order to retain functional output of the 
skeletal system80. Traditionally, autografts and allografts have been used to replace damaged 
tissue. However, these approaches come with the limitations of available supply, as well as an 
inability to directly match the patient-specific morphological and functional design requirements 
of the replacement bone to the native tissue that surrounds it81. 
 
2.4.2.1 Biocompatible Materials for Bone Tissue Engineering 
Synthetic alternatives to bone grafts fabricated by both traditional and SLA-based 
processes have been proven to have biocompatible material properties that render them useful in 
implant applications. Inspired by this early work in ceramic implants, Chu and colleagues 
demonstrated the use of a stereolithography apparatus to polymerize UV-curable polymer-
ceramic composite scaffolds that were biocompatible and suitable for use as cell-seeding 
platforms25. These hydroxyapatite implants were implanted in vivo in Yucatan minipig models 
and shown to support the regeneration of bone tissue, as dictated by the internal architecture of 
the engineered scaffold. Similarly, work with vinyl-ester resin based bone regeneration scaffolds 
fabricated via SLA and implanted in vivo in a rabbit model have shown active bone ingrowth and 
regeneration into the defect site (Figure 2.21)17.  
 
2.4.2.2 Biodegradable Materials for Bone Tissue Engineering 
Synthetic structural materials often exhibit poor integration with the surrounding tissue, 
however, as a result of the mismatch between their morphological and mechanical properties and 
those of surrounding bone. Furthermore, as they are not bioresorbable, they do not represent a 
truly biointegrated solution to the skeletal defect. As a result, the field of regenerative bone 
engineering can only be advanced by developing complex 3D substitutes for bone tissue that can 
mimic the load-bearing mechanical properties and the morphological architecture observed in 
vivo, while allowing for biodegradation and active biointegration with the host/patient over time. 
Stereolithography is ideally suited to the task of creating such complex three-dimensional 
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biodegradable substitutes for damaged bone tissue, and studies that make use of this technology 
have demonstrated significant advances in this field.  
Early work in SLA fabrication using biodegradable resins for bone regeneration made 
extensive use of poly (propylene fumarate) PPF resins diluted with diethyl fumarate (DEF), as 
previously described in Section 2.2. Complex 3D scaffolds with intricate internal architectures 
were fabricated using this resin, with promising implications for bone ingrowth in implantation 
applications28,34.  
 Grijpma and colleagues furthered this field by using stereolithography to manufacture 
scaffolds for bone tissue engineering using a novel poly (D,L-lactide) resin (PDLLA)37. While 
other biodegradable macromers used in stereolithographic fabrication of bone tissue engineering 
scaffolds, such as trimethylene carbonate or poly (propylene) fumarate (PPF) require mixing 
with a reactive diluent such as diethyl fumarate to obtain appropriate viscosity28, PDLLA is not 
so restricted. This ensured that a greater percentage of the final fabricated scaffold would 
biodegrade and resorb into engineered bone upon implantation of the scaffold into the biological 
system, promoting better bio-integration with the host/patient. Furthermore, PDLLA was proven 
to be much stiffer than its polymeric counterparts, demonstrating an elastic modulus (a measure 
of material stiffness) of 3 GPa, which approaches the properties of bone tissue in vivo (3-30 
GPa). Attachment and proliferation of mouse pre-osteoblasts cultured at physiologic conditions 
within these scaffolds demonstrated the viability of this approach for translational applications in 
bone tissue engineering (Figure 2.22). 
 SLA-fabricated bone regeneration scaffolds have also been fabricated by chemically 
modifying natural polymers, such the biocompatible and biodegradable polysaccharide chitosan. 
Wen and colleagues have shown that subcutaneous in vivo implantation of these natural material-
based scaffolds in a rat model supported osteoconductivity and regeneration51.  
 
2.4.2.3 Micro-scale Architecture in Bone Tissue Engineering 
Digital mask-based photolithographic methods have further improved on the precise 
fabrication of spatially pattern scaffolds for bone tissue engineering. Roy and colleagues have 
recently employed a DMD-based projection stereolithography apparatus to precisely distribute 
bioactive factors within a three-dimensional PEGDA scaffold with complex internal 
architecture82. The advantageous functional properties of these bioactive scaffolds were proven 
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to drive osteogenic differentiation of marrow-derived stem cells in vitro, as indicated by post-
seeding mineralization of engineered tissue constructs. 
 Two-photon laser based polymerization has also been used to target applications in bone 
tissue engineering by Ovsianikov and colleagues83. The photosensitive resin used in this study 
was a methacrylamide-modified gelatin (GelMOD) derived from native collagen, and 
demonstrated chemical properties that mimicked the cellular microenvironment in vivo. The bio-
degradation properties of this material in response to collagenase digestion were quantified and 
proven to be tuneable, a desirable property for any tissue engineered scaffold. Porcine 
mesenchymal stem cells seeded within these scaffolds demonstrated improved adhesion and 
proliferation behaviors. Osteogenic stimulants in the culture medium drove differentiation of 
these stem cells into the osteogenic line, with osteogenic cell byproduct calcium phosphate 
deposition observed in the scaffold.  
 
2.4.2.4 Multi-functional Components for Bone Tissue Engineering 
In addition to applications that target recreating the structure of cancellous and cortical 
bone, researchers have used stereolithography to fabricate the connective tissues found in bone 
marrow. Roy and colleagues used a digital micromirror device (DMD) based projection 
stereolithography system to manufacture scaffolds with intricate pore geometries, such as 3D 
honeycomb-like structures of interconnecting hexagons7,82. These 3D printed scaffolds then 
underwent surface modification to be functionalized with the extracellular matrix protein, 
fibronectin, and were sterilized prior to seeding with D1 cells, a murine bone marrow progenitor 
cell line. Successful seeding, attachment, and proliferation of D1 cells within these scaffolds was 
observed and quantified. 
 SLA-based fabrication technologies have, therefore, had significant impact on the bone 
regeneration techniques developed in recent years. By providing a mechanism of fabricating 
custom-fit and patient-specific biodegradable implants to support the regeneration of mineralized 
tissue, stereolithography is arguably one of the primary enabling technologies promoting 





2.4.3 Stereolithographic Fabrication for Cartilage Tissue Engineering 
 Many of the pioneering advances in tissue engineering have targeted applications in 
tissue engineering of cartilage, since this type of tissue is often relatively homogeneous and 
largely avascular, and hence relatively easy to fabricate. The ability to regenerate load-bearing 
and articular cartilaginous tissues can address many ongoing challenges in replacing tissues 
damaged by degenerative diseases such as progressive arthritis, ageing, or traumatic injury84. 
 
2.4.3.1 Cosmetic Tissue Engineered Cartilage 
Reminiscent of the external maxillofacial prosthetics discussed earlier in this chapter, 
Naumann and colleagues used a combination of computed tomography and ultraviolet laser 
based stereolithographic fabrication to fabricate a three-dimensional bioresorbable scaffolds for 
tissue engineering of an auricle from the hyaluronic acid derivative Hyaff 1185. As hyoluronan is 
an important component of native cartilage, this resin was chosen and tailored to suit the 
particular application targeted by this study. Histomorphology and immunohistochemistry 
performed on Hyaff 11 scaffolds seeded with living chondrocytes demonstrated the 
homogeneous expression of cartilage-specific collagen type II within the engineered tissue after 
four weeks of in vitro culture at physiologic conditions (Figure 2.23).  
 
2.4.3.2 Load-Bearing Tissue Engineered Cartilage 
Other resins used for tissue engineering of cartilage have been chosen for the close match 
between their material properties, such as water uptake and swelling depth, and mechanical 
properties, such as stiffness, and those of native cartilage tissue. For applications in tissue 
engineering of load-bearing cartilage, such as that found in intervertebral discs, match of the 
material and mechanical properties of regenerated and native tissue is of utmost importance in 
functional output. Cho and colleagues targeted this challenge by manufacturing biodegradable 
scaffolds from TMC-based oligomers, whose material and mechanical properties match those of 
native cartilage33. Chondrocytes extracted from articular cartilage and seeded within these 
scaffolds were cultured at physiologic conditions and supplemented with transforming growth 
factor (TGF) and insulin-like growth factor (IGF). Viability of cells over two weeks was 
determined by a quantitative measure of the mitochondrial metabolic activity of adhered cells 
(MTT assay), showing strong adhesion and activity of seeded chondrocytes.  
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2.4.3.3 “Bottom-Up” Fabrication of Tissue Engineered Cartilage 
Ellisseeff and colleagues improved upon these scaffold-based fabrication techniques by 
incorporating a suspension of embryonic stem (ES) cells that had formed embryoid bodies (EB) 
into a photosensitive poly (ethylene glycol) hydrogel based prepolymer solution86. A simple 
ultraviolet light and a physical mask-based stereolithography apparatus was used to encapsulate 
EBs into a three-dimensional architecture and cultured in vitro in chondrogenic medium 
containing transforming growth factor, (TGF)- β1, and bone morphogenic protein, (BMP)-2. 
Extensive characterization of regenerated tissue fabricated in this manner via gene expression 
and protein analysis as well as histological analysis, suggest that EBs encapsulated in these 
hydrogels via stereolithography up-regulated cartilage-relevant markers and induced a 
chondrocytic phenotype. The basophilic exctracellular matrix deposited in the engineered 3D 
environment was characteristic of neocartilage, suggesting that this apparatus is a promising 
approach to engineering complex functional replacements for native cartilage.   
 
2.4.4 Stereolithographic Fabrication for Cardiac and Vascular Tissue Engineering 
The increasing prevalence of cardiovascular disease, which is the primary cause of death 
in the United States and other developing countries, motivates the development of tissue 
engineered replacements for tissues in the cardiovascular system. Moreover, advancements 
pertaining to the regeneration of interconnected vascular networks are broadly applicable to all 
regenerative medicine applications. Vascularization of engineered tissues, which is the key 
challenge facing researchers aiming to create large-scale replacements for native tissue and 
organs, must be addressed before regenerative medicine technologies are adapted for widespread 
clinical use87.  
 
2.4.4.1 2D Cardiac Tissue Engineering 
As cardiac tissue is inherently an actuator in the body, advances in tissue engineering of 
cardiac muscle powered actuators have many applications in restoring pulsatile/beating function 
to damaged or ischemic cardiac tissue. Bashir and colleagues fabricated protein surface 
functionalized hydrogel cantilever-like substrates via a laser-based stereolithographic 3D 
printing apparatus and seeded primary cardiomyocytes derived from neonatal rats upon these 2D 
scaffolds88. The cardiomyocytes formed a connected cell sheet attached to the substrate and were 
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able to drive actuation of the hydrogel substrate via contraction of the engineered tissue (Figure 
2.24).  
 
2.4.4.2 3D Cardiac Tissue Engineering 
Sodian and colleagues explored 3D scaffolds for cardiac tissue engineering by fabricating 
stereolithographic plastic models for thermoplastic modeling of two elastomers, poly-4-
hydroxybutyrate (P4HB) and polyhydroxyoctanoate (PHOH), in the shape of a trileaflet heart 
valve scaffold89. These valve scaffolds were placed inside a bioreactor and subjected to pulsatile 
flow, and demonstrated synchronous opening and closing behaviors similar to those seen in 
vitro. This technique, rendered feasible by stereolithography, demonstrates the ability to 
accurately reconstruct physiological valve design and bypassing the need for a human allograft.    
  Butcher and colleagues demonstrated further improvements on this technology by 
combining stereolithographic fabrication and bio-plotting technologies to generate 3D cardiac 
tissue scaffolds for manufacturing heterogeneous aortic valves. Poly (ethylene glycol) diacrylate 
hydrogels were supplemented with alginate and cured by an ultraviolet LED crosslinking 
module, demonstrating a broadly tune-able range of mechanical properties for printed valve 
scaffolds. Porcine aortic valve interstitial cells (PAVIC) seeded within these scaffolds and 
culture in vitro at physiologic conditions for 21 days showed cell viability and spreading on this 
biocompatible fabricated scaffold (Figure 2.25). 
 
2.4.4.3 Vascular Tissue Engineering 
Kong and Bashir and colleagues demonstrated the use of a direct laser-writing apparatus 
to fabricate “living” microvascular stamps that could controllably pattern functional neo-vessels 
when tested in ovo on the chick chorioallantoic membrane90. These SLA-fabricated stamps, 
comprised of fibroblasts encapsulated in PEG-based hydrogels that were stimulated to secrete the 
angiogenic molecule VEGF (vascular endothelial growth factor), proved to demonstrate 
orchestrated control over the placement and geometry of neovasculature.  
Work by Khademhosseini and colleagues extended this work by fabricating very high-
resolution three dimensional porous scaffold architectures with intricate geometries using a 
projection stereolithography system49. The mechanical properties of these 3D scaffolds were 
tuned and regulated by varying the chemical composition of the gelatin methacrylate (GelMA) 
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resins used as photosensitive prepolymers in this study. The complex interconnected pore 
structure rendered feasibly via stereolithographic fabrication led to the formation of a high cell-
density network of seeded human umbilical vein endothelial cells (HUVECs) within the scaffold. 
Immunohistochemistry of these tissue engineered substitutes showed that seeded cells 
maintained their endothelial phenotype over time and were well distributed throughout the 
scaffold during the observed culture period, thereby demonstrating a promising method of 
engineering 3D vascular networks within SLA-fabricated tissue constructs (Figure 2.26). 
 
2.4.5 Stereolithographic Fabrication for Other Tissue Engineering Applications 
SLA-based technologies are broadly applicable in a vast array of tissue engineering 
applications. The techniques used for fabrication are the same across tissue types, but the types 
of chemically modified resins and 3D macro- and micro-scale architectures have been modified 
to suit the specific application in question. A couple notable examples that use next-generation 
multi-photon SLA processes are mentioned in this section. 
 
2.4.5.1 Liver Tissue Engineering 
Wan, Ying and colleagues fabricated three-dimensional microstructure scaffolds for 
tissue engineering of liver using a two-photon laser scanning photolithography technique91. In 
this study, a commercially available photocurable polymer manufactured by 3D systems (the 
company that pioneered stereolithographic fabrication) was selectively polymerized using laser 
pulses. Sterilized scaffolds were then functionalized with collagen and seeded with primary rat 
hepatocytes. To assess for liver-specific function of the engineered tissue, the culture medium 
was assayed for albumin and urea secretion and demonstrated that the cells had received 
adequate nutrient transport within the fabricated scaffolds and were able to preserve their 
functionality.   
 
 
2.4.5.2 Neural Tissue Engineering 
Claeyssens and colleagues used a novel multi-photon polymerization approach to 
fabricate polylactide-based scaffolds for neural tissue engineering92. The photosensitive 
polylactide resin (PLA) was cured using femto-second laser pulses of IR irradiation, with a 
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maximum resolution of 800 nm achieved for scaffold feature sizes. Neuroblastoma cells were 
culture on these structured PLA scaffolds, demonstrating cell viability and proliferation on 
scaffolds to provide proof of the biocompatibility of these structures (Figure 2.27). 
 The examples listed in this section are just a few of the many studies that serve as strong 
demonstrations of the potential of stereolithographic fabrication technologies to suit a wide 
variety of applications in tissue engineering and regenerative medicine. 
 
2.5 Conclusions 
2.5.1 Current Challenges in Stereolithographic Fabrication 
2.5.1.1 Multi-material Fabrication 
One of the primary challenges facing widespread adaptation of stereolithography for a 
vast array of translational biomedical applications is the difficulty of fabricating multi-material 
3D structures. Wicker and colleagues demonstrated wash/refill steps that could be employed to 
fabricate 3D multi-material structures with a projection micro-stereolithography apparatus8. 
Bashir and colleagues extended this work to encapsulate multiple cell types in 3D patterned 
hydrogels using a single photon laser based SLA42. This approach, while efficacious, causes a 
significant increase in part build-times. Build time can be reduced by employing automated 
syringe-pump systems for washing/filling resins. Arcaute and colleagues recently proposed an 
alternative method for fabrication using multiple resins by employing the use of an array of 
“mini-vats”, which allow for selective spatially controlled variation of material composition in 
3D architectures93. Further advancements of this and other multi-material strategies promise to 
remove the limitation from stereolithographic biofabrication (Figure 2.28). 
 
2.5.1.2 Micro-scale Control of Architecture 
The limitations posed by the difficulty of multi-material fabrication are mainly contingent 
on the resultant inability to create precise predefined spatial patterns of mechanical, material, and 
biochemical properties within 3D structures. For tissue engineering applications, the processes 
currently in common use do not allow for accurate placement of single cells or bioactive 
molecules in predefined locations. Rather, cells and molecules are mixed within resins, assumed 
to be uniformly mixed, and then selectively polymerized prior to washing and refilling steps. 
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Advances in various single-cell and molecule manipulation technologies may address some of 
the main concerns regarding this limitation of stereolithographic biofabrication.  
Timp and colleagues addressed this challenge by using optical tweezers to selectively 
manipulate single cells into precisely defined 3D spatial positions within a prepolymer solution 
prior to encapsulation via photopolymerization94. This approach, while effective, would prove to 
be extremely time consuming for the fabrication of large 3D structures containing millions of 
cells and biomolecules. Bashir and colleagues have demonstrated a higher throughput approach 
based on the principle of dielectrophoresis (DEP). In this process, a set of electrodes is 
incorporated on the build platform of a single photon SLA, allowing for selective and 
simultaneous patterning of large arrays of cells prior to photopolymerization (Figure 2.29) 95. 
Pioneering work in this field has recently been published by Anseth and colleagues, who 
have demonstrated hydrogels with tuneable range of properties (mechanical, material, 
biochemical, etc.) that can be spatiotemporally controlled with high 3D resolution96. This 
spatiotemporal control is accomplished via a novel cytocompatible “click-based” chemistry that 
uses wavelength-specific photochemical reactions to dynamically conjugate or cleave bioactive 
moieties to 3D cell-culture systems in vitro (Figure 2.30).   
 
2.5.2 New Developments in Stereolithography for Biomedical Applications 
Stereolithographic technologies have enabled the rise of reverse-engineering native tissue 
for applications in regenerative medicine, but this is not the only field of research opened up by 
work in this area. By giving researchers the ability to build systems of cells, stereolithography 
has opened up the possibility of designing novel systems that harness the innate dynamic abilities 
of cells to self-organize and respond to environmental cues. This idea of forward-engineering 
integrated cellular systems, or “biological machines”, with multiple functionalities using 
stereolithography as an enabling tool has many potential applications.  
Bashir and colleagues have designed biological machines, or “bio-bots”, that utilizes the 
autonomous and synchronous contraction of engineered cardiac or skeletal muscle tissue to 
power locomotion of an SLA-fabricated soft robotic device97–99. Further studies in this field that 
focus on creating biological machines that can accomplish such objectives of robotics as sensing, 
storage and processing of signals, and a resultant response (such as actuation) have many 
potential applications. Biological machines that dynamically respond to environmental cues can 
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target a diverse set of translational medical applications including drug-delivery, non-invasive 
surgery, dynamic implants, and biocompatible microelectronics. These machines and other 
studies that build upon them will demonstrate the power using SLA fabrication and cells as 
building blocks to engineer the machines and systems of the future. 
 
2.5.3 Stereolithographic 3D Bioprinting for Biomedical Applications 
The future of modern medicine is undoubtedly rooted in the core philosophy of 
customized/personalized healthcare. As we learn more about the underlying design principles 
and molecular mechanisms governing biological systems, we can develop precisely 
individualized and targeted cures that address patient-specific needs. This motivates the need for 
developing an enabling technology that allows us to fabricate complex 3D structures that are 
biocompatible, biodegradable, and bioactive. Such biofabricated structures can readily integrate 
with a host biological system to perform a specified task, such as targeting diseased tissues and 
promoting tissue regeneration.  
 Over the past few decades, stereolithographic fabrication technologies have advanced 
greatly in the quality, resolution, and accuracy of manufactured parts. Recent developments in 
creating photocurable resins that are biocompatible, biodegradable, and bioactive have enabled a 
vast array of biomedical and translation medical applications of SLA-based fabrication 
technologies. In a progressive manner that mimics the progression of the medical field itself, 
SLA machines have been used to manufacture: 1) data visualization and surgical planning tools 
to aid clinicians; 2) individualized prosthetics; 3) customized implants and surgical tools; 4) 
biomaterial scaffolds for tissue engineering; 5) high-density cellular constructs for tissue 
engineering. In each of these broad types of applications, stereolithographic techniques have 
been readily integrated with medical imaging technologies (MRI, CT) in order to improve 
disease diagnosis, preoperative planning, quality and morphology of prosthetics and implants, 
and functional success of complex surgeries. Furthermore, SLA has established itself as one of 
the primary enabling tools that will be useful for regenerative medicine applications in the 
coming years. 
 Limitations of stereolithographic systems, such as the difficulties involved with multi-
material construct fabrication and high-resolution spatiotemporal control over the placement of 
specific moieties within complex 3D structures, are being addressed by advances in SLA 
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technologies (projection stereolithography, multi-photon methods, automated resin dispersal 
systems, arrays of multi-material “mini-vats” etc.) as well as advances in novel resin chemistries 
(dynamic photoconjugation and photocleavage of moieties within 3D structures). New 
biodegradable and bioactive resins continue to be developed as this technology achieves even 
broader use in the field of biomedical engineering. 
 As a whole, the versatility in design, scale, resolution, and broad applicability of 
stereolithographic technologies render them the ideal enabling technology for biomedical and 




Figure 2.1 Broad categorization of the forms of stereolithographic processes into single-photon 
and multiphoton methods. Single-photon methods, which are the most commonly employed for 
translational biomedical applications, can be implemented using several forms of excitation 
radiation [5].  
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conventional single-photon stereolithography apparatus 
(SLA) are by far the most popular (Fig. 6.1).
Conventional SLA machines utilize the energy from an 
UV light source to drive the conversion of UV-irradiation-
sensitive liquid oligomers into cross-linked solid/gel-like 
polymeric networks. These machines, as well as SLA ma-
chines based on visible light irradiation, possess the advan-
tage of providing precise spatial and temporal control of 
reaction kinetics as they are governed purely by the ease 
of light manipulation. Recent advances in developing con-
trolled light sources, such as lasers, have thus greatly en-
hanced the advantages of using such systems. Conventional 
stereolithography systems have likewise seen the greatest 
use and adaption in biomedical and translational research, 
as they have the ability to drive polymerization under physi-
ologic conditions with minimal heat production and dam-
age to the raw material. This is of special relevance in 3D 
fabrication of structures containing encapsulated living 
cells, as discussed in Section 4.
As with most additive layer manufacturing technolo-
gies, the first step in fabricating a 3D structure by stereo-
lithography involves creating a digital model of the part, 
using computer-aided design software (CAD). Lately, ad-
vanced digital scanners have also been used to convert com-
plex structures into virtual 3D models. This is of special 
interest in the context of biomedical and translational ap-
plications, as many of the scanning technologies that are 
used in this field have their basis in clinical imaging tech-
nologies such as magnetic resonance imaging (MRI) and 
computed tomography (CT). Complex structures, such as 
those found inside the human body, can thus be imaged and 
readily converted into 3D digital models for manufacturing 
patient-specific models, implants, and tissue-engineered re-
placements for damaged tissue.
In order to be prepared for 3D printing, all digital 
models must first be converted to a standard tessellation 
language file format (STL) that represents the surface 
geometry of the 3D model as a series of interconnecting 
tessellated triangles. Specialized software is then used to 
virtually slice the model into sequential layers of specified 
thickness, often determined by the user-specified part size, 
required resolution, and desired accuracy of the final part. 
The resulting information is then sent to the stereolithogra-
phy apparatus, which builds the 3D model layer-by-layer 
sequentially from the bottom up. Schematics of various 
forms of SLA machines are further described in Section 2.1 
(Figs 6.2 and 6.3).
2.1 Stereolithographic Fabrication 
Apparatus
2.1.1 Single-Photon Stereolithography
Single-photon stereolithographic fabrication processes are 
so termed because the process of photoinitiator excitation in 
this process is driven by the absorption of a single photon. 
Conventional UV light-based stereolithography falls under 
this category of photopolymerization, as does visible light-
based stereolithography. The two most basic and widely ad-
opted apparatus for single-photon photolithography in the 
context of biomedical applications are direct laser writing 
and mask-based UV light-based stereolithography.
A direct laser writing stereolithographic apparatus uses 
a high-energy laser to trace lines across the resin surface, 
serially polymerizing (i.e., “rasterizing”) two-dimensional 
cross-sections of a three-dimensional design. Sequential po-
lymerization of these two-dimensional cross-sections layer 
by layer from the bottom up, with the aid of a computer-
controlled stage, drives formation of three-dimensional 
structures [5].
Similarly, mask-based stereolithography filters a high-
energy light source through a patterned physical or digital 
mask, allowing for curing of an entire two-dimensional 
FIGURE 6.1 Broad categorization of the forms of stereolithographic processes into single-photon and multiphoton methods. Single-photon 




Figure 2.2 Process flow for fabricating 3D parts via stereolithography. (A) Scanning to create a 
3D digital image of a design or creating a 3D solid model via computer-aided design software 
(CAD); (B) digitally slicing the 3D model layer-by-layer into 2D sections; (C) fabricating the 3D 
model layer-by-layer using a stereolithographic apparatus; (D) the final fabricated part with the 
desired feature sizes, scale, resolution, and surface finish [1].  
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cross-section within a single exposure, rather than serially 
tracing lines as with a laser-based apparatus. This process is 
thus considered higher-throughput than laser-based process-
es, as complete layers of resin can be polymerized within a 
single light exposure, thereby reducing build-time. It is of 
importance to remember, however, that resolution of feature 
sizes obtainable via mask-based projection stereolithogra-
phy systems is inversely proportional to the size/scale of 
FIGURE 6.3 Digital scanning of biological tissues with complex 3D structures is a multistep process. (a) CT imaging data are gathered; (b) point 
cloud data are extracted from scan using reverse engineering software; (c) point cloud data are “cleaned” to remove imaging noise/defects; (d) point cloud 
is sliced into 2D cross-sections; (e) point cloud layers are converted into spline curves; (f) a lofted surface is created from the splines; (g) a solid geometry 
model of the biological tissue is created; (h) the solid model is converted into a porous scaffold for applications in tissue engineering and regenerative 
medicine; (i) the porous model is scaled sliced into 2D layers and sent to an SLA machine for fabrication [36].
FIGURE 6.2 Process flow for fabricating 3D parts via stereolithography. (a) Scanning to create a 3D digital image of a design or creating a 3D 
solid model via computer-aided design software (CAD); (b) digitally slicing the 3D model layer-by-layer into 2D sections; (c) fabricating the 3D model 
layer-by-layer using a stereolithographic apparatus; (d) the final fabricated p rt with the desired feature sizes, scale, resolution, and surface finish [1].
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Figure 2.3 Digital scanning of biological tissues with complex 3D structures is a multistep 
process. (A) CT imaging data are gathered; (B) point cloud data are extracted from scan using 
reverse engineering software; (C) point cloud data are “cleaned” to remove imaging 
noise/defects; (D) point cloud is sliced into 2D cross-sections; (E) point cloud layers are 
converted into spline curves; (F) a lofted surface is created from the splines; (G) a solid geometry 
model of the biological tissue is created; (H) the solid model is converted into a porous scaffold 
for applications in tissue engineering and regenerative medicine; (I) the porous model is scaled 
sliced into 2D layers and sent to an SLA machine for fabrication [36].  
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cross-section within a single exposure, rather than serially 
tracing lines as with a laser-based apparatus. This process is 
thus considered higher-throughput than laser-based process-
es, as complete layers of resin can be polymerized within a 
single light exposure, thereby reducing build-time. It is of 
importance to remember, however, that resolution of feature 
sizes obtainable via mask-based projection stereolithogra-
phy systems is inversely proportional to the size/scale of 
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cloud data are extracted from scan using reverse engineering software; (c) point cloud data are “cleaned” to remove imaging noise/defects; (d) point cloud 
is sliced into 2D cross-sections; (e) point cloud layers are converted into spline curves; (f) a lofted surface is created from the splines; (g) a solid geometry 
model of the biological tissue is created; (h) the solid model is converted into a porous scaffold for applications in tissue engineering and regenerative 
medicine; (i) the porous model is scaled sliced into 2D layers and sent to an SLA machine for fabrication [36].
FIGURE 6.2 Process flow for fabricating 3D parts via stereolithography. (a) Scanning to create a 3D digital image of a design or creating a 3D 
solid model via computer-aided design software (CAD); (b) digitally slicing the 3D model layer-by-layer into 2D sections; (c) fabricating the 3D model 
layer-by-layer using a stereolithographic apparatus; (d) the final fabricated part with the desired feature sizes, scale, resolution, and surface finish [1].
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Figure 2.4 Schematic of (A) laser-based SLA that directly “writes” patterns in 
photopolymerizable resin by serially tracing 2D cross-sections of 3D designs [41]; (B) mask-
based SLA that polymerizes 2D cross-sections in a single projection to create 3D designs layer-
by-layer [49]; (D) schematic of SLA that combines a laser light source and digital micromirror 
mask device to fabricate large-scale 3D parts with complex and high-resolution features [6].  
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the final manufactured part. Hence, fabricating large parts 
with very small feature sizes can be a time-consuming pro-
cess, as it will require rasterizing several 2D projections to 
completely polymerize an entire 2D cross-section of the 3D 
model. Novel SLA that employ a combination of a laser 
light source and mask-based projection system have been 
developed to target this mismatch between part size, resolu-
tion, and fabrication time, but these apparatus are yet to be 
widely employed [6].
Physical masks used in this type of mask-based 
projection photolithography are manufactured via the mi-
crofabrication approaches that were initially developed to 
target applications in semiconductor manufacturing. Greater 
design flexibility is enabled by the use of digital masks that 
can display a vast array of different patterns. One of the 
most commonly used digital masks used in this type of ste-
reolithography is inspired by the digital light processing 
technology in projectors, projection-based television sets, 
digital signs, and digital cinema projection. The digital 
mask, or digital micromirror device (DMD), is comprised 
of an array of millions of microscopic mirrors that can be 
precisely and independently rotated into an “on” state or an 
“off” state, generating a pixelated-pattern image. Patterning 
and projection of light through this digital mask enables the 
photopolymerization of a stereolithographic resin in pre-
cisely defined patterns [7,8].
Both laser-based and mask-based SLA rely heavily on 
computer-controlled building stages that move the 2D po-
lymerized cross-sections by a precisely defined amount to 
ensure adherence of sequential layers to one another. Un-
derstanding of the cure depth relationship of the resin in 
use, as well as precise calibration of the light energy of the 
apparatus, is thus of great importance in manufacturing 3D 
parts via single-photon stereolithography (Fig. 6.4).
2.1.2 Multiphoton Stereolithography
Two-photon stereolithographic fabrication processes rep-
resent the simplest case of multiphoton absorption, and 
involve the sequential or simultaneous absorption of two 
relatively low-intensity photons in order to excite a photo-
sensitive resin to a high-energy radical state. This method 
of excitation depends quadratically on the incident light in-
tensity [5], as opposed to the linear relationship for single-
photon stereolithography, allowing for extremely rapid 
fabrication in three dimensions with submicron resolution 
(Fig. 6.5).
In two-photon initiated stereolithography, which was 
first demonstrated by Kawata and coworkers in 1997 [9], 
femtosecond light pulses from a near-IR laser are focused 
into a 3D volume/vat of liquid resin. The polymerization 
process is initiated in the precisely defined focal volume 
of the laser, limiting interaction with the resin through 
which the laser passes to reach the focal volume. Shift-
ing the focal plane of the laser enables the fabrication of 
complex three-dimensional structures with high-resolution 
feature sizes [10]. Similarly, three-photon approaches to 
photopolymerization of 3D structures with submicron reso-
lution have also been demonstrated [11]. There is great 
FIGURE 6.4 Schematic of (a) laser-based SLA that directly “writes” patterns in photopolymerizable resin by serially tracing 2D cross-sections of 3D 
designs [41]; (b) mask-based SLA that polymerizes 2D cross-sections in a single projection to create 3D designs layer-by-layer [49]; (c) schematic of SLA 




Figure 2.5 Multiphoton stereolithographic polymerization involves the absorption of multiple 
photons in order to excite a photosensitive resin to a high-energy radical state. (A) For two-
photon polymerization, this high-energy radical state can be accomplished via sequential or 
simultaneous absorption of two photons. The energy of incident photons is represented by hv 
(the product of Planck’s constants divided by 2π and angular frequency of incident light, 
respectively). A and A* denote energy levels; (B) schematic diagrams of multiphoton-initiated 
polymerization showing valence electrons in a photoinitiator excited to a high-energy state and 
transforming by: (1) decaying back to photoinitiator with emission of light, (2) generating an 
excited state quenching by oxygen, or (3) yielding an initiator species for polymerization. All 
three competing processes are required for efficient photopolymerization [10].  
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potential for using multiph ton fabri ation approaches to 
manufacture three-dimensional scaffolds with complex 
internal microarchitectures for tissue engineering applica-
tions [12]. Multiphoton methods for patterning living cells 
encapsulated within photosensitive resins have also been 
demonstrated [13]. It is to be noted that photoinitiators used 
for conventional stereolithography are often unsuitable for 
applications in two-photon initiated stereolithography (see 
Section 2.2.1), as these chemicals demonstrate reduced 
photosensitivity to light in the near-IR wavelength range [5] 
(Fig. 6.6).
2.1.3 Interference Stereolithography
A novel form of photolithography known as interference 
lithography (alternatively known as holography) is based 
on creating an interference pattern between multiple coher-
ent light waves in order to create a pattern of high inten-
sity and low intensity fringes of light [14]. Photosensitive 
resins exposed to this interference-derived pattern of light 
are thus polymerized in regions of high intensity fringes. 
This method can be used to create patterns with nanoscale 
resolution and offers the additional advantage of more rapid 
polymerization than attainable via conventional stereo-
lithography [15]. However, because interference lithography 
is restrict d in the number and type of patterns that can be 
created via light interference, it is only of interest in bio-
medical applications that require repetitive structures [16]. 
For example, tissue engineering of cancellous/trabecular 
bone requires the formation of an ossified “spongy” scaf-
fold with a repetitive porous structure. This type of scaffold, 
and other scaffolds that require similar repetitive porous 
structures, could be rapidly and accurately fabricated via 
an interference lithography fabrication apparatus (Fig. 6.7).
2.2 Stereolithographic Resins
A conventional stereolithography single-photon photo-
fabrication apparatus uses the energy from UV light to se-
lectively polymerize, or “cure” photosensitive liquids called 
resins to form solid or gel-like structures. Photosensitive 
resins, which are the raw materials used in conventional ste-
reolithography, are composed primarily of polymerizable 
oligomers, or “prepolymers,” and a radical photoinitiator. 
The polymerization process of these resins can be simply 
described in three steps: initiation, propagation, and termi-
nation. During initiation, components of the resin are ir-
radiated by light and form reactive radical species. These 
radicals then propagate between polymerizable oligomers 
FIGURE 6.5 Multiphoton stereolithographic polymerization involves the absorption of multiple photons in order to excite a photosensitive resin 
to a high-energy radical state. (a) For two-photon polymerization, this high-energy radical state can be accomplished via sequential or simultaneous 
absorption of two photons. The energy of incident photons is represented by hv (the product of Planck’s constants divided by 2π and angular frequency 
of incident light, respectively). A and A* denote energy levels; (b) schematic diagrams of multiphoton-initiated polymerization showing valence electrons 
in a photoinitiator excited to a high-energy state and transforming by: (1) decaying back to photoinitiator with emission of light, (2) generating an excited 




Figure 2.6 Multiphoton stereolithographic apparatus. (A) Optical system for two-photon laser-
based photolithographic fabrication approach [9]; (B) polymerization occurs via tracing of 
femtosecond laser through 3D vat of photosensitive resin. Shifting the plane of laser focus shifts 
the plane of polymerization, enabling high-resolution fabrication of complex 3D structures [13].  
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FIGURE 6.6 Multiphoton stereolithographic apparatus. (a) Optical system for two-photon laser-based photolithographic fabrication approach [9]; 
(b) polymerization occurs via tracing of femtosecond laser through 3D vat of photosensitive resin. Shifting the plane of laser focus shifts the plane of 
polymerization, enabling high-resolution fabrication of complex 3D structures [13].
FIGURE 6.7 Interference stereolithography relies on creating interference patterns between multiple coherent light waves in order to create 
patterns of high and low intensity light fringes. (a) Beam and sample geometry for creating interference pattern. Arrows of the same color represent 
coherent beams and arrows of different colors represent mutually incoherent (i.e., orthogonally polarized) beams; (b) intensity pattern generated by laser 
beam interference; (c) color map of intensity pattern projected onto the x–y plane; (d) simple cubic P structure intensity map for interference stereolitho-
graphic fabrication; (e) diamond-like structure with FCC translational symmetry for interference stereolithographic fabrication; (f) gyroid-like structure 
with BCC translational symmetry for interference stereolithographic fabrication. (Figure 6.7a–c reprinted with permission from Tondiglia et al. [14]; 
Figure 6.7d–f reprinted with permission from Ullal et al. [16]).
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Figure 2.7 Interference stereolithography relies on creating interference patterns between 
multiple coherent light waves in order to create patterns of high and low intensity light fringes. 
(A) Beam and sample geometry for creating interference pattern. Arrows of the same color 
represent coherent beams and arrows of different colors represent mutually incoherent (i.e., 
orthogonally polarized) beams; (B) intensity pattern generated by laser beam interference; (C) 
color map of intensity pattern projected onto the x–y plane; (D) simple cubic P structure intensity 
map for interference stereolitho- graphic fabrication; (E) diamond-like structure with FCC 
translational symmetry for interference stereolithographic fabrication; (F) gyroid-like structure 
with BCC translational symmetry for interference stereolithographic fabrication. (Figure 2.7a–c 
reprinted with permission from Tondiglia et al. [14]; Figure 2.7d–f reprinted with permission 
from Ullal et al. [16]).  
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FIGURE 6.6 Multiphoton stereolithographic apparatus. (a) Optical system for two-photon laser-based photolithographic fabrication approach [9]; 
(b) polymerization occurs via tracing of femtosecond laser through 3D vat of photosensitive resin. Shifting the plane of laser focus shifts the plane of 
polymerization, enabling high-resolution fabrication of complex 3D structures [13].
FIGURE 6.7 Interference stereolithography relies on creating interference patterns between multiple coherent light waves in order to create 
patterns of high and low intensity light fringes. (a) Beam and sample geometry for creating interference pattern. Arrows of the same color represent 
coherent beams and arrows of different colors represent mutually incoherent (i.e., orthogonally polarized) beams; (b) intensity pattern generated by laser 
beam interference; (c) color map of intensity pattern projected onto the x–y plane; (d) simple cubic P structure intensity map for interference stereolitho-
graphic fabrication; (e) diamond-like structure with FCC translational symmetry for interference stereolithographic fabrication; (f) gyroid-like structure 
with BCC translational symmetry for interference stereolithographic fabrication. (Figure 6.7a–c reprinted with permission from Tondiglia et al. [14]; 
Figure 6.7d–f reprinted with permission from Ullal et al. [16]).
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Figure 2.8 Schematic of cure mechanism of polymerizable oligomer. Resin is composed of liquid 
photosensitive resin that forms reactive radical species when irradiated with light. These radicals 
begin to propagate via cross-linking to form gel-like networks. Following termination of the 
polymeriza- tion process, a solid cross-linked network is formed [5].  
 
 
Figure 2.9 The relatively low cytotoxicity of Irgacure 2959, as compared to other commonly 
used photoinitiators, renders it favorable for use in encapsulating cells via stereolithography. (a) 
Relative survival of BC cell line after 7 min of UV exposure in resin containing Irgacure 2959, 
HPK, or Irgacure 651 photoinitiator; (b) relative survival of six cell types (BC, gMSC, hMSC, 
SIRC, LVEC, hFOB) after 5 min of UV exposure in resin containing variable concentrations of 
Irgacure 2959 [19].  
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to form cross-linked networks. The formation of covalent 
bonds in these networks terminates the polymerization 
process (Fig. 6.8).
Radical photoinitiators are a crucial component of ste-
reolithographic resins. They belong to a family of reactive 
chemical compounds that decompose to form high-energy 
free radicals, or molecules with unpaired valence electrons, 
when exposed to light. In single-photon stereolithography 
processes, a single photon from the irradiating light source 
is sufficient to excite the photoinitiator into this high-
energy state. In multiphoton stereolithography processes, 
the simultaneous or sequential absorption of two relatively 
low-intensity photons is required to xcite a photosensitive 
resin to a high-energy radical state. In both types of pro-
cesses, photoinitiators help to initiat  the stereolithograph-
ic polymerization process by forming the reactive radical 
species that drive polymerization of oligomers in the resin 
material. The choice of photoinitiator determines the rate 
of polymerization, or curing, of the resin. As several pho-
toinitiators are cytotoxic, the family of photoinitiators suit-
able for applications in biomedical engineering is limited, 
as discussed in Section 2.2.1.
The primary component of a stereolithographic resin 
is the polymerizable oligomer. Following the initiation of 
the polymerization process by radical photoinitiators, the 
functional groups of polymerizable oligomers form active 
radicals that react with one another to form cross-linked 
polymerized networks. Conventional SLA processes rely 
heavily upon fabrication with acrylate and methacrylate 
oligomers, epoxide, and vinyl ether-based resins that cure 
rapidly upon irradiation and whose chemical formulas can 
readily be modified to obtain materials with a variety of 
geometric and material properties. Indeed, many polym-
erizable oligomer systems currently used for stereolitho-
graphic biofabrication applications rely on biocompatible 
oligomers containing acrylate and methacrylate functional 
groups that form radicals in response to photoexcitation. A 
detailed description of the composition and material prop-
erties of the most commonly used stereolithographic resins 
for biomedical applications is presented in Section 2.2.2.
The process of curing photopolymerizable resins via 
conventional stereolithography is very well understood 
and is easily characterized via an adapted form of the 
Beer–Lambert equation, which is a relationship between 
the intensity of a light source and the exponential decay it 
experiences as it passes through an absorbing medium. This 
adapted equation, termed the cure-depth equation (Eq. 6.1), 
demonstrates the relationship between the amount of UV 
radiation that a liquid resin is exposed to and the depth to 












Where Cd represents the maximum cure depth of the 
resin, Dp represents the penetration depth at which UV 
energy intensity is reduced to 1/e of its maximum value 
at the surface of the resin (e is the mathematical constant 
that forms the base of the natural logarithm), Emax is the 
maximum UV energy intensity at the resin surface, and Ec 
is the critical energy intensity required to cure the resin by 
triggering its transition into a solid phase.
Resins are generally characterized by their penetration 
depths and critical energy. The penetration depth corre-
sponds to the extinction coefficient, or molar absorptivity, 
of the irradiated resin. This characteristic value can be tuned 
and modified by adjusting the concentration of photoinitia-
tor solution present in the resin. It can also be modulated by 
the addition of visible-light or UV-absorbing dyes, which 
compete for irradiation absorption during the polymeriza-
tion process [17]. Values of Dp are tuned to prevent “over-
cure,” or excessive exposure to UV light caused by repeated 
irradiation during the layer-by-layer manufacturing pro-
cess. Prevention of over-cure is of essential importance in 
preserving viability of cells in stereolithographic bioprint-
ing applications targeting tissue engineering, as excessive 
UV exposure has a detrimental effect on cellular viability 
(see Section 4). The value of the critical energy for a resin, 
Ec, is likewise dependent on the concentration of photoini-
tiator present in the solution, as well as other dissolved gas-
es (e.g., oxygen) or liquids (e.g., colored dyes) that could 
Cd=Dp lnEmaxEc
FIGURE 6.8 Schematic of cure mechanis  of polymerizable oligomer. Resin is composed of liquid photosensitive resin that forms reactive radical 
species when irradiated with light. Th se radicals begin to propagate via cross-l nking to form gel-l ke network . Following termination of the polymeriza-
tion process, a solid cross-linked network is formed [5].
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cells encapsulated in stereolithographic resins. As this field 
continues to grow and applications of stereolithography in 
regenera ive edici e become mor  popular, it is likely that 
further research will target the discovery of photoinitiator 
compounds with advantageous properties similar to or per-
haps greater than those demonstrated by Irgacure 2959 and 
LAP (Fig. 6.10).
2.2.2 Biocompatible Polymerizable Oligomers 
for Stereolithographic Biofabrication
Stereolithography systems for conventional manufactur-
ing applications have, as mentioned in an earlier section of 
this chapter, primarily used reactive acrylate/methacrylate, 
epoxide, or vinyl ether-based resins, or some hybrid com-
posi ion th reof [5]. As stereolithogr phic fabrication tech-
nology expands to target translational medical applications, 
the number of suitable resins decreases slightly, but is not 
as restricting as the requirements posed on photoinitiators 
discussed in Section 2.2.1. This is because most cross-
linked polymers are not toxic in themselves, though the 
unreacted monomers and residues of reactive photoinitiator 
residues may have cytotoxic effects. In many cases, post-
processing steps such as washes with water and/or alco-
holic solutions, sterilization with UV light irradiation, or 
FIGURE 6.10 Irgacure 2959 and LAP are two of the most successfully used photoinitiators for biocompatib e stereoli hography with resins 
containing living cells. (a) Schematic showing photon absorption leading to cleavage of Irgacure 2959 and LAP into radical reactive species; (b) molar 
absorptivities of Irgacure 2959 (-) and cleavage products (--); (c) molar absorptivities of LAP (-) and cleavage products (--) [20].
FIGURE 6.9 The relatively low cytotoxicity of Irgacure 2959, as compared to other commonly used photoinitiators, renders it favorable for use 
in encapsulating cells via stereolithography. (a) Relative survival of BC cell line after 7 min of UV exposure in resin containing Irgacure 2959, HPK, or 
Irgacure 651 photoinitiator; (b) relative survival of six cell types (BC, gMSC, hMSC, SIRC, LVEC, hFOB) after 5 min of UV exposure in resin containing 
variable concentrations of Irgacure 2959 [19].
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Figure 2.10 Irgacure 2959 and LAP are two of the most successfully used photoinitiators for 
biocompatible stereolithography with resins containing living cells. (A) Schematic showing 
photon absorption leading to cleavage of Irgacure 2959 and LAP into radical reactive species; 
(B) molar absorptivities of Irgacure 2959 (-) and cleavage products (--); (C) molar absorptivities 
of LAP (-) and cleavage products (--) [20].  
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cells encapsulated in stereolithographic resins. As this field 
continues to grow and applications of stereolithography in 
regenerative medicine become more popular, it is likely that 
further research will target the discovery of photoinitiator 
compounds with advantageous properties similar to or per-
haps greater than those demonstrated by Irgacure 2959 and 
LAP (Fig. 6.10).
2.2.2 Biocompatible Polymerizable Oligomers 
for Stereolithographic Biofabrication
Stereolithography systems for conventional manufactur-
ing applications have, as mentioned in an earlier section of 
this chapter, primarily used reactive acrylate/methacrylate, 
epoxide, or vinyl ether-based resins, or some hybrid com-
position thereof [5]. As stereolithographic fabrication tech-
nology expands to target translational medical applications, 
the number of suitable resins decreases slightly, but is not 
as restricting as the requirements posed on photoinitiators 
discussed in Section 2.2.1. This is because most cross-
linked polymers are not toxic in themselves, though the 
unreacted monomers and residues of reactive photoinitiator 
residues may have cytotoxic effects. In many cases, post-
processing steps such as washes with water and/or alco-
holic solutions, sterilization with UV light irradiation, or 
FIGURE 6.10 Irgacure 2959 and LAP are two of the most successfully used photoinitiators for biocompatible stereolithography with resins 
containing living cells. (a) Schematic showing photon absorption leading to cleavage of Irgacure 2959 and LAP into radical reactive species; (b) molar 
absorptivities of Irgacure 2959 (-) and cleavage products (--); (c) molar absorptivities of LAP (-) and cleavage products (--) [20].
FIGURE 6.9 The relatively low cytotoxicity of Irgacure 2959, as compared to other commonly used photoinitiators, renders it favorable for use 
in encapsulating cells via stereolithography. (a) Relative survival of BC cell line after 7 min of UV exposure in resin containing Irgacure 2959, HPK, or 
Irgacure 651 photoinitiator; (b) relative survival of six cell types (BC, gMSC, hMSC, SIRC, LVEC, hFOB) after 5 min of UV exposure in resin containing 
variable concentrations of Irgacure 2959 [19].
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Figure 2.11 Elastomeric resins for stereolithography that allow for the fabrication of 
compliant/flexible parts are of especial relevance in biomedical and translational applications. 
(A) Cytocompatibility of elastomeric resins developed by Emons and coworkers. SL 5510 is an 
acrylate/ epoxy-based formulation, YC 9300 R is an acrylate-based formulation, and the Flex 
materials are polyether(meth)-acrylate-based formulations; (B) a flexible breathing mask 
fabricated using the novel biocompatible Flex material [29].  
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2.2.2.4 Hydrogel Resins
The resins presented in this section have thus far been 
compatible for applications that involve fabrication of 
biomedical devices/structures that come into contact with 
biological systems after postprocessing steps. However, 
next-generation regenerative medicine applications that fall 
under the category of “tissue engineering” herald the need 
for stereolithographic resins that contain living cells. The 
most promising of photosensitive polymeric materials that 
support this requirement are a broad class of hydrophilic 
and biocompatible materials known as “hydrogels.”
Cross-linked polymeric hydrogel networks are highly 
porous and absorbent, facilitating the diffusion of biochem-
ical signals and essential nutrients through the polymeric 
network. Their structural and functional properties, such 
as network porosity and hydrophilic swelling behavior, 
can be readily tailored via chemical modifications to the 
monomers present in the resin. Their mechanical proper-
ties, which fall in the range of 1–100 kPa, are more suited 
to applications targeting engineering of soft tissues such as 
those present in the human body. Furthermore, hydrogels 
also have the ability to respond to changes in temperature, 
pH, illumination, or other physical and chemical stimuli. 
This is particularly advantageous for biomedical applica-
tions that rely on real-time response behavior such as dy-
namic medical implants or bioactuators that generate force 
in response to external stimuli. For these reasons, systems 
incorporating hydrogel polymers have seen widespread use 
in translational medical applications in recent years [38,39].
In a pioneering study in this field, Boland and 
 coworkers presented the first demonstration of encapsu-
lating live cells within a photopolymerizable hydrogel via 
stereolithography. A hydrogel prepolymer solution com-
prising a mixture of poly(ethylene oxide) and poly(ethylene 
glycol) dimethacrylate (PEGDMA), reminiscent of the 
(meth)acrylate-based polymer chemistry discussed earlier 
in this chapter, was mixed with Irgacure 2959 photoinitiator 
and Chinese hamster ovary (CHO) cells and polymerized 
using a direct-laser writing single-photon stereolithography 
machine [40]. Viability of cells cultured in vitro within these 
polymerized hydrogel constructs was assessed via live/dead 
assay, proving that SLA-based technologies could be used 
to fabricate high-density elastomeric tissue-like constructs.
Wicker and coworkers expanded upon this early work, 
which demonstrated fabrication of relatively simple geom-
etry constructs, to viably encapsulate living cells in PEG-
DMA hydrogels with more complex 3D geometries via 
SLA [41]. The hydrogel prepolymer formulation in this 
case used a combination of two photoinitiators, Irgacure 
2959 and 2-hydroxy-2-methyl-1-phenyl-1-propanone. The 
soluble fraction and swelling ratios of fabricated hydrogels 
were characterized, providing an understanding of the un-
derlying mechanisms that govern the geometric properties 
of fabricated parts as a result of polymer resin chemistry 
(Fig. 6.12).
2.2.2.5 Bioactive Resins
These and other early studies with PEG-based hydrogels, 
while promising, were still limited by the fact that cells do 
not naturally form strong adhesive interactions with net-
works of synthetic polymers. To target this, the study by 
Wicker and coworkers explored the effect of covalently 
incorporating the cell-adhesive ligand RGDS (Arg–Gly–
Asp–Ser tetrapeptide) within the fabricated hydrogel matrix 
FIGURE 6.11 Elastomeric resins for stereolithography that allow for the fabrication of compliant/flexible parts are of especial relevance in 
biomedical and translational applications. (a) Cytocompatibility of elastomeric resins developed by Emons and coworkers. SL 5510 is an acrylate/
epoxy-based formulation, YC 9300 R is an acrylate-based formulation, and the Flex materials are polyether(meth)-acryl e-based formulations; (b) a 
flexible breathing mask fabricated using the novel biocompatible Flex material [29].
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Figure 2.12 The porous and absorbent nature of polymeric hydrogel resins make them the ideal 
biocompatible resin for stereolithographic fabrication with living cells. (A) A complex 3D design 
of a chess rook immediately after fabrication: (i) following deformation via mechanical compres- 
sion, (ii) and after drying, (iii) (scale bar 5 mm) [41]; (B) relative viability of CHO cells 
encapsulated in elastic hydrogel matrices via stereolithography. Increasing photoinitiator 
concentration leads to decreased viability [40].  
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to provide cell-adhesive attachment sites throughout the po-
lymerized structure. Bashir and coworkers expanded upon 
this work by assessing the effect of RGDS on the long-term 
viability of cells encapsulated within PEG-based hydrogels 
of varying molecular weights [42]. Addition of these adhe-
sive peptide sequences showed significant increases in cell 
viability, proliferation, and spreading as compared to con-
trol samples, demonstrating that the incorporation of bioac-
tive moieties within polymeric networks could remove this 
limitation from SLA-fabricated hydrogel structures. West 
and coworkers expanded this work by using two-photon 
laser scanning photolithography to precisely dictate the 
placement of RGDS peptides within 3D fabricated acrylate-
modified PEG hydrogel architectures [43] (Fig. 6.13).
Others have similarly investigated the effects of incor-
porating different types of bioactive compounds within 
polymeric matrices. Farsari et al. utilized a multipho-
ton photopolymerization apparatus to immobilize biotin 
linked to fluorescently labeled streptavidin to 3D fabri-
cated structures, demonstrating the ability to bind proteins 
to structures via SLA [11]. Similar work by Woodbury and 
coworkers utilizing a scanning laser-based SLA in conjunc-
tion with methacrylate-based polymer resins to selectively 
graft peptides onto 3D fabricated microstructures and study 
postsource decay sequencing of peptides [44]. Bashir and 
coworkers have demonstrated spatially selective and con-
trollable patterning of proteins on hydrogel polymers by 
combining a microcontact printing approach with a direct-
laser writing SLA setup, showing that cell patterning and 
alignment in 3D structures can be readily controlled by such 
a process [45]. Roy and coworkers have also demonstrated 
the use of SLA to spatiotemporally pattern scaffolds with 
extracellular matrix components, such as heparan sulfate, 
and polymeric microparticles containing heparan-binding 
growth factors, such as basic fibroblast growth factor-2 
[46]. By demonstrating controlled predesigned spatiotem-
poral distribution of multiple bioactive factors within SLA-
fabricated polymeric matrices, these and other studies have 
set the stage for engineering complex tissue-engineered 
structures through multilineage differentiation of a single 
encapsulated population of stem cells.
An alternative approach to separately incorporating 
bioactive moieties into polymerized matrices is to modify 
the chemistry of oligomeric monomers used in photosensi-
tive resins. Liska and coworkers used a stereolithographic 
process to polymerize various methacrylate-based gelatin 
derivatives, demonstrating the ability to fabricate arbitrary 
cellular structures with a range of cell types [47]. Other 
modified methacrylated PEG- and gelatin-based systems 
incorporating oligopeptides into hydrogel networks have 
shown that such polymeric scaffolds significantly enhance 
cell adhesion and growth as compared to nonmodified ma-
terials [48]. Chen and coworkers have made extensive use 
of similar gelatin methacrylate (GelMA) hydrogel materials 
as a photosensitive resin for high-resolution 3D patterning 
using a projection SLA, demonstrating the biological func-
tionality of such manufactured constructs [49].
Methacrylate modification of naturally occurring poly-
saccharides, such as hyaluronic acid [50] and chitosan [51], 
has likewise been used in photosensitive resin composi-
tions for applications in stereolithographic biofabrication 
targeting tissue repair and regeneration. Recent studies by 
Schober and coworkers have even demonstrated multipho-
ton laser-based photofabrication of unmodified native poly-
mers, such as collagen and fibrinogen, and liquids, such as 
natural human blood and fetal calf serum [52].
FIGURE 6.12 The porous and absorbent nature of polymeric hydrogel resins make them the ideal biocompatible resin for stereolithographic 
fabrication with living cells. (a) A complex 3D esign of a chess rook immediately after fabrication: (i) following defor ation via mechanical compres-
sion, (ii) and after drying, (ii ) (scal  bar 5 mm) [41]; (b) relative viability of CHO cells encapsulated in elastic hydrogel matrices via stereolithography. 
Increasing photoinitiator concentration leads to decreased viability [40].
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Figure 2.13 Incorporating bioactive moieties, such as the cell-adhesive ligand RGDS, in 
stereolithographic resins can improve the viability and proliferation of cells encapsulated within 
the resins. (A) Relative viability of cells encapsulated in PEG-based hydrogels of varying 
molecule mo- lecular weight with/without incorporated RGDS ligands [42]; (B) selective 
patterning of RGDS peptides within 3D PEG-based hydrogels via two-photon stereolithography 
[43]; (C) confocal microscope image of human dermal fibroblasts cells (red and blue) 
undergoing migration within the RGDS-patterned region (green) of a PEG hydrogel (scale bar = 
100 mm) [43].  
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2.2.3 Multimaterial Stereolithographic 
Fabrication
While all the polymers described in this section are use-
ful for a variety of biomedical applications, true versatility 
of the stereolithographic process can only be attained by 
multimaterial fabrication of complex 3D structures. This 
type of multimaterial SLA fabrication can be accomplished 
by selectively polymerizing portions of layers with a sin-
gle resin type, washing away unpolymerized resin, and 
then adding and polymerizing a different resin, as demon-
strated by Wicker and coworkers [8]. Bashir and cowork-
ers incorporated a similar multistep system to fabricate 3D 
cell-encapsulating multimaterial hydrogel structures using a 
laser-based apparatus [42]. This set the stage for using mul-
timaterial SLA processes to coculture systems of cells, such 
as neurons and skeletal muscle, to study intercellular inter-
actions and establish a basis for engineering complex tis-
sues and organs containing multiple encapsulated cell types 
[53] (Figs 6.14 and 6.15).
2.2.4 Novel Resin Systems
As stereolithography has grown to become a fairly well es-
tablished commercial process, the number of photosensitive 
resins that rapidly solidify in response to light-excitation has 
correspondingly increased. The morphological, mechanical, 
and material properties of these polymerizable resins cover 
a broad range and are broadly relevant for a variety of trans-
lational applications in the field of biomedical engineering. 
However, the number of photopolymerizable resins for ste-
reolithography that are compatible with applications in bion-
anotechnology are still limited. A few of the most commonly 
used families of resins in this field have been elaborated 
upon in this section, and detailed information regarding pho-
tosensitive noncytotoxic resins are listed in more extensive 
reviews [54,55], but the rapidly changing nature of this field 
ensures that the variety of available resins will continue to 
increase and diversify in the coming years.
2.3 Applications of Stereolithography  
in Biomedical Engineering
The vast array of biomedical and translational applica-
tions of stereolithographic fabrication fall into a series of 
broad categories: Manufacturing of (1) data visualization 
and surgical planning tools to aid clinicians; (2) individual-
ized prosthetics; (3) customized implants and surgical tools; 
FIGURE 6.13 Incorporating bioactive moieties, such as the cell-adhesive ligand RGDS, in stereolithographic resins can improve the viability 
and proliferation of c lls encapsulated within the resins. (a) Relative viability of cells enc psulated in PEG-based hydrogels of varying molecule mo-
lecular weight with/without incorporat d RGDS ligands [42]; (b) s le tive patterning of RGDS peptides within 3D PEG-based hydrogels via two-photon 
stereolithography [43]; (c) confocal microscope image of human dermal fibroblasts cells (red and blue) undergoing migration within the RGDS-patterned 




Figure 2.14 Multimaterial stereolithography enables the fabrication of complex 3D structures 
with varying mechanical, material, and func- tional properties. (A) Chess rook design fabricated 
using three different photosensitive resins [8]; (B) NIH/3T3 cells tagged with either green or red 
dye encapsulated in different distinct layers using stereolithography, showing viability of 
multimaterial approach for resins containing living cells [42].  
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(4) biomaterial scaffolds for tissue engineering; (5) high-
density cellular constructs for tissue engineering. These ap-
plications are further elaborated upon in Sections 3 and 4.
3 APPLICATIONS OF 
STEREOLITHOGRAPHY IN SURGICAL 
PROCEDURES, PROSTHESES, AND 
IMPLANTS
The vast majority of currently used pre- and postopera-
tive surgical procedures, prostheses, and implants could 
benefit greatly from the integration of patient-specific 
models and customized design parameters. While this 
individualized treatment model would be infeasible us-
ing standardized manufacturing techniques, the relative 
ease of generating accurate digital models and rapidly 
fabricating prototypes via medical imaging and stereo-
lithography renders patient-specific treatment feasible. 
Use of stereolithographic manufacturing to manufacture 
preoperative planning models, external prosthetics, im-
plantable devices, and surgical guides and tools are dis-
cussed in this section.
3.1 Stereolithographic Fabrication of 
Preoperative Visualization and Planning 
Tools to Aid Clinicians
Structural models and analysis have been extensively used in 
the fields of architecture and civil engineering for decades, 
motivating the complex analysis of clinically relevant 3D 
models via a similar approach. Advances in clinical imag-
ing of 3D structures via CT and MRI have greatly advanced 
the practicing clinician’s ability to easily visualize exterior 
surfaces and some internal structures. Manufacturing of 
patient-specific models and three-dimensional representa-
tions of clinical data via stereolithography promises to carry 
these advances further by building physical representations 
of a patient’s anatomy. These models can be tuned to rep-
resent both hard and soft tissues and colored to distinguish 
different internal structures or pathologies, such as tumors, 
thereby augmenting the complexity of patient-specific 
models and predicting/controlling the effectiveness and 
aesthetic result of surgery [56]. Tools and models manu-
factured via stereolithography promise to aid clinicians in 
gaining a complex spatial understanding of patient anato-
my, studying pathologies, making accurate diagnoses, and 
preoperative planning.
3.1.1 Patient-Specific Models
Stoker and coworkers demonstrated early efforts in the 
construction of patient-specific anatomical models by us-
ing an SLA to manufacture plastic models of the internal 
anatomy within a closed skull, as imaged by CT [57]. Pro-
viding a 3D physical representation of the internal anato-
my of the skull has obvious applications in both physician 
and patient education, and can further aid as a model for 
surgical planning. Further developments in this field by 
FIGURE 6.14 Multimaterial stereolithography enables the fabrication of complex 3D structures with varying mechanical, material, and func-
tional properties. (a) Chess rook design fabricated using three different photosensitive resins [8]; (b) NIH/3T3 cells tagged with either green or red dye 
encapsulated in different distinct layers using stereolithography, showing viability of multimaterial approach for resins containing living cells [42].
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Figure 2.15 Multimaterial stereolithography can enable fabrication of 3D cell coculture systems 
to study intercellular interactions and estab- lish a basis for engineering complex and functional 
3D tissues. (A) Schematic of stereolithographic fabrication of resin containing either 
hippocampus neurons or skeletal muscle myoblast cells; (B) neurons and myoblasts encapsulated 
within single 3D structure via stereolithography; (C) bar graph showing increase in choline 
acetyltransferase specific activity for cells encapsulated in 3D multimaterial coculture system; 
(D) magnified fluorescence images of patterned multimaterial structure [53].  
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Wittenberg and coworkers demonstrated the use of stereo-
lithography in maxillofacial operation planning by check-
ing the “fit” of a human donor source for cranioplasty prior 
to surgical intervention [58]. This surgical planning step 
enabled by stereolithography was shown to demonstrable 
reduce operative risks and treatment time and improved 
postoperative results.
3.1.2 Preoperative Planning Tools
More recently, the efficacy of using CT/SLA-fabricated 
templates for oral implant surgeries have shown that such 
preoperative planning tools have a higher likelihood of 
implant survival and significantly lower deviation from 
planned implant positions [59]. Indeed, studies have shown 
that such stereolithographic surgical templates, in addition 
to allowing precise translation of surgical treatment plans 
into practice, also offer significant benefits over traditional 
procedures in more complex cases [59].
Implants that must function in high load-bearing en-
vironments, such as total hip replacements, require even 
more careful preoperative planning to ensure proper surgi-
cal placement. De Momi et al. utilized an SLA-fabricated 
preoperative planning model to visualize the physiological 
movement of the hip joint during daily life activities and 
generate data on patient gait analysis [60]. Understand-
ing the load-bearing capacity of this implant in the context 
of  the specific patient model provided surgeons with an 
accurate guided approach to performing the actual implan-
tation procedure (Fig. 6.16).
3.1.3 Data Visualization
Stereolithography has also found use as an aid to generate 
physical representations of clinical data that help clinicians 
visualize patient-specific scenarios. Maurer and coworkers 
introduced this concept by manufacturing polyacrylic hard 
copies of echocardiographic patient data in order to enhance 
FIGURE 6.15 Multimaterial stereolithography can enable fabrication of 3D cell coculture systems to study intercellular interactions and estab-
lish a basis for engineering co plex and functional 3D tissues. (a) Schematic of stereolithographic fabrication of resin containing either hippocampus 
neurons or skeletal muscle myoblast cells; (b) neurons and myoblasts encapsulated within single 3D structure via stereolithography; (c) bar graph showing 
increase in choline acetyltransferase specific activity for cells encapsulated in 3D multimaterial coculture system; (d) magnified fluorescence images of 
patterned multimaterial structure [53].
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Figure 2.16 Preoperative planning tools manufactured via stereo- lithography can provide 
surgeons with a guided approach to performing complex surgical procedures. (A) Simulations 
used to perform patient gait analysis; (B) combined MRI and CAD modeling to produce model 
of required implant; (C) stereolithographic reconstruction of patient-specific model that can be 
used by surgeons for practicing placement in preopera- tive planning [60].  
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surgeon’s spatial perception of the anatomy and pathology of 
the heart [61]. By providing anatomically correct models 
of mitral valve anatomy and pathology in patients, this 3D 
representation of data acquired via echocardiography helped 
improve the efficiency of diagnoses as well as preoperative 
planning for treatment of cardiovascular pathologies.
These and other studies first introduced stereolitho-
graphic fabrication into the field of medicine, by providing 
a customizable planning and educational tool for clini-
cians as well as patients. SLA-fabricated physical models 
have been used to fabricate complex external and internal 
structures within the human body and three-dimensional 
representations of clinical data sets. By providing clinicians 
with test-platforms and patient-specific models for pre-
operative planning, stereolithography has the potential to 
greatly impact the efficiency and accuracy of the diagnosis 
and treatment of a diverse set of pathologies.
3.2 Stereolithographic Fabrication 
of Individualized Prosthetics
Building upon this early work using stereolithography to 
fabricate patient-specific models and guide surgical plan-
ning, researchers began to use SLA processes to gener-
ate anatomically accurate 3D models that could be used 
directly as prosthetics. These individualized stereolitho-
graphic prosthetics can be customized to target a range of 
external patient defects [62].
3.2.1 Cosmetic Prosthetics
Initial studies in this field demonstrated much success 
in using stereolithography to fabricate high-quality pa-
tient specific hearing aids, setting the stage for mass 
customization of prosthetic devices [63]. Wilkinson and 
coworkers carried these developments further by utiliz-
ing a stereolithographic fabrication process to manufac-
ture a customized whole-ear prosthetic from a wax resin 
[64]. In this study, information gathered from a digitized 
magnetic resonance image of a patient’s ear was used to 
create a mirror-image 3D model of the missing contra-
lateral ear. The digitized data were then converted into 
a 3D mold with a cavity corresponding to the shape of 
the missing ear and fabricated from a photopolymerizable 
silicone resin via stereolithography. A wax resin was then 
injected into the silicone mold to generate a prosthetic ear 
of the precise dimensions and morphology corresponding 
to the patient. Other auricular prostheses and personal-
ized maxillofacial prostheses manufactured via mirror-
image conversion of digital models have seen similar 
success as applications of stereolithographic fabrication 
[65]. As SLA technology has continued to evolve and the 
number of available resins has increased, direct mold-less 
fabrication of customized prosthetic devices has also been 
enabled (Fig. 6.17).
3.2.2 Load-Bearing Prosthetics
The manufacturing of more complex prosthetics for func-
tional and weight bearing limbs, as opposed to mainly 
cosmetic enhancements, has likewise been enabled by new 
developments in chemically modified SLA resins with 
strong mechanical properties (i.e., hardness, stiffness, cor-
rosion resistance, etc.). Preliminary studies in this field have 
used SLA technologies to test preliminary fitting of external 
prosthetics on patient-specific “test sockets.” These sockets 
serve the purpose of testing the weight-distribution of the 
prosthetic to ensure that soft tissue is compressed only in 
pressure-tolerant areas. Ensuring a good fit through such 
test socket procedures is essential to the successful integra-
tion of the prosthetic with the patient. Stereolithographic 
fabrication of test-sockets for high load-bearing structures, 
such as transtibial prosthetics, has been successfully dem-
onstrated [66] (Fig. 6.18).
3.3 Stereolithographic Fabrication of 
Customized Implants and Surgical Guides
The advances in prosthetics enabled by stereolithogra-
phy illustrated in the previous section lead naturally to 
FIGURE 6.16 Preoperative planning tools manufactured via stereo-
lithography can provide surgeons with a guided approach to perform-
ing complex sur ical procedures. (a) Simul tions used to perf rm patient 
gait analysis; (b) combined MRI and CAD modeling to produce model of 
required implant; (c) stereolithographic reconstruction of patient-specific 




Figure 2.17 Cosmetic maxillofacial prosthetics manufactured via stereolithography can be 
readily customized and tailored to individual patients and different states of motion (e.g., mouth 
opening). (A) Digital scan and reconstruction of patient’s face provides a model for rapid 
prototyping of cosmetic prosthetic; (B) prosthetic fabricated with the aid of stereolithography can 
be placed at the sight of damage and finished using conventional techniques [65].  
 
Figure 2.18 Manufacturing and testing test sockets for load-bearing prosthetics is critical to the 
long-term success of the prosthetic devices. (A) Transtibial amputee testing a socket fabricated 
via stereolithography for fit and functionality; (B,C) magnified view of two potential patient-
specific test sockets for transtibial implant [66].  
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the use of stereolithography to manufacture customized 
patient-specific implants. These customized biocompatible 
implants, which must permanently integrate with a host 
biological system, promise to greatly improve the prospect 
for invasive surgical procedures targeting synthetic replace-
ments of native tissue and organs.
Since implants, unlike external prosthetics, are in direct 
contact with native and regenerated tissue in vivo, it is criti-
cal to ensure the long-term biocompatibility of implant ma-
terials fabricated via stereolithography. A study by Popov 
et al. demonstrated that removal of potentially toxic resi-
dues of photosensitive resins (monomers, low molecular 
weight oligomers, etc.) could be accomplished via treat-
ment with supercritical carbon dioxide, significantly 
enhancing the biocompatibility of the fabricated structures 
when implanted in vivo [21]. Other sterilization procedures 
using UV radiation or washes with alcoholic solutions have 
been similarly proven successful, as discussed further in 
Section 4.
3.3.1 Cosmetic Implants
Drawing upon the early advances in using stereolithog-
raphy to fabricate external maxillofacial prosthetics, 
there have been many successful attempts to manufacture 
patient-specific implants for cranioplasty manufactured 
via stereolithography. Some approaches used CT data 
and SLA apparatus to design molds that were then used 
FIGURE 6.18 Manufacturing and testing test sockets for load-bearing prosthetics is critical to the long-term success of the prosthetic devices. 
(a) Transtibial amputee testing a socket fabricated via stereolithography for fit and functionality; (b, c) magnified view of two potential patient-specific 
test sockets for transtibial implant [66].
FIGURE 6.17 Cosmetic maxillofacial prosthetics manufactured via stereolithography can be readily customized and tailored to individual 
patients and different states of motion (e.g., mouth opening). (a) Digital scan and reconstruction of patient’s face provides a model for rapid prototyping 
of cosmetic prosthetic; (b) prosthetic fabricated with the aid of stereolithography can be placed at the sight of damage and finished using conventional 
techniques [65].
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Figure 2.19 Cosmetic maxillofacial prosthetics can be customized to patient-specific defects and 
readily fabricated via stereolithography. (A) Digital scan of patient’s large bifrontal defect; (B) 
model of patient skull fabricated via stereolithography and used as mold for implant generation; 
(C) patient-specific implant; (D) postoperative CT scan of implant showing excellent fit and 
integration with patient host [68].  
 
Figure 2.20 Patient-specific surgical guides fabricated via stereolithography can greatly improve 
the ultimate functional performance and design aesthetics of an implanted medical device. (A) 
CT scans and CAD modeling used to generate digital models of treatment planning guides; (B) 
implants placed using surgical guides fabricated via stereolithography; (C) demonstration of 
good match between planned implants (various colors) and actual placed implants (gray) [72].  
Stereolithographic 3D Bioprinting for Biomedical Applications   Chapter | 6    107
to fabricate thermally polymerized custom implants from 
acrylic materials [67], or carbon-fiber reinforced polymeric 
composites [68]. More direct SLA-fabrication approaches 
have been demonstrated by Day and coworkers, who used 
a digital model obtained via contiguous helical CT scans 
to directly fabricate a patient-specific mandible via stereo-
lithography to fit a large surgical defect obtained as a result 
of a tumor [69]. Fitting of the manufactured implant into 
the defect site provided aesthetically appealing results with 
good fit and integration of the fabricated mandible into the 
surrounding bone (Fig. 6.19).
3.3.2 Load-Bearing Implants
Customized design of load-bearing implants has been 
enabled by the creation of SLA-fabricated replica mod-
els of individualized patients. Early studies in this field 
aimed at individualizing total knee replacements for pa-
tients were shown to successfully return weight-bearing 
capacity to damaged limbs in both animal and human 
models [70,71]. Such customized implantation procedures 
have great value for all patient models, but especially in 
complicated cases where more individualized morpholo-
gies must be taken into account. As with the prosthetic 
devices mentioned earlier, further developments in creat-
ing SLA resins with strong mechanical properties (such 
as the polymer-ceramic composites detailed in Section 
2) promise to result in the direct fabrication of patient-
specific load-bearing implants.
3.3.3 Surgical Guides
SLA technologies have also been used to manufacture surgi-
cal guides that ensure proper placement of implants within 
patients. These guides are critical to the operative proce-
dure, and are conventionally employed to direct implant 
drilling and placement systems. Customized surgical guides 
manufactured via SLA can greatly augment surgical out-
come by improving the ultimate functional performance 
and design aesthetics of the implanted device. Rosenstiel and 
coworkers have demonstrated the reliability of surgical 
guides manufactured via stereolithography, showing that a 
significantly lower mean angular deviation was obtained for 
SLA surgically guided implants as compared to implants 
placed without SLA surgical uides [72]. These and other 
similar studies have demonstrated the ability to rapidly and 
accurately manufacture patient-specific surgical guides via 
stereolithography, thereby ensuring a high quality of pre-
surgical planning and surgical execution on a customized 
case-by-case basis (Fig. 6.20).
4 APPLICATIONS OF 
STEREOLITHOGRAPHY IN TISSUE 
ENGINEERING AND REGENERATIVE 
MEDICINE
The field of tissue engineering is centered on the aim of 
creating complex biological substitutes for native tissue us-
ing a combination of cells and instructive biomaterials. This 
FIGURE 6.19 Cosmetic maxillofacial prosthetics can be customized to patient-specific defects and readily fabricated via stereolithography. 
(a) Digital scan of patient’s large bifr ntal defect; (b) model of patient skull fa ricated via stere lithography and used as mold for implant generation; 
(c) patient-specific implant; (d) postoperati e CT scan of implant showing excellent fit and integration with patient host [68].
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emerging field promises to revolutionize modern medicine 
by providing an alternative to tissue and organ transplan-
tation, and perhaps eliminating the need for implants and 
transplants altogether by aiding the rapid development 
and testing of new drugs and therapies [73]. The use of 
stereolithographic fabrication to fabricate biocompatible 
scaffolds for tissue engineering, followed by advances in 
this field pioneered by stereolithographic printing of living 
cells, is described in the following sections. As previously 
discussed in Section 2.2, advances in creating biocompati-
ble, biodegradable, and bioactive photosensitive resins have 
enabled many of the advances in this field. These resins are 
tailored to prevent inflammatory response upon implanta-
tion, controllably degrade into nontoxic byproducts that can 
achieve good renal clearance, and actively encourage the 
formation of new regenerated tissue [74,75].
4.1 Stereolithographic Fabrication 
Strategies for Tissue Engineering  
and Regenerative Medicine
4.1.1 “Top–Down” Fabrication
The conventional approach to tissue engineering has been 
the fabrication of porous biocompatible and biodegradable 
scaffold structures as platforms for cell seeding. In the early 
stages of these studies, scaffolds were often generated using 
conventional microfabrication approaches for patterning 
natural and synthetic materials [76]. Researchers have even 
explored approaches in which cadaveric tissue is decellular-
ized and repopulated with living cells to yield functional 
tissue and whole organs [77,78]. More recently, direct fab-
rication of biocompatible scaffolds via SLA processes has 
seen much success in a variety of tissue engineering appli-
cations (see Sections 4.2–4.5)
Scaffold-based approaches provide the ability to place 
cells within precise morphological designs while main-
taining the cell–cell and cell–matrix interactions observed 
in vivo. However, these approaches come with the challeng-
es of regulating the distribution of cells within the scaffolds, 
as well as the inability to engineer adequate vascular net-
works that can provide supplies of nutrients to large-scale 
engineered tissues. These challenges render scaffold-based 
“top–down” approaches undesirable for applications in tis-
sue engineering of complex tissues and organs, as they are 
unable to provide truly precise spatial control of cells and 
biochemical signals in three dimensions [79].
4.1.2 “Bottom–Up” Fabrication
The rise of “bottom–up” approaches in biofabrication, trig-
gered by the advent of highly absorbent biocompatible ste-
reolithographic resins, provides and attractive alternative 
approach to manufacturing complex biological substitutes 
for native tissue and organs. In this approach, engineered tis-
sues can be directly assembl d layer by lay r from the botto  
up by using SLA resins containing encapsulated cells, allow-
ing for complex three-dimensional control over the morpho-
logical and functional properties of engineered tissue.
The single-photon and multiphoton stereolithographic 
systems presented earlier in this chapter are ideal candidates 
for targeting applications in bottom–up tissue engineering. 
These systems have demonstrable high-resolution pattern-
ing capabilities and have been proven to viably encapsulate 
cells in polymeric networks while preserving viability and 
functionality in long-term studies by minimizing heat pro-
duction and damage to raw material during fabrication.
4.1.3 Macro- and Microscale Architecture
High-resolution fabrication of three-dimensional porous 
structures with intricate internal geometries is a necessary 
requirement of top–down and bottom–up methods of manu-
facturing viable tissue-engineered constructs. Recent stud-
ies on the effect of microscale porous internal architectures 
of scaffolds on the repair and regeneration rate of damaged 
tissue have demonstrated the need for creating 3D struc-
tures with controllable morphologies on the macro- and 
microscales. This level of microenvironmental control has 
the further advantage of facilitating architecture for vas-
cular networks and conduits, setting the stage for develop-
ing large-scale engineered tissues and organs in the future. 
High-resolution spatiotemporal patterning of bioactive moi-
eties can also drive advances in multilineage differentiation 
FIGURE 6.20 Patient-specific surgical guides fabricated via stereolithography can greatly improve the ultimate function l performance and 
design aesthetics of an implanted medical device. (a) CT scans and CAD modeling used to generate igital models of treatment planning guides; (b) 
implants placed using surgical guides fabricated via stereolithography; (c) demonstration of good match between planned implants (various colors) and 
actual placed implants (gray) [72].
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Figure 2.21 Biocompatible scaffolds for bone tissue engineering manufactured via 
stereolithography. (A) SEM image of SLA-fabricated scaffold manufactured with a 
biocompatible vinyl ester resin; (B) placement of SLA-fabricated scaffold in situ; (C) magnified 
view of fabricated scaffold 8 weeks after in vivo implantation showing newly formed bone with 
excellent host system integration; (D) bone apposition along serrated surface shows enhanced 
proliferation and growth in response to microscale scaffold architecture [82].  
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of a single population of encapsulated patient stem cells, 
creating truly customized replacement tissues. Hence, 
while many of the pioneering studies in SLA-based tis-
sue engineering utilized the direct laser writing strategies 
and conventional UV irradiation driven polymerization, 
the rise of digital mask projection micro-SLA promise to 
further improve our ability to fabricate biodegradable and 
biocompatible architectures with single micron resolution 
[36]. Two-photon methods improve upon this even more by 
establishing biocompatible fabrication mechanisms with 
submicron resolution [12]. The fundamental challenge un-
derlying all these fabrication strategies is based on negotiat-
ing the balance between fabricating macroscale structures 
while incorporating microscale features.
The use of SLA fabrication strategies to target regenera-
tive medicine applications in tissue-engineered bone, carti-
lage, and cardiovascular tissue/networks are presented in the 
following sections. SLA technologies that target a range of 
other tissue/organ systems, such as liver, connective tissues, 
and neural conduits, have also been demonstrated, proving 
the readily customizable nature of this fabrication process.
4.2 Stereolithographic Fabrication for Bone 
Tissue Engineering
Tissue-engineered substitutes for bone are motivated 
by clinical need: skeletal defects, caused by disease or 
traumatic fracture, are increasingly common in a growing 
and ageing population and require treatment with bone 
grafts in order to retain functional output of the skeletal sys-
tem [80]. Traditionally, autografts and allografts have been 
used to replace damaged tissue. However, these approaches 
come with the limitations of available supply, as well as an 
inability to directly match the patient-specific morphologi-
cal and functional design requirements of the replacement 
bone to the native tissue that surrounds it [81].
4.2.1 Biocompatible Materials for Bone Tissue 
Engineering
Synthetic alternatives to bone grafts fabricated by tradi-
tional and SLA-based processes have been proven to have 
biocompatible material properties that render them useful in 
implant applications. Inspired by this early work in ceramic 
implants, Chu et al. demonstrated the use of a SLA to po-
lymerize UV-curable polymer-ceramic composite scaffolds 
that were biocompatible and suitable for use as cell-seeding 
platforms [25]. These hydroxyapatite implants were im-
planted in vivo in Yucatan minipig models and shown to 
support the regeneration of bone tissue, as dictated by the 
internal architecture of the engineered scaffold. Similarly, 
work with vinyl ester resin based bone regeneration scaf-
folds fabricated via SLA and implanted in vivo in a rabbit 
model have shown active bone ingrowth and regeneration 
into the defect site [17] (Fig. 6.21).
FIGURE 6.21 Biocompatible scaffolds for bone tissue engineering manufactured via stereolithography. (a) SEM image of SLA-fabricated scaffold 
manufactured with a biocompatible vinyl ester resin; (b) placement of SLA-fabricated scaffold in situ; (c) magnified view of fabricated scaffold 8 weeks 
after in vivo implantation showing newly formed bone with excellent host system integr ion; (d) bone apposition along serrated surface shows enhanced 
proliferation and growth in response t  microscale scaffold architecture [82].
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Figure 2.22 Biodegradable scaffolds for bone tissue engineering support the ingrowth and 
regeneration of bone. (A) SLA-fabricated scaffold manufactured using biodegradable resin; (B) 
SEM image of fabricated structure showing complex gyroid architecture; (C) 3D cell culture in 
SLA- fabricated scaffold showing cell adhesion, proliferation, and spreading on the scaffold 
surface 1 week postseeding; (D) cell migration and invasion in 3D into internal pores 4 weeks 
postseeding. (Figure 6.22a,b reprinted with permission from Melchels et al. [37]; Figure 6.22c,d 
reprinted with permission from Lee et al. [35].).  
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4.2.2 Biodegradable Materials for Bone Tissue 
Engineering
Synthetic structural materials often exhibit poor integration 
with the surrounding tissue; however, as a result of the mis-
match between their morphological and mechanical proper-
ties and those of surrounding bone. Furthermore, as they 
are not bioresorbable, they do not represent a truly biointe-
grated solution to the skeletal defect. As a result, the field 
of regenerative bone engineering can only be advanced by 
developing complex 3D substitutes for bone tissue that can 
mimic the load-bearing mechanical properties and the mor-
phological architecture observed in vivo, while allowing 
for biodegradation and active biointegration with the host/
patient over time. Stereolithography is ideally suited to the 
task of creating such complex three-dimensional biodegrad-
able substitutes for damaged bone tissue, and studies that 
make use of this technology have demonstrated significant 
advances in this field.
Early work in SLA fabrication using biodegrad-
able resins for bone regeneration made extensive use of 
PPF resins diluted with DEF, as previously described in 
Section 2. Complex 3D scaffolds with intricate internal 
architectures were fabricated using this resin, with prom-
ising implications for bone ingrowth in implantation ap-
plications [28,34].
Grijpma and coworkers furthered this field by using 
stereolithography to manufacture scaffolds for bone tissue 
engineering using a novel PDLLA resin [37]. While other 
biodegradable macromers used in stereolithographic fabri-
cation of bone tissue engineering scaffolds, such as TCM or 
PPF require mixing with a reactive diluent such as DEF to 
obtain appropriate viscosity [28], PDLLA is not so restricted. 
This ensured that a greater percentage of the final fabricated 
scaffold would biodegrade and resorb into engineered bone 
upon implantation of the scaffold into the biological sys-
tem, promoting better biointegration with the host/patient. 
Furthermore, PDLLA was proven to be much stiffer than its 
polymeric counterparts, demonstrating an elastic modulus (a 
measure of material stiffness) of 3 GPa, which approaches 
the properties of bone tissue in vivo (3–30 GPa). Attach-
ment and proliferation of mouse preosteoblasts cultured at 
physiologic conditions within these scaffolds demonstrated 
the viability of this approach for translational applications in 
bone tissue engineering (Fig. 6.22).
SLA-fabricated bone regeneration scaffolds have also 
been fabricated by chemically modifying natural polymers, 
such as the biocompatible and biodegradable polysaccha-
ride chitosan. Wen and coworkers have shown that subcuta-
neous in vivo implantation of these natural material-based 
scaffolds in a rat model supported osteoconductivity and 
regeneration [51].
4.2.3 Microscale Architecture in Bone Tissue 
Engineering
Digital mask-based photolithographic methods have further 
improved on the precise fabrication of spatially patterned 
FIGURE 6.22 Biodegradable scaffolds for bone tissue engineering support the ingrowth and regeneration of bone. (a) SLA-fabricated scaf-
fold manufactured using biodegradable resin; (b) SEM image of fabricated structure showing complex gyroid architecture; (c) 3D cell culture in SLA-
fabricated scaffold showing cell adhesion, proliferation, and spreading on the scaffold surface 1 week postseeding; (d) cell migration and invasion in 3D 
into internal pores 4 weeks postseeding. (Figure 6.22a,b reprinted with permission from Melchels et al. [37]; Figure 6.22c,d reprinted with permission 
from Lee et al. [35].).
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Figure 2.23 Cosmetic tissue engineered cartilage. (A) CAD model of contralateral (i.e., 
undamaged) ear; (B) Stereolithographic fabrication of mirror image design; (C) bioresorbable 
hyoluronan-based scaffold fabricated with the aid of stereolithography; (D) confocal microscopy 
of scaffold after 4 weeks in vitro culture showing homogeneous distribution of vital 
chondrocytes (green) distributed throughout scaffold, with relatively few avital cells (red); (E) 
histomorphology and immunohistochemistry of chondrocyte constructs after 4 weeks in vitro 
culture showing homogenous expression of cartilage-specific collagen type II [86].  
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of embryonic stem cells that had f rmed embryoid bodies 
(EB) into a photosensitive PEG hydrogel-based prepolymer 
solution [87]. A simple UV light and a physical mask-based 
SLA was used to encapsulate EBs into a three-dimensional 
architecture and cultured in vitro in chondrogenic medium 
containing (TGF)- !1, and bone morphogenic protein-2. 
Extensive characterization of regenerated tissue fabricated 
in this manner via gene expression and protein analysis as 
well as histological analysis, suggest that EBs encapsu-
lated in these hydrogels via stereolithography up-regulated 
cartilage-relevant markers and induced a chondrocytic phe-
notype. The basophilic exctracellular matrix deposited in 
the engineered 3D environment was characteristic of neo-
cartilage, suggesting that this apparatus is a promising ap-
proach to engineering complex functional replacements for 
native cartilage.
4.4 Stereolithographic Fabrication for 
Cardiac and Vascular Tissue Engineering
The increasing prevalence of cardiovascular disease, which 
is the primary cause of death in the United States and other 
developing countries, motivates the development of tissue-
engineered replacements for tissues in the cardiovascular 
system. Moreover, advancements pertaining to the regen-
eration of interconnected vascular networks are broadly 
applicable to all regenerative medicine applications. 
Vascularization of engineered tissues, which is the key 
challenge facing researchers aiming to create large-scale re-
placements for native tissue and organs, must be addressed 
before regenerative medicine technologies are adapted for 
widespread clinical use [88].
4.4.1 2D Cardiac Tissue Engineering
As cardiac tissue is inherently an actuator in the body, ad-
vances in tissue engineering of cardiac muscle powered 
actuators have many applications in restoring pulsatile/
beating function to damaged or ischemic cardiac tissue. 
Bashir and coworkers fabricated protein surface function-
alized hydrogel cantilever-like substrates via a laser-based 
stereolithographic 3D printing apparatus and seeded pri-
mary cardiomyocytes derived from neonatal rats upon these 
2D scaffolds [89]. The cardiomyocytes formed a connected 
cell sheet attached to the substrate and were able to drive 
actuation of the hydrogel substrate via contraction of the 
engineered tissue (Fig. 6.24).
4.4.2 3D Cardiac Tissue Engineering
Sodian et al. explored 3D scaffolds for cardiac tissue en-
gineering by fabricating stereolithographic plastic models 
for thermoplastic modeling of two elastomers, poly-
4-hydroxybutyrate and polyhydroxyoctanoate, in the shape 
FIGURE 6.23 Cosmetic tissue engineered cartilage. (a) CAD model of contralateral (i.e., undamaged) ear; (b) Stereolithographic fabrication of 
mirror image design; (c) bioresorbable hyoluronan-based scaffold fabricated with the aid of stereolithography; (d) confocal microscopy of scaffold 
after 4 weeks in vitro culture showing homogeneous distribution of vital chondrocytes (green) distributed throughout scaffold, with relatively few avital 
cells (red); (e) histomorphology and immunohistochemistry of chondrocyte constructs after 4 weeks in vitro culture showing homogenous expression of 
cartilage-specific collagen type II [86].
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Figure 2.24 2D engineered cardiac tissue manufactured with the aid of stereolithography. (A) 
Primary neonatal cardiomyocytes seeded on PEG- based cantilevers of high stiffness (top) and 
low stiffness (bottom) fabricated via stereolithography; (B) computer aided simulation showing 
the distribution of stresses in the prototyped cantilevers as a result of contraction of the 
engineered cell sheet; (C) actuation amplitude of cardiac myocytes on PEG-based cantilevers; 
(D) force exerted by the engineered cardiac myocyte cell sheet [89].  
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of a trileaflet heart valve scaffold [90]. These valve scaffolds 
were placed inside a bioreactor and subjected to pulsatile 
flow, and demonstrated synchronous opening and closing 
behaviors similar to those seen in vitro. This technique, ren-
dered feasible by stereolithography, demonstrates the abil-
ity to accurately reconstruct physiological valve design and 
bypassing the need for a human allograft.
Butcher and coworkers demonstrated further improve-
ments on this technology by combining stereolithographic 
fabrication and bioplotting technologies to generate 3D 
cardiac tissue scaffolds for manufacturing heterogeneous 
aortic valves. PEGDA hydrogels were supplemented with 
alginate and cured by an UV LED crosslinking module, 
demonstrating a broadly tunable range of mechanical prop-
erties for printed valve scaffolds. Porcine aortic valve in-
terstitial cells seeded within these scaffolds and cultured 
in vitro at physiologic conditions for 21 days showed cell 
viability and spreading on this biocompatible fabricated 
scaffold (Fig. 6.25).
4.4.3 Vascular Tissue Engineering
Kong and coworkers demonstrated the use of a direct 
laser-writing apparatus to fabricate “Living” microvascular 
stamps that could controllably pattern functional neovessels 
when tested in ovo on the chick chorioallantoic membrane 
[92]. These SLA-fabricated stamps, comprised of fibroblasts 
encapsulated in PEG-based hydrogels that were stimulated 
to secrete the angiogenic molecule vascular endothelial 
growth factor (VEGF), proved to demonstrate orchestrated 
control over the placement and geometry of neovasculature.
Work by Khademhosseini and coworkers extended this 
work by fabricating very-high-resolution three-dimensional 
porous scaffold architectures with intricate geometries us-
ing a projection stereolithography system [49]. The me-
chanical properties of these 3D scaffolds were tuned and 
regulated by varying the chemical composition of the 
GelMA resins used as photosensitive prepolymers in this 
study. The complex interconnected pore structure rendered 
feasibly via stereolithographic fabrication led to the forma-
tion of a high cell-density network of seeded human um-
bilical vein endothelial cells (HUVECs) within the scaffold. 
Immunohistochemistry of these tissue-engineered substi-
tutes showed that seeded cells maintained their endothelial 
phenotype over time and were well distributed throughout 
the scaffold during the observed culture period, thereby 
demonstrating a promising method of engineering 3D 
FIGURE 6.24 2D engineered cardiac tissue manufactured with the aid of stereolithography. (a) Primary neonatal cardiomyocytes seeded on PEG-
based cantilevers of high stiffness (top) and low stiffness (bottom) fabricated via stereolithography; (b) computer aided simulation showing the distribution 
of stresses in the prototyped cantilevers as a result of contraction of the engineered cell sheet; (c) actuation amplitude of cardiac myocytes on PEG-based 
cantilevers; (d) force exerted by the engineered cardiac myocyte cell sheet [89].
	57	
 
Figure 2.25 3D tissue-engineered aortic valve. (a) Porcine aortic valve model; (b) printed aortic 
valve model formed from PEG-based resins. Root (blue) formed from stiffer hydrogel and 
leaflets formed from less stiff hydrogel; (c) aortic valve scaffolds printed at different scales 
(Inner diameter = 22, 17, and 12 mm) for shape fidelity and resolution analysis [91].  
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vascular networks within SLA-fabricated tissue constructs 
(Fig. 6.26).
4.5 Stereolithographic Fabrication  
for Other Tissue Engineering Applications
SLA-based technologies are broadly applicable in a vast 
array of tissue engineering applications. The techniques 
used for fabrication are the same across tissue types, but 
the types of chemically modified resins and 3D macro- and 
microscale architectures have been modified to suit the spe-
cific application in question. A couple notable examples 
that use next-generation multiphoton SLA processes are 
mentioned in this section.
4.5.1 Liver Tissue Engineering
Wan and coworkers fabricated three-dimensional micro-
structure scaffolds for tissue engineering of liver using a 
two-photon laser scanning photolithography technique 
[93]. In this study, a commercially available photocurable 
polymer manufactured by 3D systems (the company that 
pioneered stereolithographic fabrication) was selectively 
polymerized using laser pulses. Sterilized scaffolds were 
then functionalized with collagen and seeded with primary 
rat hepatocytes. To assess for liver-specific function of the 
engineered tissue, the culture medium was assayed for albu-
min and urea secretion and demonstrated that the cells had 
received adequate nutrient transport within the fabricated 
scaffolds and were able to preserve their functionality.
4.5.2 Neural Tissue Engineering
Claeyssens and coworkers used a novel multiphoton polym-
erization approach to fabricate polylactide-based scaffolds 
for neural tissue engineering [94]. The photosensitive 
polylactide resin (PLA) was cured using femtosecond la-
ser pulses of IR irradiation, with a maximum resolution 
of 800 nm achieved for scaffold feature sizes. Neuroblas-
toma cells were cultured on these structured PLA scaffolds, 
demonstrating cell viability and proliferation on scaffolds 
to provide proof of the biocompatibility of these structures 
(Fig. 6.27).
The examples listed in this section are just a few of the 
many studies that serve as strong demonstrations of the po-
tential of stereolithographic fabrication technologies to suit 
a wide variety of applications in tissue engineering and re-
generative medicine.
5 CONCLUSIONS
5.1 Current Challenges in 
Stereolithographic Fabrication
5.1.1 Multimaterial Fabrication
One of the primary challenges facing widespread adapta-
tion of stereolithography for a vast array of translational 
FIGURE 6.25 3D tissue-engineered aortic valve. (a) Porcine aortic valve model; (b) printed aortic valve model formed from PEG-based resins. Root 
(blue) formed from stiffer hydrogel and leaflets formed from less stiff hydrogel; (c) aortic valve scaffolds printed at different scales (Inner diameter = 22, 
17, and 12 mm) for shape fidelity nd resolution analy i  [91].
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Figure 2.26 Tissue engineered vasculature is required to create large-scale replacements for any 
tissue/organ system. (A) Hydrogel patch containing VEGF-secreting fibroblasts fabricated via 
stereolithography; (B) patterned formation of neovasculature in response to in ovo incubation of 
the hydrogel on the chick chorioallantoic membrane; (C,D) adhesion and spreading of HUVECs 
on GelMA scaffold fabricated via stereolithography shown Day 2 and Day 4 postseeding. 
(Figure 6.26a,b reprinted with permission from Jeong et al. [92]; Figure 6.26c,d reprinted with 
permission from Gauvin et al. [49].).  
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biomedical applications is the difficulty of fabricating mul-
timaterial 3D structures. Wicker and coworkers demon-
strated wash/refill steps that could be employed to fabricate 
3D multimaterial structures with a projection micro-SLA 
[8]. Bashir and coworkers extended this work to encapsu-
late multiple cell types in 3D patterned hydrogels using a 
single photon laser-based SLA [42]. This approach, while 
efficacious, causes a significant increase in part build-times. 
Build time can be reduced by employing automated 
syringe-pump systems for washing/filling resins. Arcaute 
et al. recently proposed an alternative method for fabrica-
tion using multiple resins by employing the use of an array 
of “minivats,” which allow for selective spatially controlled 
variation of material composition in 3D architectures [95]. 
FIGURE 6.26 Tissue engineered vasculature is requi  to create larg -scale replacem nts for any tissue/organ system. (a) Hydrogel patch 
containing VEGF-secreting fibroblasts fabricated via stereolithography; (b) patterned formation of neovasculature in response to in ovo incubation of the 
hydrogel on the chick chorioallantoic membrane; (c, d) adhesion and spreading of HUVECs on GelMA scaffold fabricated via stereolithography shown 
Day 2 and Day 4 postseeding. (Figure 6.26a,b reprinted with permission f om Je ng et al. [92]; Figur  6.26c,d reprinted with permission from Gauvin 
et al. [49].).
FIGURE 6.27 Neural tissue engineering. (a) 3D microscaffolds manufactured via multiphoton stereolithography using a PLA resin. Neuroblastoma 
cells cultured within these scaffolds demonstrate excellent adhesion and spreading 5 days postseeding; (b) complex microscale architectures, such as 
seashells, can be printed using stereolithography and used to control the directional spreading of seeded cells [94].
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Figure 2.27 Neural tissue engineering. (A) 3D microscaffolds manufactured via multiphoton 
stereolithography using a PLA resin. Neuroblastoma cells cultured within these scaffolds 
demonstrate excellent adhesion and spreading 5 days postseeding; (B) complex microscale 
architectures, such as seashells, can be printed using stereolithography and used to control the 
directional spreading of seeded cells [94].  
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Figure 2.28 Multimaterial fabrication is one of the primary challenges facing stereolithography. 
(A) Schematic of self-aligning minivat setup proposed by Arcaute et al.; (B) spatially controlled 
variation of resin within a single printed layer; (C) complex 3D chess rook structure with 
fluorescent internal staircase manufactured using this multimaterial stereolithographic fabrication 
approach [95].  
 
Figure 2.29 High-resolution patterning of single cells within a complex 3D structure is a major 
challenge facing stereolithography. (A) Optical tweezers used to precisely manipulate arrays of 
fluorescently labeled Escherichia coli before encapsulation within a photosensitive polymer [96]; 
(B) DEP used as a high-throughput approach to manipulating fluorescently labeled cells and 
beads into precisely defined spatial patterns prior to encapsulation in a photosensitive polymer 
[97].  
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Further advancements of this and other multimaterial strat-
egies promise to remove the limitation from stereolitho-
graphic biofabrication (Fig. 6.28).
5.1.2 Microscale Control of Architecture
The limitations posed by the difficulty of multimaterial 
fabrication are mainly contingent on the resultant inability 
to create precise predefined spatial patterns of mechanical, 
material, and biochemical properties within 3D structures. 
For tissue engineering applications, the processes cur-
rently in common use do not allow for accurate placement 
of single cells or bioactive molecules in predefined loca-
tions. Rather, cells and molecules are mixed within resins, 
assumed to be uniformly mixed, and then selectively po-
lymerized prior to washing and refilling steps. Advances 
in various single-cell and molecule manipulation technolo-
gies may address some of the main concerns regarding this 
limitation of stereolithographic biofabrication.
Timp and coworkers addressed this challenge by us-
ing optical tweezers to selectively manipulate single 
cells into precisely d fined 3D spatial positions with n 
a prepolymer solution prior to ncapsulation via pho-
topolymerization [96]. This approach, while effective, 
would prove to be extremely time consuming for the 
fabrication of large 3D structures containing millions 
of cells and biomolecules. Bashir and coworkers have 
demonstrated a higher throughput approach based on 
the principle of dielectrophoresis (DEP). In this pro-
cess, a set of electrodes is incorporated on the build 
platform of a single photon SLA, allowing for selec-
tive and simultaneous patterning of large arrays of cells 
prior to photopolymerization [97] (Fig. 6.29).
Pioneering work in this field has recently been pub-
lished by Deforest and Anseth, who have demonstrated 
hydrogels with tunable range of properties (mechanical, 
material, biochemical, etc.) that can be spatiotemporally 
controlled with high 3D resolution [98]. This spatiotem-
poral control is accomplished via a novel cytocompatible 
“click-based” chemistry that uses wavelength-specific 
photochemical reactions to dynamically conjugate or 
cleave bioactive moieties to 3D cell-culture systems in 
vitro (Fig. 6.30).
5.2 New Developments in Stereolithography  
for Biomedical Applications
Stereolithographic technologies have enabled the rise 
of reverse-engineering native tissue for applications in 
regenerative medicine, but this is not the only field of re-
search opened up by work in this area. By giving research-
ers the ability to build systems of cells, stereolithography 
has opened up the possibility of designing novel systems 
that harness the innate dynamic abilities of cells to self-
organize and respond to environmental cues. This idea 
of forward-engineering integrated cellular systems, or 
“biological machines,” with multiple functionalities using 
stereolithography as an enabling tool has many potential 
applications.
Bashir and coworkers have recently designed a bio-
logical machine, or “biobot,” that utilizes the autonomous 
and synchronous contraction of engineered cardiac tissue 
to power locomotion of an SLA-fabricated soft robotic de-
vice [99]. Further studies in this field that focus on creating 
biological machines that can accomplish such objectives 
of robotics as sensing, storage, and processing of signals, 
and a resultant response (such as actuation) have many po-
tential applications. Biological machines that dynamically 
respond to environmental cues can target a diverse set of 
translational medical applications including drug-delivery, 
noninvasive surgery, dynamic implants, and biocompatible 
microelectronics. These machines and other studies that 
build upon them will demonstrate the power using SLA 
fabrication and cells as building blocks to engineer the ma-
chines and systems of the future.
5.3 Stereolithographic 3D Bioprinting 
for Biomedical Applications
The future of modern medicine is undoubtedly rooted in 
the core philosophy of customized/personalized healthcare. 
FIGURE 6.28 Multimaterial fabrication is one of the primary challenges facing stereolithography. (a) Schematic of self-aligning minivat setup 
proposed by Arcaute et al.; (b) spatially controlled variation of resin within a single printed layer; (c) complex 3D chess rook structure with fluorescent 
internal staircase manufactured using this multimaterial stereolithographic fabrication approach [95].
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As we learn more about the underlying design principles 
and molecular mechanisms governing biologic l systems, 
we can develop precisely individualized and targeted cures 
that address patient-specific needs. This motivates the need 
for developing an enabling technology that allows us to 
fabricate complex 3D structures that are biocompatible, 
biodegradable, and bioactive. Such biofabricated structures 
can readily integrate with a host biological system to per-
form a specified task, such as targeting diseased tissues and 
promoting tissue regeneration.
FIGURE 6.29 High-resolution patterning of single cells within a complex 3D structure is a major challenge facing stereolithography. (a) Optical 
tweezers used to precisely manipulate arrays of fluorescently labeled Escherichia coli before encapsulation within a photosensitive polymer [96]; (b) DEP 
used as a high-throughput approach to manipulating fluorescently labeled cells and beads into precisely defined spatial patterns prior to encapsulation in 
a photosensitive polymer [97].
FIGURE 6.30 High-resolution spatiotemporal control of mechanical, material, and bioch mical properties within a 3D structure is the next-
generation requirement for stereolithographic fabrication. (a) Formation of a 3D hydrogel; (b) single or multiphoton visible light used to chemically 
pattern bioactive moieties within a 3D hydrogel matrix; (c) single or multiphoton UV light used to selectively degrade portions of the polymerized gel [98].
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Figure 2.30 High-resolution spatiotemporal control of mechanical, material, and biochemical 
properties within a 3D structure is the next- generation requirement for stereolithographic 
fabrication. (A) Formation of a 3D hydrogel; (B) single or multiphoton visible light used to 
chemically pattern bioactive moieties within a 3D hydrogel matrix; (C) single or multiphoton 
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CHAPTER 3: MACRO-STEREOLITHOGRAPHIC 3D PRINTING 
 This section details the use of a commercial stereolithographic apparatus, that has 
previously been adapted for printing with biological materials 42, for applications in high-
throughput drug testing (Section 3.1) and targeted drug-delivery (Section 3.2).  
 
3.1 Photopatterning of Hydrogel Scaffolds Coupled to Filter Materials Using Stereolithography 
for Perfused 3D Culture of Hepatocytes2 
 
3.1.1 Introduction 
 Developing in vitro model systems that recreate the structural and functional properties of 
native tissue have many applications in biomedical engineering, including high-throughput drug 
testing and fundamental studies of disease development and in vivo physiology. Previous 
demonstrations have shown that perfused culture of hepatocytes in rigid scaffolds placed within 
microfluidic bioreactors can be used to develop micro-scale 3D liver tissues that can be targeted 
at these biomedical engineering applications 100. We hypothesized that adapting the rigid 
scaffolds which served as templates for manufacturing these micro-scale liver tissues, by giving 
them mechanical properties more closely aligned with soft biological tissues, could yield in vitro 
behaviors that more closely mimicked in vivo functionality. We thus developed a 
stereolithographic 3D printing process to fabricate soft hydrogel scaffolds coupled to micro-
porous filters. When placed within microfluidic bioreactors and subjected to perfused culture 
with primary hepatocytes, micro-scale liver tissues demonstrated prolonged maintenance of 
liver-specific functions within these 3D printed hydrogel scaffolds. 
 
																																																								
2	This section is an adaptation of the following second authored journal article and the copyright 
owner has granted permission to reprint (Appendix A.2): 
Neiman, J.A.S., Raman, R., Chan, V., Rhoads, M.G., Raredon, M.S.B., Velazquez, J.J., Dyer, 
R.L., Bashir, R., Hammond, P.T. and Griffith, L.G., 2015. Photopatterning of hydrogel scaffolds 
coupled to filter materials using stereolithography for perfused 3D culture of 
hepatocytes. Biotechnology and bioengineering, 112(4), pp.777-787. 
 
Author contributions: The sections on 3D printing the hydrogel scaffolds, written primarily by 
R.R., have been reproduced in this dissertation. The remaining sections on hepatocyte culture 
and assessment, performed and written by J.N., have been presented in adapted and truncated 
form in this dissertation, and can be found in full in the publication. 
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3.1.2 Methods 
Track-etched, PC filters with 5-micron pore size or interwoven, PVDF filters with 5-
micron pore size (Millipore, Billerica, MA) were treated with air plasma for 10 minutes using a 
Harrick Plasma Cleaner. Filters were subsequently soaked for 1 h in a 20% solution of ethylene 
diamine (Aldrich, St. Louis, MO) in PBS, pH adjusted to 10.0 ± 0.05 with hydrochloric acid. 
Activated filters were rinsed for 10 min in 1mM hydrochloric acid followed by two 10-min 
rinses in Millipore water. Filters were then allowed to dry at room temperature and shipped dry 
at ambient conditions to the University of Illinois at Urbana-Champaign (UIUC) for completion 
of filter activation and hydrogel fabrication.  
Following arrival at UIUC, a solution of 12mM acrylic acid N- hydroxysuccinimide ester 
(NHS-acryl, Sigma) solution was prepared by first dissolving 200 mg of NHS-acryl in 4mL 
dimethyl sulfoxide (DMSO, Fisher Scientific, Pittsburgh, PA), and then dissolving this solution 
in 96mL of 1X phosphate buffered saline (PBS, Lonza, Allendale, NJ). Aminated filters were 
immersed in this solution in the dark for 3 h. After soaking, filters were dried in the dark for 3 h, 
and then taped to glass coverslips with the treated side facing up. The glass coverslips and filters 
were then taped to a 35 mm dish that had been rendered hydrophilic via oxygen plasma 
treatment. 
The pre-treatment solution for the filters consisted of 20% (v/v) poly(ethylene glycol) 
diacrylate of MW 700 g mol-1 (PEGDA 700, Sigma-Aldrich) dissolved in PBS, with 2.5% (w/v) 
1-[4-(2- hydroxyethoxy) phenyl]-2-hydroxy-2-methyl-1-propanone-1-one photoinitiator 
(Irgacure 2959 or I2959, BASF, Chicago, IL) mixed from a 50% (w/v) stock solution in dimethyl 
sulfoxide (DMSO, Fisher Scientific). 50 0mL of this pre-treatment solution was pipetted onto 
each prepared filter. The filters were incubated in this pre-treatment solution in the dark for 2 
min, followed by gentle aspiration of the pre-treatment solution from the filter surface.  
A polymerization solution of 20% (v/v) PEGDA 700 containing 0.5% (w/v) Irgacure 
2959 was prepared and 900 mL of this solution was pipetted onto each prepared filter 
immediately after photo- initiator pre-treatment to form a liquid macromer layer 0.105 mm. 
Hydrogel scaffold designs were generated in the form of CAD files using SolidWorks CAD 
Software (Dassault Systemes, Velizy, France) and exported to stereolithography (STL) format. 
These files were then prepared in 3D Lightyear Software (3D Systems, Rock Hill, SC) to slice 
the files into 2D layers of a specified thickness. In this case, hydrogel scaffolds were 
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polymerized onto the filters using a single-layer process at an energy density of 513 mJ cm-2, 
unless noted otherwise, using a stereolithography apparatus (SLA, 250/50 3D Systems, Rock 
Hill, SC). The SLA operates a 325 nm ultraviolet laser with a nominal laser beam width of 250 
µm. Since the effective beam width illuminating hydrogel precursor solution during crosslinking 
corresponds to the limiting feature size, the beam width is equivalent to the resolution of the 
SLA for non-swelling materials.  
We have previously reported the threshold energy density, Ec, required to crosslink 
solutions containing 20% PEGDA-700 and 0.5% (w/v) I2959 as 41 mJ cm-2 and measured a 
molar extinction coefficient for I2959 at the illumination wavelength (325 nm) as 677 M-1 cm-1 
leading to a molar extinction coefficient for these conditions of 15 cm-1 42,88. Hence, for a 
nominal macromer solution depth of 105 µm above the filter, a minimum illumination energy 
density of 48 mJ cm-2 would be required to achieve crosslinking at the filter-macromer interface. 
However, energy intensities the energy attenuation properties of the filters are unknown, and 
thus we investigated intensities 3x and 11x this minimum threshold to find conditions that 
adequately crosslinked the precursor throughout the filter region. Unless otherwise noted, 
scaffolds were polymerized at an energy density of 513 mJ cm-2.  
The average energy density is a function of the laser power and laser scan speed. The 
SLA laser power is constant, thus energy density is modulated by adjusting the laser scan speed. 
To polymerize the photosensitive resin into the hydrogel scaffold design, the laser first traced the 
outer border of each scaffold. The laser was then rasterized across the surface of the resin in a 
process termed “hatching”. The hatch process was performed in two steps: 1) horizontal parallel 
traces with a user-defined hatch spacing; 2) vertical parallel traces with a user-defined hatch 
spacing. In this case, hatch spacing was specified as 125 µm, corresponding to half the nominal 
laser beam width, to ensure planar and homogeneous polymerization of the layer pattern. 
Following the hatching process, the laser traced the borders of individual open channels in order 
to precisely define features in the polymerized part. Therefore, while hatch areas were 
illuminated two times by overlapping horizontal and vertical traces, the areas where border and 
hatch traces overlap (surrounding each channel) were illuminated three times. This resulted in a 
greater density of cross-linking in these border regions of the open channels, as can be observed 
by the increased opacity of the hydrogel (Figure 3.1C). Fabricated parts were rinsed, stored, and 
shipped to Massachusetts Institute of Technology (MIT, Cambridge, MA) in PBS in coplin jars. 
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Upon arrival at MIT, hydrogel scaffolds were transferred to 12 well plates with 2mL of 70% 
ethanol per well for sterilization and removal of unreacted constituents. After 2 h, the 70% 
ethanol solution was aspirated and replaced with 2 mL of sterile PBS per well and stored at 4 C. 
Scaffolds were imaged with phase microscopy and final channel dimensions were measured in 
ImageJ (NIH). 
 
3.1.3 Results and Discussion 
3.1.3.1 Scaffold Design and Characterization 
 Scaffolds having different open channel geometries, namely, aligned or staggered ellipses 
and rectangles having nominal lengths of 900 µm and widths of 600 µm with channel spacing of 
300 µm were drawn in a CAD file and exported to STL format. Channel packing densities were a 
function of channel geometry and channel alignment (staggered or aligned), and were 30, 34, and 
43 per scaffold for staggered rectangular, aligned rectangular, and staggered elliptical designs, 
respectively. A low molecular weight PEGDA (700 Da) was selected to minimize swelling, 
potentially reducing delamination of the hydrogel from the filter. Further, gels made from 
PEGDA 700 induce moderate cell adhesion, presumably via adsorption of serum or cell-secreted 
proteins, even when no bioadhesion ligands are incorporated into the gel. Poly(ethylene oxides) 
with molecular weights below 1500 g mol-1 have been shown to adsorb proteins 101. Given the 
specified SLA parameters, the hydrogel scaffolds were polymerized via a rasterizing process 
termed “hatching”, followed by a single border trace of each channel. As a consequence, each 
open channel is separated by two laser traces in both the rectangular and elliptical designs. The 
appearance of a typical scaffold following swelling in culture medium is shown in (Figure 3.1) to 
illustrate the relationship between fabrication parameters and final feature resolution.  
As illustrated by the representative scaffolds shown in Figure 3.1, the actual dimensions 
of the features differ from the nominal dimensions due to post-fabrication swelling of the 
crosslinked hydrogel. Actual dimensions of PEGDA scaffold channels bonded to PC membranes 
after equilibrium swelling measured 850 µm by 350 µm (nominal 900 µm by 600 µm) with a 560 
µm wide hydrogel wall in between channels for rectangular scaffolds, and 698 µm by 313 µm 
(nominal 900 µm by 600 µm), with a 460 µm wide hydrogel wall in between channels for 
elliptical open channel designs. For adjacent rectangular channels, where the laser border traces 
are parallel, the thickness of the hydrogel walls between channels is a little over twice the 
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nominal laser beam width after swelling. For adjacent elliptical channels, the curved geometry of 
the channels leads to some overlap between the laser border traces, explaining the reduced width 
of the hydrogel wall for channels with more rounded geometries.  
Based on these measurements, the nominal degree of swelling is ~150%, consistent with 
the results previously observed for SLA- driven polymerization of this macromer solution (Chan 
et al 2010). The vertical thickness of hydrogels fabricated on glass substrates was estimated to be 
as 175 ± 20mm. The width of the hydrogel wall between channels was measured for rectangular 
channel geometries from three different scaffolds and three different wells per scaffold and 
varied with photoinitiator (PI) concentration and energy density as follows: 0.5% PI and 138 mJ 
cm-2 measured 219 ± 10mm, 1% PI and 138 mJ cm-2 measured 242 ± 10mm, and 0.5% PI and 
513 mJ cm-2 measured 297 ± 8mm. Thus, hydrogel formulations and SLA energy doses 
modulate the spacing between open channels.  
 
3.1.3.2 Formation of Hepatic Spheroids and Maintenance of Liver Specific Functions 
 Primary hepatocytes were seeded within the 3D printed scaffolds through perfused 
culture in microfluidic bioreactors, and viability of cells was assessed via live/dead staining 
(Figure 3.1C). Maintenance of liver specific functionality was assessed by measuring albumin 
secretion, an indicator of metabolic functionality in hepatocytes. We demonstrated that 
bioreactor cultures of micro-scale liver tissues were able to maintain albumin production levels 
for prolonged periods of time as compared to 2D culture controls 102. 
 
3.1.4 Conclusion 
We developed a robust and high-throughput approach for coupling 3D printed hydrogel 
scaffolds to micro-porous filters, and demonstrated the applicability of these soft scaffolds for 
liver tissue engineering. This versatile approach can be modified and targeted at a wide variety of 




3.2 3D Printing Enables Separation of Orthogonal Functions Within A Hydrogel Particle3 
 
3.2.1 Introduction 
In recent years, an increasing number of multifunctional particle formulations have been 
developed for a variety of applications, ranging from consumer products to drug delivery devices 
103. Incorporating multiple functionalities into a single particle significantly reduces the total 
number of particles needed for any given application, as in the case of theranostic (dual 
therapeutic and diagnostic) nano- and micro-particles 104. Moreover, spatial separation of dual 
functionalities in a single particle may enable a synergistic physical or chemical property that 
cannot be replicated by two single-functional particles in the same dispersion 105. This motivates 
developing a fabrication methodology for assembly of multiphasic particles, in which different 
functional modalities are spatially separated to avoid interference between them. A series of 
fabrication strategies have been proposed to prepare multiphasic particles, such as electrojetting, 
emulsification, and standard lithography techniques 106–108. Despite impressive results reported to 
date, concerns still remain regarding the customizability of these techniques.  
 A wide variety of 3D printing technologies and printable biomaterials have been 
developed to suit the needs of biomedical applications 1,109. Of these materials, highly absorbent 
hydrogels have been of particular interest to the biomedical community due to their tunable 
stiffness and permeability. Hydrogels can be functionalized with various bioactive moieties by 
chemical modification of gel-forming polymers 110,111. Taking advantage of the rapid 
development of this field, this study demonstrates a 3D printing-based strategy to manufacture 
biphasic hydrogel particles with spatially distributed functional moieties. Specifically, a 
stereolithographic apparatus (SLA) was used to fabricate hydrogel particles with distinct 
functional compartments. Using this fabrication technology, we examined whether controlling 
laser irradiation speed, which in turn allows for tuning of the energy dose delivered to pre-gel 
																																																								
3	This section is a reproduction of the following co-first authored journal article and the 
copyright owner has granted permission to reprint (Appendix A.3): 
Raman, R.*, Clay, N.E.*, Sen, S., Melhem, M., Qin, E., Kong, H. and Bashir, R., 2016. 3D 
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solutions, could be used to predict and control the cross-linking kinetics of the radical 
polymerization reaction. By doing so, we were able to customize and control the shape, size, and 
aspect ratio of the layers of the gel particles with great precision. We tested boundary stability 
across different layers using brightfield and confocal microscopy, and used these results to 
incorporate two moieties, bovine serum albumin (BSA) and superparamagnetic iron oxide 
nanoparticles (SPIONs), into biphasic gel particles. The release kinetics of BSA and magnetic 
resonance imaging (MRI) contrast of particles were evaluated to test the effect of spatially 
segregating orthogonal functions within a particle. The results of this study demonstrate an 
expedited approach for assembling multifunctional bioactive gel particles for a diverse array of 
biomedical applications including image-based targeted drug delivery. 
 
3.2.2 Results and Discussion 
3.2.2.1 3D Printing of Hydrogel Particle Arrays 
A commercial SLA was modified for printing photosensitive hydrogel polymers as 
previously demonstrated and shown in Figure 3.2A 42. Liquid pre-gel solution, composed of poly 
(ethylene glycol) diacrylate (PEGDA) and a biocompatible photo-initiator, was injected onto the 
motorized stage and selectively cured by the SLA’s ultraviolet laser. Following fabrication of 
each layer, the motorized stage moved down by a prescribed amount, and a new layer of pre-gel 
solution was manually injected and subsequently polymerized.  
To enable high-throughput fabrication of many gel particles, the computer-controlled 
laser traced a 2D cross-section of the 3D hydrogels prescribed by a computer aided design 
(CAD) file, shown in Figure 3.2B. This file contained a 30 x 30 array of cylinders of specified 
diameter and spacing. Due to the swelling properties of the hydrogels used in this study, these 
CAD-prescribed dimensions were not preserved in the final fabricated part. Figure 3.2B shows 
that an array of PEGDA 700 g mol-1 cylinders 200 µm in diameter spaced 200 µm apart 
becomes, after immersion and swelling in a solution of phosphate buffered saline (PBS) for an 
hour, an array of cylinders 270 µm in diameter spaced 130 µm apart. This trend was preserved 
for gel cylinders of larger diameters, as demonstrated in Figures 3.2C,D and Figure 3.3, with gel 
arrays demonstrating an average swelling ratio of 140%. This result is consistent with results 
previously demonstrated for polymerization of PEGDA hydrogels 102,112.  
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 The ultraviolet illumination energy dose required to cure photosensitive polymer 
solutions has been previously characterized by the cure-depth equation 5,38, an adapted form of 
the Beer-Lambert equation which relates the intensity of a light source to the exponential decay 
of its intensity in an absorbing medium. The SLA regulates ultraviolet light intensity by keeping 
the laser power constant (23 mW cm-2) and adjusting laser scan speed to regulate the energy 
density delivered (ranging from 108-266 mJ cm-2 in this study). 
The effect of ultraviolet light density on pre-gel solutions of PEGDA (400 g mol-1 and 
700 g mol-1) was tested, revealing that the degree of cross-linking was directly dependent on the 
energy dose delivered to the PEGDA, as shown in Figure 3.4A. The thickness of the gels was 
likewise regulated by tuning the energy dose, as shown in Figure 3.3B and Figure 3.4B. Gel 
thickness was also shown to be dependent on the concentration of PEGDA in the pre-gel solution 
(20% and 30% PEGDA 700 g mol-1), with increasing concentration correlated with increasing 
thickness, as demonstrated in Figure 3.4C.  
 
3.2.2.2 Fabrication of Multi-Layered Hydrogel Particles 
The ability of the SLA to precisely tune the diameter, thickness, and spacing of gel arrays 
provided a highly reproducible methodology with which to fabricate multi-layered gel particles. 
The dimensions and properties of each layer could be tuned by regulating the composition of the 
pre-gel solution used in each layer. For instance, solutions of PEGDA 700 g mol-1 prepared with 
different fluorescent dyes (i.e., red-colored rhodamine and green-colored fluorescein) were used 
to study the spatial separation and boundary stability of multi-layer gel particles via confocal 
imaging. Specifically, a confocal microscope was used to measure the fluorescence intensity 
(represented by gray value) emitted by the gels in response to illumination at two different 
excitation wavelengths. Plots of measured mean gray value as a function of position along the 
thickness of two-layer, three- layer, and four-layer gels are shown in Figure 3.5 for 20% and 
30% PEGDA. While the thickness of each layer is dependent on the polymer composition, a 
defined interface between layers can be created in both cases, as long as the polymer 
concentration is the same across layers. This boundary stability suggests that this high-
throughput 3D printing approach can be used to spatio-selectively distribute different properties 
within a single gel particle. 
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3.2.2.3 Spatial Compartmentalization of Function Epitopes in Multi-Layered Hydrogel Particles 
Coupling the SLA fabrication approach with a chemical conjugation technique enabled 
the spatioselective localization of biomolecules within specific layers of the gels (Figure 3.6). 
One layer of the gel particle was modified by introducing alginate methacrylate (AM), which can 
cross-link with PEGDA, into the pre-gel solution as shown in Figure 3.6A and Figure 3.7. 
Incorporation of fluorescent protein A, 1-ethyl-3-carbodiimide (EDC), and n-
hydroxysuccinimide (NHS) into the fabricated gel containing PEGDA and AM resulted in 
protein A molecules chemically conjugated to AM molecules via a carbodiimide-induced 
chemical reaction. A stability test conducted using rhodamine-tagged protein A shows one 
compartment of the gel selectively conjugated with protein A (Figure 3.6B). Protein A has been 
previously used to immobilize a variety of antibodies on different nanoparticle surfaces (Lai, 
2015). Therefore, this chemistry and processing technique will be broadly applicable to the 
spatioselective biochemical modification of multi-layered gels. 
To highlight the importance of spatially organizing different functional moieties in these 
gels, each layer of the two-layer gel particle was functionalized with superparamagnetic iron 
oxide nanoparticles (SPIONs) and bovine serum albumin (BSA), respectively, as shown in 
Figure 3.6C. SPIONs are widely used as a magnetic resonance (MR) imaging contrast agent 
90,114. By separating SPIONs from BSA, a model large molecule drug, we aimed to minimize 
interferential effects between SPIONs and BSA. The SPIONs would generate larger contrast in 
MR images, while BSA molecules would be released at controlled rates. 
As shown in Figure 3.6D, MR images of an agarose gel loaded with bi-layered gel 
particles demonstrated that particles loading BSA and SPIONs within different gel layers created 
a larger contrast than those in which BSA and SPIONs are encapsulated in the same layer. Using 
ImageJ, the average pixel intensity (mean gray value) was quantified for each image captured 
with a spin-echo sequence. At a given echo time, an image with more contrast correlates with a 
darker image and a lower mean gray value.  The gray value for gels with BSA and SPIONs in 
separate compartments indicated the highest degree of contrast, demonstrating the advantage of 
segregation of functional moieties within a gel.  
Furthermore, measurements of the cumulative fraction of BSA released, shown in Figure 
4e, demonstrate that a significantly larger amount of BSA was released from the gels in which 
BSA and SPIONs were loaded in separated layers. The gels in which SPIONs and BSA were 
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encapsulated in the same layer released only 50% of loaded BSAs over 4 days, thus implicating 
the presence of uncontrolled attraction between SPIONs and BSA in the gels. By contrast, the 
gels with spatial segregation between SPIONs and BSA released 80% of BSA molecules within 
48 h. As determined from the Peppas-Ritger equation 115, the gels with BSA and SPIONs in 
separate layers had a 1.9-fold larger release rate constant (k) than the gels with BSA and SPIONs 
in the same gel layer. Spatial segregation thus circumvented undesirable interactions between 
nanoparticles and proteins in the biphasic configuration. 
 
3.2.3 Conclusions 
This study demonstrates a customizable fabrication methodology for creating biphasic gel 
particle arrays. Stereolithographic fabrication allows for precise tuning of the gel array shape, 
size, and cross-linking density by providing mechanisms for precise regulation of polymerization 
kinetics. The properties of gels can be readily tuned to suit different applications through spatial 
segregation of bioactive moieties within different compartments. In future studies, multi-layered 
multi-functional gel constructs can be targeted at a wide variety of biomedical applications 
including medical diagnosis and therapeutics. 
 
3.2.4 Methods 
3.2.4.1 Pre-gel Solution Production 
Poly (ethylene glycol) diacrylate (PEGDA) with molecular weights of 400 and 700 g 
mol-1 (Sigma-Aldrich) were dissolved in phosphate buffered saline (PBS, Corning CellGro) at 
concentrations of either 200, 250, or 300 mg mL-1. Separately, 1-[4-(2-hydroxyethoxy) phenyl]-
2-hydroxy-2-methyl-1-propanone-1-one photoinitiator (Irgacure 2959, Ciba Chemicals) was 
dissolved in dimethyl sulfoxide (DMSO, Fisher Scientific), and mixed with the PEGDA solution 
to reach a final concentration of 1-5 mg mL-1  Irgacure 2959. Alginate methacrylate 
(AM)/PEGDA pre-gel solution, a mass of PEGDA was weighed, dissolved in the presence of 5 
mg/mL AM in PBS, and degassed under vacuum in the dark for at least 12 h. AM was prepared 
by conjugating 2-aminoethylmethacrylate to the carboxylic acids of alginate (FMC) via 
carbodiimide chemistry, as previously reported (Cha, 2009). Bovine serum albumin (BSA, 
Sigma-Aldrich) was functionalized with either fluorescein-isothiocyanate or rhodamine B-
isothiocyanate to form BSA-FITC or BSA-RBITC, respectively. 
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3.2.4.2 Stereolithographic 3D Printing 
CAD software (SolidWorks, Dassault Systems) was used to fabricate arrays of particles 
of varied dimensions and spacing. These were manufactured using a laser-based 
stereolithographic apparatus (SLA 250/50, 3D Systems). As the laser (325 nm) rasterized across 
the surface of the pre-gel solution in the pattern prescribed by the CAD file, it was cross-linked 
or “cured” in regions that were exposed to ultraviolet light. Following fabrication of each layer 
of the array, the motorized SLA stage moved down by a prescribed amount and the rasterizing 
process was repeated. Once the multi-layer array was complete, the particles were washed and 
stored in PBS and kept in the dark at 4 °C until imaging. 
 
3.2.4.3 Confocal Imaging 
After fabrication, particles were gently detached from the glass slide using a plastic 
pipette tip, placed in a dish, and imaged using a confocal microscope (Zeiss LSM 700, 
objectives: 10x/0.3 or 20X/0.8). The excitation wavelength was either 488 nm (for BSA-FITC) 
or 555 nm (for BSA-RBITC). As needed, brightfield images were captured in parallel with 
fluorescent images. All image analysis was done with ImageJ software (NIH) or Zen 2 Lite 
(Zeiss). 
 
3.2.4.4 Modification of Particles with Fluorescent Staphylococcus Aureus (SpA; protein A)  
SpA was modified with RBITC, as previously described 113. Particles were incubated in 
7mg/mL of 1-ethyl-3-carbodiimide (EDC) and 10 mg mL-1  of n-hydroxysuccinimide (NHS) for 
30 min. The particles were then washed, and a small volume of 2-mercaptoethanol was added. 
They were then incubated in SpA-RBITC (protein A) for 15 min, washed 5 times, and imaged. 
 
3.2.4.5 Magnetic Resonance Imaging 
Particles were fabricated with PEGDA containing superparamagnetic iron oxide 
nanoparticles (SPIONs, SHP-10-10; Ocean NanoTech) and BSA-RBITC. BSA-RBITC and 
SPION concentration were constant at 1 mg mL-1  and 100 µg Fe mL-1, respectively. After 
fabrication, particles were dispersed in PBS, then rapidly mixed with warm 10 mg mL-1 agarose 
solution in a borosilicate tube and gelled at room temperature. Agarose gel with no particles was 
	73	
prepared as a control. MR images were captured with a spin-echo sequence on a Varian 600 
MHz Small-Bore Scanner.  
 
3.2.4.6 Quantification of BSA release  
After fabrication, particles were released, mixed in PBS, then incubated at 37 ˚C and 
shaken at 100 rpm (Heidolph Rotamax 120). At each time-point, the particles were centrifuged at 
100 rcf for 3 min (Eppendorf centrifuge 5424). The fluorescent intensity of the supernatant was 
then measured (Tecan Infinite 200 PRO). The total theoretical amount of BSA-RBITC 
encapsulated was estimated by considering the volume of a rod-shaped particle with a diameter 
of 250 µm and a height of 250 µm loaded with 1 mg mL-1 of BSA. BSA release rate was 
quantified according to the Peppas-Ritger equation: 𝑀!/𝑀! = (𝑘)(𝑡!), where Mt is the mass 
released at time t, M∞ corresponds to the mass released at time infinity (total amount 
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Figure 3.1 Filter activation and hydrogel scaffold fabrication. PC and PVDF filters were 
activated by amination and NHS chemistry to expose acrylate groups that participate in free 
radical polymerization during hydrogel scaffold photopolymerization (A). A stereolithography 
apparatus (SLA) was used to fabricate PEGDA hydrogel scaffolds on chemically activated 
PC/PVDF filters. Serial rasterizing of the SLA’s ultraviolet laser was used to cure the 
photosensitive prepolymer resin and form arrays of channels within the hydrogel scaffold. (B). 
Individual channel borders were outlined by the SLA laser for both rectangular and elliptical 
channel geometries. As a consequence, open channels were separated by two laser traces for both 
channel geometries. Aligned rectangular and staggered ellipses had final dimensions on the order 
of 300 mm in width and 700 to 900 mm in length; both of which promoted hepatocyte viability 
as shown by a live (green)/dead (red) staining, hydrogel scaffolds retain Hoechst (blue) (C) 102.  
stresses of sterilization procedures, crosscontinental shipping, and
long-term perfusion flow of up to 1 mL/s, with the additional
constraint of ensuring the final composite contained no cytotoxic
residues. Parameters and process steps investigated included filter
activation chemistry, filter pretreatment with concentrated photo-
initiator concentrations, polymerization conditions (laser energy,
photoinitiator concentration), and methods of packaging final
products for shipment. During filter activation, increasing the plasma
treatment time from 15 s to 10 min significantly improved hydrogel
binding to PC filters from 2/9 to 14/20 intact scaffolds following the
sterilization soak. Increasing the plasma treatment of PC for these
times decreases contact angle measurements from 60 to 22
(Kang et. al., 2008), indicating a greater number of –OOH groups
exposed on the filter surface for subsequent chemical activation.
Scaffolds fabricated on chemically activated PC filters that were
shipped taped on glass coverslips and fully hydrated with PBS in
coplin jars lead to more intact samples following shipping relative to
scaffolds shipped fully hydrated in a 50 mL conical tube.
With the optimal shipping protocol and using a standard 2 h 70%
ethanol sterilization protocol (see Methods), we found that pre-
treating PC membrane filters with photoinitiator, which in theory
would mitigate any local interfacial depletion effects due to
adsorption of hydrophobic photoinitiator to the membrane, did
indeed reduce delamination, from 1/16 (no pretreatment) to 0/16
(with pre-treatment) for scaffolds produced with an optimal energy
density (513 mJ/cm2). More importantly, modulation of the SLA
energy dose significantly improved scaffold robustness, as most
(9/16) scaffolds delaminated when fabricated with an energy dose
of 138 mJ/cm2, even with 1% photoinitiator present and pre-
treatment of the filter with photoinitiator. The mechanism of
delamination appeared to be insufficient polymerization at the filter
interface, suggesting insufficient energy penetration.
We anticipated fewer delamination problems on PDVF filters
than on PC filters due to the stark differences in microstructure of
the membranes. The track-etch through-holes on the PC
membranes result in relatively little surface area for gel-membrane
bonding, and also forces a very abrupt interface where stress can be
concentrated during swelling. In contrast, the PDVF membranes
have a more porous fiber-like architecture that is penetrated by the
liquid macromer solution, and after gelation, the gel is physically
bonded by virtue of the interpenetrating network around the
membrane fibers. Indeed, we saw no delamination of gels formed
on PDVF filters post-fabrication. The PC membranes have more
desirable optical properties, hence we evaluated both types of
membranes in cell culture studies.
Next, the membrane-scaffold constructs were assessed for their
robustness to delamination and ability to foster liver cell viability and
aggregation under perfusion flow in the bioreactor. The scaffold was
designed with open channels to allow facile cell seeding into the channels
and then formation of tissue-like structures in the channels under
perfusion flow with minimal capture of cells on the upper surface of the
scaffold. Calcein AM staining of cells in the scaffold on day 3 demonstrate
the localization of cells to the channels with minimum cells located on top
of the hydrogel (Fig. 2). Photoinitiator concentration and pretreatment
Figure 1. Filt r activation and hydrogel scaffold f brication. PC and PVDF filters were activated by ami ation and NHS chemistry to expose acrylate groups that participate in
free radical polymerization during hydrogel scaffold photopolymerization (a). A stereolithography apparatus (SLA) was used to fabricate PEGDA hydrogel scaffolds on chemically
activated PC/PVDF filters. Serial rasterizing of the SLA’s ultraviolet laser was used to cure the photosensitive prepolymer resin and form arrays of channels within the hydrogel
scaffold. (b). Individual channel borders were outlined by the SLA laser for both rectangular and elli tical channel geometries. As a consequenc , open channels were separated by
two laser traces for both channel geometries. Aligned rectangular and staggered ellipses had final dimensions on the order of 300 mm in width and 700 to 900 mm in length; both of
which promoted hepatocyte viability as shown by a live (green)/dead (red) staining, hydrogel scaffolds retain Hoechst (blue) (c).
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Figure 3.2 Hydrogel array fabrication schematic. (A) Schematic of stereolithographic 3D printers 
used to fabricate hydrogel particles. (B) Comparison of hydrogel particle diameter and spacing 
specified in CAD file (top view, zoom inset of digital rendering) and fabricated part (top view, 
zoom inset of brightfield image). (C) Quantitative comparison of PEGDA 700 g mol-1 hydrogel 
particle specified and fabricated part diameter reveals a swelling ratio of 140 %. (D) Quantitative 










shown in Fig. 3 for 20 % and 30 % PEGDA. While the thick-
ness of ach layer is ependent on the polymer composition, a
defined interface between layers can be created in both cases,
as ong as the polymer concentration is the same across layers.
Fig. 1 Hydrogel array fabrication schematic. a Schematic of
stereolithographic 3D printers used to fabricate hydrogel particles. b
Comparison of hydrogel particle diameter and spacing specified in CAD
file (top view, zoom inset of digital rendering) and fabricated part (top view,
zoom inset of brightfield image). c Quantitative comparison of PEGDA
700 gmol−1 hydrogel particle specified and fabricated part diameter reveals
a swelling ratio of 140 %. d Quantitative comparison of PEGDA 700 g
mol−1 hydrogel particle spacing
Fig. 2 Multi-material 3D fabrication. a Regulation of ultraviolet energy
dose provides a mechanism of control over polymerization kinetics and
cross-linking density, with the degree of crosslinking mediated by the
composition of the polymer. Scale bars correspond to 500 μm. b
Thickness of hydrogel particles can also be regulated by tuning the
ultraviolet energy dose, with higher energy doses corresponding to
larger thicknesses (note that x- axes do not start from zero values). c
Varying the concentration of PEGDA in the pre-gel solution provides
an additional mechanisms of control over particle thickness




Figure 3.3 (A) Example of a 30% PEGDA 700 g mol-1 disc-shaped hydrogel particle formed by 
changing the CAD file sent to the stereolithographic 3D printer, showing the versatility and 
customizability of this rapid fabrication approach. Scale bar corresponds to 500 µm. (B) 
Example of a 30% PEGDA 400 g mol-1 “matchstick” hydrogel particle formed by varying the 
energy dose applied for each layer during fabrication, resulting in significantly different 







Figure 3.4 Multi-material 3D fabrication. (A) Regulation of ultraviolet energy dose provides a 
mechanism of control over polymerization kinetics and cross-linking density, with the degree of 
crosslinking mediated by the composition of the polymer. Scale bars correspond to 500 µm. 
(B)Thickness of hydrogel particles can also be regulated by tuning the ultraviolet energy dose, 
with higher energy doses corresponding to larger thicknesses (note that x- axes do not start from 
zero values). (C) Varying the concentration of PEGDA in the pre-gel solution provides an 










shown in Fig. 3 for 20 % and 30 % PEGDA. While the thick-
ness of each layer is dependent on the polymer composition, a
defined interface between layers can be created in both cases,
as long as the polymer concentration is the same across layers.
Fig. 1 Hydrogel array fabrication schematic. a Schematic of
stereolithographic 3D printers used to fabricate hydrogel particles. b
Comparison of hydrogel particle diameter and spacing specified in CAD
file (top view, zoom inset of digital rendering) and fabricated part (top view,
zoom inset of brightfield image). c Quantitative comparison of PEGDA
700 gmol−1 hydrogel particle specified and fabricated part diameter reveals
a swelling ratio of 140 %. d Quantitative comparison of PEGDA 700 g
mol−1 hydrogel particle spacing
Fig. 2 Multi-material 3D fabrication. a Regulation of ultraviolet energy
dose provides a mechanism of control over polymerization kinetics and
cross-linking density, with the degree of crosslinking mediated by the
composition of the polymer. Scale bars correspond to 500 μm. b
Thickness of hydrogel particles can also be regulated by tuning the
ultraviolet energy dose, with higher energy doses corresponding to
larger thicknesses (note that x- axes do not start from zero values). c
Varying the concentration of PEGDA in the pre-gel solution provides
an additional mechanisms of control over particle thickness
Biomed Microdevices  (2016) 18:49 Page 3 of 7  49 
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Figure 3.5 Boundary stability characterization of multi-layer hydrogel particles. (A-C) Confocal 
images (i) and plots of light intensity/Gray value as a function of position along the thickness of 
a gel particle (ii) for two-layer (A), three layer (B), and four-layer (C) hydrogel particles 
fabricated using 20 % PEGDA 700 g mol-1 tagged with red or green fluorophore. Scale bars 
correspond to 500 µm. (D-F) Confocal images (i) and plots of light intensity/Gray value as a 
function of position along the thickness of a gel particle (ii) for two-layer (D), three layer (E), 
and four-layer (F) hydrogel particles fabricated using 30 % PEGDA 700 g mol−1 tagged with 
red or green fluorophore. Scale bars correspond to 500 µm 117. 
This boundary stability suggests that this high-throughput 3D
printing approach can be used to spatio-selectively distribute
different properties within a single gel particle.
2.3 Spatial compartmentalization of function epitopes
in multi-layered hydrogel particles
Coupling the SLA fabrication approach with a chemical con-
jugation technique enabled the spatioselective localization of
biomolecules within specific layers of the gels (Fig. 4). One
layer of the gel particle was modified by introducing alginate
methacrylate (AM), which can cross-link with PEGDA, into
the pre-gel solution as shown in Fig. 4a and Fig. S2.
Incorporation of fluorescent protein A, 1-ethyl-3-
carbodiimide (EDC), and n-hydroxysuccinimide (NHS) into
the fabricated gel containing PEGDA and AM resulted in pro-
tein A molecules chemically conjugated to AM molecules via
a carbodiimide-induced chemical reaction. A stability test con-
ducted using rhodamine-tagged protein A shows one compart-
ment of the gel selectively conjugated with protein A (Fig. 4b).
Protein A has been previously used to immobilize a variety of
antibodies on different nanoparticle surfaces (Lai et al. 2015).
Therefore, this chemistry and processing technique will be
broadly applicable to the spatioselective biochemical modifi-
cation of multi-layered gels.
To highlight the importance of spatially organizing differ-
ent functional moieties in these gels, each layer of the two-
layer gel particle was functionalized with superparamagnetic
iron oxide nanoparticles (SPIONs) and bovine serum albumin
(BSA), respectively, as shown in Fig. 4c. SPIONs are
widely used as a magnetic resonance (MR) imaging
contrast agent (Annabi et al. 2013; Jeong et al. 2012). By
separating SPIONs from BSA, a model large molecule drug,
we aimed to minimize interferential effects between SPIONs
and BSA. The SPIONs would generate larger contrast in
MR images, while BSA molecules would be released at
controlled rates.
As shown in Fig. 4d, MR images of an agarose gel loaded
with bi-layered gel particles demonstrated that particles load-
ing BSA and SPIONs within different gel layers created a
larger contrast than those in which BSA and SPIONs are en-
capsulated in the same layer. Using ImageJ, the average pixel
Fig. 3 Boundary stability characterization of multi-layer hydrogel
particles. a-c Confocal images (i) and plots of light intensity/Gray value as
a function of position along the thickness of a gel particle (ii) for two-layer
(a), three layer (b), and four-layer (c) hydrogel particles fabricated using
20% PEGDA 700 g mol−1 tagged with red or green fluorophore. Scale bars
correspond to 500 μm. d-f Confocal images (i) and plots of light intensity/
Gray value as a function of position along the thickness of a gel particle (ii)
for two-layer (d), three layer (e), and f ur-layer (f) hydrogel particles
fabricated using 30 % PEGDA 700 g mol−1 tagged with red or green
fluorophore. Scale bars correspond to 500 μm
 49 Page 4 of 7 Biomed Microdevices  (2016) 18:49 
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Figure 3.6 Spatioselective functionalization of hydrogel particles. (A) Schematic of chemical 
composition of pre-gel solutions in each layer of a two-layer particle. One layer contains pure 
PEGDA and the other is a mixture of PEGDA and alginate methacrylate, allowing for the 
fabrication of a cross-linked 3D matrix of inter-locked PEGDA and alginate monomers 
following UV-initiated cross-linking (i). Spatial segregation of alginate in one layer of a two-
layer particle allows for spatially selective localization of fluorophore-tagged proteins (ii).  (B) 
Spatial segregation of fluorophore-tagged protein as visualized using fluorescence imaging. 
Scale bar corresponds to 200 µm. (C) Schematic depicting particles loaded into an agarose gel in 
a glass tube for MR imaging. (1) depicts the gel particle with BSA-RBITC and SPIONs 
segregated, (2) depicts the gel particle with BSA-RBITC and SPIONs co-encapsulated, and (3) 
depicts a blank agarose gel as a control. (D) The resulting MR images (i) of (1), (2), and (3). 
Scale bar corresponds to 6 mm. Gray values show greater contrast in particles with phase 
separation (ii). (E) Cumulative fraction of encapsulated BSA released as a function of time for 
the separate and combined cases (i) demonstrating the enhanced release kinetics observed in 
biphasic particles (ii) 117. 
 
  
intensity (mean gray value) was quantified for each image
captured with a spin-echo sequence. At a given echo time,
an image with more contrast correlates with a darker image
and a lower mean gray value. The gray value for gels wit
BSA and SPIONs in separate co partments indicat d the
highest degree of contrast, demonstrating the advantage of
segregation of functional moieties within a gel.
Furthermore, measurements of the cumulative fraction of
BSA released, shown in Fig. 4e, demonstrate that a signifi-
cantly larger amount of BSA was released from the gels in
which BSA and SPIONs were loaded in separated layers.
The gels in which SPIONs and BSA were encapsulated in
the same layer released only 50% of loadedBSAs over 4 days,
thus implicating the presence of uncontrolled attraction be-
tween SPIONs and BSA in the gels. By contrast, the gels with
spatial segregation between SPIONs and BSA released 80 %
of BSA molecules within 48 h. As determined from the
Peppas-Ritger equation (Ritger and Peppas 1987), the gels
with BSA and SPIONs in separate layers had a 1.9-fold larger
release rate constant (k) than the gels with BSA and SPIONs
in the same gel layer. Spatial segregation thus circumvented
undesirable interactions between nanoparticles and proteins in
the biphasic configuration.
3 Conclusions
This study demonstrates a customizable fabrication method-
ology for crea t ing biphas ic gel par t ic le ar rays .
Stereolithographic fabrication allows for precise tuning of
the gel array shape, size, and cross-linking density by provid-
ing mechanisms for precise regulation of polymerization ki-
netics. The properties of gels can be readily tuned to suit
different applications through spatial segregation of bioactive
moieties within different compartments. In future studies,
multi-layered multi-functional gel constructs can be targeted
at a wide variety of biomedical applications including medical
diagnosis and therapeutics.
Fig. 4 Spatioselective functionalization of hydrogel particles. a
Schematic of chemical composition of pre-gel solutions in each layer of
a two-layer particle. One layer contains pure PEGDA and t e other is a
mixture of PEGDA and alginate methacrylate, allowing for the
fabrication of a cross-linked 3D matrix of inter-locked PEGDA and
lginate m nomers following UV-initiated cross-link ng (i). Spatial
segregation of alginate in one layer of a two-layer particle allows for
spatially selective localization of fluorophore-tagged proteins (ii). b
Spatial segregation of fluoroph re-tagged protein as visualiz d using
fluorescence imaging. Scale bar corresponds to 200 μm. c Schematic
depicting particles loaded into an agarose gel in a glass tube for MR
imaging. (1) depicts the gel particle with BSA-RBITC and SPIONs
segregated, (2) depicts the gel particle with BSA-RBITC and SPIONs
co-encapsulated, and (3) depicts a blank agarose gel as a control. d The
resulting MR images (i) of (1), (2), and (3). Scale bar corresponds to 6
mm. Gray values show greater contr st in particles with phase separation
(ii). e Cumulative fraction of encapsulated BSA released as a function of
time for the separate and combined cases (i) demonstrating the enhanced
release kinetics observed in biphasic particles (ii)
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Figure 3.7 (A) Schematic of cross-linking in pure PEGDA hydrogels. (B) Schematic of cross-
linking in hydrogels containing a mix of PEGDA and methacrylated alginate. 
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CHAPTER 4: HIGH-RESOLUTION MICROSTEREOLITHOGRAPHY4 
 
4.1 Introduction 
Cells in their native environment are arranged in precise three-dimensional architectures 
that promote cell-cell and cell-matrix interactions 118. A complex range of dynamic biological, 
chemical, electrical, and mechanical signals from the surrounding microenvironment control 
cellular function 119 . To gain a quantitative understanding of the way cells sense, process, and 
respond to dynamic environmental signals in real-time, we need to develop in vitro model 
systems that accurately replicate the 3D structure and function of native tissue. Such models 
have a range of applications including fundamental studies of extracellular matrix interactions, 
high throughput drug testing of physiologically relevant substitutes for native tissue, and 
programmable tissue engineering for applications in regenerative medicine 98,102,120–122. 
Recent efforts to replicate the in vivo cellular environment in an in vitro setting have 
harnessed the ability of additive manufacturing, or “3D printing”, apparatus to pattern cells in 
complex architectures 123,124. Stereolithography, a subtype of additive manufacturing, was the 
first commercially available 3D printing technology and is widely used in a variety of industry 
sectors due to its efficiency, versatility, and superior quality of fabricated parts 2. The mass 
commercial adaptation of SLA technologies, combined with increasing availability of 
biocompatible, bioactive, and biodegradable photosensitive resins, has led to widespread 
adaptation of SLA for biomedical engineering applications 1,109. 
Conventional stereolithography relies on the use of ultraviolet light to selectively 
polymerize photosensitive materials into complex 3D architectures. Most commercially available 
stereolithographic apparatus (SLA) manufacture parts by using a UV laser to sequentially trace 
2D cross-sections of a 3D model. Parts are thus sequentially built layer by layer from the bottom 
up. Projection stereolithography offers a variation on this traditional method. Rather than tracing 
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of 2D cross-sections, these apparatus project UV light through a mask, polymerizing entire 
cross-sections in a single exposure. While the first projection SLA machines utilized physical 
masks 94,125,126, these were soon replaced by dynamic digital masks that allowed for high-
resolution and high-throughput patterning and fabrication of a myriad array of 3D architectures 
127,128. 
At the forefront of 3D bioprinting is the fabrication of 3D structures with encapsulated 
cells, which has been demonstrated using both laser-based and projection SLA 42,53,95,129. 
Engineering in vitro model systems that recreate the structure and function of native tissue 
requires the ability to pattern cells and cell signals at physiologically relevant length scales (1-50 
µm).130 There have been limited reports on projection SLA-based cellular patterning at length 
scales < 50 µm 129, but no demonstrations of patterning at resolutions < 10 µm, the diameter of 
single cells. Furthermore, there has been no reported assessment of long-term cellular viability 
following the projection SLA fabrication process, and no demonstration of practical applications 
for such a technology.  
Here we present a custom-built projection SLA apparatus (µSLA) capable of patterning 
features at < 5 µm resolution using a biocompatible hydrogel resin. We demonstrate multi-
material fabrication of complex structures in 3D, and a novel method of building 3D objects with 
smooth features in a single exposure using a grayscale digital mask. Long-term viability of 
multiple cell types encapsulated within different hydrogel compositions using the µSLA is 
demonstrated, proving the applicability of this technology for a wide variety of applications in 
biomedical engineering. To specifically target an application of this technology in 
vascularization, we use the µSLA to fabricate angiogenic “patches” that encapsulate cells 
capable of endogenously secreting a series of proangiogenic cytokines and growth factors. 
Following design optimization of the angiogenic patches via  enzyme-linked immunosorbent 
assay (ELISA), the patches are tested in a chick chorioallantoic membrane (CAM) model and 
proven to encourage the formation of neovasculature in ovo. This sets the stage for future work 
in printing angiogenic patches with micro-scale feature sizes for therapeutic applications in 
treating tissue ischemia and defects in vivo. As the first demonstration of gray-scale fabrication, 
long-term cellular viability, and a practical application of a projection SLA, this study establishes 
projection micro-stereolithography as a promising enabling tool for a wide variety of 
applications in biomedical engineering. 
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4.2 Results and Discussion 
4.2.1 High-Resolution 3D Fabrication 
A high-resolution µSLA was designed and custom-built around a spatial light modulator 
(SLM) extracted from a commercial digital multimedia projector (Figure 4.1A). For ease of 
implementation, the SLM, which acts as a dynamic mask for polymerization, was integrated in 
the optical path while remaining connected to the projector through an extended cable. As a 
result, the projector can simply be connected to a computer as in regular use, and images on the 
computer screen are reproduced as grayscale pixelated images on the SLM. This enables 
dynamic 2D patterning of light projected through the digital mask. UV light (365 nm) is 
collimated and projected through the SLM and the resulting image is de-magnified through a 
10X microscope objective (NA = 0.3) onto the polymerization plane. Prepolymer solution is 
rendered photosensitive via the addition of a biocompatible photoinitiator (Irgacure 2959) known 
to react to light at this wavelength.19,131 This solution is then dispensed in controlled volumes at 
the polymerization plane, forming 2D hydrogel patterns in response to patterned UV light 
exposure. Illuminated regions form cross-linked hydrogel networks, whereas non-illuminated 
regions do not polymerize.  
 
4.2.1.1 Fabrication Resolution for Hydrogel Resins 
Among the most promising photosensitive polymer resins for SLA are hydrogels, highly-
hydrophilic materials formed from chemical or physical cross-linking of monomers 38. Synthetic 
hydrogels can be readily tuned to have well defined biochemical and mechanical properties, 
rendering them an attractive biomaterial for biomedical engineering applications 132. Specifically, 
synthetic poly (ethylene glycol) (PEG) based hydrogels, sometimes modified with integrin-
binding peptides and proteins, have been widely used due to their ability to viably encapsulate 
living cells and sustain proliferation in vitro 111.   
The challenge of fabricating high-resolution features with PEG-based hydrogel resins 
arises from the swelling behavior of these incredibly absorbent materials. With increasing 
molecular weight of the base monomer, the porosity and swelling of the cross-linked network 
increases. As a result, cells demonstrate greater viability in hydrogel networks with base 
monomers of higher molecular weight, as the increased porosity allows for enhanced diffusion of 
nutrients from the surrounding media into the cross-linked 3D structure 42. Figure 4.1B-1 
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demonstrates fabrication with a poly (ethylene glycol) dimethacrylate (PEG-dma) resin of 
molecular weight (Mw) 1000 g mol−1. A pattern of lines and holes of decreasing size is 
polymerized, demonstrating that feature sizes down to 3 µm (in a 100 µm thick hydrogel) can be 
fabricated using the µSLA. A resin of higher molecular weight, namely poly (ethylene glycol) 
diacrylate (PEG-da) of Mw 3400 g mol−1, was also tested for fabrication resolution. Patterns of 
lines and holes down to 30 µm were fabricated using the µSLA (Figure 4.2A). This increase in 
minimum feature size is attributed to the larger swelling ratios of cross-linked hydrogel networks 
composed of longer chain monomers.  
The incorporation of additional materials (such as cells, colored dyes, etc.) into the 
prepolymer solution can cause dispersion of the projected UV light, resulting in a reduced ability 
to resolve small features. However, at moderate cell concentrations ranging from 5x106 to 1x107 
cells/mL, fabrication resolution is not compromised (Figure 4.1B-2). Cells mixed within the 
prepolymer solution are encapsulated in the cross-linked hydrogel network during 
polymerization. Diffusion of nutrients from surrounding media is enabled by the porous nature of 
the 3D hydrogels of both molecular weights 1000 and 3400 g mol−1.  
 
4.2.1.2 Multi-Material 3D Fabrication 
The thickness of a polymerized hydrogel is dictated by the degree of UV-mediated cross-
linking, as predicted by an adapted form of the Beer-Lambert equation which relates the intensity 
of a light source to its penetration depth within a resin 133.  Regulating the energy dose of UV 
light, which is a function of both light source power and exposure time, thereby provides a 
precise method of fabricating 3D structures of specified layer thicknesses. Figure 4.2B shows the 
relationship between energy dose and thickness for both 1000 and 3400 g mol−1 PEG-based 
resins. The lines fitted to these data were used to fabricate 3D structures of precisely dictated 
layer thickness.  
To enable fabrication of multi-layer structures, the prepolymer solution was injected onto 
the hydrophobic polymerization plane and covered by a glass coverslip connected to a 
micrometer stage. The surface of this coverslip was chemically modified to present methacrylate 
functional groups which cross-linked with the prepolymer resin during UV exposure and 
patterning. Following the polymerization of the first layer of a 3D part, the micrometer stage 
moved up, and the chemically tethered first layer moved up with the stage. This allowed for the 
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injection of more resin onto the polymerization plane and cross-linking of the second layer. In 
this manner, 3D structures were polymerized layer-by-layer from the bottom-up.  
One of the disadvantages of both laser-based and projection SLA has been the difficulty 
of fabricating multi-material structures. In prior studies, researchers have accomplished multi-
material fabrication with SLA by incorporating multiple wash steps between fabricated layers 
8,42, or modifying the fabrication platform through the addition of mini “vats” containing 
different polymers 93. A simple design modification allowed us to simplify the process of 
building multi-material 3D structures, thereby increasing fabrication efficiency. Most previously 
presented projection SLA systems build parts layer by layer from the bottom-up, as does the 
µSLA presented here 8,49,128. However, while these apparatus build parts in the “right-side-up” 
orientation (Figure 4.3A), where the stage moved down for each polymerized layer, our system 
builds parts “upside down”, or inverted (Figure 4.3B). This modification removes each 
fabricated layer from the surrounding resin, rather than submerging it deeper within, thus 
eliminating the need for a wash step. Furthermore, the next layer of prepolymer can be directly 
injected onto the polymerization stage, without requiring the removal of the stage. This allows 
for a significant increase in fabrication efficiency. When fabricating with cells encapsulated 
within a polymer, the traditional “right-side-up” orientation comes with the disadvantage of cells 
settling to the bottom of the stage during polymerization. With our inverted fabrication setup, 
cells in each layer are thoroughly mixed and polymerized before settling, enabling 3D uniformity 
in cell-laden hydrogels (Figure 4.4). 
 The µSLA’s ability to fabricate parts with high-resolution feature sizes is maintained 
while fabricating 3D multilayer and multimaterial structures. A demonstration of negative 
features (i.e. holes/channels) in a two-layer dual material structure is presented in Figure 4.5A-1. 
This 3D design is fabricated by first polymerizing a uniform rectangle using a pink-dyed PEG-
dma 1000 g mol−1 resin followed by polymerization of a cross-hatch pattern using a clear PEG-
dma 1000 g mol−1 resin. As observed in top view and side view images taken 1 h post-fabrication, 
5 µm wide channels are formed in the second layer. Similarly, Figure 4.5A-2 presents fabrication 
of positive features (concentric cylinders of decreasing diameter) in a two-layer dual material 
structure.  
 Multi-material 3D fabrication is also demonstrated with encapsulated NIH/3T3 fibroblast 
cells (Figure 4.5B). Unlike the structures presented in Figures 2.37A, in which the resin itself 
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was dyed, the cells encapsulated in each layer of this dual-layer structure are stained with long-
term live cell fluorescent stains (Layer 1 – Green, Layer 2 – Red) and encapsulated within a clear 
PEG-da 3400 g mol−1 resin. The fluorescent image, taken 24 h post-fabrication, shows that the 
stained cells are segregated in each layer, with some cells crossing the boundary between layers 
due to proliferation and migration over the 24 h incubation. This demonstration sets the stage for 
fabricating multi-material 3D structures composed of multiple cell types, a capability that is 
fundamental to developing tissue/organ mimics in vitro for applications in tissue engineering and 
organ-on-a-chip devices.  
 
4.2.1.3 Grayscale Fabrication 
Most projection stereolithography apparatus employ digital micro-mirror devices (DMD) 
as dynamic masks for polymerization 128,134. These devices, which rely on moving micro-scale 
metal mirrors to turn pixels “on” and “off”, can be reliably used to reproduce black and white 
images. Grayscale fabrication with digital masks that produce three grayscale levels (black, 
white, grey) have also been demonstrated with projection SLA, with applications in creating self-
sacrificial structures that are chemically etched to produce overhanging features 135. Building on 
this demonstration, the SLM used in the µSLA system presented here is one of the three chips 
from a multimedia projector (Epson Powerlite S5) which is capable of producing multi-level (8-
bit) grayscale images. Since the thickness of a hydrogel structure is dictated by the degree of 
exposure to UV light, this grayscale projection enables the fabrication of smooth 3D structures in 
a single exposure. For example, fabricating a simple dome-shaped 3D structure with a DMD-
based SLA would require sequential exposure of multiple circular layers, each with decreasing 
diameter. This gives the dome a rough ladder-like surface, with surface roughness dictated by 
layer thickness (Figure 4.6A). Using the SLM-based µSLA, however, this dome-shaped structure 
can be fabricated in one step by projecting a grayscale 2D image with light intensity decreasing 
radially from the center (Figure 4.6B and Figure 4.7A1-2). Processing these images in 3D and 
plotting the relative intensity along a line drawn across the dome shows that the height of 
different regions in the fabricated part is dictated by the corresponding intensity of projected 
light at that region (Figure 4.7A-3). A similar demonstration of a negative feature (dome-shaped 
hole) shows that grayscale-enabled fabrication of smooth features is applicable to a variety of 3D 
part designs (Figure 4.7B). 
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4.2.2 Cell Viability 
There have been limited reports of cellular viability post-encapsulation using a projection 
stereolithography apparatus 129, and no demonstrations of viability in multiple cell types over a 
long-term in vitro culture period (more than a week). Establishing projection SLA as an enabling 
tool for applications in tissue engineering thus requires definitive proof of cellular viability and 
maintenance of cellular function following the printing process. In this study, we mixed murine 
cells of four types (C2C12 myoblasts, C166 endothelial cells, NIH/3T3 fibroblasts, and D1 bone 
marrow stromal cells) with prepolymer PEG-dma 1000 g mol−1 and PEG-da 3400 g mol−1 resins. 
Rectangular hydrogel blocks (740 µm by 530 µm wide, 360 µm thick) containing cells 
encapsulated at 7.5x106 cells mL−1 concentration (corresponding to ~1000 cells/hydrogel block) 
were fabricated for each cell type and each hydrogel resin. Viability of cells seeded within these 
blocks was quantitatively assessed via MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)- 2-(4-sulfo-phenyl)-2H-tetrazolium)) colorimetric assay, which 
measures the absorbance of a purple formazan byproduct that indicates the presence of 
metabolically active cells (Figure 4.8A). The MTS assay was performed on the day after 
fabrication (day 1), to establish a baseline on cell viability. Relative cell viability on days 5, 9, 
and 14 were then calculated by normalizing the measured absorbance on each day with the 
absorbance measured on day 1. The actual viability (specified by the number of live cells divided 
by the total number of encapsulated cells) for each resin formulation was calculated via live/dead 
fluorescent staining. These viability results, which show statistically significant improvements in 
viability for PEG-da 3400 g mol-1 as compared to PEG-dma 1000 g mol-1, are presented for 
NIH/3T3 cells but were consistent across the four cell types (Figure 4.8B). 
For PEG-dma Mw 1000 g mol−1, viability was calculated via live/dead staining to be 70 ± 
10 % on day 1 following fabrication. The viability of all four cell types demonstrated neither 
significant increase nor decrease over the two-week culture period, proving that cellular viability 
was maintained in this resin following encapsulation via the µSLA (Figure 4.8C-1). For PEG-da 
Mw 3400 g mol-1, viability was calculated to be 93 ± 3 % on day 1 following fabrication. The 
relative cell viability, as calculated via the MTS assay, increased for all cell types over the two-
week culture period, with statistically significant increases seen for C2C12, 3T3, and D1 cell 
types (Figure 4.8C-2). The enhanced viability in PEG-da Mw 3400 g mol-1 as compared to PEG-
dma Mw 1000 g mol−1 is attributed to the larger pore sizes present in hydrogel networks 
	88	
composed of higher molecular weight (i.e. longer-chain) monomers 42. While the increased 
swelling ratio of this resin post-crosslinking limits the highest observable resolution in fabricated 
parts (30 µm for PEG-da Mw 3400 g mol-1 vs. 3 µm for PEG-dma Mw 1000 g mol−1), the 
corresponding increase in diffusion of nutrients from surrounding media motivates the use of Mw 
3400 g mol-1 in biomedical applications that require maximum cellular viability.  
 
4.2.3 Patterning of Neovasculature 
Trauma or disease that results in the reduction of blood supply to tissue in vivo produces 
ischemia, which can severely damage surrounding tissue 136. Current treatment for ischemia 
relies largely on the use of anticoagulants, but recent developments in regenerative medicine 
motivate therapeutic treatment of ischemia by an alternative method: encouraging the formation 
of neovasculature to renew blood supply to the damaged tissue 137. Prior studies have 
demonstrated that targeted secretion of angiogenic factors, such as vascular endothelial growth 
factor (VEGF) and endothelin, from cell-encapsulating hydrogel patches can drive the formation 
of new blood vessels on a chick chorioallantoic membrane in ovo model 90. The incorporation of 
channels hundreds of micrometers wide within these centimeter-scale patches enhanced the flux 
of cell-secreted VEGF onto the CAM. This micropatterned release of biomolecules into tissue 
helped guide the growth direction and spacing of new blood vessels. This demonstration was 
sufficiently successful as a first demonstration, but true applicability as an in vivo therapy 
requires that such angiogenic patches be scaled down to the sub-millimeter length scale to allow 
for noninvasive injection into tissue via catheters. This scale reduction would increase the 
viability of cells encapsulated within the angiogenic patches, and the incorporation of smaller 
channels within these patches would increase the diffusive flux of VEGF from patch to tissue. 
This design challenge can readily be addressed by the high-resolution fabrication capabilities of 
the µSLA. 
 
4.2.3.1 Analysis of VEGF Secretion in vitro via ELISA 
Two angiogenic patch designs were assessed for VEGF secretion via ELISA: 1) A “plain 
patch” consisting of a simple hydrogel block (740 µm by 530 µm wide, 360 µm thick), and 2) A 
“microchanneled patch” consisting of a hydrogel block (740 µm by 530 µm wide, 360 µm thick 
with four 100 µm diameter channels). Both types of patches encapsulated approximately 900 
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NIH/3T3 fibroblast cells activated to release proangiogenic factors. These channels were 
expected to increase the diffusive flux of VEGF out of the patches and into the surrounding 
medium by enhancing the ratio of surface area/volume (Figure 2.9A). Furthermore, by reducing 
the distance between any encapsulated cell and the surrounding medium, the microchanneled 
design enhanced diffusion of nutrients from the surrounding medium into the patches. To test the 
hypothesis that microchanneled patches would enhance the diffusive flux of cell-secreted VEGF, 
we fabricated patches of each design and incubated them in warm growth medium containing 
tetradecanoylphorbol 13-acetate (TPA), a chemical known to stimulate cells to secrete VEGF 90. 
Optical density of the fluorescent signal produced during the ELISA test (performed after 3 d of 
incubation) was measured for both patch designs, as well as for a negative control (growth 
medium containing TPA, no patches or cells) and a positive control (cells seeded in a well 
containing growth medium supplemented with TPA) (Figure 2.10A). Optical density was 
converted to an actual concentration using a calibration curve (Figure 2.10B). Microchanneled 
patches produced 136.1 ± 4.8 ng mL−1 VEGF, significantly greater than the amount produced by 
plain patches of 72.4 ± 27 ng mL−1 VEGF (Figure 2.9B). As expected, no VEGF was detected in 
the negative control. Both plain and microchanneled patches produced greater amounts of VEGF 
than the positive control. This was explained by the observation that cells were migrating out of 
the patches and proliferating on the base of the wells, contributing to the increased VEGF 
production observed via ELISA. Based on these results, microchanneled patches were used in 
subsequent CAM assay experiments. 
 
4.2.3.2 Analysis of VEGF Secretion in ovo via CAM Assay 
To test the efficacy of the microchanneled patches in producing VEGF and encouraging 
vascular regeneration in an in ovo setting, we fabricated microchanneled patches with 
encapsulated NIH/3T3 fibroblasts, incubated them in growth medium containing TPA for 1 d, 
and then placed them onto a chick chorioallantoic membrane for one week (Figure 2.11A). The 
membranes were then sectioned and stained for DAPI (4′6-diamidino- 2-phenylindole) (cell 
nuclei) and smooth actin (Figure 2.11B). The number of blood vessels and the areas of blood 
vessels were quantified in a control group and a test group by imaging histological cross-
sections.. The control group membranes were incubated with “unloaded” microchanneled 
patches that didn’t contain encapsulated cells, and the test group membranes were incubated with 
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“loaded” microchanneled patches containing encapsulated and TPA-stimulated NIH/3T3 
fibroblasts. After one week, the membranes incubated with loaded patches had 12.1 ± 1.1% 
vessel area/tissue area whereas membranes incubated with unloaded patches had a significantly 
lower percentage of 6.3 ± 0.6% vessel area/tissue area (Figure 2.11C-1). These results indicate 
that the loaded microchanneled patches were indeed angiogenic and encouraged the formation of 
neovasculature in ovo. A histogram displaying the distribution of blood vessel area for a 
representative sample from the unloaded and loaded patch groups shows the broad variation in 
vessel size for both groups (Figure 2.11C-2). Loaded patches had, on average, 133 vessels mm-2 
tissue area and unloaded patches had, on average, 54 vessels mm-2 tissue area. Hence it is evident 
that the loaded patches enhanced angiogenesis in the membrane by stimulating the growth of 
new blood vessels.   
 
4.3 Conclusion 
Adaptation of 3D printing technologies to biofabrication has recently enabled many 
applications in biomedical engineering. While stereolithography has long been established as one 
of the most robust approaches for patterning cells and biomaterials in 3D, high-resolution 
projection SLA machines have only recently been applied to this area. As a result, very few 
studies have examined the use of projection SLA systems for fabricating complex 3D structures 
with encapsulated cells, and none to date have demonstrated multi-material 3D patterning at 
resolutions < 10 µm. We have demonstrated high-resolution fabrication and long-term viability 
of four cell types encapsulated within µSLA patterned hydrogels. The µSLA we have built is 
capable of multi-material fabrication with high-resolution feature sizes in 3D and furthermore, 
has the ability to build smooth 3D structures in a single exposure using the grayscale capabilities 
of the SLM digital mask.  
In this study, we exploit the high-resolution fabrication capabilities of the µSLA to 
address a design challenge posed by treatment of tissue ischemia via targeted angiogenesis. By 
fabricating sub-millimeter scale angiogenic patches containing VEGF-secreting cells and 
optimizing the design parameters via ELISA, we produced a therapeutic hydrogel patch that can 
be used to stimulate the growth of neovasculature in ovo as assessed via CAM assay. This 
demonstration sets the stage for future in vivo studies that employ a noninvasive surgical 
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approach to treating ischemia by injecting VEGF-secreting patches via a catheter. This is 
anticipated to produce enhanced therapeutic outcomes as compared to traditional approaches.  
 While the angiogenic patches presented here represent one possible application of the 
µSLA technology, this machine is widely adaptable to a range of applications that require 
patterning of cells and cell signals at high resolution. This novel 3D printing apparatus could be 
used to engineer micro-scale tissues and organs for high-throughput drug testing, or to study 
disease development in vitro. There are also myriad applications of this 3D printing machine in 
cell therapy and regenerative medicine for other tissue types, beyond vasculature. By providing 
an efficient and viable method of engineering micro-scale tissues with cells and cell signals 
patterned at resolutions on the order of single cells, this apparatus establishes itself as an 
enabling technology with broad applicability in the field of biomedical engineering. 
 
4.4 Methods 
4.4.1 Design of µSLA Apparatus  
Broadband light in the 350-650 nm wavelength range (with an intensity peak at 365 nm) 
from a light source (X-Cite Series 120, Lumen Dynamics) is passed through a liquid filled light 
guide (Lumen Dynamics). A plano-convex lens, L1 (focal length = 300.0 mm, Thorlabs), is 
placed after the collimating adaptor (Zeiss Axio Standard, BioVision Technologies) attached at 
the end of the light guide, to focus the light onto a spatial light modulator (800 x 600 pixels) 
sandwiched between two orthogonal polarizers (PowerLite S5, Epson). A plano convex lens, L2 
(focal length = 250.0 mm, Thorlabs), acts as a tube lens prior to the objective lens (10X, NA = 
0.3, WD = 16.5, Nikon). The objective is mounted in a commercial inverted microscope base 
(Nikon Epiphot 200) which has its internal tube lens removed and its turning mirror replaced 
with a UV enhanced aluminum mirror (Thorlabs). In this manner, the projection apparatus is 
interfaced with the microscope through its side camera port. The objective lens projects the de-
magnified image of the SLM pattern onto the polymerization plane. A micrometer translation 
stage (Thorlabs) was used to move the printed layers axially by a prescribed amount during the 
fabrication of 3D parts. To ensure chemical tethering of hydrogel parts to the translation stage, 
glass slides attached to the stage were pretreated with 2% v/v 3-trimethoxysilyl) propyl 
methacrylate (Sigma-Aldrich) in 100% ethanol (Decon Labs) for 5 min, washed in 100% ethanol 
for 5 min, and baked at 110°C for 3 min. 
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4.4.2 Formulation of Hydrogel Resins  
Hydrogel resins used for fabricating parts without encapsulated cells were composed of 
either 40% w/v poly (ethylene glycol) dimethacrylate Mw 1000 g mol-1 (PolySciences, Inc.) or 
poly (ethylene glycol) diacrylate Mw 3400 g mol-1 (Laysan Bio) in phosphate buffered saline 
(PBS, Lonza) with 1% w/v 1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propanone-1-
one photoinitiator (Irgacure 2959, BASF) dissolved in dimethyl sulfoxide (DMSO, Fisher 
Scientific). Hydrogel resins used for fabricating parts with encapsulated cells were dissolved in 
phenol red-free Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies) supplemented 
with 1% L-glutamine (Cellgro Mediatech, Inc.) and 1% penicillin-streptomycin (Cellgro 
Mediatech, Inc.). Murine cells (NIH/3T3 fibroblasts, C2C12 myoblasts, C166 endothelial cells, 
and D1 bone marrow stromal cells) were cultured in DMEM with L-glutamine and sodium 
pyruvate (DMEM, Corning CellGro) supplemented with 10% fetal bovine serum (FBS, Lonza), 
1% L-glutamine (Cellgro Mediatech, Inc.), and 1% penicillin-streptomycin (Cellgro Mediatech, 
Inc.) (GM). Prior to encapsulation, they were trypsinized (TrypeLe, Life Technologies), counted, 
and gently resuspended in the prepolymer solution at concentrations ranging from 5E6 to 1E7 
cells/mL. Fabricated parts were washed in DMEM prior to incubation at 37 °C in GM. For 
visualization of cells stained different colors in different layers of a 3D structure, cells were 
incubated with 1/1000 of green or red cell tracker (CMFDA and CMTPX Dye, Invitrogen) prior 
to suspension in the prepolymer solution.   
 
4.4.3 Assessment of Cellular Viability 
Live/Dead staining of cells was conducted using a viability/cytotoxicity kit for 
mammalian cells (Life Technologies). Hydrogels containing encapsulated cells were incubated 
with calcein AM (2 µM) and ethidium homodimer (4 µM) for 15 min in phenol red-free DMEM 
(Corning CellGro), washed twice in phosphate buffered saline (PBS, Lonza), and imaged in an 
inverted fluorescence microscope. Live cells, stained green, were imaged using a FITC filter and 
dead cells, stained red, were imaged used a TRITC filter. ImageJ was used for counting cells 
from each channel and viability was calculated as the ratio of live cells to the total number of 
cells. Viability was quantitatively assessed over two weeks using a CellTiter 96® AQueous One 
Solution cell proliferation assay (MTS, Promega) by incubating hydrogels containing cells in 
phenol red-free DMEM (200 µL) (Life Technologies) and thawed MTS reagent (20 µL) for 4 h 
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in the dark at 37°C. The assay solution was then removed from the wells and absorbance 
(relative to a control) was measured at 490 nm using a microplate reader (BioTek). Viability 
relative to day 1 was calculated by first subtracting the control absorbance reading from the 
sample absorbance reading, and then dividing by the absorbance on day 1. 
 
4.4.4 Analysis of VEGF Secretion via ELISA 
NIH/3T3 cells were encapsulated within plain and microchanneled patches 
(approximately 900 cells per patch) using prepolymer solution of PEG-da Mw 3400 g mol-1. 
Patches were incubated in  wells (three patches per well) containing GM (200 µL) supplemented 
with 12-O-Tetradecanoylphorbol-13-acetate (100 ng mL-1) (TPA, Sigma Aldrich) for 3 days. 
The media was then removed from the wells and frozen at -20 °C until ready for ELISA.  A 
sandwich enzyme immunoassay kit (R&D Systems) was used to quantify the amount of VEGF 
secreted by the cells in the patches. The frozen media was thawed and incubated for 2 hours in a 
well pre-coated with a polyclonal antibody specific for mouse VEGF, followed by incubation 
with an enzyme-linked polyclonal antibody specific for mouse VEGF. The color intensity of the 
resultant blue byproduct was measured using a microplate reader (BioTek), and the amount of 
VEGF was calculated from a calibration curve (Figure 4.10).  
 
4.4.5 Analysis of Angiogenesis via CAM 
The angiogenic functionality of the VEGF-secreting patches was analyzed in ovo via 
implantation onto a chick chorioallantoic membrane. Patches that had been incubated overnight 
in GM supplemented with TPA (100 ng mL-1) were placed on the membranes and incubated for 
one week. After this period, the membrane tissue was fixed in paraffin and histological sections 
were stained for cell nuclei (haematoxylin) and alpha-smooth actin (α-SMA Immunohistology 
Kit, Sigma Aldrich). Cross-sections were imaged using a digital pathology system (Nanozoomer, 







4.4.6 Statistical Analysis 
Statistical analysis performed via one-way ANOVA followed by Tukey’s Multiple 
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Figure 4.1 µSLA setup and high resolution fabrication demonstration. (A) Schematic of µSLA 
showing UV light collimated and projected through a spatial light modulator that acts as a 
dynamic mask for polymerization. Patterned UV light is demagnified through a microscope 
objective and focused onto the polymerization stage, where it selectively cross-links 
photosensitive resins. 3D parts are built layer by layer from the bottom up in an upside down 
orientation (Figure A.4B). (B) High resolution fabrication of biocompatible hydrogels. B-1) 
Fabrication with PEG-dma 1000 g mol-1 at < 5 µm x–y resolution. B-2) Polymerization with 
PEG-dma 1000 g mol-1 containing encapsulated cells (at a concentration 5E6 cells mL-1) does 
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the prepolymer solution are encapsulated in the cross-linked 
hydrogel network during polymerization. Diffusion of nutrients 
from surrounding media is enabled by the porous nature of the 
3D hydrogels of both molecular weights 1000 and 3400 g mol−1.
2.1.2. Multimaterial 3D Fabrication
The thickness of a polymerized hydrogel is dictated by the degree 
of UV-mediated cross-linking, as predicted by an adapted form 
of the Beer–Lambert equation which relates the intensity of a 
light source to its penetration depth within a resin.[28] Regu-
lating the energy dose of UV light, which is a function of both 
light source power and exposure time, thereby provides a precise 
method of fabricating 3D structures of specified layer thicknesses. 
Figure S1-B (Supporting Information) shows the relationship 
between energy dose and thickness for both 1000 and 3400 g mol−1 
PEG-based resins. The lines fitted to these data were used to fabri-
cate 3D structures of precisely dictated layer thickness.
To enable fabrication of multilayer structures, the pre-
polymer solution was injected onto the hydrophobic poly-
merization plane and covered by a glass coverslip connected to 
a micrometer stag . The surface of this coverslip was chemi-
cally modified to present methacrylate functional groups which 
cross-linked with the prepolymer resin during UV exposure and 
patterning. Following the polymerization of the first layer of a 
3D part, the micrometer stage moved up, and the chemically 
tethered first layer moved up with the stage. This allowed for 
the injection of more resin onto the polymerization plane and 
cross-linking of the second layer. In this manner, 3D structures 
were polymerized layer-by-layer from the bottom-up (Movie S1, 
Supporting Information).
One of the disadvantages of both laser-based and projection 
SLA has been the difficulty of fabricating multimaterial struc-
tures. In prior studies, researchers have accomplished multi-
material fabrication with SLA by incorporating multiple wash 
steps between fabricated layers,[18,29] or modifying the fabrica-
tion platform through the addition of mini “vats” containing 




Figure 1. µSLA setup and high resolution fabrication demonstration. A) Schematic of µSLA showing UV light collimated and projected through a spatial 
light modulator that acts as a dynamic mask for polymerization. Patterned UV light is demagnified through a microscope objective and focused onto the 
polymerization stage, where it selectively cross-links photosensitive resins. 3D parts are built layer by layer from the bottom up in an upside down ori-
entation (Figure S2B, Supporting Information). B) High resolution fabrication of biocompatible hydrogels. B-1) Fabrication with PEG-dma 1000 g mol−1 
at <5 µm x–y resolution. B-2) Polymerization with PEG-dma 1000 g mol−1 containing encapsulated cells (at a concentration 5E6 cells mL−1) does not 
compromise high-resolution fabrication capabilities.
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Figure 4.2 (A) High resolution fabrication of lines and holes with PEG-da 3400 g mol-1 hydrogel 
resin showing feature sizes down to 30 µm. (B) Semi-log graph showing polymerized part 
thickness as a function of UV energy dose for PEG-based resins of molecular weights 1000 

























Figure 4.5 Multi-material 3D fabrication with µSLA. (A) Multi-material fabrication of 3D 
structures is demonstrated with both “negative” features A-1) and positive features A-2). Parts 
are fabricated by projecting UV light in the pattern and onto the resin prescribed as Layer 1. The 
micrometer stage then moves up 75 µm and the second layer is fabricated with the resin and UV 
light pattern labeled Layer 2. The fabricated part is then released from the stage. (B) Multi-
material fabrication of 3D structures containing encapsulated cells. Layer 1 contains cells stained 
with a green fluorescent dye and Layer 2 contains cells stained with a red fluorescent dye. Image 
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different polymers.[30] A simple design modification allowed 
us to simplify the process of building multimaterial 3D struc-
tures, thereby increasing fabrication efficiency. Most previously 
presented projection SLA systems build parts layer by layer 
from the bottom-up, as does the µSLA presented here.[17,29,31] 
However, while these apparatus build parts in the “right-
side-up” orientation (Figure S2A, Supporting Information), 
where the stage moved down for each polymerized layer, our 
system builds parts “upside down,” or inverted (Figure S2B, 
Supporting Information). This modification removes each 
fabricated layer from the surrounding resin, rather than sub-
merging it deeper within, thus eliminating the need for a wash 
step. Furthermore, the next layer of prepolymer can be directly 
injected onto the polymerization stage, without requiring the 
removal of the stage. This allows for a significant increase in 
fabrication efficiency. When fabricating with cells encapsulated 
within a polymer, the traditional “right-side-up” orientation 
comes with the disadvantage of cells settling to the bottom of 
the stage during polymerization. With our inverted fabrication 
setup, cells in each layer are thoroughly mixed and polymerized 
before settling, enabling 3D uniformity in cell-laden hydrogels 
(Figure S3, Supporting Information).
The µSLA’s ability to fabricate parts with high-resolution fea-
ture sizes is maintained while fabricating 3D multilayer and 
multimaterial structures. A demonstration of negative features 
(i.e., holes/channels) in a two-layer dual material structure is 
presented in Figure 2A-1. This 3D design is fabricated by first 
polymerizing a uniform rectangle using a pink-dyed PEG-dma 
1000 g mol−1 resin followed by polymerization of a cross-hatch 
pattern using a clear PEG-dma 1000 g mol−1 resin. As observed 
in top view and side view images taken 1 h postfabrication, 5 µm 
wide channels are formed in the second layer. Similarly, 
Figure 2A-2 presents fabrication of positive features (concentric 
cylinders of decreasing diameter) in a two-layer dual material 
structure.
Multimaterial 3D fabrication is also demonstrated with 
encapsulated NIH/3T3 fibroblast cells (Figure 2B). Unlike the 
structures presented in Figure 2A, in which the resin itself 
was dyed, the cells encapsulated in each layer of this dual-layer 
structure are stained with long-term live cell fluorescent stains 
(Layer 1—Green, Layer 2—Red) and encapsulated within a clear 
PEG-da 3400 g mol−1 resin. The fluorescent image, taken 24 h 
postfabrication, shows that the stained cells are segregated in 
each layer, with some cells crossing the boundary between layers 
due to proliferation and migration over the 24 h incubation. 
This demonstration sets the stage for fabricating multimaterial 
3D structures composed of multiple cell types, a capability that 
is fundamental to developing tissue/organ mimics in vitro for 
applications in tissue engineering and organ-on-a-chip devices.
2.1.3. Grayscale Fabrication
Most projection stereolithography apparatus employ digital 
micromirror devices (DMD) as dynamic masks for poly-
merization.[17,32] These devices, which rely on moving 




Figure 2. Multimaterial 3D fabrication with µSLA. A) Multimaterial fabrication of 3D structures is demonstrated with both “negative” features A-1) 
and positive features A-2). Parts are fabricated by projecting UV light in the pattern and onto the resin prescribed as Layer 1. The micrometer stage 
then moves up 75 µm and the second layer is fabricated with the resin and UV light pattern labeled Layer 2. The fabricated part is then released from 
the stage. B) Multimaterial fabrication of 3D structures containing encapsulated cells. Layer 1 contains cells stained with a green fluorescent dye and 











Figure 4.7 Grayscale fabrication of structures. (A) A grayscale projected image (A-1, top) 
produces a smooth dome-like structure (A-2, top) in a single exposure. 3D projection of light 
intensity is shown for both the projected image (A-1, bottom) and the fabricated part (A-2, 
bottom). A-3) Graph showing the relative light intensity of both the projected image and the 
fabricated part along a line drawn across both images. (B) A grayscale projected image (B-1, 
top) produces a smooth dome-like hole (B-2, top) in a single exposure. 3D projection of light 
intensity is shown for both the projected image (B-1, bottom) and the fabricated part (B-2, 
bottom). B-3) Graph showing the relative light intensity of both the projected image and the 
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microscale metal mirrors to turn pixels “on” and “off,” can be 
reliably used to reproduce black and white images. Grayscale 
fabrication with digital masks that produce three grayscale 
levels (black, white, and gray) have also been demonstrated 
with projection SLA, with applications in creating self-sacrificial 
structures that are chemically etched to produce overhanging 
features.[33] Building on this demonstration, the SLM used in 
the µSLA system presented here is one of the three chips from 
a multimedia projector (Epson Powerlite S5) which is capable 
of producing multilevel (eight-bit) grayscale images. Since the 
thickness of a hydrogel structure is dictated by the degree of 
exposure to UV light, this grayscale projection enables the 
fabrication of smooth 3D structures in a single exposure. For 
example, fabricating a simple dome-shaped 3D structure with a 
DMD-based SLA would require sequential exposure of multiple 
circular layers, each with decreasing diameter. This gives the 
dome a rough ladder-like surface, with surface roughness dic-
tated by layer thickness (Figure S4A, Supporting Information). 
Using the SLM-based µSLA, however, this dome-shaped struc-
ture can be fabricated in one step by projecting a grayscale 2D 
image with light intensity decreasing radially from the center 
(Figure 3A1–2 and Figure S4B, Supporting Information). Pro-
cessing these images in 3D and plotting the relative intensity 
along a line drawn across the dome show that the height of 
different regions in the fabricated part is dictated by the corre-
sponding intensity of projected light at that region (Figure 3A3). 
A similar demonstration of a negative feature (dome-shaped 
hole) shows that grayscale-enabled fabrication of smooth fea-
tures is applicable to a variety of 3D part designs (Figure 3B).
2.2. Cell Viability
There have been limited reports of cellular viability postencap-
sulation using a projection stereolithography apparatus,[21] and 
no demonstrations of viability in multiple cell types over a long-
term in vitro culture period (more than a week). Establishing 
projection SLA as an enabling tool for applications in tissue 
engineering thus requires definitive proof of cellular viability 
and maintenance of cellular function following the printing 
process. In this study, we mixed murine cells of four types 
(C2C12 myoblasts, C166 endothelial cells, NIH/3T3 fibroblasts, 
and D1 bone marrow stromal cells) with prepolymer PEG-
dma 1000 g mol−1 and PEG-da 3400 g mol−1 resins. Rectan-
gular hydrogel blocks (740 µm × 530 µm wide, 360 µm thick) 
containing cells encapsulated at 7.5 × 106 cells mL−1 concen-
tration (corresponding to ≈1000 cells/hydrogel block) were fab-
ricated for each cell type and each hydrogel resin. Viability of 
cells seeded within these blocks was quantitatively assessed via 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfo-phenyl)-2H-tetrazolium)) colorimetric assay, which 
measures the absorbance of a purple formazan byproduct that 
indicates the presence of metabolically active cells (Figure 4A). 
The MTS assay was performed on the day after fabrication (day 1), 




Figure 3. Grayscale fabrication of structures. A) A grayscale projected image ( -1, top) produces a smooth dome-like structure (A-2, top) in a single 
exposure. 3D projection of light intensity is shown for both the projected image (A-1, bottom) and the fabricated part (A-2, bottom). A-3) Graph showing 
the relative light intensity of both the projected image and the fabricated part along a line drawn across both images. B) A grayscale projected image 
(B-1, top) produces a smooth dome-like hole (B-2, top) in a single exposure. 3D projection of light intensity is shown for both the projected image 
(B-1, bottom) and the fabricated part (B-2, bottom). B-3) Graph showing the relative light intensity of both the projected image and the fabricated 
part along a line drawn across both images.
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Figure 4.8 Long-term viability of printed cells. (A) Hydrogel blocks imaged after an MTS assay 
used to quantify cell viability. The formation of purple formazan crystals indicates the presence 
of living cells. (B) Live/dead staining of 3T3 fibroblast cells encapsulated in hydrogel PEG-
based resins of Mw 1000 and 3400 g mol
-1. Cells encapsulated in the lower molecular weight 
polymer demonstrate a viability of 70% ± 10%, whereas cells encapsulated in the higher 
molecular weight polymer (representative live/dead stained fluorescent image shown on right) 
demonstrate a viability of 93% ± 3% on day 1 after printing (P < 0.05, n = 4, one-way analysis of 
variance (ANOVA), post hoc Tukey test). (C) Cell viability over a two week period is assessed 
via MTS assay for four cell types (C2C12 myoblasts, C166 endothelial cells, 3T3 fibroblasts, 
and D1 bone marrow stromal cells) for PEG-based resins of Mw 1000 (C-1) and 3400 g mol
-1 
(C-2) (P < 0.05, n = 3, one-way ANOVA, post hoc Tukey test). Viability is shown relative to 
viability on day 1 (i.e., all MTS absorbance values are normalized to the absorbance on day 1). 
For all cell types in PEG-dma Mw 1000 g mol
-1, viability does not significantly change over the 
two week period. For all cell types in PEG-da Mw 3400 g mol
-1, viability increases over the two 
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to establish a baseline on cell viability. Relative cell viabilities 
on days 5, 9, and 14 were then calculated by normalizing the 
measured absorbance on each day with the absorbance meas-
ured on day 1. The actual viability (specified by the number of 
live cells divided by the total number of encapsulated cells) for 
each resin formulation was calculated via live/dead fluorescent 
staining. These viability results, which show statistically signifi-
cant improvements in viability for PEG-da 3400 g mol−1 as com-
pared to PEG-dma 1000 g mol−1, are presented for NIH/3T3 
cells but were consistent across the four cell types (Figure 4B).
For PEG-dma Mw 1000 g mol−1, viability was calculated via 
live/dead staining to be 70% ± 10% on day 1 following fabrica-
tion. The viability of all four cell types demonstrated neither sig-
nificant increase nor decrease over the two-week culture period, 
proving that cellular viability was maintained in this resin fol-
lowing encapsulation via the µSLA (Figure 4C-1). For PEG-da 
Mw 3400 g mol−1, viability was calculated to be 93% ± 3% on 
day 1 following fabrication. The relative cell viability, as calcu-
lated via the MTS assay, increased for all cell types over the two-
week culture period, with statistically significant increases seen 
for C2C12, 3T3, and D1 cell types (Figure 4C-2). The enhanced 
viability in PEG-da Mw 3400 g mol−1 as compared to PEG-dma 
Mw 1000 g mol−1 is attributed to the larger pore sizes present in 
hydrogel networks composed of higher molecular weight (i.e., 
longer-chain) monomers.[18] While the increased swelling ratio 
of this resin postcrosslinking limits the highest observable reso-
lution in fabricated parts (30 µm for PEG-da Mw 3400 g mol−1 
vs 3 µm for PEG-dma Mw 1000 g mol−1), the corresponding 
increase in diffusion of nutrients from surrounding media 
motivates the use of Mw 3400 g mol−1 in biomedical applica-
tions that require maximum cellular viability.
2.3. Patterning of Neovasculature
Trauma or disease that results in the reduction of blood supply 
to tissue in vivo produces ischemia, which can severely damage 
surrounding tissue.[34] Current treatment for ischemia relies 
largely on the use of anticoagulants, but recent developments 
in regenerative medicine motivate therapeutic treatment of 
ischemia by an alternative method: encouraging the forma-
tion of neovasculature to renew blood supply to the damaged 
tissue.[35] Prior studies have demonstrated that targeted secre-
tion of angiogenic factors, such as vascular endothelial growth 
factor (VEGF) and endothelin, from cell-encapsulating hydrogel 
patches can drive the formation of new blood vessels on a chick 




Figure 4. Long-term viability f printed cells. A) Hydrogel blocks imaged after an MTS assay used to quantify cell viability. The formation of purple 
formazan crystals indicates the presence of living cells. B) Live/dead staining of 3T3 fibroblast cells encapsulated in hydrogel PEG-based resins of Mw 
1000 and 3400 g mol−1. Cells encapsulated in the lower molecular weight polymer demonstrate a viability of 70% ± 10%, whereas cells encapsulated 
in the higher molecular weight polymer (representative live/dead stained fluorescent image shown on right) demonstrate a viability of 93% ± 3% on 
day 1 after printing (P < 0.05, n = 4, one-way analysis of variance (ANOVA), post hoc Tukey test). C) Cell viability over a two week period is assessed 
via MTS assay f r four cell types (C2C12 myoblasts, C166 endothelial cells, 3T3 fibroblasts, a d D1 bone marrow stromal cells) for PEG-based resins 
of Mw 1000 C-1) and 3400 g mol−1 C-2) (P < 0.05, n = 3, one-way ANOVA, post hoc Tukey test). Viability is shown relative to viability on day 1 (i.e., all 
MTS absorbance values are normalized to the absorbance on day 1). For all cell types in PEG-dma Mw 1000 g mol−1, viability does not significantly 
change over the two week period. For all cell types in PEG-da Mw 3400 g mol−1, viability increases over the two week period, with significant increases 
observed in C2C12, 3T3, and D1 cells.
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Figure 4.9 Angiogenic patch design verification. (A) Patch design and dimensions shown 
(without encapsulated cells) for both the plain patch (A-1) and microchanneled patch (A-2) 
designs. Plain patches had a calculated surface area to volume ratio of 1.2% and microchanneled 
patches had a calculated surface area to volume ratio of 1.6%. (B) VEGF secretion assessed via 
ELISA. Using the calibration curve and fitted equation shown in Figure 4.10B, optical density 
values (Figure 4.10A) are converted to concentrations of secreted VEGF for plain patches and 
microchanneled patches. Microchanneled patches produced significantly higher concentrations 
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chorioallantoic membrane in ovo model.[36] The incorporation 
of channels hundreds of micrometers wide within these cen-
timeter-scale patches enhanced the flux of cell-secreted VEGF 
onto the CAM. This micropatterned release of biomolecules 
into tissue helped guide the growth direction and spacing of 
new blood vessels. This demonstration was sufficiently suc-
cessful as a first demonstration, but true applicability as an in 
vivo therapy requires that such angiogenic patches be scaled 
down to the submillimeter length scale to allow for noninvasive 
injection into tissue via catheters. This scale reduction would 
increase the viability of cells encapsulated within the angio-
genic patches, and the incorporation of smaller channels within 
these patches would increase the diffusive flux of VEGF from 
patch to tissue. This design challenge can readily be addressed 
by the high-resolution fabrication capabilities of the µSLA.
2.3.1. Analysis of VEGF Secretion In Vitro Via ELISA
Two angiogenic patch designs were assessed for VEGF secretion 
via ELISA: (1) a “plain patch” consisting of a simple hydrogel block 
(740 µm × 530 µm wide, 360 µm thick) and (2) a “microchan-
neled patch” consisting of a hydrogel block (740 µm × 530 µm 
wide, 360 µm thick with four 100 µm diameter channels). 
Both types of patches encapsulated ≈900 NIH/3T3 fibroblast 
cells activated to release proangiogenic factors. These chan-
nels were expected to increase the diffusive flux of VEGF out 
of the patches and into the surrounding medium by enhancing 
the ratio of surface area/volume (Figure 5A). Furthermore, by 
reducing the distance between any encapsulated cell and the 
surrounding medium, the microchanneled design enhanced 
diffusion of nutrients from the surrounding medium into the 
patches. To test the hypothesis that microchanneled patches 
would enhance the diffusive flux of cell-secreted VEGF, we 
fabricated patches of each design and incubated them in warm 
growth medium containing tetradecanoylphorbol 13-acetate 
(TPA), a chemical known to stimulate cells to secrete VEGF.[36] 
Optical density of the fluorescent signal produced during the 
ELISA test (performed after 3 d of incubation) was measured 
for both patch designs, as well as for a negative control (growth 
medium containing TPA, no patches or cells) and a positive 
control (cells seeded in a well containing growth medium sup-
plemented with TPA) (Figure S5A, Supporting Information). 
Optical density was converted to an actual concentration using 
a calibration curve (Figure S5B, Supporting Information). 
Microchanneled patches produced 136.1 ± 4.8 ng mL−1 VEGF, 
significantly greater than the amount produced by plain patches 
of 72.4 ± 27 ng mL−1 VEGF (Figure 5B). As expected, no VEGF 
was detected in the negative control. Both plain and microchan-
neled patches produced greater amounts of VEGF than the 
positive control. This was explained by the observation that cells 
were migrating out of the patches and proliferating on the base 
of the wells, contributing to the increased VEGF production 
observed via ELISA. Based on these results, microchanneled 
patches were used in subsequent CAM assay experiments.
2.3.2. Analysis of VEGF Secretion In Ovo Via CAM Assay
To test the efficacy of the microchanneled patches in producing 
VEGF and encouraging vascular regeneration in an in ovo set-
ting, we fabricated microchanneled patches with encapsulated 
NIH/3T3 fibroblasts, incubated them in growth medium con-
taining TPA for 1 d, and then placed them onto a chick chorio-
allantoic membrane for one week (Figure 6A). The membranes 
were then sectioned and stained for DAPI (4′6-diamidino-
2-phenylindole) (cell nuclei) and smooth actin (Figure 6B). The 
number of blood vessels and the areas of blood vessels were 
quantified in a control group and a test group by imaging his-
tological cross-sections. The control group membranes were 
incubated with “unloaded” microchanneled patches that did 
not contain encapsulated cells, and the test group membranes 
were incubated with “loaded” microchanneled patches con-
taining encapsulated and TPA-stimulated NIH/3T3 fibroblasts. 
After one week, the membranes incubated with loaded patches 
had 12.1% ± 1.1% vessel area/tissue area, whereas membranes 
incubated with unloaded patches had a significantly lower per-
centage of 6.3% ± 0.6% vessel area/tissue area (Figure 6C-1). 
These results indicate that the loaded microchanneled patches 
were indeed angiogenic and encouraged the formation of 




Figure 5. Angiogenic patch design verification. A) Patch design and dime sions shown (without encapsulated cells) for both the plain patch A-1) and 
microchanneled patch A-2) designs. Plain patches had a calculated surface area to volume ratio of 1.2% and microchanneled patches had a calculated 
surface area to volume ratio of 1.6%. B) VEGF secretion assessed via ELISA. Using the calibration curve and fitted equation shown in Figure S5B (Sup-
porting Information), optical density values (Figure S5A, Supporting Information) are converted to concentrations of secreted VEGF for plain patches 
and microchanneled patc es. Micro hann led patches produced significantly higher concentrations of secreted VEGF than plain patches (P < 0.05, 
n = 3, one-way ANOV , post hoc Tukey test).
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Figure 4.10 (A) Optical density of the fluorescent signal produced after the ELISA assay by all 
four cases (negative control, positive control, plain patches, and microchanneled patches). (B) 
Calibration curve relating optical density to VEGF concentration. A fitted regression formula is 
used to calculate VEGF concentration presented in Figure 4.9B 112. 
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Figure 4.11 Angiogenic functionality of patches assessed via CAM assay. (A) Schematic of 
CAM assay showing a microchanneled patch containing encapsulated fibroblasts placed on a 
chick chorioallantoic membrane. The encapsulated cells are TPA-stimulated to secrete VEGF, 
encouraging the formation of neovasculature on the CAM. (B) A histological section of the 
CAM assay, stained for cell nuclei stain (haematoxylin, blue) and alpha-smooth actin (brown), is 
used to quantify the number of blood vessels as well as the area of blood vessels within the 
membrane. Two vessels are specifically highlighted to show how areas were measured. (C) 
Comparison of vessel areas in the control (unloaded patches) and loaded patches groups. Patches 
loaded with VEGF-secreting fibroblasts had a greater percentage of vessel area/tissue area (C-1) 
than the control (P < 0.05, n = 3, one-way ANOVA, post hoc Tukey test). The vessel areas were 
widely distributed in both experimental groups (C-2), with an increased number of vessels 












neovasculature in ovo. A histogram displaying the distribu-
tion of blood vessel area for a representative sample from the 
unloaded and loaded patch groups shows the broad variation 
in vessel size for both groups (Figure 6C-2). Loaded patches 
had, on average, 133 vessels mm−2 tissue area and unl aded 
patches had, on average, 54 vessels mm−2 tissue area. Hence 
it is evident that the loaded patches enhanced angiogenesis in 
the membrane by stimulating the growth of new blood vessels.
3. Conclusion
Adaptation of 3D printing technologies to biofabrication has 
recently enabled many applications in biomedical engineering. 
While stereolithography has long been established as one of 
the most robust approaches for patterning cells and bioma-
terials in 3D, high-resolution projection SLA machines have 
only recently been applied to this area. As a result, very few 
studies have examined the use of projection SLA systems for 
fabricating complex 3D structures with encapsulated cells, and 
none to date have demonstrated multimaterial 3D patterning 
at resolutions <10 µm. We have demonstrated high-resolution 
fabrication and long-term viability of four cell types encapsu-
lated within µSLA patterned hydrogels. The µSLA we have built 
is capable of multimaterial fabrication with high-resolution 
feature sizes in 3D and furthermore, has the ability to build 
smooth 3D structures in a single exposure using the grayscale 
capabilities of the SLM digital mask.
In this study, we exploit the high-resolution fabrication 
capabilities of the µSLA to address a design challenge posed 
by treatment of tissue ischemia via targeted angiogenesis. By 
fabricating submillimeter scale angiogenic patches containing 
VEGF-secreting cells and optimizing the design parameters 
via ELISA, we produced a therapeutic hydrogel patch that 
can be used to stimulate the growth of neovasculature in ovo 
as assessed via CAM assay. This demonstration sets the stage 
for future in vivo studies that employ a noninvasive surgical 
approach to treating ischemia by injecting VEGF-secreting 
patches via a catheter. This is anticipated to produce enhanced 
therapeutic outcomes as compared to traditional approaches.
While the angiogenic patches presented here represent one 
possible application of the µSLA technology, this machine is 
widely adaptable to a range of applications that require patterning 
of cells and cell signals at high resolution. This novel 3D printing 
Figure 6. Angiogenic functionality f patches assessed via CAM assay. A) Schematic of M assay showing a microchanneled patch containing 
encapsulated fibroblasts placed on a chick chorioallantoic membrane. The encapsulated cells are TPA-stimulated to secrete VEGF, encouraging the 
formation of neovasculature on the CAM. B) A histological section of the CAM assay, stained for cell nuclei stain (haematoxylin, blue) and alpha-smooth 
actin (brown), is used to quantify the number of blood vessels as well as the area of blood vessels within the membrane. Two vessels are specifically 
highlighted to show how areas were measured. C) Comparison of vessel areas in the control (unloaded patches) and loaded patches groups. Patches 
loaded with VEGF-secreting fibroblasts had a greater percen ge of vessel area/tissue area C-1) th n t e contr l (P < 0.05, n = 3, one-way ANOVA, post 
hoc Tukey test). The vessel areas were widely distributed in both experimental groups C-2), with an increased number of vessels observed in loaded 
patches as compared to the control.
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CHAPTER 5: 3D PRINTED MUSCLE-POWERED BIO-BOTS 
 
5.1 3D Printed Skeletal Muscle-Powered Bio-Bots Controlled Via Electrical Signals5 
5.1.1 Introduction 
Soft robotic devices composed of adaptable materials permit deformation, locomotion, 
and control with greater degrees of freedom in a simple, low power, and cost-effective manner 
compared to traditional robotics composed of metallic and rigid structures 138–140. Combining 
biological entities such as cells or tissues with soft materials can yield biological machines with 
the ability to dynamically sense and adapt to environmental cues and applied stimuli. A bio-
integrated approach to soft robotics can allow for the realization of biological machines with the 
ability to interface with the environment and other living systems. An intuitive demonstration of 
a biological machine is a system that can generate force resulting in net locomotion. To that end, 
many studies have explored the use of biological components, such as DNA 141, swarms of 
bacterial cells 142, motile sperm cells 143, and contractile muscular tissues excised from living 
organisms 144–146 as power sources with the ability to exhibit a dynamic locomotive response 
across length scales 147–150.  
Recent advances in cardiac muscle tissue engineering have yielded dense tissues that 
form a syncytium, enabling the coordinated propagation of electrical signals and synchronous 
contraction of engineered muscle 151. This advantageous property has helped to produce 
machines that include self-assembling microelectromechanical system (MEMS)-based 
cantilevers 152, 2D biohybrid ‘muscular thin films’ 153, and ‘crab-like’ robots 154. These systems 
were powered by applied electric field stimulation or spontaneous contraction of engineered 
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cardiac muscle 155, which have also been utilized as power sources for locomotive machines such 
as a swimming muscle-elastomer ‘jellyfish’ 156,157, a self-propelled swimming robot 158, and a 
walking millimeter-scale ‘biological bimorph’ cantilever 88,97, respectively.  
Although these soft robots have used cardiac muscle, it should be noted that skeletal 
muscle is the primary generator of actuation in animals. In vivo, skeletal muscle exhibits 
organized modular tissue architecture on a range of length scales and supports uniaxial force 
production. Unlike cardiac tissue, it does not demonstrate significant spontaneous contractility, 
allowing for more precise control over actuation via external signaling from sources such as 
electrical stimulation, neural signals, or optogenetics 159. Furthermore, skeletal muscle can 
interface with multiple other mammalian cell types, such as neurons and endothelial cells, 
making it an ideal platform for producing locomotion in living cellular systems 148,149,160.  
 In this paper, we present an untethered locomotive biological machine, or ‘bio-bot,’ 
powered by the contraction of engineered skeletal muscle. The structure of the bio-bot was 
fabricated from a synthetic hydrogel using stereolithographic 3D printing, which boasts a short 
fabrication time, potential for scalability, and spatial control. The use of additive manufacturing 
processes for a myriad of biomedical applications has increased in recent years, owing to the 
user’s ability to rapidly polymerize an assortment of biocompatible materials with controllable 
geometric and mechanical properties at the micro- and macro- scales 1. Skeletal muscle 
myoblasts were embedded in a natural extracellular matrix (ECM) of collagen I and fibrin matrix 
proteins, differentiated in the presence of insulin-like growth factor 1 (IGF-1) growth factor, and 
self-assembled into a 3D muscle strip capable of contractility and sufficient force generation to 
power net locomotion of the bio-bot upon electrical signaling (Figure 5.1). To our knowledge, 
this is the first demonstration of an untethered biological machine powered by engineered 
mammalian skeletal muscle and controlled purely via external signaling, and hence represents an 
important advance in building bio-integrated soft robotic devices for a myriad array of 
applications in sensing and actuation. 
 
5.1.2 Results and Discussion 
5.1.2.1 Design and Fabrication of 3D Bio-Bots 
To construct the structure of the bio-bot, we utilized a modified Stereolithography 
Apparatus (SLA), a liquid-based rapid prototyping technology 1, to print a millimeter-scale 
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hydrogel  poly (ethylene glycol) diacrylate) of Mr 700 g mol-1 (PEGDA Mr 700) device 
composed of two stiff pillars connected by a compliant beam (Figure 5.2A,B). We utilized a 
linear elastic simulation to determine optimal beam and pillar dimensions that would combine 
high deflection with a robust mechanical structure (Figure 5.3). A liquid suspension of  mouse 
myoblast cell line C2C12 skeletal muscle myoblasts and ECM proteins was added around the 
pillars of the bio-bot and polymerized via gelation of the matrix proteins (Figure 5.2C,D). 
Embedded cells exerted traction forces on the fibrous proteins via integrin attachments to 
compact the matrix into a 3D muscle strip over time (Figure 5.4D,E), and the capped pillars 
acted as a physical anchor for the muscle strip. This bio-inspired design mimics the in vivo 
musculoskeletal arrangement in which force transmission occurs from a contracting muscle to 
bone through a connecting tendon (Figure 5.4F). 
The ECM contributes to maintaining cellular processes and communication in normal 
growth and maturation of skeletal myoblasts. Collagen I and fibrin are natural hydrogels that 
allow for muscle cell proliferation, spreading, and alignment, as well as tissue contraction on a 
macroscopic scale 161,162. We tested both matrix proteins for their ability to support the 
development and organization of embedded myoblasts and provide a compliant system for tissue 
contraction. The cell-matrix solution consisted of either matrix protein with cell concentrations 
varying from 1 – 10 x 106 cells ml-1 (Figure 5.5). We observed that cell traction forces increased 
with cell concentrations; lower concentrations resulted in less compaction, whereas higher cell 
concentrations caused muscle strip fracture. We deemed an intermediate concentration of 5 x 106 
cells ml-1 as optimal.  
 
5.1.2.2 Muscle Strip Differentiation and Robustness 
To improve the formation and functional performance of 3D muscle strips, we studied the 
effect of IGF-1 on myotube formation in 2D and 3D culture. Insulin-like growth factors play a 
role in skeletal tissue growth in vertebrates by encouraging myoblast proliferation and 
differentiation 163,164. Over-expression or exogenous addition of IGF-1 also enhances muscle 
hypertrophy 165 and decelerates muscle decline in differentiated myofibers 166. In 2D culture, as 
expected, the fusion of myoblast precursor cells during myogenesis produced elongated, multi-
nucleated myotubes 167. Over 2.5 wk, the average myotube density of myoblast cultures 
supplemented with 50 ng ml-1 IGF-1 significantly increased from 31.8 ± 8.3 to 126.9 ± 30.3 
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myotubes mm-2 compared to the control with no added IGF-1 (Figure 5.6A,B), and did not 
change significantly after day 7, when muscle strips were electrically stimulated. 
Translating these results to 3D, we then studied the effect of IGF-1 addition (beyond that 
included in the MatrigelTM basement membrane) on the formation and functionality of fibrin and 
collagen muscle strips. Differentiated, multinucleated myotubes were distributed throughout 
muscle strips supplemented with IGF-1 (Figure 5.7A,B). Muscle strips cultured without IGF-1 
contained populations of both undifferentiated myoblasts as well as multinucleated myotubes at 
later time points (Figure 5.7C,D), signaling that although IGF-1 increased the rate of fusion and 
maturation, its absence did not hinder muscle strip development. With the addition of 50 ng ml-1 
IGF-1, the portion of the fibrin-based muscle strip occupied by cells significantly increased 
(Figure 5.6D,E).  
Despite cross-linking during polymerization, fibrinogen is extremely susceptible to rapid 
degradation by cell-secreted proteases such as plasmin 168. In vivo, natural inhibitors of plasmin 
prevent indiscriminate matrix digestion; however, in vitro, C2C12s can produce plasmin-
activating plasminogen, and a protease inhibitor such as ε-aminocaproic acid (ACA) must be 
added to ensure stability of the system 169. Addition of 1 mg ml-1 ACA helped to maintain the 
structural integrity of the muscle strip, significantly increasing the lifetime of the muscle strip 
before rupture (Figure 5.6C). The bio-bots presented in this study were supplemented with 1 mg 
ml-1 ACA, and 0 (without) or 50 (with) ng ml-1 IGF-1. 
Hematoxylin and eosin (H&E) staining of histological sections of IGF-1 supplemented 
fibrin muscle strips revealed an increased peripheral cell density compared to the center (Figure 
5.7E-H). We located over 75% of cells within 200 µm of the edge of the fibrin muscle strip, a 
distance consistent with the upper limit of diffusion of oxygen within a tissue 87. Finally, we used 
a MTS assay to evaluate cell viability over time. The relative absorbance of muscle strips 
(normalized to day 0) indicated a 85.76 ± 10.74% and 79.71 ± 14.78% viability of cells within 
the muscle strip after days 6 and 9, respectively (Figure 5.6F). As compared to the control 






5.1.2.3 Optimization of Muscle Force Generation.  
To optimize force production capabilities of the engineered muscle strip, we studied the 
effect of varying biological and mechanical environmental cues during muscle differentiation 
and maturation. By varying the laser energy dose of polymerization of the SLA, we created 
hydrogel structures with a range of tunable properties and conformations without changing the 
composition or molecular weight of the material. The elastic modulus of the hydrogel beam (as 
measured by tensile testing in a hydrated sample chamber) increased logarithmically from 214.6 
– 741.6 kPa with laser energy doses varying from 108.7 – 512.6 mJ cm-2, due to a higher degree 
of cross-linking by higher energy doses. With compaction of the muscle strip, traction forces 
exerted by cells produced an inward force on the pillars, which gave rise to varying degrees of 
bending in the beam. As expected, the stiffer hydrogel structures offered a greater resistance to 
bending; thus, beams with higher elastic moduli exhibited a lower deflection in response to 
passive tension forces exerted by the muscle strips (Figure 5.8A and Figure 5.9A).  
Using Euler-Bernoulli linear bending theory (see Methods and Fig. 5.9C), we derived a 
formula relating the observed hydrogel beam deflection to the muscle-generated passive tension 
force. An increase in beam stiffness resulted in an increased tension in the muscle strip at rest. 
For elastic moduli of 214.6, 319.4, 411.2, and 489.3 kPa, the passive tension averaged 860.6 ± 
47.2, 992.7 ± 34.3, 1103.6 ± 45.8, and 1146.0 ± 69.0 µN, respectively, in fibrin-based muscle 
strips cultured with IGF-1. We then used finite element analysis (ANSYS) to model and simulate 
global displacement of the beam and pillars in response to an applied force (Figure 5.8C,D). The 
simulated deflection values differed 18-19% from actual measurements (Figure 5.9D), validating 
our methods to extract passive tension and predict muscle force output. 
The bio-bot pillars provided uniaxial constraint for cell alignment during compaction, 
allowing the myotubes to mature in a macro-environment that mimics the native organization of 
functional skeletal muscle. The increase in passive tension generated by the muscle strip with 
increasing hydrogel stiffness indicated that the forces exerted by cells could be modified in 
relation to mechanical environment of the muscle. Others have validated an increase in force 
output with dynamics mechanical stimulation 170; here, we also demonstrate that a static 
mechanical cue imposed during muscle development contributes to improved functionality, 
providing further evidence that many types of mechanical stresses are required for muscle 
development 171. Bio-bot hydrogel structures with a beam stiffness of 319.4 kPa were selected 
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for subsequent experiments, as they combined the advantages of sufficiently high passive tension 
forces with deformable structures suitable for locomotion.  
To determine an optimal matrix system for engineered muscle functionality, we 
compared the passive tension forces generated by collagen- and fibrin-based cell-matrix systems. 
In muscle strips containing the same number of cells, we observed a significant increase in 
passive tension in those containing fibrin (629.3 ± 8.2 µN) compared to collagen (534.2 ± 5.8 
µN) (Figure 5.9E). Advantageously, fibrin polymerizes relatively quickly when compared to 
other ECM proteins, and it can undergo large deformations without breaking 172,173. The ability to 
sustain large strains while maintaining structural integrity during muscle contraction was a 
necessary characteristic for applications in bio-actuation. 
Examining the effect of varying other biological environmental cues, we observed that 
fibrin-based muscle strips supplemented with IGF-1 demonstrated a 70.7% increase in passive 
tension force, from 581.4 ± 20.6 to 992.7 ± 34.3 µN (P<0.001, n=4), compared to the control 
without IGF-1. We attributed this significant increase in force production to a greater number of 
differentiated myotubes in muscle strips supplemented with IGF-1, an observation confirmed by 
immunostaining and other reported variations of 3D engineered muscle constructs 174. We 
calculated a normalized stress in the muscle strips with IGF-1 by dividing the passive tension by 
the cross-sectional area of the tissue, which averaged 1.2 ± 0.04 mm2 (n=9, Figure 5.9F). The 
passive stress in the muscle strips averaged 0.84 ± 0.03 kPa, values that are comparable to those 
of similar muscle-based 3D cell-matrix systems with collagen or fibrin 159,162,175,176. 
 
5.1.2.4 Electrically Paced Actuation of Bio-bots.  
To externally control muscle contraction and bio-bot locomotion, we utilized a custom-
designed setup 177 to stimulate reproducible contraction of excitable cells within the muscle strip 
with a bipolar electrical pulse train (Figure 5.10A and Figure 5.11). By mimicking signals 
necessary for the generation of an action potential in vivo, electrical pulse stimulation can induce 
protein expression, contractile ability, cell alignment, and differentiation of skeletal muscle in 
vitro 178–181; here, we harnessed the stimulation to coordinate contraction of multiple myotubes 
within the muscle strip, which collectively generated sufficient force to visibly deform the 
hydrogel structure of the bio-bot. Fibrin-based muscle strips supplemented with IGF-1 and 
stimulated at constant frequencies of 1, 2, or 4 Hz demonstrated a consistent output of 1.01 ± 
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0.003, 2.01 ± 0.01, and 3.95 ± 0.05 contractions s-1, respectively (n=10, Figure 5.10B), 
establishing that the bio-bots could reliably paced with this method. We witnessed twitch 
contractions below 8-10 Hz and tetanus above this upper frequency limit. In contrast, non-IGF-1 
supplemented muscle strips did not respond to stimulation during this time period, a result 
attributed to fewer myotubes. We predict a response at later time points, as others have shown 
electrically induced contractility of C2C12s or primary cells in 3D tissue constructs after 14 (and 
sometimes up to 30+) days following formation 162,182–185. However, IGF-1 treatment presents a 
simple and physiologically relevant method to enhance differentiation for functional output via 
electrical stimulation on a shorter time scale (here, as early as day 7). Additionally, we observed 
that the range of active tension remained above 99.3% of the initial value during 8 min of 
electrical stimulation at hour 0, and above 98.8% of the initial value at hour 6, revealing a 
consistent force output from the engineered muscle strips both within a constant stimulation 
period and at later time points (Figure 5.12A). 
A Kelvin-Voigt viscoelasticity model that correlated the observed cyclic displacement to 
the contractile force was used to extract the active tension generated by IGF-1 supplemented 
muscle strips in response to electrical stimulation (Figure 5.10C). The range of active tension 
during contraction decreased with increasing stimulation frequency, from a dynamic fluctuation 
of 198.68 µN during 1 Hz stimulation to 109.48 µN during 4 Hz stimulation (Figure 5.10D). The 
active tension data followed a positive force-frequency relationship in which the magnitude of 
the active tension exerted by the muscle increased, even while the range of pillar motion 
decreased. Furthermore, as a consequence of muscle relaxation times exceeding the period 
between electrical pulses at higher frequencies, we observed a temporal summation of force that 
resulted in a baseline tension increase over time. The muscle strips therefore displayed functional 
behavior characteristic to physiological skeletal muscle, in which force output increases with 
frequency before reaching tetanus 148.  
 
5.1.2.5 Demonstration of Controlled Directional Movement.  
We aimed to create a biomimetic ‘crawling’ mechanism reminiscent of an inchworm’s 
movement. Using finite element simulations, we explored a symmetric and an asymmetric design 
for the bio-bots (Figure 5.13A). For the asymmetric design, we extended the length of one pillar 
of the bio-bot hydrogel structure, allowing for asymmetric bending of the flexible beam (Figure 
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5.4A), hypothesizing that the introduction of deliberate asymmetry within the structure would 
increase the moment arm between the muscle strip anchor point and the beam, as well as the 
range of motion between pillars during displacement. It would also change the contact area of the 
base to the surface for one pillar versus the other. These simulations revealed that as expected, 
the symmetric structure did not demonstrate significant locomotion. However, an asymmetric 
structure exhibited non-uniform distribution of stress in the hydrogel structure in response to 
muscle contraction, corresponding to asymmetric pillar displacements (Figure 5.13A). 
Simulations revealed that asymmetric actuation and force generation of the muscle strips by 
geometric design of the bio-bot would produce greater net displacement over a fixed time and 
create a more efficient and predictable locomotive mechanism as compared to the symmetric 
design.   
Consistent with the simulation results, we experimentally observed that for a symmetric 
hydrogel structure, electrical pacing of skeletal muscle strips attached to bio-bot structures either 
did not result in net locomotion of the bio-bot across a substrate, or in some cases, resulted in a 
very small locomotion (Figure 5.13B). Since the hydrogel structure itself was symmetric, we 
hypothesized that any observed small locomotion of the symmetric structure was attributed to 
asymmetry in muscle strip formation and force distribution. From a top-view video, we tracked 
bio-bot pillar displacements in response to muscle contractions over time and observed that when 
both pillars displaced equally, the bio-bot did not move. Interestingly, for the minimally 
locomotive bio-bots, when one pillar displaced more than the other (Figure 5.13C), the bio-bot 
always ‘crawled’ in the direction of the pillar that demonstrated greater displacement in response 
to muscle contraction. For the case of these symmetric devices, these small velocities were found 
to be less than 4.34 µm s-1 at electrical stimulation of 1 Hz frequency (Figure 5.13D).  
We found that muscle strips coupled to the asymmetric compliant hydrogel structure 
drove inchworm-like crawling locomotion with maximum velocity. Contraction of muscle strips 
on asymmetric bio-bots resulted in a maximum velocity of 117.8 µm s-1 in response to electrical 
stimulation of 1 Hz frequency, an increase in velocity of more than 25-fold increase compared to 
the symmetric design (Figure 5.12 and Figure 5.13E-G). During electrically paced locomotion, 
the asymmetric bio-bot produced an active tension force of 394.7 ± 56.6 µN, or 27.9% of the 
maximum force (Figure 5.13G).  
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Although bio-bot pillar displacement decreased with increasing stimulation frequency, 
the observed increase in force generation led us to test the effect of stimulation frequency on bio-
bot locomotion. The increased number of contractions with increasing stimulation frequency 
within a given time period resulted in an increased average velocity of the asymmetric bio-bot, 
which was measured to be 117.8, 132.2, and 156.1 µm s-1 at 1, 2, and 4 Hz, respectively, during 
the time period shown (Figure 5.13H). At all frequencies, the asymmetric bio-bot moved in the 
direction of the pillar that demonstrated greater displacement, as predicted (Figure 5.12C). 
 
5.1.3 Conclusions 
Soft robotic devices integrated with biological systems combine the advantages of high 
degree-of-freedom compliant response with dynamic sensing and actuation capabilities. We 
report the design and fabrication of a skeletal muscle powered machine that can be controlled 
and paced via external signaling, instead of relying on spontaneous muscle contraction. 
Modeling and simulations were used to study the effect of changing design parameters on 
functional response, resulting in a more comprehensive picture of the locomotive mechanisms. 
We improved the force generation capacity and functional performance of this engineered tissue 
by differentiating muscle strips in an optimized fibrin-based ECM environment supplemented 
with IGF-1 growth factor. Muscle strips displayed a tunable functional response in relation to the 
static stress imposed by a 3D printed hydrogel structure, mimicking the in vivo mechanical 
environment of muscle maturation. Finally, electrical stimulation triggered contraction of 
engineered muscle, driving a biomimetic and controllable directional locomotion.  
Although other studies have explored the use of excised and engineered biological 
components such as cardiac muscle tissues for applications in bio-actuation, these studies lack a 
fabrication methodology that offers flexibility in precisely specifying geometric, material, and 
biological component design parameters (Figure 5.14). Our stereolithographic 3D-printing-based 
biofabrication system supports the integration of a variety of scaffolding materials and multiple 
cell types, representing a significant advancement towards engineering biological machines 
capable of complex and controllable functional behaviors. Furthermore, our biofabrication 
methodology can readily be modified to demonstrate other mechanisms of locomotion and force 
output (such as swimming and pumping) while also creating a platform for future studies 
integrating different biomaterials and cell types. The incorporation of motor neurons resulting in 
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neuromuscular junction formation would lead to more complex mechanisms of functional 
control of the engineered muscle. Additionally, integration of endothelial cells to engineer an 
internal vasculature would increase diffusion of nutrients and oxygen to the muscle tissue, 
thereby increasing efficiency and long-term viability of a living biological machine. 
Forward engineering of biological machines can help to advance the understanding of the 
fundamental scientific and design principles underlying living systems and lead to a quantitative 
understanding of the way integrated cellular systems sense and respond to environmental signals 
138. In the long term, we envision that this system could serve as a basis for target applications 
such as micro-scale tissue fabrication for drug screening and tissue- and organ-on-a-chip mimics, 
dynamic biocompatible microelectronics and medical implants, and forward-engineered 
biological machines and systems. 
 
5.1.4 Methods 
5.1.4.1 Pre-Polymer Solutions.  
Pre-polymer solution for bio-bots consisted of 20% (v/v) poly(ethylene glycol) diacrylate 
of MW 700 g mol-1 (PEGDA MW 700, Sigma-Aldrich) dissolved in phosphate buffered saline 
(PBS), with 0.5% (w/v) 1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propanone-1-one 
photoinitiator (Irgacure 2959, BASF) mixed from a 50% (w/v) stock solution in dimethyl 
sulfoxide (DMSO, Fisher Scientific). Material properties and swelling ratio of this polymerized 
hydrogel have been previously characterized 42.  Pre-polymer solution for holders was made 
from 20% (w/v) poly(ethylene glycol) dimethacrylate of MW 1,000 g mol-1 (PEGDMA MW 
1,000, Polysciences, Inc.) dissolved in PBS and mixed with 0.5% (w/v) Irgacure 2959. 
 
5.1.4.2 Characterization of Working Curve and Control of Energy Dose.  
After the SLA polymerizes the first layer of a part, the stage moves down a distance that 
is equal to the height of the first layer, the surface is re-coated with pre-polymer solution, the 
laser power is recalibrated, and the second layer is polymerized. This “bottom-up” assembly 
process continues until the entire part is built. Because the SLA fabricates a part in multiple 
steps, layers can be produced with different materials or properties. Following a well-
characterized Working Curve Equation 41,186, which quantifies the relationship between 
maximum exposure (polymerization energy) and thickness of the fabricated layer, we varied two 
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parameters that control the polymerization energy of the SLA (laser penetration depth into the 
material and critical energy dose needed to polymerize the material from a liquid to a solid gel 
state) to obtain bio-bots with varying beam stiffness and bending profiles (Fig. 5.3).  
The Working Curve Equation is derived from the Beer-Lambert Law, which describes 
the intensity of light’s exponential decay as it travels through an absorbing medium. The 
equation quantifies the relationship between the maximum exposure (Emax), the critical energy 
dose needed to polymerize the material from a liquid to a solid gel state (EC), the thickness or 
cure depth (CD), and the penetration depth (DP) of the laser into the material 186. 




Cylinders with a radius of 1 cm and a height of 100 µm were fabricated from PEGDA 
MW 700 with 0.2 µm Nile Red fluorescent microbeads (Spherotech) encapsulated in a 1:500 ratio 
of beads to polymer. Emax was varied from 71 to 512 mJ cm-2 by maintaining a constant EC value 
and changing the input DP value. The thicknesses of the fabricated parts (CD) were measured 
using an inverted fluorescent microscope with a TRITC excitation filter. The beads encapsulated 
in the bottom-most plane of the cylinder were brought into focus and this location was set as 
zero. The focus was then set on the top-most plane of encapsulated beads in the cylinder and this 
change in displacement was recorded as the height of the cylinder. Four parts were fabricated for 
each energy dose and an average height was taken from four points per part. The average 
thickness was plotted against the applied energy dose and a logarithmic trendline was fit to the 
data to create a Working Curve (Fig. 5.3C). As described in the text, the energy dose of the laser 
was altered by inputting values of DP and EC in order to polymerize with a certain Emax. The 
hydrogel’s stiffness varied logarithmically with Emax. 
 
5.1.4.3 Design and fabrication of parts 
A commercial Stereolithography Apparatus (SLA, 250/50, 3D Systems) was modified for 
polymerization as previously described 97,187. Parts generated using computer-aided design 
software were exported to 3D Lightyear software (v1.4, 3D Systems), which sliced the part into 
layers. Pre-polymer solutions for bio-bots and holders are described in 5.1.4.1. For fabrication of 
bio-bots, an 18 x 18-mm-square cover glass was secured to the center of a 35-mm culture dish 
(both with hydrophilic surfaces) before fabrication. For bio-bot holders, cover glass slides were 
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first treated with 2% (v/v) 3-(trimethoxysilyl)propyl methacrylate (3-TPM, Sigma-Aldrich) in 
200 proof ethanol (100% EtOH) for 5 min and then washed in 200-proof ethanol (100% EtOH) 
for 3 min, dried, and taped to the bottom of a 35-mm dish. Following fabrication, each structure 
was rinsed in PBS, sterilized in 70% EtOH for 1 h, and allowed to re-swell in PBS for at least 1 
h. 
 
5.1.4.4 Cell Culture 
C2C12 murine myoblasts were transfected with pAAV-Cag-Chr2-GFP-2A-Puro plasmid 
to express ChR2 159. Cells were maintained in growth medium (GM) consisting of Dulbecco’s 
Modified Eagle Medium with L-glutamine and sodium pyruvate (DMEM, Corning Cellgro), 
supplemented with 10% fetal bovine serum (Lonza), 1% penicillin-streptomycin, and 1% L-
glutamine (both Cellgro Mediatech, Inc.). Differentiation medium (DM) consisted of DMEM 
supplemented with 10% horse serum (HS, Lonza), 1% penicillin-streptomycin, and 1% L-
glutamine. 
 
5.1.4.5 Components of Collagen- and Fibrin-Based Muscle Strips.  
Before cell seeding, bio-bots were positioned beam-down in polymerized holders in a 35-
mm cell culture dish and aspirated of excess liquid. For collagen muscle strips, an ice-cold cell-
matrix solution of MatrigelTM basement membrane matrix (30% of total cell-matrix volume, BD 
Biosciences), liquid type I collagen (1.4 mg ml-1, BD Biosciences) neutralized with NaOH (0.01 
N), and C2C12s of densities varying from 1 – 10 x 106 cells ml-1 suspended GM (at a volume 
equal to that of collagen) were added to each holder in a total volume of 100 µl. For fibrin 
muscle strips, an ice-cold cell-matrix solution of MatrigelTM (30% of total cell-matrix volume), 
fibrinogen (4 mg ml-1, Sigma-Aldrich), thrombin from bovine plasma (0.5 U mg fibrinogen-1, 
Sigma-Aldrich), and C2C12s suspended in GM at a concentration of 5 x 106 cells ml-1 were 
added to each holder in a total volume of 120 µl unless otherwise specified. After 1 h, 4 ml of 
GM was added. After 24 h, bio-bots were released from holders and switched to DM with anti-
fibrinolytic 6-ACA and human IGF-1 (both Sigma-Aldrich) as noted. All cells and bio-bots were 




5.1.4.6 Mechanical testing 
To characterize the mechanical properties of PEGDA Mr 700, dogbone-shaped test 
specimens fabricated were fabricated with the same thickness as that of the beam and with 
energy doses ranging from 105 – 513 mJ cm-2. Specimens were super glued to stainless steel 
bars, then fixed in custom-fabricated structures in a hydrated sample chamber filled with PBS. 
An ElectroForce® BioDynamic® test instrument (5100, Bose) with a 1,000-g load cell applied 
uniaxial tension at each end of the structure at 0.05 mm s-1 (Figure 5.9B). A video extensometer 
tracked the displacement of four points on the sample until fracture, which was used to calculate 
elastic modulus for different polymerization energy doses (Fig. 5.6B). Control software 
(Wintest) was used to track load, displacement, and strain ε. Elastic modulus E was determined 
from the linear portion of stress-strain curves according to Hooke’s Law (σ = εE = F/A), 
assuming a slow strain rate. Moduli of energy doses not measured were extrapolated from a best-
fit curve. Cross-sectional area was measured with calipers. 
 
5.1.4.7 Calculation of Compaction Area.  
To measure the cross-sectional compaction area, holders containing the bio-bots seeded 
with 90 µl of cell-matrix suspension were imaged at 0.8X using a stereoscope with a digital 
microscope camera at 1, 6, 12, and 24 h after cell seeding (Fig. S2D). The Measure tool in 
ImageJ was used to calculate the cross-sectional area by quantifying the visible compacted area 
of the cell-matrix solution and subtracting the cross-sectional area of the pillars.  
 
5.1.4.8 Beam deflection and muscle strip passive tension.  
Bio-bots structures were polymerized with varying energy doses from 109 – 512 mJ cm-2. 
The cell density was kept constant at 1 x 106 cells ml-1 and bio-bots were cultured in GM with 
10% FBS. Images were acquired daily using a stereoscope with a digital microscope camera 
(Fig. 5.6A). Side-view images of symmetric bio-bots were taken every 24 h using a 
stereomicroscope (MZ FL III, Leica Microsystems) with a digital microscope camera (Flex, 
SPOT Imaging Solutions). To model bio-bot deformation in the passive (bent but unmoving) 
state, designs was reconstructed using SolidWorks and imported into ANSYS. Appropriate 
material properties were assigned and a force equal to the calculated passive tension was applied 
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to the base at a distance specified by the measured moment arm. Resultant solutions of total 
deformation were examined to find maximum beam deflection.  
Passive tension in the muscle strip at rest was determined using Euler-Bernoulli linear 
beam theory relating deflection of a curved beam to an applied moment. Assuming negligible 
rotation in the beam and a small angle approximation, equating the applied moment M to tension 
P times the moment arm l from the muscle strip to the beam reduced the second-order 
differential equation to 
𝑑!𝑦




where 𝐼 is the moment of inertia of the rectangular cross-section and y is the horizontal 
deflection of the beam. Boundary conditions were applied by assuming zero deflection at ends of 
the beam (L = 0) and maximum deflection δmax at the center (L/2).  
𝛿!"# =  𝑦 𝐿/2  =  
𝑀𝐿!
8𝐸𝐼 =  
𝑃𝑙𝐿!
8𝐸𝐼  (C2) 
Beam dimensions, moment arm, and maximum deflection were averaged from 3 measurements 
of each device using the Measure Tool in ImageJ (NIH). Solving for P yielded the relation 
𝑃 =  
8𝐸𝐼𝛿!"#
𝑙 𝐿!  
(C3) 
To verify the accuracy of the calculation method, the computed passive tension values 
were input into ANSYS (finite element software), and the simulation produced values for 
deflection of the beam (Fig. 5.6D).  
Stress was calculated by dividing the tension by the muscle strip’s cross-sectional area A, 
determined from transverse H&E sections. 
 
5.1.4.9 Electrical stimulation.  
A custom-designed electrical setup was built as previously described 177 (Figure 5.11). To 
create the electrical stimulation setup, the output from a waveform generator was amplified 
through an AD797 inverting amplifier. A capacitor C was added in series to minimize 
electrolysis of the media by converting the square pulse to a biphasic pulse; the system was then 
treated as an RC circuit (Fig. 5.9A). A 35-mm culture dish was modified to allow Pt electrodes of 
diameter 0.762 mm to pass through the lid of the dish 177. The average resistance of the electrical 
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stimulation medium (DMEM without serum) was calculated by measuring the time constant τ 
from the oscilloscope and dividing by C for each volume at 23ºC and 37 ºC. The conductivity of 
the medium was measured using a pH/Conductivity meter (Orion 4-Star, Thermo Scientific), at 
23 ºC and 37 ºC (Fig. 5.9B). During stimulation, the bio-bot was placed in 4 ml of warm 
electrical stimulation medium between the positive and ground electrodes and a current was 
applied perpendicular to the long axis, with stimulation frequencies up to 10 Hz and never 
exceeding more than half of the sampling frequency, as per the Nyquist criterion. Simultaneous 
imaging was achieved by positioning the dish on the stage of a stereoscope (Fig. 5.9D,E). 
Bio-bots were stimulated with bipolar electrical pulses of 20 V amplitude (21.6 V/cm 
field strength) and 50 ms pulse width. Top-view movies were acquired with a stereomicroscope 
with a digital microscope camera at 9.2 fps. Side-view movies were acquired using a camcorder 
(Handycam DCR-SR65, Sony) at 30 fps. Electrodes were sterilized in 70% EtOH and rinsed 
with PBS between experiments. 
 
5.1.4.10 Characterization of movement and force.  
Active tension exerted by contracting muscle strips upon electrical stimulation was 
calculated by treating the bio-bot structure as a viscoelastic body governed by a Kelvin-Voigt 
model: 




The active stress generated by the muscle strip was computed as a function of the strain 𝜀 𝑡  and 
strain rate !"(!)
!"
 observed in the hydrogel beam with viscosity 𝜂. The time-varying displacement 
data was converted into time-varying strain and the equation above was used to compute the 
resulting active stress. 
An automated Matlab script was designed to track the location of a user-specified feature 
with a normalized 2D cross-correlation and provided X-Y coordinates of a specific point on the 
bio-bot for each frame. This software tracked the distance between the longer and shorter pillar 
caps during stimulation from a top-view movie (Figure 5.12E). Frequency was measured by 
manually counting contractions in identical time segments. 
 
5.1.4.11 Simluation of Locomotion 
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To model deformation and stress in the active (contracting) state, pillar displacements 
(from the Matlab script) were imported into the simulation to recapitulate the walking motion 
captured from top-view movies of symmetric and asymmetric bio-bots. Bio-bots were placed on 
a frictionless support surface (“ground”) and allowed to deform and move with respect to the 
ground in response to the displacement input. The simulation provided time-varying stresses in 
the bio-bot structure and time-varying reaction forces from the ground.  
 
5.1.4.12 Calculation of Relative Pillar Displacement.  
To find the time-averaged ratios of pillar movement, the difference in X and Y 
coordinates of the pillar caps for each point was converted to a total distance moved between 
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The difference in X and Y position between two consecutive frames is shown for one pillar in 
Fig. 5.12E. 
 
5.1.4.13 Immunofluorescence and histology.  
Bio-bot pillars were cut to allow for muscle strip isolation and removal. Tissues were 
rinsed in PBS, fixed in 4% (v/v) paraformaldehyde and permeabilized with 0.2% (v/v) Triton X-
100 (Sigma-Aldrich) for 5-10 min. Image-iT® FX Signal Enhancer (Invitrogen) was added for 
30 min. Tissues were first incubated with mouse MF-20 anti-myosin heavy chain (1:400, 
Developmental Studies Hybridoma Bank (DSHB), The University of Iowa Department of 
Biology) and rabbit sarcomeric α-actinin (1:600, Abcam) primary antibodies in Image-iT® FX 
Signal Enhancer (Invitrogen) for 2 h at room temperature (fibrin muscle strips) or overnight at 
4ºC (collagen muscle strips) and washed with PBS. Fibrin muscle strips were incubated with 
Alexa Fluor® 488 goat anti-mouse IgG and Alexa Fluor® 568 F(ab')2 fragment of goat anti-
rabbit IgG secondary antibodies (1:400, Invitrogen) in Image-iT® FX for 2 h in the dark. 
Collagen tissues were incubated with Alexa Fluor 594 goat anti-rabbit and Alexa Fluor 488 goat 
anti- mouse secondary antibodies for 2 h. 4′,6-diamindino-2-phenylindole (DAPI, 1:5000 in 
sterilized DI water, Sigma-Aldrich) was added for 5-10 min in the dark. Muscle strips were fixed 
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to a 35-mm glass-bottom microwell dish (MatTek) with warm agarose gel. Muscle strips were 
imaged with a confocal microscope (LSM 710, Zeiss) or inverted fluorescent microscope (IX81, 
Olympus). Image stacks were processed using Zen software (2010, Zeiss) and ImageJ.  
For histological staining, muscle strips were fixed for a minimum of 12 h in 70% EtOH, 
then dehydrated and fixed in an overnight tissue processor (ASP300, Leica). Samples were 
embedded in paraffin, cut into 5-15 µm sections with a microtome (Leica), mounted on glass 
slides, and stained with hematoxylin and eosin (H&E). After 24 h, they were imaged with a 
Digital Pathology System (Nanozoomer). For quantification of cell distribution, a threshold was 
applied to each H&E image to distinguish nuclei from background. The ImageJ Analyze 
Particles feature was used to determine X-Y coordinates of each nucleus on every image, and the 
minimum distance of each nucleus to the perimeter was calculated. 
 
5.1.4.14 Statistical analysis.  
Results are presented as mean ± standard deviation (SD). All statistical analyses were 
performed with OriginPro software and represent one-way ANOVA followed by Tukey’s 
Multiple Comparison Test for P<0.001, P<0.01 or P<0.05 as noted. 
 
5.1.5 Acknowledgments 
 We thank Dr. Michael Poellmann, Prof. Amy Wagoner Johnson, Dr. Mayandi Sivaguru, 
Donna Epps, Samir Mishra, Stephanie Nemec, Daniel Perlitz, and Prof. K. Jimmy Hsia at the 
University of Illinois at Urbana– Champaign (UIUC), and Devin Neal, Prof. Roger Kamm, and 
Prof. Ron Weiss from the Massachusetts Institute of Technology for assistance with various 
aspects of this project. This work was funded by the National Science Foundation (NSF) Science 
and Technology Center Emergent Behavior of Integrated Cellular Systems (EBICS) Grant 
CBET-0939511, and NSF Grant 0965918 IGERT at UIUC: Training the Next Generation of 




5.2 3D Printed Skeletal Muscle-Powered Bio-Bots Controlled via Optical Signals6 
 
5.2.1 Introduction 
Understanding complex biological systems requires uncovering the mechanisms through 
which integrated multi-cellular networks accomplish sensing, internal processing, and 
coordinated action in response to dynamic environmental signals. Attempting to reverse engineer 
these mechanisms for applications in regenerative medicine has been the focus of the burgeoning 
field of tissue engineering 73, and seminal advances in this field have targeted nearly every organ 
system in the body 188. These developments, in addition to improving the state of the art in 
therapeutics, have furthered our understanding of the design principles governing the 
organizational structure and function of natural biological systems. With this as a guide, we are 
ideally poised to start forward engineering biological machines, or bio-bots, capable of complex 
controllable non-natural functional behaviors, thereby broadening the potential applications for 
building with biological materials. 
Before we can design bio-integrated machines for a range of applications, we must first 
engineer modular tissue building blocks that respond to external signals with complex functional 
behaviors. Observing and controlling the coordinated action of such building blocks in series and 
parallel will help us understand the emergent behavior of natural biological systems 189,190. 
Nearly all machines require actuators, modules that convert energy into motion, to produce a 
measurable output in response to input stimuli. Efforts to manufacture bio-integrated actuators 
have targeted a range of cell types 150, including flagellated bacteria 191, cardiac muscle 97,153,156, 
and skeletal muscle 98,159,192,. We have previously demonstrated a millimeter-scale soft robotic 
device, or bio-bot, that uses the contractile force produced by electrically paced skeletal muscle 
to drive locomotion across a substrate 98. This bio-bot was the first demonstration of an 
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untethered locomotive skeletal muscle powered biological machine and set the stage for building 
hierarchical actuators inspired by natural systems. However, like other previous demonstrations 
of bio-integrated machines, the actuator was coupled to the surrounding device and did not allow 
for unrestricted use in a variety of design applications. A significant step forward in this field 
thus requires a modular bioactuator that demonstrates a variety of controllable and tunable 
functional behaviors in response to a noninvasive external signal.   
Here, we present a bioactuator that can be coupled to many different mechanical bio-bot 
skeletons to provide a desired contractile force output. Two major design advances enable 
forward engineering bio-bots capable of more complex behaviors: (i) skeletal muscle cells are 
transduced to express a light sensitive cation channel, using an existing protocol (these 
optogenetic cells demonstrated controlled contractility in response to noninvasive and 
spatiotemporally precise optical stimuli); and (ii) muscle actuators are redesigned as “rings” that 
can be readily coupled to a variety of bio-bot skeleton designs. The resulting bioactuators 
produced paced active tension forces approaching 300 µN per muscle ring. Implementing these 
rings as the power source in untethered bio-bots enabled directional locomotion at average 
speeds of 310 µm s-1 (1.3 body-lengths min-1) in response to optogenetic stimulation at 2 Hz. The 
precise spatiotemporal stimulus provided by optogenetic control also enabled the demonstration 
of rotation and 2D steering in a muscle-powered device, with average rotational speeds of 2° s-1  
(120° min-1). Furthermore, “exercise training” of muscle rings with dynamic optical stimuli and 
static mechanical stimuli during differentiation resulted in a significant increase in functional 
performance, with generated forces being approximately 550% greater in exercised muscle rings 
as compared to a control. These advances in design and implementation of modular muscle 
actuators thus set the stage for building hierarchical multi-cellular bio-integrated machines and 
systems for a range of applications. Primary applications in medicine include noninvasive drug 
delivery and design of dynamic multifunctional implants. 
 
5.2.2 Results 
5.2.2.1 Design and Fabrication of Optogenetic Muscle Ring Powered Bio-Bots.  
In vivo, muscle is anchored to bone via tendons, and the concerted contraction of 
sarcomeres acting in parallel along a muscle fiber drives articulation of bones across joints. We 
designed and 3D printed a poly (ethylene glycol) diacrylate (PEGDA) hydrogel skeleton 
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composed of two pillars (artificial tendons) that connect the muscle to a flexible beam 
(articulating joint) to mimic in vivo structure (Figure 5.15A). We then 3D printed a PEGDA 
“ring mold” that served as a template for the formation of a muscle ring. To enable comparisons 
to our previous muscle strip design 98, we also manufactured a strip mold (Figure 5.16A). 
 Optogenetics, the method of genetically engineering light-responsive cells, enables 
noninvasive external control over cellular function 193. Ion channels that respond to light stimuli 
have been implemented in a variety of applications that require cellular manipulation. While the 
seminal studies in this field were performed on neurons, recent studies have demonstrated 
optogenetic approaches to control other cell types, including skeletal muscle 159. To implement 
optogenetic control of our muscle actuators, we used an existing lentiviral transduction protocol 
to engineer C2C12 murine myoblast cells with a mutated variant of the blue-light sensitive ion 
channel, Channelrhodopsin-2 (ChR2), namely ChR2(H134R) (Figure 5.16B). Transduced cells, 
labeled with a tdTomato tag, were selected using fluorescence activated cell sorting (FACS) to 
maximize expression of ChR2(H134R). Multi-nucleated myotubes differentiated from these 
myoblasts were anticipated to demonstrate paced contractility in response to an external light 
stimulus of 470-nm wavelength.  
Optogenetic myoblasts were combined with a solution of Matrigel basement membrane, 
fibrinogen, and thrombin (Figure 5.16C). This cell/gel solution, designed to mimic native 
extracellular matrix, was injected into the molds, and traction forces exerted by embedded cells 
drove self-assembly into densely packed muscle strips and rings (Figure 5.16D). Muscle strips 
formed around (and thus were permanently tethered to) the bio-bot skeletons. Muscle rings were 
manually transferred to bio-bot skeletons one day after seeding (Day 1) (Figure 5.16E and Figure 
5.17). This allowed for mechanical coupling of the actuator to the device while still preserving 
modularity of design, since muscle rings could be transferred to any of a wide variety of 
mechanical skeletons. To simplify manual transfer, bio-bot skeletons were chemically tethered to 
an underlying glass slide during transfer and mechanically released from the slide on day 2 after 
seeding. Both muscle strip and ring devices were cultured in growth medium (DMEM + 10% 
FBS) containing the fibrinolytic inhibitor aminocaproic acid (ACA) for 3 d to induce cell 
proliferation. They were then transferred to differentiation medium [DMEM + 10% horse serum 
(HS)] containing ACA on day 4 to drive fusion of individual myoblasts into multinucleated 
myotubes with mature contractile sarcomeres. This medium was supplemented with human 
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insulin-like growth factor (IGF-1) to accelerate the differentiation process and induce muscle 
hypertrophy 98,194.  
The thickness of engineered muscle tissue is dependent on the formulation of the cell/gel 
solution. Until a certain lower limit, higher concentrations of cells and fibrin form thinner muscle 
rings that lead to more densely compacted tissue. Beyond this limit, increasing the cellular and 
fibrin concentration cannot reduce the muscle tissue thickness further, as the embedded cells and 
fibrin network occupy a finite volume. The thickness of muscle rings was thus used as a metric 
to select cell/gel solution formulations that would maximize muscle tissue compactness and 
cellular density (Figure 5.16F and Figure 5.18A). This characterization of optimal muscle 
dimensions coupled with the modularity of the ring design enabled forward engineering of many 
types of machines including larger scale bio-bots, bio-bots powered by multiple muscle rings, 
and multilegged bio-bots (Figure 5.18B-D).  
 
5.2.2.2 Characterization of Optogenetic Muscle Ring Force Output.  
Macro-scale muscle contraction is the sum of many micro-scale contractions of 
individual myotubes acting in parallel. Aligning the axis of contractility for myotubes within 
muscle is thus critical to observing large combined forces. We performed immunofluorescence 
staining on muscle rings to observe the distribution of the mature muscle marker, myosin motor 
protein. A fast Fourier transform (FFT) algorithm was used to determine local alignment (Figure 
5.19A). Myotubes in muscle rings are aligned at 90° in regions parallel to the bio-bot beam 
(Figure 5.19A-1) and shift in alignment around the edges of the skeleton with smaller peaks at 
90° and a larger peaks at 45° (Figure 5.19A-2) and 135° (Figure 5.19A-3) respectively. This 
analysis reveals a high degree of local alignment along the axis of tension imposed by the 
mechanical constraint of the bio-bot skeleton. 
We performed a closer inspection of muscle ring architecture in the region represented in 
Figure 5.19A-2 via multichannel fluorescence imaging of DAPI cell nucleus marker, the ChR2 
tdTomato tag, and the immunostained myosin marker (Figure 5.19B). Cells were evenly 
distributed throughout the muscle ring and expressed the tdTomato marker for optogenetic ion 
channels, indicating that they could be expected to generate functional contractile responses to 
blue light stimulation. Scanning electron microscopy imaging likewise showed densely 
compacted and evenly distributed myotubes with a high degree of local alignment (Figure 
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5.19C). A cross-section image of the muscle ring was used to verify that hierarchical 
organization of muscle architecture and alignment was preserved in 3D (Figure 5.19D). 
To measure the passive tension force exerted by both muscle strip and muscle ring 
devices, we used Euler-Bernoulli beam bending theory to correlate bio-bot skeleton deformation 
with muscle force production. On average, passive tension forces for muscle strip and ring 
devices were not significantly different, with muscle strips exerting passive tension forces of 
1940 ± 350 µN and muscle rings exerting passive tension forces of 1710 ± 230 µN on Day 9 
after seeding (Figure 5.20A). This corresponds to a passive tension stress of 1.6 ± 0.3 kPa for 
muscle strips, which had average cross-sectional areas of 1.2 ± 0.04 mm2 (n=3), and 3.2 ± 0.4 
kPa for muscle rings, which had had average cross-sectional areas of 0.54 ± 0.06 mm2 (n=3). 
These stress values are comparable to those previously reported for tissue engineered skeletal 
muscle 98,159,195. 
Mature muscle was stimulated optically and electrically using custom-built apparatus 
(Figure 5.21A), and a Kelvin-Voigt viscoelasticity model was used to correlate contraction-
induced displacement of bio-bot skeletons to active tension forces produced by engineered 
muscle. Optical stimulation of muscle strip and ring devices at 1, 2, and 4 Hz with 50 ms pulses 
produced paced contractions (Figure 5.20B) and physiological force-frequency response 
behavior (Figure 5.21B-1, C-1), where the dynamic fluctuation of active tension force reduced 
with increasing frequency. As with native skeletal muscle at high frequency stimulation, the 
passive tension baseline increased during the stimulation period, indicating that the muscle was 
not allowed to fully relax from one received stimulus prior to the next received stimulus. For 
muscle strips, forces produced by optical stimulation (45 ± 11, 32 ± 12, and 25 ± 12 µN at 1, 2, 
and 4 Hz respectively) are significantly lower (Figure 5.21B-2) than those produced by electrical 
stimulation (195 ± 19, 112 ± 26, and 88 ± 30 µN at 1, 2, and 4 Hz). By contrast, there was no 
significant difference between optical and electrically stimulated active tension forces in muscle 
rings (Figure 5.21C-2). At stimulation frequencies of 1, 2, and 4 Hz, optical stimulation of rings 
produced active tension forces of 195 ± 7.3, 114 ± 8.1, and 110 ± 16 µN respectively, whereas 
electrical stimulation produced active tension forces of 185 ± 17, 117 ± 19, and 119 ± 6.7 µN.  
This difference in functional performance of optogenetic muscle strips and rings is 
explained by an analysis of the effective penetration depth (500-740 µm) of 470-nm light into 
biological tissue 196,197. While muscle strips had maximum thicknesses up to 1200 µm, the 
	128	
densely compacted muscle ring actuators were less than 700 µm thick (Figure 5.16D). Hence, 
light stimulation of muscle rings excited a larger number of myotubes than in muscle strips, 
resulting in greater force production. This was verified by demonstrating that increasing light 
energy density increased muscle ring functional performance (Figure 5.20C). A maximum 
energy density of 1.9 mW mm-2 was used for all experiments, a value that falls within the range 
of saturation intensity values reported in the literature on optogenetic cells 159,198,199. Electrical 
stimulation of muscle strips and rings revealed comparable active tension force production for 
both designs, indicating that similar numbers of myotubes were recruited in each case (Figure 
5.20D). When normalized by cross-sectional area, however, muscle rings produced significantly 
greater active tension stresses with a maximum of 0.34 ± 0.03 kPa at 1 Hz stimulation as 
compared to muscle strips which produced active tension stresses of only 0.16 ± 0.02 kPa. 
 
5.2.2.3 Optimizing Functional Performance of Optogenetic Muscle Rings.  
“Exercise training” of engineered muscle during differentiation has been shown to 
increase force output. For electrically stimulated conditioning, improved functionality is 
attributed to increased differentiation, improved alignment, and increased glucose uptake 200,201. 
For mechanically stimulated conditioning, improved functionality is attributed to a change in 
gene regulation and protein expression, increased metabolic activity, cellular proliferation, and 
improved myofiber organization 98,170. 
A previous study has shown that optical stimulation during differentiation of optogenetic 
C2C12s in 2D can improve the alignment of sarcomeric proteins and increase the fraction of 
contractile myotubes 202. We hypothesized that optical conditioning of muscle rings during 
differentiation could thus lead to an enhancement in functional performance (force production). 
The mechanism of periodic cellular depolarization and contraction would be similar to that of 
electrical stimulation, but less invasive, as it avoids electrolysis of the surrounding media. 
Furthermore, we hypothesized that combining mechanical and optical stimulation could lead to 
synergistic enhancements in functional performance. 
To provide a passive mechanical stimulus during differentiation, we kept bio-bots 
chemically tethered to an underlying glass slide throughout differentiation to maximize cellular 
alignment and myotube formation. Bio-bots were mechanically released from the stiff underlying 
substrate prior to stimulation. To provide optical conditioning during differentiation, we 
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subjected muscle rings to a daily regimen of optical stimulation at 1, 2, and 4 Hz. We measured 
active tension force output for four different groups: control group 1 – no mechanical 
conditioning (bio-bots released from substrate on day 1), no optical conditioning; control group 2 
– mechanical conditioning (bio-bots tethered to substrate until day 12), no optical conditioning; 
exercise group 1 - no mechanical conditioning, optical conditioning during differentiation (days 
4-11); exercise group 2 - mechanical conditioning, optical conditioning (Figure 5.22A).  
An analysis of force output for exercise group 1 revealed that active tension forces grew 
from 56 ± 11 µN on day 7 (the first day with observable macroscale contractility) to 195 ± 24 µN 
on day 12 at 1 Hz stimulation (Figure 5.22B-1). By contrast, control group 1 produced active 
tension forces of only 43 ± 6.0 µN on day 12. Control group 2 produced forces of 91 ± 37 µN on 
day 12. While these forces were higher than those of bio-bots from control group 1, the results 
were not significantly different. Exercise group 2, which was subjected to both mechanical and 
optically stimulated exercise during differentiation, produced active tension forces of 283 ± 32 
µN on day 12. (Figure 5.22B-2). These data serve to demonstrate that mechanically and optically 
stimulated exercise can lead to significant improvements in muscle functional performance, and 
the combination of both types of stimuli synergistically enhances force output even further. This 
result is consistent with previous demonstrations of mechanical and electrical multimodal 
stimulation for engineered muscle 203,204, but is the first demonstration of optical conditioning 
driving functional improvements in muscle performance. As optical stimulation provides a less 
invasive and cell-type specific approach for localized control of muscle contraction, this 
approach to enhancing functional performance is a significant improvement over the current state 
of the art. 
To validate our hypothesis that optical stimulus conditioning improves myotube 
formation, we assessed the DNA and protein content in control group 2 and exercise group 2 
muscle rings and compared the ratio of protein/DNA in each case. Larger protein/DNA ratios are 
correlated with greater cellular hypertrophy 195. As all rings contained the same number of 
embedded myoblasts, the DNA content for all muscle rings was 1.76 ± 0.35 µg DNA mg-1-
muscle. However, the protein content for exercise group 2 rings was 51.2 ± 2.6 µg protein mg-1-
muscle, as compared to 41.7 ± 2.7 µg protein mg-1-muscle for control group 2. The ratio of 
protein/DNA was thus significantly larger in the exercise conditioned case, 29.1 ± 1.5 µg protein 
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mg-1-DNA, as compared to the control group, 23.7 ± 1.5 µg protein mg-1-DNA, corroborating the 
theory that exercise conditioning resulted in increased cellular hypertrophy (Figure 5.22C). 
 
5.2.2.4 Directional Locomotion and 2D Steering in Optogenetic Muscle Ring Powered Bio-Bots.  
Because the most readily observable form of work produced by an actuator is 
locomotion, this was chosen as the desired functional output for our muscle-powered machines. 
First, to observe directional (1D) locomotion in response to optical stimulation, the design of the 
bio-bot skeleton was made asymmetric by increasing the length of one of the hydrogel pillars. 
With each contraction of the engineered muscle tissue, the longer pillar displaced a greater 
amount than the shorter pillar, as the “moment arm” from the muscle to the beam was greater. 
This drove net movement in the direction of the longer pillar (Figure 5.23A). This inch-worm-
like “walking” was readily observed and measured, allowing for a simple method of assessing 
bio-bot functional performance. A comparison of bio-bot speed for the muscle rings in the 
exercise training study revealed that rings in exercise group 2 powered walking at speeds of 138 
± 6.4 µm s-1 (optical stimulation, 1 Hz) and 145 ± 19 µm s-1 (electrical stimulation, 1Hz). By 
contrast, rings in control group 2 powered walking at significantly slower speeds of 35 ± 8.5 µm 
s-1 (optical stimulation, 1 Hz) and 38 ± 5.1 µm s-1 (electrical stimulation, 1Hz ) (Figure 5.23B). 
Increasing the frequency of stimulation correspondingly increased locomotive speed, despite the 
reduction in the dynamic range of active tension at higher frequencies. Bio-bot speed increased 
nearly 80% from 138 ± 6.4 µm s-1 at 1 Hz to 246 ± 59 µm s-1 to 4 Hz, providing an added 
mechanism of improving and controlling performance (Figure 5.23C). 
The true advantage of incorporating optogenetics is the precision stimulation enabled by 
enhanced spatial control. Focusing light onto different regions of the muscle ring enables control 
over the number and location of excited myotubes, and hence control over the magnitude and 
direction of macro-scale force output. Directional locomotion in 1D and steering in 2D can thus 
be induced and controlled via the external stimulus without requiring asymmetric modifications 
to the physical geometry of the bio-bot device itself. To provide a simple demonstration of this 
design principle, we took advantage of the modularity of the muscle ring actuators to design a 
“two-leg” geometrically symmetric skeleton powered by a muscle ring actuator tethered to each 
leg (Figure 5.15B). Finite element analysis (FEA) simulations predicted that stimulation of both 
muscle rings at the same time would result in zero net movement, due to overall symmetry of 
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pillar displacement (Figure 5.24A-1). This was verified by electrical stimulation of a two-leg 
bio-bot device, which demonstrated paced contractility but zero net locomotion in response to 
whole device stimulation at 2Hz (Figure 5.24A-2). FEA simulations also predicted that 
stimulation of only one muscle ring would drive directional locomotion in the direction of the 
stimulated leg (Figure 3.11B-1). Optical stimulation of only one leg, for the same bio-bot device 
electrically stimulated in Figure 3.11A-2, resulted in net locomotion in the direction of the 
stimulated leg at speeds of up to 310 µm s-1 (1.3 body lengths min-1) at 2 Hz stimulation (Figure 
5.24B-2). Furthermore, exciting only half of a muscle ring with a light stimulus resulted in 
rotational locomotion as predicted by FEA (Figure 5.24C-1) and verified empirically (for the 
same bio-bot device shown in Figure 5.24A-2 and 5.24B-2) at 2.25° s-1 (135° min-1) at 2 Hz 
stimulation (Figure 5.24C-2). These results, presented for a single representative bio-bot, 
indicate that the demonstrated differences in locomotive behavior for this device can be 
attributed purely to the mode of external stimulation (both rings, one ring, half ring).  
On average, two-legged bio-bots conditioned using the regimen specified for exercise 
group 2 demonstrated directional locomotion (in response to one ring stimulation) at 312 ± 63 
µm s-1 at 2 Hz (Figure 5.25A-1), significantly greater than control group 2 two-leg bio-bots, 
which demonstrated speeds of only 97.5 ± 16 µm s-1 at 2 Hz (Figure 5.25A-2). The same 
exercise group and control group two-legged bio-bots were tested with half ring stimulation at 2 
Hz, to show that differential responses could be obtained by changing the mode of external 
stimulation (Figure 5.25B). Exercised bio-bots demonstrated rotational locomotion at 2.1 ± 0.5° 
s-1, significantly greater than the control bio-bots, which demonstrated rotational locomotion at 
speeds of 0.95 ± 0.2° s-1. In future, a moving light stimulus that combines whole and partial ring 
stimulation could be used to direct and drive both directional locomotion and 2D steering of 
symmetric bio-bot devices in a precisely controlled manner. 
 
5.2.3 Discussion 
Here we have presented a controllable and modular bioactuator that can be readily 
adapted to a variety of device designs and applications. While locomotion is presented as the 
desired functional output in this study, muscle rings produce significant contractile force output 
even when untethered to a mechanical skeleton. Such rings can thus be combined in parallel and 
series to fabricate pumps, swimmers, etc. in future designs that harness the modularity of this 
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technology, proving to be more reproducible and widely adaptable than the bioactuators 
originally presented as proof-of-concept studies. Using the well defined characterization of ring 
composition, dimensions, and modulated force output, we can now treat engineered muscle 
rings, or rings formed from other cell types, as “building blocks” that enable the fabrication of 
complex multi-cellular bio-integrated machines and systems.  
Incorporating optogenetic ion channels into muscle rings provided us with a noninvasive 
method of exciting groups of aligned myotubes with precise spatiotemporal control. Compared 
with previously presented approaches, which controlled muscle-powered bioactuators via 
electrodes in close proximity to the bioactuator device, optogenetics provided non-contact yet 
localized control of stimulation. This fundamental distinction drove complex controllable 
directional locomotion and 2D steering of bio-bots, a capability that has not been previously 
presented in untethered biological machines powered by engineered muscle. This design 
modification, enabled by targeted genetic engineering of skeletal muscle myoblasts, thus resulted 
in a profound improvement in the complexity of functional behaviors produced by engineered 
muscle. An important advancement presented in this study is the improvement in functional 
performance produced by exercise training of muscle rings with combined optical and 
mechanical stimuli. This evidence of increased muscle force production in response to 




Forward engineered biological machines harness the ability of biological materials to 
sense, process, and respond to environmental signals in real time. The modular bioactuators we 
present in this study power bio-bots that demonstrate adaptive behavior in response to 
noninvasive light stimuli, enabling a variety of applications that require dynamic sensing and 
actuation. This type of adaptive behavior, which emerges from the coordinated interactions in a 
multi-cellular network, drives much of the complex functionality we observe in natural 
biological systems 205. Future generations of bio-bots could further harness the power of 
biological materials by incorporating self-assembling or self-healing functionalities, or serving as 
factories of cell-secreted factors. Incorporating multiple cell types, such as neurons for signal 
processing or endothelial cells for vascularization and nutrient transport, would enable the design 
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and fabrication of more complex biological machines. As many such machines will require 
modular bioactuators, this demonstration of a light-controlled adaptive skeletal muscle-powered 
biological machine thus enables a variety of applications, while simultaneously setting the stage 
for the next generation of bio-integrated machines and systems. 
 
5.2.5 Methods 
5.2.5.1 Cell Infection and Culture 
C2C12 murine myoblasts were infected with pLenti2-EF1α-ChR2[H134R]-tdTomato-
WPRE plasmid to express a mutated variant of the light-sensitive ion channel, Channelrhodopsin 
(ChR2[H134R]). The tdTomato tag was used to selectively enrich myoblasts that expressed 
ChR2[H134R] via FACS. Cells were maintained in growth medium (GM) consisting of 
Dulbecco’s Modified Eagle Medium with L-glutamine and sodium pyruvate (DMEM, Corning 
Cellgro) supplemented with 10% (vol/vol) fetal bovine serum (FBS, Lonza), 1% (vol/vol) L-
glutamine (Cellgro Mediatech), and 1% (vol/vol) penicillin-streptomycin (Cellgro Mediatech).  
 
5.2.5.2 Design and Fabrication of Flexible 3D Printed Bio-Bot Skeletons 
A commercial stereolithographic 3D printing apparatus (SLA 250/50, 3D Systems) was 
used to manufacture parts designed in CAD software (SolidWorks) and sliced into printed layers 
by 3D Lightyear software (v1.4, 3D Systems). The injection molds were fabricated on glass 
slides using a prepolymer solution composed of 20% (wt/vol) PEGDMA MW 1000 g mol-1 
(Polysciences) in phosphate buffered saline (PBS, Lonza) with 0.5% w/v 1-[4-(2-
hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propanone-1-one photoinitiator (Irgacure 2959, 
BASF) dissolved in DMSO (Fisher Scientific). The bio-bot skeletons were fabricated on glass 
slides using a prepolymer solution composed of 20% (vol/vol) PEGDA MW 700 g mol-1 (Sigma-
Aldrich) in PBS with 0.5% w/v Irgacure 2959 photoinitiator dissolved in DMSO. Following 
fabrication, molds and bio-bot skeletons were rinsed in PBS, sterilized in 100% ethanol (Decon 
Labs) for 1 h, and stored in PBS for at least 1 h prior to use. For parts that required chemical 
tethering to the underlying slides, the glass was pre-treated with 2% (vol/vol) 3-(trimethoxysilyl) 
propyl methacrylate (Sigma-Aldrich) in 100% ethanol for 5 min, washed in 100% ethanol for 5 
min and baked at 110 °C for 3 min.  
 
	134	
5.2.5.3 Formation of Optogenetic Muscle Rings and Strips  
Strip molds were assembled by placing bio-bot skeletons within holders. Both strip molds 
and ring molds were kept moist, but un-submerged, in PBS during the injection molding process. 
Optogenetic C2C12 myoblasts were trypsinized (TrypLE, Life Technologies), suspended in a 
solution of GM supplemented with 1 mg mL-1 aminocaproic acid (ACA, Sigma Aldrich) (GM+), 
and combined with ice cold 30% (vol/vol) Matrigel basement membrane matrix (BD 
Biosciences), 4 mg mL-1 fibrinogen (Sigma-Aldrich), and 0.5 units mg-fibrinogen-1 thrombin 
(Sigma-Aldrich) for a total cell/gel solution volume of 120 µL per muscle strip or ring. This 
cell/gel solution was immediately injected into the strip/ring molds and incubated at 37°C for 1 h 
prior to the addition of enough GM+ to submerge the muscle. The muscle actuators were then 
incubated for 3 d in GM+, with daily media changes, and incubated after that in differentiation 
medium (DM++) with daily media changes. The differentiation medium consisted of Dulbecco’s 
Modified Eagle Medium with L-glutamine and sodium pyruvate (Corning Cellgro) supplemented 
with 10% (vol/vol) heat inactivated HS (Lonza), 1% (vol/vol) L-glutamine, 1% (vol/vol) 
penicillin-streptomycin, 1 mg mL-1 ACA, and 50 ng mL-1 IGF-1 (Sigma-Aldrich). 
 
5.2.5.4 Optical and Electrical Stimulation 
Muscle strip and ring actuators were optically stimulated using a 470-nm LED (Mightex). 
Trains of 50 ms pulses of specified frequency (1, 2, and 4 Hz) were generated using a custom-
built device. The LED output was focused using a lens, and a maximum power of 1.9 mW mm-2 
was used (corresponding to a spot diameter of 8 mm). Optical stimulation of bio-bots was 
conducted in DM++ media and all videos were taken through a red camera filter to make the 
focused nature of the light stimulus easier to visualize. During exercise training, a 2-min rest 
period was incorporated between stimulation at different frequencies, and all experiments were 
performed at 37 °C. Electrical stimulation was conducted using a custom-built electrical setup 
designed to provide bipolar electrical pulses of 20-V amplitude (21.6 V cm-1 field strength) and 
50 ms pulse width, as previously described 98. Electrical stimulation of bio-bots was conducted in 





5.2.5.5 Measurement of Force Production and Locomotive Speed 
Passive tension force was measured by correlating the deflection of the curved beam in 
the bio-bot skeleton to the contractile force applied on the bio-bot skeleton’s pillars. 
Displacements were measured in ImageJ (National Institutes of Health) and passive tension force 
was calculated from an equation derived from Euler-Bernoulli beam-bending theory: 𝑃 =
(8𝐸𝐼/𝑙𝐿!)𝛿!"#. In this equation, E represents the Young’s Modulus of the beam (319 kPa) as 
measured using a tensile mechanical testing apparatus. I is the moment of inertia, L is the beam 
length, l is the measured moment arm from the muscle strip to the beam, and 𝛿!"# is the 
measured beam deflection. Active tension force was measured by correlating the displacement of 
the ends of the bio-bot skeleton to the active contractile force produced in response to an external 
stimulus. The bio-bot was treated as a Kelvin-Voigt viscoelastic structure composed of a spring 
and damper in parallel, where applied stresses are related to measured strains by the following 
equation: 𝜎 𝑡 =  𝐸𝜀 𝑡 +  𝜂 !"(!)
!"
, as previously described 98. Speed was calculated by dividing 
distance traveled by time.  
 
5.2.5.6 Immunofluorescence Imaging 
Muscle strips and rings were rinsed in PBS, fixed in 4% (vol/vol) paraformaldehyde 
(EMD Chemicals Inc.) for 30 min, permeabilized with 0.2% (vol/vol) Triton X-100 (Sigma-
Aldrich) for 10 minutes, and stored in blocking solution (Image-iT FX Signal Enhancer, 
Invitrogen) prior to staining. The muscle was then incubated in mouse MF-20 antimyosin heavy 
chain (1:400 dilution in Image-iT FX, Developmental Studies Hybridoma Bank, The University 
of Iowa Department of Biology) for 6 hours at 4°C. They were then incubated with Alexa Fluor 
488 goat anti-mouse IgG secondary antibody (1:400 dilution in Image-iT FX, Invitrogen) for 12 
hours at 4°C. Next, they were incubated in 4’,6-diamindino-2-phenylindole (DAPI, 1:5000 in 
sterilized deionized water, Sigma-Aldrich) for 10 minutes prior to fixation onto a glass-bottom 
dish (MatTek) with warm agarose gel and imaging with a confocal microscope (LSM 710; 
Zeiss). 
 
5.2.5.7 DNA/Protein Quantification 
Muscle rings were detached from hydrogel skeletons, rinsed in PBS, and snap frozen in 
liquid nitrogen before storage at -80 ºC. At the time of analysis, rings were weighed, halved, and 
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weighed again. The DNA concentration in each half was measured using a spectrophotometer 
(NanoDrop 1000) at 260 nm after genomic DNA was isolated using a DNeasy Blood and Tissue 
Kit (Qiagen). Total DNA content was calculated from the concentration using the known elution 
volume and total muscle ring mass. The other halves of the muscle rings were lysed in RIPA 
Buffer (Thermo Scientific) on ice and briefly sonicated (Digital Sonifier 150; Branson). Cells 
were centrifuged and the supernatant was collected and diluted. Protein concentration in these 
halves was determined with a spectrophotometer by comparing absorbance of each sample at 
562nm to a standard curve of bovine serum albumin (BSA) protein absorbance versus 
concentration, using a Pierce BCA Protein Assay Kit (Thermo Scientific). Total protein content 
was calculated from the concentration using known supernatant volume and total muscle ring 
mass.  
 
5.2.5.8 Statistical Analysis 
Statistical analysis performed via one-way ANOVA followed by Tukey’s Multiple 
Comparison Test for P < 0.05 using OriginPro software. Results are presented as mean ± SD. 
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Figure 5.1 Bio-bot development and timeline. (A) Flowchart of design and optimization 
parameters, including structural design, material properties, ECM microenvironment, and 
conditions of cell seeding and culture. (B) A timeline representing the development of a 




Figure 5.2 Fabrication of hydrogel structures and formation of 3D muscle strips. (A) Computer-
aided design soft- ware was used to design bio-bots with desired dimensions. Measurements are 
in millimeters. (B)An SLA was used to polymerize hydrogel structures in an additive process. 
(C)The cell–matrix solution consisted of C2C12 skeletal muscle myoblasts, matrix proteins 
(fibrin or collagen I), and Matrigel. (D) Fabricated bio-bot (i, side view) and holder (ii, top 
view).Cell–matrix solution was pipetted into a polymerized holder containing the bio-bot 
structure (iii and iv, side view). Cells and matrix compacted around the pillars to form a solid 
muscle strip (v and vi, top view with immunostaining for MF-20, green and DAPI, blue) and the 





Figure 5.3 Linear elastic simulation of PEGDA hydrogel bio-bot deflection with varying 
dimensions. The deflection was simulated using ANSYS in response to a constant passive 
tension force of 992.7 µN (corresponding to a beam of modulus 319.4 kPa). Bio-bot design 
dimensions were optimized to maximize de- flection and reduce scaffold weight, while 
preserving ease of manipulation during experimentation and electrical stimulation. The optimal 
design (column highlighted by a dotted box), therefore, was chosen for its ability to combine 
high deflection with a robust mechanical structure. Shown are structures with global deflection 
(A) and plots of deflection versus varied dimensions (B), including beam–pillar width, beam 
thickness, pillar thickness, pillar height, and beam length. Optimal dimensions are 





Figure 5.4 Bio-bot design and fabrication. SolidWorks parts and dimensions of the bio-bot are 
shown. (A) The asymmetric design for the walking bio-bot had a taller cap at the end of the pillar 
and is shown from top-angled and side views. (B) Parameters from Fig. B.2 are assigned to bio- 
bot dimensions. (C)A working curve for PEGDA Mr 700 correlates the energy dose from the 
SLA laser with the polymerized layer thickness. (D) Time-lapse compaction of cell–matrix 
solution with IGF-1. During the 24–48 h after seeding, the liquid suspension of cells and fibrin 
Matrigel™ matrix polymerized and condensed around the pillars to form a solid muscle strip 
(top view). Skeletal myoblasts embedded in extracellular matrix proteins were induced to 
differentiate and self-assemble into 3D muscle strips anchored at both ends, an arrangement 
which facilitated cell growth, spreading, and differentiation in a supportive and constrained 
environment. (E) Cross-sectional compaction area of muscle strips decreased over the first 24 h 
due to compaction of the matrix and the exertion of traction forces from the cells (n = 20). Data 
are presented as mean ± SD (shaded region). (F) Schematic of a physiological muscle–tendon 
bone architecture, in which force transmission occurs from a contracting muscle to bone through 





Figure 5.5 Effect of cell density on bio-bot bending with constant modulus. Bio-bots structured 
fabricated with 138-mJ cm−2 energy dose were seeded with collagen-based cell–matrix solutions 
with varying cell densities (1–10 × 106 cells ml−1) in growth medium. After 72 h, DM with 1 




Figure 5.6 Muscle strip formation, viability, and differentiation. (A) Fluorescent images 
demonstrating the differentiation and maturation of myotubes over time with the addition of 50 
ngml−1 IGF-1 to differentiation medium containing 2% HS. Scale bar, 100 µm. (B) The 
myotube density was significantly increased for each time point after day 3 with the addition of 
IGF-1 compared with the control (n = 3). Fusion of multinucleated myotubes with additional 
myoblasts during myogenic differentiation explains the decrease in density between days 3 and 
7. Non–IGF-1–supplemented samples displayed an average myotube density of 11 ± 0 myotubes 
mm2 on day 3, which explains the lack of error bar at this time point. (C) The lifetime of the 
fibrin bio-bots (i.e., days until fracture of the muscle strip) was characterized by culture in 
differentiation medium in the presence or absence of 50 ng ml−1 IGF-1 and/or 1 mg ml−1 ACA. 
We noted a significant increase in the muscle strip lifetime compared with the control of 10% HS 
(from 8.75 ± 7.63–25 ± 1.15 d; P < 0.01, n = 4) with the addition of 1 mg ml−1 ACA. The 
addition of 50 ng ml−1 IGF-1 decreased the number of days until fracture compared with the 
control (51.43% decrease) and 1 mg ml−1 ACA condition (22.0% decrease). (D)A longitudinal 
slice (−IGF-1) and region of the fibrin muscle strip with immunostaining of antimyosin heavy 
chain MF-20 and DAPI staining contained myoblasts and myotubes. Scale bars, 500 µm. 
Fluorescence analysis demonstrated a significantly higher portion of cells in muscle strip 
sections (as indicated by percentage of MF-20 fluorescence area, representing skeletal muscle 
cells) with the addition of IGF-1 (74.7 ± 12.2%, n = 7) compared with no IGF-1 treatment (41.4 
± 8.7%, n = 4). For B–D, statistics represent one-way ANOVA and Tukey’s test, with * = P < 
0.01 and ** = P < 0.001. (E) Multinucleated myotubes were aligned along the perimeter of the 
fibrin muscle strip (+IGF-1). Scale bar, 200 µm. (F) Relative absorbance, indicative of viability 
of cells within the muscle strip at various time points from day 0 (day of cell seeding) to day 9 
(day of electrical stimulation). Statistical significance was not calculated between +IGF-1 and  
IGF-1 samples on day 9, because differences in cell density (resulting from addition of IGF-1) 
can lead to differences in absorbance values. The image at left demonstrates a qualitative 
difference in formazan product formation. For all charts, values are presented as mean ± SD. For 




Figure 5.7 Biological characterization of muscle strips. (A) Longitudinal fibrin muscle strip slice 
(day 9). Scale bar, 500 µm. (Inset)Scale bar, 200 µm. (B) Myotubes aligned along the fibrin 
muscle strip perimeter. Scale bar, 200 µm. (C) Longitudinal collagen muscle strip slice (day 
14).Scale bar, 500 µm. (D) Multinucleated myotubes in the collagen muscle strip. Scale bar, 50 
µm. (E–H) H&E staining of fibrin muscle strip sections (day 9). All scale bars, 200 µm. (E) 
Longitudinal and (F) transverse muscle strip sections. (G) Quantitative analysis of transverse 
sections demonstrated 75% of cells within 200 µm from the edge (n = 8). (H) Perimeter of 
transverse section of the muscle strip 98. 
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Figure 5.8 Analysis of bending and passive tension. (A) Over time, bio-bot beams polymerized 
with varying energy doses exhibited different bending profiles. Scale bar, 1 mm. (B) Elastic 
modulus of the beam as a function of energy dose (R2 > 0.99, n = 5). Increasing polymerization 
energy resulted in a higher modulus and less bending. (C) Finite-element analysis simulation 
demonstrating global deflection of the bio-bot beam and pillars on day 8. (D) Passive tension in 
the muscle strip as a function of time, modulus, and addition of IGF-1 (n = 3, 489.3 kPa; n = 4, 
others). Increasing beam stiffness resulted in a higher muscle strip tension. (Inset) Addition of 
IGF-1 significantly increased the average tension by 70.7% (for 319.4-kPa stiffness) over time 
period shown. Statistics represent one-way ANOVA and Tukey’s test, with ** = P < 0.001. All 





Figure 5.9 Mechanical characterization of stiffness, tension, and stress. (A) Effect of beam 
stiffness on collagen bio-bot bending. The bending in the stiffer beams was negligible in 
comparison with those with lower elastic moduli, and could not support net displacement of the 
bio-bot. (B) Setup of hydrated tensile testing chamber. (C) Schematic showing beam in 
compression undergoing nonlinear bending. The midpoint of the beam is set as the origin. Δmax 
is the maximum deflection of the beam and l is the moment arm from the muscle strip to the 
beam. (D) The measured and simulated values of maximum beam deflection recorded for bio 
bots of various energy doses on day 8. To verify the accuracy of the calculation method, the 
computed passive tension values were input into ANSYS, and the simulation produced values for 
deflection of the beam. The error between the actual and simulated values was calculated as 
∼18% for the three bio-bots, validating the use of linear bending theory to predict the force in the 
muscle strip. (E) Fibrin muscle strips exhibited 17.8% higher passive tension, on average (n = 6 
for days 3 and 4; n = 2 for day 5), compared with collagen muscle strips (n = 2) over the time 
period shown for 1 × 106 cells ml−1 density. Statistics represent one-way ANOVA and Tukey’s 
test, with * = P < 0.01 and ** = P < 0.001. (F) Transverse histological cross-sections were used 
to calculate the cross-sectional area of the muscle strips for calculation of stresses 98.  
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Figure 5.10 Electrical control and pacing. (A) During stimulation, bio-bots were placed standing 
up on the surface of the dish, with the muscle strip’s longitudinal axis parallel to the electrodes 
and perpendicular to the applied field. (B) IGF-1-supplemented bio-bots were reliably paced at 
stimulation frequencies of 1, 2, or 4 Hz. Bio-bots not supplemented with IGF-1 did not respond 
to stimulation at any frequency in the observed time period. (C)A Kelvin–Voigt viscoelasticity 
model was used to extract active tension generated by the muscle strip in response to electrical 
stimulation. (D) Muscle strip time-varying active tension was calculated for a bio-bot undergoing 
varying electrical stimulation (0, 1, 2, 3, 4, 0 Hz) during one experiment, and followed a positive 





Figure 5.11 Electrical stimulation setup and characterization. (A) Schematic of custom-built 
electrical stimulation setup. (B) Average resistance (n = 3) and conductivity (Inset, n = 4) of the 
electrical stimulation medium (DMEM without serum) at 23 °C and 37 °C. Boxes represent 25th, 
50th, and 75th percentile; • represents mean value; whiskers represent minimum–maximum 
values. (C)Average number of contractions per second of electrically stimulated bio-bots, 
measured over a stimulation period of 130 s (n = 5 for each condition). The introduction of 
asymmetry into the design did not significantly alter the response to stimulation. (D and 
E)Stimulation and imaging setup. In most cases, net movement was observed with electrical 





Figure 5.12 Characterization of bio-bot movement at various stimulation frequencies. (A) Over 8 
min, the range of active tension remained between 99.3%and 111.0%of the initial tension (i.e., 
the first time point of 0–10 s) for hour 0, and between 98.8% and 150%for hour 6 of the same 
bio-bot. (B)Top-view time- lapse montage (1-s increments) showing the movement and net 
displacement of the bio-bot characterized in Figure 3.5 with electrical stimulation at 1 Hz. Scale 
bar, 1mm.(C) Top-view time-lapse images of the movement of the bio-bot characterized in  
Figure 3.5 with electrical stimulation at 2 Hz (Left) and 4 Hz (Right). Examination of top-view 
movies revealed the relative range of motion of each pillar during contraction, which dictated the 
degree of net displacement. The direction of net displacement corresponded to that of the pillar 
with a greater average range of motion (ratio > 1). (D)Normal forces are shown for a symmetric 
(Left) and asymmetric (Right) bio-bot, shown over a time period of 3 s (three contractions at 1 
Hz stimulation). Directional movement occurred when discrepancies in coefficients of friction 
between the pillars and the ground, resulting from a phase delay in the spatially varying 
contractile response of the muscle strip in response to electrical stimulation, caused one to 
“stick” and the other to “slide” with respect to the surface. (E) Calculation method to determine 
time-averaged ratios of relative pillar displacement. The difference in X and Y position between 
two consecutive frames is shown for one pillar in this figure. The unequal range of motion 
between the pillars was attributed to two causes: first, variability in cell–matrix compaction 
which led to uneven moment arms in the two pillars, causing uneven bending in the beam and 
hence unequal pillar displacements; and second, time-varying normal reaction forces and 
therefore time-varying frictional forces that restricted the range of motion of each pillar, due to 
an imbalanced distribution of mass within the muscle strip that caused the weight assumed by 




Figure 5.13 Simulation and movement profiles of symmetric and asymmetric bio-bots 
supplemented with IGF-1. (A) von Mises stress of a symmetric and asymmetric bio-bot. The 
range of one contraction is shown over a period of 10 s (10 “steps” at 1-Hz stimulation). (B and 
E). Top-view time-lapse images of the symmetric (B)and asymmetric (E)bio-bot’s movement. 
All scale bars, 1 mm. (C and F)Relative ratios of pillar movement over time during 1-Hz 
stimulation. The bio-bots moved in the direction of greater pillar movement during contraction. 
(D)Displacement (µm) of a symmetric bio-bot at 1-Hz stimulation during a 25-s interval when 
contraction produced maximum displacement along the surface. (G) Active tension force of the 
asymmetric bio-bot during locomotion. (H) The increased number of contractions with 
increasing stimulation frequency within a given time period resulted in an increased average 
velocity of the asymmetric bio-bot. (Inset, Left) Velocity (gray) and total displacement. (Inset, 




Figure 5.14 Design, fabrication, and simulation of multilegged designs. Due to a fabrication 
technology offering a great deal of flexibility in specifying geometric and design parameters, the 
designs presented in the main figures were adapted to demonstrate the ability to build machines 
with varying number and arrangement of pillars. Images of computer-aided designs (A), 
fabricated hydrogel machines (top views, B, and side angled views, C), and finite-element  
analysis simulations of deflections (D) are shown for three different designs. Scale bars, 2 




Figure 5.15 (A) Design dimensions for asymmetric one-leg bio-bot skeletons shown as side view 
(A-1) and top view (A-2) schematics. (B) Design dimensions for symmetric two-leg bio-bot 
skeletons shown as side view (B-1) and top view (B-2) schematics 99. 
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Figure 5.16 Design and fabrication of optogenetic muscle ring-powered bio- bots. (A) 
Stereolithographic 3D printing is used to fabricate ring and strip injection molds and bio-bot 
skeletons from a PEGDA photosensitive resin. (B) C2C12 myoblasts are engineered to 
incorporate a mutant variant of the blue-light sensitive cation channel, Channelrhodopsin-2, in 
the cell membrane. The ion channel is tagged with a red fluorescent tdTomato tag. (C) 
Optogenetic myoblasts embedded within a natural hydrogel matrix. (D) Injection molding of 
cell/gel solution into muscle strip and ring molds. (E) Manual transfer of muscle rings from the 
injection mold to the bio-bot skeleton. (F) Optimization of muscle ring thickness as a function of 





Figure 5.17 Schematic showing timeline of growth, differentiation, and exercise training of 









Figure 5.18 (A) Characterization of ring thickness as a function of fibrin concentration. A 
concentration of 4 mg/mL was chosen for its ability to generate compact muscle strips with high 
cellular density. Higher concentrations than this resulted in marginal changes in muscle strip 
thickness. (B) The dimensions of rings can be readily modified to power larger-scale bio-bot 
structures by adjusting the volume of the cell/gel solution. This ring was formed from 240 µL 
cell/gel solution, compared with those used in the study, which were formed from 120 µL 
cell/gel solution. (C) The modularity of the muscle ring actuator design allows for the addition of 
multiple muscle rings per device, providing an added mechanism of improving functional 
performance of bio-integrated machines and systems in the future. (D) The modularity of the 
muscle ring actuator design also enables the fabrication of multilegged bio-bot structures, such as 
the “four-leg” bio-bot shown here. Because directional locomotion and 2D steering proved to be 





Figure 5.19 Characterization of muscle ring architecture. (A) Alignment of myotubes within 
various regions of muscle rings assessed via FFT analysis of fluorescent myosin marker. 
Fluorescence image (Upper Left), FFT (Upper Right), and normalized gray value of the FFT as a 
function of angle (Lower Left) are presented for three regions of muscle rings, shown as green 
highlights on a whole device (Lower Right). (B) Multichannel fluorescence imaging of DAPI 
cell nucleus marker, the optogenetic ChR2 tdTomato tag, and the MF-20 myosin marker imaged 
via confocal fluorescence microscopy and presented as a merged 3D stack. (C) Scanning electron 
microscopy image of muscle ring surface. (D) Cross-section of fluorescent immunostained 






Figure 5.20 (A) Passive tension force produced by muscle strips and muscle rings. There is no 
significant difference between the passive tension forces produced by muscle strips and rings (P 
< 0.05, n = 9, one-way ANOVA, post hoc Tukey test). (B) Optogeneticmuscle rings produced 
paced contractions in response to optical stimulus at frequencies from 1 to 4 Hz. Muscle rings 
tested at higher-frequency stimulations produced paced contractions until a tetanus frequency 
above 8–10 Hz (n = 4). (C) Effect of increasing optical intensity on the directional locomotive 
speed of optically stimulated asymmetric one-leg bio-bots. A maximum energy density of 1.9 
mW/mm2 was used for all experiments presented in this study. (D) Active tension force 
produced by muscle strips and rings in response to electrical stimulation reveals that electrical 
stimulation produces comparable contractile forces for both actuator designs (P < 0.05, n = 3, 
one-way ANOVA, post hoc Tukey test) 99.  
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Figure 5.21 Optically stimulated actuation of muscle strips and rings. (A) Apparatus used to 
optically stimulate engineered muscle. (A-1) 470-nm light is focused on to bio-bots at a 
maximum intensity of 1.9 mW mm-2. (A-2) At the microscale, light stimulation induces 
contraction of individual myotubes. The coordinated contraction of several sarcomeres produces 
observable macro- scale contraction. (B) Active tension force produced by muscle strips (day 
12). (B-1) Active tension force tracked over time for a representative muscle strip. Inset of 4-Hz 
stimulation over 2 s shown for clarity, with a dashed blue line indicating the stimulus pulse train. 
(B-2) Active tension force compared be- tween optical and electrical stimulation of muscle strips 
(P < 0.05, n = 3, one- way ANOVA, post hoc Tukey test). (C) Active tension force produced by 
muscle rings (day 12). (C-1) Active tension force tracked over time for a representative muscle 
ring. Inset of 4-Hz stimulation over 2 s shown for clarity, with a dashed blue line indicating the 
stimulus pulse train. (C-2) Active tension force compared between optical and electrical 
stimulation of muscle rings (P < 0.05, n = 3, one-way ANOVA, post hoc Tukey test). All data 




Figure 5.22 Functional performance optimization via exercise training. (A)Exercise stimulation 
regimen for four experimental groups during growth (days 1–3) and differentiation (days 4–11) 
(Fig. S2). Force output in response to optical stimulation is compared on day 12. (B) 
Improvement of muscle functional performance in response to optical conditioning. (B-1) Active 
tension produced by exercise group 1 assessed from days 7 to 12 (P < 0.05, n = 3, one-way 
ANOVA, post hoc Tukey test). (B-2) Active tension comparison between all four experimental 
groups (P < 0.05, n = 3, one-way ANOVA, post hoc Tukey test). (C) Assessment of mechanisms 
underlying functional performance improvement. (C-1) Ratio of protein content to DNA content 
measured for control group 2 and exercise group 2 (P < 0.05, n = 4, one-way ANOVA, post hoc 
Tukey test). (C-2) Immunofluorescence stained cross-sections of exercise group 2 and control 
group 2, showing visibly greater expression of myosin marker in exercised muscle rings. All data 




Figure 5.23 Optically stimulated 1D locomotion. (A) Directional locomotion of optogenetic 
muscle ring powered bio-bots shown as a schematic (A-1) and time lapse images from a movie 
(A-2). (B) Assessment of bio-bot speed from control group 2 and exercise group 2 in response to 
optical and electrical stimulation at 1 Hz (P < 0.05, n = 3, one-way ANOVA, post hoc Tukey 
test). (C) Speed-frequency response of bio-bots at 1 and 4 Hz. Inset shows displacement over a 






Figure 5.24 Optically stimulated 2D locomotion and steering. (A) Whole device stimulation of a 
geometrically symmetric two-leg bio-bot shows zero net locomotion predicted via FEA (A-1) 
and confirmed via electrical stimulation (A-2). Side view image of two-leg device shown for 
clarity. (B) Single leg stimulation of a geometrically symmetric structure drives locomotion in 
the direction of the stimulated leg predicted via FEA (B-1) and confirmed via optical stimulation 
for the same device presented in A-2 (B-2). (C) Half of a single leg in a geometrically symmetric 
structure is stimulated to drive rotational locomotion, as predicted via FEA (C-1) and confirmed 
via optical stimulation for the same device presented in A-2 and B-2 (C-2). Statistical analyses of 





Figure 5.25 (A) Passive tension force produced by muscle strips and muscle rings. There is no 
significant difference between the passive tension forces produced by muscle strips and rings (P 
< 0.05, n = 9, one-way ANOVA, post hoc Tukey test). (B) Optogenetic muscle rings produced 
paced contractions in response to optical stimulus at frequencies from 1 to 4 Hz. Muscle rings 
tested at higher-frequency stimulations produced paced contractions until a tetanus frequency 
above 8–10 Hz (n = 4). (C) Effect of increasing optical intensity on the directional locomotive 
speed of optically stimulated asymmetric one-leg bio-bots. A maximum energy density of 1.9 
mW/mm2 was used for all experiments presented in this study. (D) Active tension force 
produced by muscle strips and rings in response to electrical stimulation reveals that electrical 
stimulation produces comparable contractile forces for both actuator designs (P < 0.05, n = 3, 




Figure 5.26 (A) Directional locomotion in response to single-leg stimulation of two-legged bio- 
bots. (A-1) X-Y tracking of top-view movies of bio-bots over 15 s at 2-Hz optical stimulation. 
Average locomotive speed for exercise group 2 bio-bots is 312 ± 63 µm/s. Devices also 
demonstrated small rotations under full-ring stimulation, with an average speed of 0.24 ± 0.1°/s. 
(A-2) Comparison of directional locomotive speed in response to optical stimulation at 2 Hz for 
exercise group 2 bio-bots (labeled E) (n = 6) and control group 2 bio-bots (labeled C) (n = 3). 
Exercised bio-bots demonstrate significantly higher locomotive speeds than control bio-bots (P < 
0.05, one-way ANOVA, post hoc Tukey test). (B) Rotational locomotion in response to half-leg 
stimulation of two-legged bio-bots. (B-1) X-Y tracking of top-view movies of the same bio-bots 
presented in A-1 over 15 s at 2-Hz optical stimulation. Average rotational speed for exercise 
group 2 bio- bots is 2.1 ± 0.5°/s. Devices also small translocations under full-ring stimulation, 
with an average speed of 33 ± 10 µm/s. (B-2) Comparison of rotational lo- comotive speed in 
response to optical stimulation at 2 Hz for exercise group 2 bio-bots (labeled E) (n = 6) and 
control group 2 bio-bots (labeled C) (n = 3). Exercised bio-bots demonstrate significantly higher 
locomotive speeds than control bio-bots (P < 0.05, one-way ANOVA, post hoc Tukey test) 99. 
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CHAPTER 6: DAMAGE, HEALING, AND REMODELING IN BIO-BIOTS 
 
6.1 Introduction 
The functional properties of man-made machines and systems are a direct result of, and 
therefore limited by, the properties of the materials with which they are built. Biological 
materials, the most prevalent materials in the natural world, have the ability to sense, process, 
and respond to a range of environmental signals in real-time. Our deepening understanding of 
biological materials, and the design principles that govern them, have spurned an era of bio-
inspired and bio-mimetic design.206–209 This has driven advances in the field of “smart” 
materials, where attempts to mimic the complex functionalities demonstrated by biological 
systems, such as self-assembly and self-healing, have met with significant success.210–213   
The concurrent rise of advanced manufacturing technologies, such as 3D printing, have 
enabled ready fabrication of complex geometries from a range of synthetic and biological 
materials.1,122,214 With this tool in hand, we are ideally poised to design and manufacture bio-
integrated or “bio-hybrid” machines and systems. Such machines, which harness the strengths of 
both classes of materials, have the potential to achieve more complex functionalities than 
machines composed of synthetic materials alone.189,215 This idea has spurned the creation of a 
range of bio-hybrid robots, or “bio-bots”, which have largely focused on proof-of-concept 
functional demonstrations, such as locomotion driven by biological actuators.97–99,153,156,158 For 
example, we have previously presented the first demonstrations of skeletal muscle-powered 
locomotion in untethered soft robotic devices, controlled by both electrical and optical 
signals.98,99 
These bio-bots, formed by coupling tissue engineered skeletal muscle to 3D printed 
flexible skeletons, are currently capable of directional locomotion and 2D steering in response to 
non-invasive external signals. Incorporating other types of biological tissue in these machines, 
such as vascular systems for nutrient transport or neuronal networks for signal processing and 
higher-level control, promises to expand the range of bio-bot functional behaviors even 
further.73,150,200 Such bio-hybrid systems readily lend themselves towards primary applications in 
healthcare, such as high-throughput drug testing, targeted drug delivery, and dynamic functional 
implants. Advanced research in bio-batteries and exoskeletons could further expand the scope of 
such machines to applications in bio-security and environmental cleanup.  
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Bridging the gap between the first generation of bio-bots and their eventual real-world 
applications requires a fundamental understanding of the biological design rules and principles 
that govern such machines. Any application of these bioactuator technologies will require them 
to be dynamically responsive to changing environmental loads and robustly resilient to induced 
damage. Since the predominant cause of skeletal muscle loss of function is mechanical damage, 
it is essential to investigate the underlying mechanisms of muscle damage in vitro, and to 
develop in vivo-inspired healing strategies to counteract this damage.216,217 Understanding and 
exploiting the adaptive response behaviors inherent within biological systems is a crucial step 
forward in designing robust bioactuators that are broadly applicable to engineering grand 
challenges.  
 
6.2 Results and Discussion 
Mechanical damage of muscle in vivo can take many forms, including contusion, 
overstrain, and laceration.216 In this study, we chose to investigate muscle functional behavior in 
response to induced laceration, as this represents the most immediate and severe case of muscle 
loss of function. Muscle ring bioactuators were formed by injecting a natural hydrogel solution, 
composed of extracellular matrix mimicking compounds such as Matrigel™ and fibrin, into a 3D 
printed mold (Figure 6.1a). Optogenetic C2C12 murine skeletal myoblasts embedded within this 
natural hydrogel exerted traction forces on this matrix, compacting to form dense 3D muscle 
tissue ring. This ring was manually transferred to a 3D printed skeleton, and the resulting device, 
or “bio-bot”, was matured and differentiated using the protocol outlined in Figure 6.2. Given the 
geometric and material properties of the bio-bot skeleton, which was composed of the 
biocompatible hydrogel poly (ethylene glycol) diacrylate (PEGDA Mw 700 g mol-1), contractile 
forces exerted by the muscle ring bioactuators in response to a blue-light stimulus (470 nm) 
could be readily calculated from the resultant displacement of the skeleton (Figure 6.3a-b).99,218 
This provided us with a simple and efficient meso-scale model with which to investigate the 
effects of mechanical damage on skeletal muscle in vitro.  
Mechanical damage was induced via manual laceration of the muscle ring using sterile 
microscissors (Figure 6.1b). Muscle tissue cross-sectional area, represented as a percentage of its 
pre-damage value and measured from top-view images, decreased significantly 24 hours post-
damage and reached a steady-state thereafter for damages ranging from 40-60% original cross-
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section (Figure 6.1c). This trend was preserved for smaller-scale damages above 60% original 
cross-section. Larger damages (below 40% original cross-section) led to more rapid reduction in 
cross-sectional area 24 hours post-damage and continuing decreases in area thereafter (Figure 
6.4a-b). The rate of complete rupture for the bioactuators by Day 17 was 50% for muscle below 
40% of the original cross-section, and 20% for 40-60%, and 0% for damaged muscle above 60% 
original cross-section. Post-damage cross-sectional area demonstrated a linear correlation with 
the percentage loss in passive tension exerted by the muscle (Figure 6.1d). Damaged muscle 
rings in the range of 45-55% original cross-section, which represented significant loss of 
function without a resultant instability in the remaining undamaged tissue, were used for all 
future experiments. Cellular viability in these muscle rings demonstrated a significant drop to 
91% ± 3% of the healthy tissue value one hour post-damage, further reducing to 86% ± 4% one 
week post-damage (Figure 6.1e). However, the viability decrease between Day 10 and Day 17 
was not significant, indicating that cellular viability and functionality in the undamaged portion 
of muscle tissue did not continue to decrease after induced mechanical laceration.  
To obtain further evidence that the differentiated myotubes in the lacerated section of the 
tissue had undergone irreversible damage, we sealed the tear in the muscle using a biological 
glue of the same composition as the surrounding muscle matrix (Figure 6.5a-b). Passive and 
active tension generated by muscle rings healed with this glue were not significantly different 
from those generated by damaged muscle rings (Figure 6.5c-d), indicating that the reduction in 
force production was not merely a result of inefficient force transmission across the matrix. 
Sealing the wound with the glue did, however, have the positive effect of reducing complete 
rupture of muscle rings from 20% to 0%, as compared to damaged muscle rings one week post-
damage. 
 Since myotubes are irreversibly mitotic,216 it is perhaps unsurprising that healing the 
lacerative damage with a biological glue did not result in improved force production. In vivo, 
skeletal muscle damage is healed via satellite cells which migrate to the site of injury, proliferate 
to form myoblasts, and differentiate into contractile myotubes.217 To mimic this procedure in 
vitro, we incorporated undifferentiated optogenetic C2C12 myoblasts within the biological glue 
used to seal muscle damage. This resulted in significant increases in passive and active tension 
one week post-damage, on the order of 86% ± 10% (1230 ± 140 µN) and 84% ± 5% (138 ± 8.1 
µN) of pre-damage values respectively (Figure 6.5c-d). A comparison of the expression levels of 
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a range of muscle specific proteins (Figure 6.5e) revealed that damaged muscle rings that did not 
undergo any healing process expressed significantly higher levels of myostatin, an inhibitory 
factor that prevents muscle growth and differentiation.219 Muscle rings healed with biological 
glue, both with and without embedded cells, expressed significantly higher levels of Myogenin, a 
factor that helps coordinate muscle growth and repair.220 Only muscle rings healed with 
biological glue containing cells showed significant increases in the expression of Myogenic 
factor 5 (Myf5), a protein that performs an important role in muscle regenerative growth and 
differentiation.221 While these results were a promising indication of the regenerative effects of 
the biological glue containing myoblasts, the values of force production generated by muscle 
healed with this method were still significantly lower than those for healthy tissue. This indicated 
a need to develop a strategy for more accelerated and complete recovery of force production. 
Muscle force production in vivo can be improved via exercise.217,222 Several studies of 
tissue engineered skeletal muscle have shown that force production can be improved in vitro 
through “exercise” in the form of a static mechanical stimulus, dynamic mechanical stimulus, or 
dynamic electrical stimulus.170,200,201,218 We have previously shown that the functional 
performance of optogenetic tissue engineered muscle can likewise be tuned through dynamic 
optical stimulation during differentiation.99 While this noninvasive approach of regulating force 
production has been proven, it has yet to be empirically optimized. To investigate the possibility 
that an optical exercise stimulation protocol could be used to accelerate the recovery of force 
production in healed muscle rings, we optically stimulated muscle rings at 1 Hz for timescales 
ranging from 15-60 minutes using a 470 nm LED (Figure 6.6a and Figure 6.7a). Our engineered 
muscle tissue demonstrated physiological response behavior, where an increase in stimulation 
frequency corresponded to a reduction in the corresponding dynamic range of active tension 
force (Figure 6.7b). Therefore, the stimulation frequency of 1 Hz was chosen to optimize the 
exercise protocol because it would result in the greatest contractile strain imposed on the muscle. 
Passive and active tension force production improved in response to exercise training, with 
significant increases observed up to 30 minutes of stimulation (Figure 6.6b and Figure 6.7c). 
Muscle rings subjected to the 30 minute optical stimulation regimen produced passive tension 
forces of 2250 ± 120 µN and active tension forces of 371 ± 29 µN on Day 17. Stimulation for 
longer time periods did not result in further increases in force production. An analysis of protein 
expression in muscle rings exercised for 30 minutes showed significant increases in the 
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expression of factors that play key roles in myogenesis and differentiation (Desmin, Myosin 
Heavy Chain 1, Myogenic Factor 5, Myogenic Factor 6, MyoD, and Myogenin), as compared to 
control muscle rings that did not undergo exercise (Figure 6.6c).223  
Having optimized the optical stimulation protocol for improving muscle force production, 
we investigated the effect of integrating an exercise regimen with the healing approach outlined 
in Figure 6.5. Specifically, we compared three groups on their ability to recover the force 
produced by undamaged muscle rings: Group 1 contained optogenetic muscle rings healed with 
optogenetic myoblasts, Group 2 contained optogenetic muscle rings healed with wild type 
C2C12 myoblasts (myoblasts that have not been engineered to respond to blue light), and Group 
3 contained muscle rings composed of wild type C2C12 myotubes healed with optogenetic 
C2C12 myoblasts (Figure 6.6d). Healed muscle rings were tested via electrical stimulation, 
which activates contraction in both wild type and optogenetic C2C12 myotubes. Muscle rings in 
Groups 2 and 3 demonstrated significant increases in force production when measured 2 days 
and one week post-healing (Figure 6.6e). However, they were unable to reproduce the contractile 
forces generated by healthy muscle tissue. By contrast, muscle rings in Group 1 produced active 
tension forces comparable to those produced by healthy undamaged tissue one week post-
damage (Figure 6.6e). Muscle rings in Group 1 produce active tension forces of 169 ± 19 µN on 
Day 17, similar to healthy undamaged tissue which produced active tension forces of 175 ± 31 
µN. This shows that exercise stimulation of both the undamaged tissue and the newly formed 
tissue created during the healing process is required to regain force production at pre-damage 
levels. 
While regaining pre-damage functionality is a significant accomplishment, accelerating 
the healing process to recover functional performance over a shorter time period could prove to 
be of great value in real-world bioactuator applications. The hypertrophic effect of human 
insulin-like growth factor (IGF-1) on skeletal muscle tissue has been well established in vivo and 
in vitro.163,194 We have previously shown that incorporating IGF-1 at a concentration of 50 ng 
mL-1 into our muscle differentiation media results in significant improvements in muscle force 
production, as well as accelerated maturation of muscle tissue to a contractile state.218 To test the 
effects of a concentrated and sustained local release of IGF-1 near the site of damage, we 
incorporated IGF-loaded poly (lactic-co-glycolic acid) (PLGA) microparticles into the biological 
glue containing undifferentiated optogenetic myoblasts (Figure 6.8a and Figure 6.9).  
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The biological glue containing microparticles was prepared at concentrations of 50, 100, 
and 200 ng mL-1 IGF-1. Muscle ring active tension was measured one hour post-heal (Day 10) 
and measured every day following up to one week post-damage (Day 17). Muscle rings were 
also subjected to 30 minutes of daily optical stimulation at 1 Hz during this period. In all three 
cases, muscle rings produced active tension forces on the order of healthy tissue values by Day 
15 (Figure 6.8b). Furthermore, muscle rings treated with the higher concentrations of 100 and 
200 ng mL-1 IGF-1 produced active tension forces of 126 ± 21 µN and 136 ± 7.7 µN respectively, 
on the order of healthy tissue values, by Day 12. By contrast, the Group 1 muscle rings healed 
without microparticles (Figure 6.6e) did not regain pre-damage force production values until Day 
17. This indicated that concentrated release of IGF-1 near the site of damage served to accelerate 
the rate of wound healing in muscle rings. Healing response to a biological glue containing IGF-
loaded nanoparticles at a concentration of 100 ng mL-1 IGF-1 was also tested, revealing that 
muscle rings did not regain pre-damage values of force production until one-week post-heal 
(Figure 6.8c), similar to the Group 1 muscle rings shown in Figure 6.6. The difference in healing 
rates between the microparticle-containing glue and the nanoparticle-containing glue could be 
attributed to diffusion of the nanoparticles out of the tissue. Microparticles were 2-3 µm in 
diameter, similar to single C2C12 myoblasts (8-10 µm diameter), as compared to the 
nanoparticles which were 200-300 nm in diameter. Microparticles were thus more likely to be 
trapped within the 3D muscle matrix, resulting in sustained local release of IGF-1 at the damage 
site. 
Expression levels of a range of muscle specific proteins in muscle rings healed with IGF-
loaded micro- and nano-particles are shown in Figure 6.8c, represented as fold increases over 
muscle rings healed with cells and exercise alone. The expression levels of Desmin, Myf5, 
MyoD, and Myogenin on Day 17 are not significantly different across experimental groups. 
However, muscle rings treated with the highest concentration of IGF-1 (200 ng mL-1) expressed 
Myosin Heavy Chain 1, the protein that forms the muscle contractile apparatus and converts 
chemical energy from ATP hydrolysis to mechanical energy,224 at significantly higher levels than 
all other experimental groups. Furthermore, they expressed Myogenic Factor 6 (Myf6) and 
Troponin 1, a regulatory protein that controls myosin-actin binding,225 at significantly higher 
levels than rings treated with microparticles at 50 ng mL-1 and nanoparticles at 100 ng mL-1. 
Muscle rings in the 200 ng mL-1 IGF-1 treatment group did produce larger active tension forces 
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(184 ± 20 µN on Day 17) in response to optical stimulation at 1 Hz (Figure 6.8a), but these 
increases were not significantly greater than those in other test groups.  
It is interesting to note that, while the muscle rings in the damaged and healed groups 
were exercised daily for 30 min, they did not produce significantly greater values of active 
tension force than the un-exercised healthy tissue. This contrasts with the data shown in Figure 
6.6b, where undamaged muscle rings that were exercised demonstrated, on average, a 210% 
increase in force production by Day 17. This indicates that, even though healed muscle rings 
rapidly recover force production on the order of healthy unexercised tissue, there is still a lasting 
effect of damage on the skeletal muscle bioactuators that effects muscle performance one week 
post-damage. Future studies could further investigate the longer term mechanisms underlying 
muscle remodeling post-damage. 
To visualize muscle architecture in the muscle rings healed with microparticles (200 ng 
mL-1 IGF-1), we imaged immunostained muscle rings in a fluorescence confocal microscope 
(Figure 4d). Muscle rings fixed and stained one hour post-damage, and imaged at the damage 
site (Figure 4di), showed cell nuclei (DAPI, blue) throughout the damage site. The original 
muscle tissue (red) occupies the inner undamaged portion of the muscle ring, while the outer 
damaged portion is composed primarily of myoblasts (green) added during the healing process. 
Since these added cells are undifferentiated, Myosin (yellow) is only visible in the inner portion 
of the muscle ring, which is composed of mature muscle tissue. By Day 17, the added myoblasts 
spread across the muscle rings (4dii) and are not physically separated from the original 
undamaged portion of the muscle tissue (4diii). Myosin is expressed uniformly in the original 
and new muscle tissue, corroborating the recovery in force production observed empirically.  
 
6.3 Conclusion 
In conclusion, we have developed a meso-scale model for studying skeletal muscle 
physiology in vitro and used it to create an efficient and effective healing strategy to counteract 
mechanical damage in engineered skeletal muscle. A similar approach could be used to study 
skeletal muscle pathologies and test the effects of various drugs on both muscle architecture and 
functional performance. A deepening understanding of muscle healing in vitro could also be 
applied to develop optimized healing methodologies for volumetric muscle loss injuries in 
vivo.203,226  
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In addition to these more immediate applications in healthcare, this study presents a 
significant step forward in creating a more robust, resilient, and adaptive bioactuator technology 
for other engineering challenges. While recent advances in developing self-healing synthetic 
materials have met with significant success, they have yet to demonstrate, to our knowledge, 
complete recovery of pre-damage functionality in such materials.210,227–229 Furthermore, these 
studies have focused on healing static materials, using mechanical strength as a measure of 
recovery, rather than on healing dynamic materials capable of controllable actuation. 
Considering that skeletal muscle can produce larger strains and forces from a compact volume 
than any synthetic actuator to date,230 and that biological materials have the ability to 
dynamically adapt to a range of environmental cues, there is a strong motivation to develop 
robust skeletal muscle bioactuators for bio-hybrid machines and systems.  
We have developed a skeletal muscle bioactuator that can completely recover from large 
volume damages within two days post-damage, when treated with an optimized healing strategy 
that combines new myoblasts, extracellular matrix proteins, exercise, and sustained local release 
of insulin-like growth factor. Future work could further increase the degree of autonomy, or 
“self-healing” demonstrated by these actuators, by incorporating vascular-like networks within 
the muscle rings which release myoblasts or biochemical factors upon induced damage. 
By coupling the complex and adaptive functional capabilities of biological tissues with 
the increasingly vast array of synthetic materials, we have the opportunity to create bio-hybrid 
machines and systems that have broad applicability towards real-world challenges in health, 
security, and the environment.99,189,218 This study advances the goal of understanding and 
exploiting the fundamental design rules and principles that govern “building with biology”, and 
sets the stage for forward-engineering the next generation of bio-hybrid machines and systems. 
 
6.4 Methods 
6.4.1 Stereolithographic 3D printing of muscle ring injection molds and bio-bot skeletons 
 An adapted form of a commercially available stereolithographic 3D printer (SLA 250/50, 
3D Systems) was used to manufacture muscle ring injection molds and bio-bot skeletons as 
previously described.99 Molds were printed using a 20% (w/v) poly (ethylene glycol) diacrylate 
(PEGDA) resin of molecular weight 1000 g mol-1 (Polysciences) and skeletons were printed 
using a 20% (v/v) PEGDA resin of molecular weight 700 g mol-1(Sigma Aldrich). Fabricated 
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parts were sterilized prior to cell culture by immersion in 70% (v/v) ethanol for 1 h, followed by 
immersion in phosphate buffered saline (PBS) for 1 h.  
 
6.4.2 Muscle ring seeding and differentiation 
C2C12 murine myoblasts transduced to express a mutant variant of the 470 nm blue light 
sensitive cation channel, Channelrhodopsin-2 (ChR2[H134R])231 were cultured in growth 
medium (GM) consisting of Dulbecco’s Modified Eagle Medium with L-glutamine and sodium 
pyruvate (DMEM, Corning) and supplemented with 10% (v/v) fetal bovine serum (FBS, Lonza), 
1% (v/v) L-glutamine (Cellgro Mediatech) and 1% (v/v) penicillin-streptomycin (Cellgro 
Mediatech). Muscle cells were trypsinzed and resuspended (at a concentration of 1E7 cells mL-1) 
in a natural hydrogel matrix consisting of 30% (v/v) Matrigel™ (BD Biosciences), 4 mg mL-1 
fibrinogen (Sigma Aldrich), and 0.5 units mg-fibrinogen-1 thrombin (Sigma Aldrich). This 
suspension was pipetted into the 3D printed injection molds and incubated for 1 h at 37°C prior 
to being immersed in growth medium supplemented with 1 mg mL-1 aminocaproic acid (ACA, 
Sigma Aldrich) (GM+). On Day 3 post-seeding, muscle rings were transferred to differentiation 
medium consisting of DMEM supplemented with 10% (v/v) heat inactivated horse serum (HS, 
Lonza), 1% (v/v) L-glutamine (Cellgro Mediatech) and 1% (v/v) penicillin-streptomycin 
(Cellgro Mediatech). This differentiation medium (DM) was further supplemented with 1 mg 
mL-1 ACA and 50 ng mL-1 human insulin-like growth factor-1 (IGF-1, Sigma Aldrich) (DM++). 
Muscles started demonstrated controllable twitch response to optical stimulation at Day 7 post 
seeding. 
 
6.4.3 Damage and healing of muscle rings with biological glue 
 Muscle damage was induced via laceration with sterile microscissors (Ted Pella). The 
biological glue used to heal the tear in the muscle was composed of the same cell/hydrogel 
matrix used during the muscle ring seeding process. For muscle rings healed with IGF-loaded 
micro- and nanoparticles, the particles were mixed thoroughly in the cell/hydrogel solutions at 
concentrations of 50, 100, and 200 ng mL-1 IGF-1. For muscle rings healed for confocal imaging, 




6.4.4 Muscle optical and electrical stimulation and force measurement 
Muscle rings were stimulated optically using a 470 nm blue light LED connected to a 
function generator producing pulse trains of specified frequencies (1-4 Hz) and pulse widths (50 
ms). Muscle rings were stimulated electrically in serum-free media using a custom-built 
apparatus.98 Passive tension force was measured by correlating bio-bot skeleton beam deflection 
to the force generated by the engineered muscle, using a formula derived from Euler-Bernoulli 
beam bending theory, as previously described (Figure 6.3b).98 Active tension force was similarly 
calculated by correlating skeleton deflection to muscle contractile force production using a 
formula derived from Kelvin-Voigt viscoelasticity theory, as previously described (Figure 
6.3c).98 
 
6.4.5 Synthesis of IGF-loaded microparticles and nanoparticles 
 IGF-containing poly (lactic-co-glycolic acid) (PLGA) micro- and nanoparticles were 
prepared via a double emulsification method (W1/O/W2). 100 µg of IGF-1 (Sigma Aldrich) was 
dissolved in 100 mL of 10 mM HCl solution for preparing a stock solution of 1 mg mL-1. The 
water phase 1 (W1) was prepared by adding 10 µL of IGF-1 stock solution into 200 µL cell-
culture grade water (Corning). This was then added to an organic phase (O) consisting of 
dichloromethane (DCM, 1.5 mL) containing 20 mg PLGA (LACTEL®, lactic:glycolic = 50:50, 
MW 6,000 - 10,000 g mol-1, DURECT) followed by vortexing (microparticle) or sonication 
(nanoparticle) for 3 min to form a W1/O emulsion. This primary emulsion (W1/O) was then 
transferred to 12 mL of 1% (w/v) aqueous PVA solution (W2), and the mixture was vortexed 
(microparticle) or sonicated (nanoparticle) again for 3 min to form the secondary emulsion 
(W1/O/W2). This mixture was continuously stirred for 6 h. The resulting micro- and nanoparticles 
were collected via centrifugation at 2000 and 12000 rpm for 10 min and washed with cell-culture 
grade water, respectively. This purification process was repeated three times. After this 
purification step, IGF-PLGA particles were lyophilized and stored at -20 °C. 
 
6.4.6 Analysis of protein expression via quantitative PCR 
 Muscle rings were flash-frozen in liquid nitrogen. The rings were homogenized by 
vortexing in RLT buffer (Qiagen) with 10 uL mL-1 B-mercaptoethanol, and centrifuged using the 
QIAshredder (Qiagen) column. RNA was extracted using the RNeasy Plus RNA isolation kit 
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(Qiagen) according to the manufacturer’s instructions. cDNA synthesis was done using the 
qScript cDNA SuperMix (Quanta Biosciences) from 100 ng of RNA and reactions were 
performed as directed by the supplier. For RT-qPCR, SsoFast EvaGreen Supermix (Bio-Rad) 
was added to cDNA and primers targeting the genes of interest and GAPDH (Table 6.1).  
Following 30s at 95°C, qPCR (5s at 95°C, 20s at 55°C, 40 total cycles) preceded melt-curve 
analysis of the product by the CFX Connect Real-Time System (Bio-Rad). Ct values were used 
to calculate changes in expression level, relative to GAPDH and control samples by the 2 -ΔΔCt 
method.  
 
6.4.7 Immunohistochemical staining and confocal imaging of muscle rings 
 Muscle rings were rinsed in PBS and fixed in 4% (v/v) paraformaldehyde (EMD 
Chemicals) for 30 min, prior to permeabilization with 0.2% (v/v) Triton X-100 (Sigma Aldrich) 
for 10 min and immersion in Image-iT FX Signal Enhancer blocking solution (Invitrogen). 
Muscle rings were incubated in mouse antimyosin heavy chain (MF-20, Developmental Studies 
Hybridoma Bank, The University of Iowa Department of Biology) at a 1:300 (v/v) dilution in 
Image-iT FX blockin solution for 8 h at 4°C on a shaker. They were then incubated in anti-
mouse IgG secondary antibody (Alexa Fluor 647) at a 1:300 (v/v) dilution in blocking solution 
for 12 h at 4°C. They were finally incubated in 4’,6-diamindino-2-phenylindole (DAPI, Sigma-
Aldrich) at a 1:5000 (v/v) dilution in sterile deionized water for 10 min. Stained muscle rings 
were placed onto a glass-bottom petri dish (MatTek) and covered in a warm agarose gel prior to 
imaging with a fluorescence confocal microscope (LSM 710, Zeiss).  
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Figure 6.1 Effect of Mechanical Damage on Tissue Engineered Skeletal Muscle. (A) Schematic 
of muscle ring bioactuator formation in a 3D printed mold. (B) Schematic (i) and photographs 
(ii, iii) of mechanical damage of muscle tissue induced via laceration by sterile microscissors. 
(C) Wound closure over time, measured via top-view images of muscle tissue cross-sectional 
area (n = 3). (D) Reduction in muscle passive tension force production is directly correlated to 
degree of damage inflicted by laceration. Damaged muscle rings in the shaded portion of this 
graph (45-55% original cross-section) were used for all the data shown in this study. (E) 
Comparison of viability between healthy muscle tissue and damaged muscle tissue one hour 
post-damage (Day 10) and one week post-damage (Day 17) shows a significant reduction of 











Figure 6.3 (A) Formula, derived from Euler-Bernoulli beam theory, used to calculate passive 
tension force generated by tissue engineered skeletal muscle. (B) Formula, derived from a 
Kelvin-Voigt viscoelasticity model, used to calculate active tension force generated by tissue 





Figure 6.4 (A) Wound closure over time for large wounds (below 40% of original cross-section), 
measured via top-view images of muscle tissue cross-sectional area (n = 3). (B) Top-view 
images of representative large wound muscle tissue immediately post-damage (i) and one week 






Figure 6.5 Repairing Mechanical Damage in Tissue Engineered Skeletal Muscle. (A) Schematic 
(i) and photograph (ii) of sealing laceration in damaged muscle using a biological glue. Bio-bots 
are placed within a 3D printed PEGDA holder to keep them in place during the wound sealing 
process. (B) Top-view images of muscle tissue immediately post-damage (i) and one week post-
wound sealing using a biological glue (ii). (C) Plot of passive tension for damaged and healed 
muscle tissue, represented as a percentage of passive tension generated by healthy muscle tissue 
on Day 10. Sealing the damage with a biological glue does not significantly affect force 
production, but healing the damage with a biological glue containing undifferentiated myoblasts 
yields significant increases in force production (P < 0.05, n = 3, one-way ANOVA, post hoc 
Tukey test). (D) Plot of active tension for damaged and healed muscle tissue, represented as a 
percentage of active tension generated by healthy muscle tissue on Day 10. Sealing the damage 
with a biological glue does not significantly affect force production, but healing the damage with 
a biological glue containing undifferentiated myoblasts yields significant increases in force 
production (P < 0.05, n = 3, one-way ANOVA, post hoc Tukey test). (E) Quantitative PCR is 
used to compute fold increase in protein expression across three groups (damaged, biological 
glue, and biological glue containing myoblasts) as compared to a control (undamaged). Proteins 





Figure 6.6 Remodeling Tissue Engineered Skeletal Muscle. (A) Schematic of 470 nm blue light 
stimulation (1.9 mW mm-2 power density) of tissue engineered optogenetic skeletal muscle. (B) 
Active tension force generated by skeletal muscle is regulated by daily optical stimulation 
exercise training (0-60 min at 37 °C), with significant increases observed up to 30 min 
stimulation. Stimulation for longer time periods does not result in significant increases in force 
production. (C) Quantitative PCR is used to compute fold increase in protein expression for the 
optimized exercise treatment groups (30 min) as compared to a control (0 min). Proteins 
analyzed include: Desmin, MYH1, Myf5, Myf6, MyoD, Myogenin, and Troponin. (D) 
Schematic of three test groups designed to test the efficacy of exercising the myotubes in the 
muscle ring and the myoblasts in the biological glue separately and together. (E) Plot of active 
tension for damaged and healed muscle tissue, represented as a percentage of active tension 
generated by healthy muscle tissue on Day 10. Muscle rings in which both the undamaged 
myotubes and myoblasts added during healing were exercised for 30 min showed the most 








Figure 6.7 (A) Photograph of optical stimulation of tissue engineered skeletal muscle, 
accomplished using a 470 nm LED coupled to a function generator producing dynamic pulse 
signals at specified frequencies (1-4 Hz, 50 ms pulse width). (B) Force generated by healthy 
tissue engineered skeletal muscle in response to optical stimulation at 1 and 4 Hz, showing an 
increase in passive tension baseline for stimulation at higher frequencies, consistent with 
physiological behavior. Axis does not start at 0. (C) Passive tension force generated by skeletal 
muscle is regulated by daily optical stimulation exercise training (0-60 min at 37 °C), with 
significant increases observed up to 30 min stimulation. Stimulation for longer time periods does 










Figure 6.8 Figure 4. Accelerating Wound Healing Response in Tissue Engineered Skeletal 
Muscle. (A) Plot of active tension for damaged and healed muscle tissue, represented as a 
percentage of active tension generated by healthy muscle tissue on Day 10. Incorporating IGF-
loaded microparticles in the biological glue accelerated wound healing response for all three 
concentrations tested, with all cases resulting in force production values on the order of healthy 
tissue by Day 15. Higher concentrations of IGF-1 (100 and 200 ng mL-1) resulted in faster 
recovery times, with healthy tissue functionality gained within two days of damage and healing. 
(B) Plot of active tension for damaged and healed muscle tissue, represented as a percentage of 
active tension generated by healthy muscle tissue on Day 10. The incorporation of nanoparticles 
in the biological glue did not accelerate wound healing response time, with healthy tissue levels 
of functionality only regained one week post-fab, as in the Group 1 muscle presented in Figure 
6.6. (C) Quantitative PCR is used to compute fold increase in protein expression for the IGF-
loaded micro- and nanoparticle treatment groups (exercised 30 min daily) as compared to a 
control (healed with biological glue containing cells and no microparticles, exercised 30 min 
daily). Proteins analyzed include: Desmin, MYH1, Myf5, Myf6, MyoD, Myogenin, and 
Troponin. (D) Confocal images of damaged and healed muscle tissue on Day 10 (i) and Day 17 
(ii, iii). Original muscle tissue is represented by red, new muscle tissue is dyed green, cell nuclei 
are blue (DAPI), and myosin is marked by a yellow dye. Muscle cells added during the wound 
sealing process spread across the existing tissue and develop mature functional myotubes during 




Figure 6.9 Schematic of modification to biological glue used to seal and heal mechanical 
laceration damage in muscle tissue, showing the addition of IGF-loaded microparticles and 
nanoparticles to the glue composition.  
 
 




CHAPTER 7: BUILDING WITH BIOLOGY 
 
7.1 Design And Integration Of A Problem-Based Biofabrication Course Into An Undergraduate 
Biomedical Engineering Curriculum7 
 
7.1.1 Introduction 
Training engineers to solve ill-structured real-world problems, including the 
unanticipated complications and conflicting constraints such problems entail, has long been a 
challenge to engineering educators. The traditional lecture-based approach of teaching a set 
curriculum, which focuses on solving well-structured problems, does not yield a skill set that is 
readily transferrable to engineering practice232. This finding has inspired a widespread transition 
to project-based learning in core engineering classes233. This new pedagogical model for 
teaching design requires students to identify and prioritize functional outcomes and employ 
different approaches to devising a solution, a closer mimic to the real-world engineering 
environment. While the importance of having design-integrated classes during every year of 
undergraduate education has been demonstrated in established engineering fields234, the 
emerging field of bioengineering and biomedical engineering is still in the process of instituting 
discipline-wide standards and practices for undergraduate education235.  
 Lab- and project-based approaches have successful records of teaching core engineering 
principles in interdisciplinary fields236,237. This is especially important in biomedical engineering, 
which develops students’ fluency in a diverse breadth of topics, such as biomaterials and 
biomechanics, while equipping them with fundamental skills and topical depth in new biological 
frontiers, such as tissue engineering and synthetic biology238–240. In a discipline that is evolving 
as quickly as biomedical engineering, it is likely that an adaptive and inquiry-based approach 
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that teaches the scientific method, in the context of cutting-edge biomedical research, will prove 
well suited to undergraduate education241–243. This manuscript outlines a modular and inquiry-
based approach to teaching the fundamental principles of the burgeoning field of biofabrication, 
or “building with biology”, at the undergraduate level. Furthermore, we provide details regarding 
the semester-long course schedule and lab funding structure to enable other educators to adapt 
this course design for their needs. We hypothesize that this curriculum structure will effectively 
teach upper-level undergraduate students to design and execute experiments, preparing them for 
interdisciplinary careers as biomedical researchers and industry practicians. 
 
7.1.2 Methods 
7.1.2.1 Course Structure 
This study employed four teams of two students each, all senior undergraduates in the 
bioengineering program at the University of Illinois at Urbana-Champaign (UIUC) and enrolled 
in “BioE 306: Biofabrication Lab”.  Since proficiency in aseptic mammalian cell culture 
technique is a pre-requisite to the labs in this course, enrollment was limited to students who had 
previously completed a cell culture lab course required of sophomores in the bioengineering 
program. Enrolled students were also required to complete online safety training as required by 
the Division of Research Safety (IBC-3923) and undergo a practical laboratory test on aseptic 
cell culture technique during the first week of class. 
The course (BioE 306: Biofabrication) was structured as a series of four labs, each  
addressing a distinct aspect of biofabrication and tissue engineering, leading up to the final 
capstone project that required students to draw on skills learned in the prior labs (Table 7.1-7.3). 
Students attended weekly lectures (50 min) and labs twice a week (2 h per session), and were 
expected to maintain their experiments during the week outside the regularly scheduled lab 
sessions. This course structure thus required a fully functional cell culture lab well-equipped with 
the supplies and reagents necessary for biofabrication experiments. A list of required lab 
supplies, as well as estimated total cost, is provided in Table 7.4. 
The lectures for the first two labs were led by the course instructor, Prof. Pablo Perez-
Pinera. The lectures for the third lab were led by the teaching assistant, Colin Castleberry. The 
lectures for the fourth lab and the final project were led by guest lecturer, Ritu Raman. Students 
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also participated in an hour-long ethics discussion focused on building biological machines, led 
by Ritu Raman.  
 
7.1.2.2 Capstone Design Project 
The capstone final project required students to design, 3D print, and build a biological 
machine for any application of their choice. Such machines, which are composed of biological 
materials as well as synthetic materials, can utilize the dynamic sensing, processing, and 
actuation capabilities of biological tissues to perform controlled robotic functions (Figure 7.1, 7. 
2). Unlike traditional robots made of synthetic materials, such bio-integrated robots (bio-bots) 
could demonstrate the real-time adaptive behavior typical of biological systems and potentially 
be tuned to suit a variety of applications in health, security, and the environment 97–99. The idea 
of forward engineering living tissues and using these tissues to power novel machines and 
systems has gained much attention in recent years, enabled by emerging manufacturing 
technologies such as 3D printing1,109. This is the primary focus of the National Science 
Foundation Science and Technology Center EBICS (Emergent Behavior of Integrated Cellular 
Systems, NSF Grant CBET-0939511)189. Transitioning research in this pioneering field from the 
lab bench to the real world requires equipping the next generation of engineers and scientists 
with specific skills in biofabrication. Teaching the fundamental design principles and practices of 
“building with biology” is thus an important objective in training biomedical engineers for future 
careers in industry and academia. With this goal in mind, student teams were given 3 weeks to 
build muscle-powered bio-bots to target a specific challenge in biomedical engineering. Teams 
consulted with the course instructors during individual meetings in the first week to test and 
iterate the proposed bio-bot design for feasibility and functionality. After these initial design 
meetings, the instructors and teaching assistant assumed facilitator roles while students led their 
projects independently. 
 
7.1.2.3 Student Assessment 
The parameters considered for grading student performance were effort in the lab and 
participation (30 %), computer-aided design (CAD) project (10 %), team laboratory reports (four 
reports: 1.5, 4.5, 6, and 18 %) and a final presentation on the capstone design project (30 %) to 
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course instructors, fellow students, and professors and graduate student researchers in related 
fields.  
 
7.1.2.4 Course Evaluation 
Students were assessed on the metrics listed in Table 7.5 in mid-course and end-of-course 
surveys. Additional metrics analyzed in the end-of-course survey are listed in Table 7.6. Students 
were also assessed on their responses to the open-ended questions listed in Table 7.7 (mid-course 
survey) and Table 7.8 (end-course survey). All raw data is presented in Supplementary Tables 
7.9-7.12. Significance tests were conducted using Mann-Whitney U tests with p values signified 
in figure captions. This study was approved by the Institutional Review Board (Reference 
#12224, Appendix A.6). All students in the course signed consent forms before participating in 
this study. 
 
7.1.3 Results and Discussion 
The quantitative survey metrics assessed over the course of the class all increased from 
the mid- to end-course time points, indicating an overall positive trend in the students’ course 
experience (Figure 7.3, Table 7.9).  
When assessed during the mid-course time point, 100 % of students in the class 
confirmed that the course was being taught at an appropriate level. Additionally, 100 % of 
students in the class noted that they did not need the biology explained more explicitly in the 
context of the material being taught. These percentages did not change when assessed again at 
the end of the course, indicating they already had a strong grounding in the fundamentals of the 
biological concepts used in the class, and that the instructors thoroughly explained new 
terminology. Students stated that “Everything we didn’t know was explained very well” and that, 
more than learning new terminology, they valued learning “about new applications of the 
knowledge most of us had already been taught which introduced new viewpoints.” Considering 
83 % of student indicated that the final project was the aspect of the course they were most 
looking forward to, it is not surprising that the metric assessing introduction to new topics and 
concepts showed a demonstrable increase over the semester between the mid- and end-course 
surveys. Some students indicated that learning new skills that are not a part of standard 
bioengineering curriculum, such as CAD design and 3D printing, was an important motivator 
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driving enthusiasm regarding the final project. Students also cited the ability to “use some 
creativity with our designs” as a source of excitement, indicating that the open-ended and ill-
structured nature of the final design problem was a source of motivation for the students. 
 The metric that showed the most significant increase between the mid- and end-course 
time points concerned assessing whether the format of the course was appropriately suited to the 
material being taught. Responses to specific questions regarding the format of the class, listed in 
Table 4.4, are presented in Figure 7.4 and Table 7.10. The results indicate that the students were 
already quite familiar with the main theoretical concepts underlying the field of tissue 
engineering. Since tissue engineering is a well-developed sub-field of the broader discipline of 
biomedical engineering, it is unsurprising that a group of senior undergraduates pursuing 
bioengineering majors would report familiarity with the field. However, student responses also 
show that the labs helped strengthen understanding of tissue engineering concepts by teaching 
practical lab techniques applicable to this field. Students stated that core concepts are “much 
easier to understand when the class is structure more hands on, where we can discuss the 
concepts and then actually implement them ourselves.” Furthermore, 100 % of the students 
indicated that the labs leading up to the final project helped them understand the goals of the 
capstone and main course objectives better, stating “I’m enjoying how each experiment we do on 
a weekly basis is building up to ultimately building a bio-bot”. The first four labs thus served as 
practice in versatile experimental techniques, and the cumulative nature of the final project 
proved to be a fair assessment of the training they received. 
 During the mid-course survey, the students reported lowest satisfaction with the process 
of writing lab reports as a method of developing a deeper understanding of course material. 
Students expressed specifically that they would “like more help with the data analysis”. An 
important objective of this class, in addition to teaching the design principles of biofabrication, 
was to establish a solid foundation in practicing the experimental method, as students specifically 
expressed a desire to “have a much stronger ability to design experiments for cell-culture 
applications in the future” and expected to “learn both lab techniques as well as the best way to 
plan out experiments and all the variables necessary to take into account”. To address these 
concerns, the course format was altered to include 20 min of lab discussion time the week before 
the due date for each lab report. Student teams presented their results to all the instructors, as 
well as the other teams, and were given the opportunity to discuss their results prior to writing 
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the lab report. Portions of the lab sessions were also allotted to instructor-led data analysis on 
practice data sets, followed by guided team-based analysis of data generated during the labs. This 
led to an increase in the level of satisfaction students reported with the lab reports by the end of 
course survey, with students specifically stating that the in-class presentations “helped clear up 
any misunderstandings and forced me to think about why we were doing what we did in lab” and 
were valuable because of their “informal, discussion-based format”. By the end of the semester, 
50 % of the students indicated that the lab reports and in-class presentations were the most useful 
aspects of the course (the other 50 % cited lab work), and 40 % of students cited lab reports as 
the aspect of the course that helped them learn most efficiently (the other 60 % cited lab work).  
The capstone project was intentionally designed to be open-ended, requiring that students 
form a hypothesis and devise a robust experiment to test that hypothesis using the techniques 
taught in previous labs. Specifically, students were asked to design and build a biological 
machine to achieve a functional behavior relevant to an application in biomedical engineering. 
The student teams, which were self-assigned, reported no conflicts over the course of the 
semester. Indeed, two of the teams coalesced to form a larger team for the capstone project, in 
order to test more sample sets and generate more data. Some students attempted to make the 
walking bio-bots developed in Lab 4 walk at greater speeds by incorporating flexible 3D printed 
hinges into the bio-bot skeletons. Other students designed an entirely new 3D printed skeleton, 
mimicking the natural architecture of the esophagus in the human body, to create a muscle-
powered peristaltic pump that could potentially be used as an implant for applications in 
regenerative medicine. Another group of students incorporated skills taught in other 
bioengineering undergraduate classes, such as genetic engineering of cells and 
bioinstrumentation, to incorporate new functionalities into the biological machines they had 
learned to fabricate. The student projects thus displayed broad diversity in terms of target 
application, while still maintaining a core focus in biofabrication. This served as additional 
validation that the capstone design project provided students with the unique opportunity to 
freely pursue empirical inquiry in the field of biomedical engineering and understand the 
underlying design rules and principles of “building with biology”.  
Students were actively engaged in the final project throughout the semester, and 
presented their ideas for the capstone to instructors prior to the scheduled start of the final lab. 
The layered roles of the primary instructor with expertise in teaching fundamental biological 
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concepts, the guest lecturer specializing in the topic area of biofabrication and biological 
machines, and the teaching assistant well versed in the experimental techniques, provided 
students with different types and levels of individual mentorship and attention, which has been 
shown to generate positive learning outcomes 234.  
By the end of the semester, 100 % of the students in the class indicated that the course 
fulfilled their expectations, that they enjoyed the course experience, and that they would 
recommend the course to other students. Additionally, all the student presented their capstone 
design projects to professors and graduate students in the department working in relevant 
research fields, and 50 % of the students in the class signed up to continue working on their final 
projects the following semester under the guidance of the guest lecturer and course instructor. As 
ethics training is an especially important component of biomedical engineering education 244,245, 
all students were required to participate in a discussion on the ethics of building with biology 
during one of the regularly scheduled class lectures. During this discussion, students discussed 
vignettes of specific scenarios involving novel biofabrication technology with other students and 
the instructors 19. In future iterations of this class, we would like to formally assess how student 
perceptions and understanding of the ethics of building biological machines shift over the course 
of the class, in order to improve the quality and focus of our undergraduate bioengineering ethics 
education programming.  
 
7.1.4 Conclusion 
The rapidly evolving field of biomedical engineering requires adaptive teaching 
approaches that teach students how to target and solve multi-pronged and ill-structured problems 
at the cutting edge of scientific research. This is especially important in interdisciplinary fields 
such as biomedical engineering, as they are subject to many types of conflicting constraints, and 
require problem-solvers that are well versed in a variety of relevant topics while maintaining 
depth of expertise in specific focus disciplines. One such discipline that is widely applicable 
across the field of biomedical engineering, as well as the adjacent fields of mechanical, materials 
science, and chemical engineering, is that of biofabrication – using modern manufacturing 
technologies (such as 3D printing) to design and build with biological materials. This course 
provided students with a foundation in the core design rules and principles of “building with 
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biology”, coupled with specific tools and techniques that were broadly applicable to engineering 
living tissue for a variety of applications.  
The lab-based format of this course, building towards the cumulative yet open-ended 
final capstone design project, proved to be an effective method of translating the latest 
biomedical research from the lab bench to the classroom. Incorporating in-class discussion of lab 
results as preparation for writing lab reports, motivated by mid-course student survey feedback, 
was shown to enhance student learning outcomes. This format of four relatively well-structured 
labs leading to a final open-ended project is modular and can readily be adapted to other 
interdisciplinary courses. In future iterations of the course, we plan to extend the length of time 
allotted for the final independent project, allowing student teams to truly experience the iterative 
and adaptive nature of scientific study design. Furthermore, we plan to evaluate the next cohort 
of students in this course alongside  students in more traditional lab classes in the field of 
biological research. We believe this future study will provide more evidence that the skills-
building and independent thinking encouraged by the format of this course directly resulted in 
improved learning outcomes. 
We have shown that a lab-focused structure and layered roles of individual student 
mentorship can be an efficient and effective method of teaching students to employ the scientific 
method for designing and executing robust experiments. We anticipate that nurturing these 
skillsets in undergraduate education will generate engineers who are well prepared for future 
careers in interdisciplinary fields. 
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Biological materials have the ability to sense, process, and respond to a range of dynamic 
environmental signals in real-time. This capability allows biological systems to demonstrate 
complex behaviors such as self-assembly, self-organization, self-healing, self-replication, and 
constant adaptation of composition and functionality to best suit their environment. Recent 
advances in manufacturing technologies, such as 3D printing, combined with progress in the 
field of biomaterials, have synergistically produced robust approaches for manufacturing 
complex 3D structures from biological materials1,109,112. This has driven fundamental advances in 
the fields of tissue engineering and regenerative medicine by providing a method of reverse 
engineering native tissues and organs123,124,246.  
Thus far, use of these technologies has primarily been limited to replicating biological 
structures found in nature while largely neglecting applications in forward engineered biological 
systems capable of non-natural functional behaviors. Bio-integrated robots, or bio-bots, built 
using a combination of biological and synthetic materials have the potential to develop enhanced 
functional attributes as compared to robots made with traditional synthetic materials alone189,215. 
The dynamically adaptive nature of biological materials makes them ideal candidates for serving 
as the building blocks of “smart” responsive machines and systems for a variety of applications. 
 Nearly all machines require actuators, modules that convert energy into motion, to 
produce a measurable output in response to varied input stimuli150. Skeletal muscle is a natural 
actuator, capable of generating larger forces from more compact structures than actuators made 
from synthetic materials, and designed to be modular and adaptive to changing environmental 
loads200,217,247. As locomotion is a powerful and intuitive demonstration of force production, we 
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have developed muscle-powered bio-bots that can walk on 2D surfaces in response to external 
electrical or optical signals99,218. In this protocol, we describe a repeatable and customizable 
approach to 3D printing injection molds for engineered muscle and mechanical bio-bot 
skeletons. We then describe how to seed and differentiate muscle actuators within these molds 
and mechanically couple them to printed skeletons to accomplish functional output behaviors 
when stimulated with external signals. The convergence of the two disciplines of tissue 
engineering and 3D printing thus enables the iterative design and rapid fabrication of adaptive 
forward engineered biological machines whose functionality can be tuned to suit a variety of 
applications in health, security, and the environment. 
 
7.2.2 Development of the Protocol 
The first demonstrations of bio-integrated machines, composed of synthetic skeletons 
coupled to biological actuators, employed the autonomous contraction of engineered cardiac 
muscle as a source of power88,97,153,156,248. The continuous beating of cardiac muscle did not 
provide “on-off” control over such machines, motivating the development of bio-integrated 
machines powered by skeletal muscle. Significant advances in approaches to culturing skeletal 
muscle cells in vitro have provided a baseline methodology for engineering 3D skeletal muscle 
tissue constructs159,195,249. While these studies detailed robust techniques of engineering micro-
scale tissues with applicability in high-throughput drug screening and studies of muscle 
development, they required significant modifications to be suited to applications that required 
force production at the millimeter- to centimeter- scale.   
 In this protocol, we present a modular and step-wise approach to designing, fabricating, 
and controlling skeletal muscle-powered locomotive biological machines at the millimeter- to 
centimeter-scale (Figure 7.5). We show that the enabling technology of stereolithographic 3D 
printing can be used to iteratively design and custom manufacture soft robotic devices for a 
variety of purposes. These 3D printed devices, when coupled to tissue engineered skeletal 
muscle actuators, can drive locomotion across 2D surfaces and designed to suit a variety of 
applications.  
 The design of the 3D printed skeleton we use was inspired by the architecture of the 
musculoskeletal system in vivo. In the body, skeletal muscle is tethered to bones via tendons, and 
contraction of the muscle drives articulation of the bones across flexible joints. The bio-bot 
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skeleton is thus composed of a flexible beam, mimicking an articulating joint, with two pillars at 
each end, which serve as anchor points for tissue engineered muscle. In the first iteration of our 
bio-bot design218, this skeleton was placed inside a 3D printed injection mold, which served as a 
template for a solution of skeletal muscle cells in a suspension of natural hydrogels. Cells seeded 
within this hydrogel matrix, meant to mimic the extracellular matrix in vivo, applied traction 
forces to compact into a dense 3D tissue, or “muscle strip”, over time. When differentiated over 
the course of several days, the muscle strips became capable of controllable contraction in 
response to external electrical pulse stimuli. By introducing asymmetry into the 3D printed 
skeleton via a change in the length of one of the pillars, electrically stimulated contraction was 
shown to drive directional locomotion of muscle-powered bio-bots in the direction of the longer 
pillar.  
 While this was a powerful first demonstration of untethered locomotion in a skeletal 
muscle-powered machine, the design of the bio-bot had two significant limitations. First, the 
muscle tissue was engineered in a way that permanently tethered it to the bio-bot skeleton, 
making it difficult to adapt the methodology for different skeleton designs. Second, since 
electrical stimulation drove contraction of the entire body of muscle tissue, locomotion was only 
enabled by introducing permanent and one-directional asymmetry into the skeleton design. To 
target this first limitation, we redesigned the 3D printed injection mold to produce skeletal 
muscle “rings” which could be manually transferred to any of a wide variety of bio-bot 
skeletons99. These rings were shown to produce passive and active tension forces similar to those 
generated by muscle strips. Analysis of the myotubes’ nuclear orientation and morphology 
within the muscle tissues revealed a higher degree of cellular alignment, metabolic activity (and 
cellular viability), and nuclear elongation in muscle rings as compared to the muscle strips 
(Figure 7.6 and Figure 7.7). Alignment of myotubes along the longitudinal axis of the bio-bot 
provided an axis along which the majority of the mature muscle fibers contracted synchronously 
upon stimulation, a characteristic of hierarchical skeletal muscle in vivo. 
To target our second design limitation, we employed the technique of optogenetics to 
genetically engineer a light-responsive skeletal muscle cell line that could be stimulated to 
contract by pulses of 470 nm blue light. The resultant optogenetic muscle rings were coupled to 
multi-legged bio-bot skeletons with symmetric geometric designs. Localized stimulation of 
contraction, rendered possible by the greater spatiotemporal control of light stimuli over 
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electrical stimuli, was used to drive directional locomotion and 2D rotational steering. This 
protocol details a step-wise procedure for designing and manufacturing muscle ring-powered 
bio-bots, while discussing potential technique modifications that will broaden the applicability of 
this methodology. 
 
7.2.3 Applications of the Protocol 
 Actuators and motors have fundamental roles to play in converting external sources of 
energy into controlled movement and power generation. To present compelling demonstrations 
of muscle-powered functionality in bio-integrated machines, we have focused on directional 
locomotion and 2D steering of millimeter-scale bio-bots as primary applications of this protocol. 
However, integrating muscle actuators into bio-hybrid machines can provide control over force 
generation and motility at multiple length scales215, with broad applicability in a variety of fields. 
More immediate applications of this technology include fundamental studies of muscle 
development and disease, high-throughput drug testing, and dynamic functional implants. We 
envision that future generations of bio-bots will integrate multiple cell and tissue types, including 
neuronal networks for sensing and processing and vascular networks for delivery of nutrients and 
other biochemical factors. This next iterations of bio-hybrid machines could, for example, be 
designed to sense chemical toxins, locomote towards them, and neutralize them through cell-
secreted factors. Such a functionality could have broad relevance in medical diagnostics and 
targeted therapeutics in vivo, or even extended to environmental use as a method of cleaning up 
public water supplies from pathogens. Future generations of bio-bots could also demonstrate 
some of the higher-order properties of biological materials, such as self-organization and self-
healing, once researchers develop a fundamental understanding of the design rules and principles 
that govern such behaviors. The muscle bioactuators presented in this protocol are thus meant to 
serve as biological building blocks that both motivate and enable the design and manufacture of 
the machines of the future.  
 
7.2.4 Comparisons to Other Methods 
In vivo, skeletal muscle produces large contractile forces and its hierarchical and modular 
structure allows for ready scalability and adaptation to changing environmental loads217. The 
contractile forces generated by our skeletal muscle bioactuators are comparable to those 
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demonstrated by other researchers in the field of skeletal muscle tissue engineering159,195,200,203. 
Furthermore, we have shown that exercise training during differentiation can yield significant 
increases in force production99,218. However, the forces produced by engineered skeletal muscle 
tissue have yet to demonstrate force production values on the order of magnitude observed in 
primary skeletal muscle184. As a result, some have investigated alternative approaches to building 
bio-hybrid machines by coupling excised skeletal muscle tissue to synthetic skeletons144. While 
these machines have demonstrated impressive functionality, due to the fact that primary cells 
typically produce larger forces than those produced by cell lines, primary cells are arguably a 
less sustainable source of material and their functional performance can vary widely depending 
on the age and health of the animal source250. As a result, we believe that continuing to 
investigate the potential of engineered skeletal muscle constructs provides an opportunity for 
future growth in the field of tissue engineering. Uncovering the design rules and principles that 
govern skeletal muscle growth and differentiation in vitro may, in future, lead to engineering 
skeletal muscle tissue that replicates force production in vivo.  
 Recent demonstrations of bio-hybrid machines powered by cardiac muscle have likewise 
met with significant success, with biomimetic designs and primary cells combining to produce 
complex locomotive behaviors97,156,248. However, in addition to the disadvantages of a platform 
that relies on primary cells, these demonstrations are also at a disadvantage due to the use of 2D 
sheets of cardiac muscle as actuators for bio-hybrid machines. The 3D hierarchical structure of 
skeletal muscle, which we mimic in our muscle rings, is critical to the modularity of design and 
scalability of force production that are required for a range of functional applications.  
Additionally, skeletal muscle is capable of “on-off” control, unlike cardiac muscle which 
spontaneously contracts, which will allow us to forward engineer higher-level control when such 
muscle bioactuators are couple to neural networks via neuromuscular junctions. Therefore, while 
the use of primary skeletal or cardiac cells is appealing at present, we believe that skeletal 
muscle bioactuators engineered from cell lines will provide significant advantages over other 
methods in the future. 
 
7.2.5 Limitations of the Protocol 
The methodology presented in this protocol has been optimized for generating 
millimeter- to centimeter- scale modular muscle bioactuators with active force generation 
	195	
capabilities up to 300 µN (approximately 0.5 kPa) when matured and stimulated in conditions 
suited to mammalian cells. Modifications of this protocol to produce bioactuators at different 
length scales, or 3D tissues made with different cell types, are mentioned in this protocol, but not 
fully developed for functional use. Further optimization of this procedural approach is thus 
required for any application beyond the scope of those discussed in this protocol. 
 
7.2.6 Experimental Design 
Development of this protocol is dependent on the force generation and actuation 
requirements of a given application. This can be determined using an iterative process of 
designing and printing new bio-bot skeletons, predicting force production behavior via finite 
element analysis (FEA), and comparing predicted responses to actual responses observed when 
skeletons are coupled to engineered muscle in vitro. Bio-bots can be further customized to 
incorporate different cell types and different stimulation mechanisms, as befits the requirements 
of the application of concern. For example, we have applied this technique to C166 endothelial 
and NSC-34 neuron-like cell lines, both in the presence and absence of C2C12s, with no 
modifications to the protocol except exchanging the cell type and culture media used. 
 
7.2.6.1 Overview of the Procedure 
Forward engineering bio-hybrid machines involves designing and optimizing modular 
skeletal muscle bioactuators and 3D printed skeletons in parallel, before combining them to 
produce functional behaviors in response to external electrical or optical stimuli. This protocol 
outlines an approach that utilizes the externally stimulated contraction of skeletal muscle to drive 
directional locomotion of synthetic skeletons. 
 
7.2.6.2 Design and Optimization of Modular Skeletal Muscle Actuators 
The injection molds that serve as templates for the muscle actuators are 3D printed with 
the biocompatible and bio-inert poly (ethylene glycol) diacrylate (PEGDA) hydrogel polymer 
using a commercial stereolithographic apparatus (SLA) adapted to print mm-scale structures42. 
The ultraviolet laser of the SLA traces 2D cross-sections of 3D designs onto the polymer resin, 
rendered light-sensitive through the addition of a biocompatible photoinitiator (Irgacure 2959), 
building the part layer-by-layer from the bottom up. The shape and dimensions of the injection 
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mold are prescribed by a computer-aided design (CAD) file, and can be readily modified to 
generate a variety of different muscle architectures. Fabricated mold dimensions will be larger 
than those prescribed by the CAD file, due to the swelling behavior of the highly absorbent and 
hydrophilic PEGDA polymer. The swelling ratio of the hydrogel is dictated by the molecular 
weight and concentration of monomer in the printable resin, with an average value of ~150% for 
the polymer composition used in this protocol102,117. While we chose to utilize a 
stereolithographic 3D printing approach, due to the versatility of this technique and ready 
availability of biocompatible photosensitive resins1,109, this mold could also be manufactured 
using other biocompatible polymers and fabrication methodologies. For example, manufacturing 
hydrogel skeletons with feature sizes much smaller than 250 µm (the x-y resolution limit of our 
commercial SLA) will require using a printer capable of much higher resolution capabilities. We 
have custom-built a projection micro-stereolithographic 3D printer (µSLA) capable of printing 
hydrogel polymers at < 5 µm resolution112, which could be utilized to print smaller bio-bot 
skeletons, or skeletons with micro-scale features. Many fabrication methodologies and materials 
are suitable for manufacturing injection molds, as long as ease of sterilization and precise 
reproducibility of dimensions is maintained. 
 The cell/gel solution injected into the mold, composed of the C2C12 murine skeletal 
muscle cell line in a suspension of fibrinogen, thrombin, and Matrigel®, cross-links into a stable 
3D gel network following the molding process. The final size of the muscle actuators is a 
function of cell density, cell distribution, hydrogel matrix composition, injection mold 
dimensions, and cell culture parameters. Higher concentrations of cells or fibrin in the solution, 
for example, lead to thinner muscle rings until a saturation point (1E7 cells mL-1 and 4 mg mL-1 
fibrin respectively). Past this point, the finite volume occupied by the added material renders 
further thinning of muscle rings impossible. In general, cell/gel compositions and volumes that 
generate muscle ring actuators thicker than ~500 µm in diameter should be avoided, as this 
exceeds the diffusive distance of nutrients and biochemical factors from the surrounding media 
into the tissue87 as well as the penetration depth of blue light (~500-740 µm) into tissue196,197. 
Each component of the cell/gel solution can thus be readily tuned and modified to suit the needs 
of a given application, as elaborated upon in the Experimental Design section of the protocol. 
However, all modifications to the cell/gel solution must be subjected to an optimization process 
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that studies the effects of the solution parameter change on muscle ring architecture and 
functional performance. 
 The passive and active tension forces exerted by muscle actuators in response to external 
stimulation must be suited to the design and application of the mechanical skeletons to which 
they are tethered. The maximum force produced can be regulated by an exercise training regimen 
of controlled external stimulation of a specified frequency and duration, as well as by 
biochemical growth factors present in the media during muscle differentiation203. Others have 
demonstrated the performance enhancing effects of electrical stimulation201 and dynamic 
mechanical stretch stimulation170 on skeletal muscle during differentiation. We have shown that 
increases in muscle force production can likewise be driven by static mechanical cues218 and 
dynamic optical stimulation99 imposed during muscle maturation, with synergistic increases in 
force production demonstrated when mechanical and optical stimulation are combined. These 
increases in functional performance are attributed to greater degrees of cellular hypertrophy, as 
assessed by the ratio of total protein to DNA content in the engineered muscle tissue. Exercise 
protocols for muscle actuators that utilize regimens of biochemical, mechanical, optical, or 
electrical stimulation separately or in parallel can be precisely tuned and optimized to suit the 
force production needs of a bio-bot designed for a specific application. 
 
7.2.6.3 Design, Simulation and Fabrication of Bio-Bot Skeletons 
 The design of the mechanical skeleton to which a modular muscle ring actuator is 
tethered is critical to the ability of the biological machine to perform the required output 
function. We have created several designs for producing directional locomotion and 2D steering 
in millimeter- to centimeter-scale structures via CAD and optimized them using FEA software. 
Skeleton designs for applications beyond locomotion, such as pumping, can likewise be designed 
in CAD and tested prior to manufacture via FEA. We fabricated these CAD designs via the same 
SLA printing approach used to fabricate injection molds, but modified the polymer composition 
to enhance the stiffness of the skeletons. This change helped preserve mechanical integrity of 
skeletons during fabrication, muscle transfer and maturation, and bio-bot stimulation.  
The process of mechanically coupling the elastic muscle ring actuators to the 3D printed 
bio-bot skeletons is critical to the modularity of this method of fabricating biological machines. 
Once optimal skeleton dimensions have been prescribed via CAD and FEA analysis, the 
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injection mold must be redesigned to suit the shape and dimensions of the skeleton. Molds must 
be engineered to generate muscle ring actuators of the same shape as the site of tethering in the 
mechanical skeleton, and with inner diameters larger than the outer diameter of the mechanical 
skeleton, to maintain muscle structural integrity and ensure ease of transfer. Cultured muscle 
rings can then be manually transferred to printed skeletons prior to differentiation using sterile 
tweezers. Proliferation of cells within the rings will drive further compaction until limited by the 
mechanical constraint of the bio-bot skeleton, leading to secure coupling of the actuator to the 
skeleton. Rings can then be differentiated until maturation, defined by the point at which the 
muscle is capable of observable force production.  
 
7.2.6.4 Stimulation and Control of Muscle-Powered Bio-Bots 
 The muscle differentiation process (Figure 7.8) outlined in this protocol is primarily 
driven by a change in the formulation of cell culture media used, from media containing fetal 
bovine serum (FBS) to heat-inactivated horse serum (HS). In conjunction with other results 
reported in earlier literature163, we have also shown that the addition of insulin-like growth factor 
(IGF-1) can increase the rate of myoblast differentiation into contractile myotubes in engineered 
muscle tissue218.  
 We have custom-built equipment for delivering electrical and optical pulse train stimuli 
to differentiated muscle in order to stimulate contraction. Bio-bots stimulated electrically are 
placed between two parallel platinum electrodes generating bipolar electrical pulses. Bio-bots 
stimulated optically are placed beneath a 470 nm LED emitting pulse trains of defined frequency 
and pulse width. Both forms of stimulation produce similar force outputs, until the upper limit of 
muscle rings thicker than the penetration depth (500-740 µm) of blue light into the dense 
engineered tissue196,197. For a given application, therefore, it is essential to match the shape and 
size of the engineered muscle ring and bio-bot skeleton to the intended form of external 
stimulation. 
The functional measures of muscle maturity applicable to bioactuators are passive tension 
produced by the muscle in a static resting state and active tension produced by the muscle during 
externally stimulated contraction. We have derived formulas for calculating passive and active 
tension using measurable geometric and material properties of functional bio-bots in conjunction 
with mechanics equations derived from Euler-Bernoulli beam theory and Kelvin-Voigt 
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viscoelasticity models. This approach for calculating force has demonstrated the ability of these 
bioactuators to produce physiological force-frequency response behavior, with higher frequency 
stimulations resulting in smaller dynamic fluctuation in active tension. Furthermore, this 
methodology has been validating using FEA modeling and proven to be a robust and repeatable 
method of testing the effects of different variables, such as exercise training protocols, on muscle 
functionality. The force generation data can also be used to predict output response behaviors for 
bio-bots of different sizes and designs, as suit the need of new applications, prior to manufacture 
and testing in vitro. 
 
7.3 Methods 
7.3.1 Materials and Equipment 
7.3.1.1 Materials 
7.3.1.1.1 3D Printing Injection Molds and Bio-Bot Skeletons 
• 3-(Trimethoxysilyl)propyl methacrylate (3-TPM, Sigma Aldrich, 440159). 
Caution: 3-TPM is flammable. Consult the 3-TPM safety data sheet and use appropriate 
engineering controls, such as a chemical fume hood and proper personal protective 
equipment (PPE). 
• Ethanol, 200 proof (Decon Laboratories, Inc., 2716 or DSP-MD.43) 
• Poly (ethylene glycol) diacrylate (PEGDA) 700 g mol-1 (Sigma Aldrich, 455008) 
• Poly (ethylene glycol) diacrylate (PEGDA) 1000 g mol-1 (Polysciences Inc., 15178) 
• Sterile phosphate buffered saline (PBS, Lonza, 17-516F) 
• Irgacure 2959 (BASF, 55047962). Critical: We have shown that the concentration of 
Irgacure 2959 used as a photoinitiator in our PEGDA resins is biocompatible and renders 
the resin sensitive to the 325 nm ultraviolet light produced by our SLA42,112. Use of a 
different photoinitiator will need to be preceded by tests of biocompatibility and 
photosensitivity to the wavelength of light produced by the 3D printer in use. 
• Dimethyl sulfoxide (DMSO, Fisher Scientific, D128-500). Caution: DMSO is flammable. 
Consult the DMSO safety data sheet and use appropriate engineering controls, such as a 
chemical fume hood and proper personal protective equipment (PPE). 





7.3.1.1.2 Cell Culture and Manufacture of Muscle Ring Bioactuators 
• C2C12 murine myoblasts (ATCC) infected with pLenti2-EF1α-ChR2[H134R]-tdTomato-
WPRE plasmid to express mutant variant of the 470 nm blue light-sensitive ion channel, 
Channelrhodopsin (ChR2[H134R]).99,231 Caution: Cell lines should be regularly checked 
to ensure that they are authentic and not infected with Mycoplasma.  
• Dulbecco’s Modified Eagle Medium with 4.5 g/L glucose, L-glutamine and sodium 
pyruvate (Corning, 10-013-cv) 
• Fetal Bovine Serum (FBS, Lonza, 14-502F) 
• Penicillin/Streptomycin (Cellgro Mediatech, 30-002-CI) 
• L-glutamine (Cellgro Mediatech, 25-005-CI) 
• Trypsin (TrypLE, ThermoFisher Scientific, 12605010) 
• Trypan Blue (ThermoFisher Scientific, 15250061) 
• Thrombin (Sigma Aldrich, T4648) 
• Fibrinogen (Sigma Aldrich, F8630) 
• Matrigel® (Corning, 354248) 
• Horse Serum, Heat Inactivated (Fisher Scientific, 26-050-070) 
• Aminocaproic acid (Sigma Aldrich, A2504) 
• LONG® R3 Human Insulin-like Growth Factor-1 (IGF-1, Sigma Aldrich, I1271) 
• Bovine Serum Albumin (BSA, Sigma-Aldrich, A3059) 
 
7.3.1.1.3 Quantification of Muscle Ring Viability 
• Cell Titer 96® AQueous One Solution MTS Cell Proliferation Assay (Promega, G3580) 
• Dulbecco’s Modified Eagle Medium with 4.5 g/L glucose, no glutamine, no phenol red 
(ThermoFisher Scientific, 31053028) 
 
7.3.1.1.4 Immunohistochemical Staining of Muscle Rings 
• Paraformaldehyde, EM grade, 16% (Electron Microscopy Sciences, 15710) 
• TritonTM X-100 for molecular biology (Sigma-Aldrich, T8787) 
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• Image-iT® FX Signal Enhancer (ThermoFisher Scientific, I36933) 
• MF 20 Antibody (Developmental Studies Hybridoma Bank at the University of Iowa)  
• Anti-Sarcomeric Alpha-actinin antibody (Abcam, ab109776)  
• Goat anti-Mouse IgG (H+L) Secondary Antibody, Alexa Fluor® 488 conjugate  
(ThermoFisher Scientific, A-11029) 
• F(ab')2-Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 568 conjugate 
(ThermoFisher Scientific, A-21069)   
• 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI, ThermoFisher Scientific, 
D1306)   
• Agarose (Bio-Rad, 162-0100) 
 
7.3.1.1.5 Histological Staining of Muscle Rings 
• Tissue-Tek® O.C.T. Compound (VWR, 25608-930) 
• Hematoxylin Stain (ThermoFisher Scientific/ Richard-Allan Scientific™, 7221) 
• Eosin-Y Stain (Fisher HealthcareTM, 22-220-104) 
 
7.3.1.1.6 Quantification of Total Protein and DNA Content of Muscle Rings 
• DNeasy Blood and Tissue Kit (Qiagen, 69504) 
• RIPA Lysis and Extraction Buffer (ThermoFisher Scientific, 89900) 
• PierceTM BCA Protein Assay Kit (ThermoFisher Scientific, 23227) 
 
7.3.1.2 Equipment 
7.3.1.2.1 3D Printing Injection Molds and Bio-Bot Skeletons 
• 22 mm x 22 mm glass coverslips (VWR, 48366067) 
• Glass petri dishes (PYREX, Corning, 70165-152) 
• Tweezers (VWR, 72927) 
• Conical tubes, 15 mL and 50 mL (Denville Scientific Inc.) 
• Centrifuge tubes, 1.5 mL (Fisher Scientific, 05-408-129) 
• Syringe, 1mL (BD, DGW87703 - 8036000) 
• Needle, 26G x 3/8 (BD, 305110) 
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• Serological pipette tips, 10, 200, 1000 µL (Denville Scientific Inc.) 
• Vortexer (Fisher Scientific, 080131008) 
• Chemical fume hood (Fisher Hamilton, SafeAire, 70864)  
• Solvent waste container (Ecofunnel, 1-415-883-2600) 
• Hot plate (Corning, PC-420D) 
• Double sided tape (3M Scotch 34-8716-0599-3)  
• 35 mm plastic petri dishes (Corning Inc., 351008)  
• Stereolithographic 3D Printer (3D Systems, SLA 250/50) 
• UV Laser safety goggles (Laservision)  
 
7.3.1.2.2 Cell Culture and Manufacture of Muscle Ring Bioactuators 
• Serological pipette tips, 10, 200, 1000 µL (Denville Scientific Inc.) 
• Serological pipettes, 5, 10, 25 mL (Fisher Scientific) 
• Pipette aid (Eppendorf, Easypet 3) 
• Micropipettes (Eppendorf, Research Plus)  
• Culture flasks (Denville Scientific Inc.) 
• Conical tubes, 15 mL and 50 mL (Denville Scientific Inc.) 
• Centrifuge tubes, 1.5 mL (Fisher Scientific, 05-408-129) 
• 35 mm plastic petri dishes (Corning Inc., 351008)  
• Vortexer (Fisher Scientific, 080131008) 
• Water bath (Fisher Scientific, Isotemp 210) 
• Biosafety cabinet (Nuaire, NU-437-600) 
• Mammalian culture incubator (Thermo Electron Corporation, Napco Series 8000 WJ 
CO2 incubator)  
• Fridge (Thermo Electron Corporation, Revco) 
• Freezer (VWR) 
• Centrifuge (Eppendorf, 5810R) 
• Hemacytometer (Fisher Scientific, 0267110)  
• Upright microscope (Zeiss, Primovert)  




7.3.1.2.3 Optical Stimulation of Muscle Contraction 
• Spatula (Fisher Scientific, 14375253) 
• 470 nm LED (Luxeon) 
• Alligator clip wires (DigiKey) 
• Function generator (Agilent, 33250A) 
 
7.3.1.2.4 Electrical Stimulation of Muscle Contraction 
• Spatula (Fisher Scientific, 14375253) 
• Resistors, 1kΩ and 10 kΩ (DigiKey) 
• Capacitor, 220 µF (DigiKey) 
• Operational amplifier (DigiKey, OPA445AP) 
• Alligator clip wires (DigiKey) 
• Platinum electrodes, 0.762 mm diameter (Alfa Aesar, 14195) 
• Breadboard (All Electronics Corporation, PB-3260) 
• Function generator (Agilent, 33250A) 
• Power supply (Agilent, E 3630A) 
• Oscilloscope (Tektronix, TDS 3012) 
 
7.3.1.2.5 Quantification of Muscle Ring Viability 
• 24 well plate (Corning Costar® CLS3527) 
• 96 well plate (Corning Costar® CLS3997) 
• Microplate reader (BioTek, Synergy HT) 
 
7.3.1.2.6 Histological Staining of Muscle Rings 
• Benchtop liquid nitrogen container (ThermoFisher Scientific, 2129) 
• Cryostat (Leica, CM3050 S) 
• Microscope slides, 3x1 (Fisher Scientific, 12550343) 
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7.3.1.2.7 Imaging of Muscle Rings 
• Glass bottom culture dish, 35 mm (MatTek, P35G-0-20-C) 
• Stereomicroscope (LEICA MZFLIII) 
• Confocal microscope (Zeiss, LSM 710) 
• NanoZoomer 2.0-HT Digital slide scanner (Hamamatsu, C9600) 
 
7.3.1.2.8 Quantification of Total Protein and DNA Content of Muscle Rings 
• Scissors (VWR, 82027588) 
• Benchtop liquid nitrogen container (ThermoFisher Scientific, 2129) 
• Digital Sonicator (Branson, 150) 
• Micro Centrifuge (Eppendorf, 5415) 
• Spectrophotometer (NanoDrop, 1000) 
 
7.3.1.2.9 Software 
• SOLIDWORKS (Dassault Systemes): used to design parts for 3D printing. 
• 3D Lightyear (3D Systems): used to slice 3D designs into sequential 2D layers in 
preparation for 3D printing. 
• SPOT (SPOT Imaging): used for digital microscopy and imaging. 
• ANSYS Workbench (ANSYS, Inc.): used to test and verify performance of bio-bot 
designs via finite element analysis.  
• ImageJ (NIH): used to visualize and extract data from still images and videos of bio-bots. 
 
7.3.1.3 Reagent Setup 
• 3-TPM working solution: Using a syringe, add 400 µL of 3-TPM stock solution to 20 mL 
of 200 proof ethanol inside a chemical fume hood. This yields a final concentration of 2% 
(v/v) 3-TPM. Mix vigorously using a vortexer. This solution should be prepared fresh for 
each experiment. 
• Irgacure 2959 working solution: Add 1 mL of DMSO to 1 g of Irgacure 2959 powder. 
This yields a final concentration of 50% (w/v) Irgacure 2959. Mix vigorously using a 
vortexer. This solution should be prepared fresh for each experiment. 
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• PEGDA 700 g mol-1 working solution: Add 10 mL of PEGDA 700 g mol-1 stock solution 
to 39.5 mL of PBS. Add 500 µL of Irgacure 2959 working solution and mix thoroughly. 
This yields a final concentration of 20% (v/v) PEGDA700 g mol-1  and 0.5% (w/v) 
Irgacure 2959. Allow bubbles to settle before use. This solution can be stored at room 
temperature (24 °C) for six months. Efforts should be made to ensure sterility of the 
solution (accomplished via filtration) during storage. 
• PEGDA 1000 g mol-1 working solution: Add 10 g PEGDA 1000 g mol-1 to 40.4 mL of 
PBS. Add 500 µL of Irgacure 2959 working solution and mix thoroughly. . This yields a 
final concentration of 20% (v/v) PEGDA 1000 g mol-1 and 0.5% (w/v) Irgacure 2959. 
Allow bubbles to settle before use. This solution can be stored at room temperature for 
six months. Efforts should be made to ensure sterility of the solution (accomplished via 
filtration) during storage. 
• 70% ethanol sterilization solution: Mix 70 mL 200 proof ethanol with 30 mL distilled 
water, yielding a final concentration of 70% (v/v) ethanol. This solution can be stored at 
room temperature for one month. 
• Growth medium (GM): Supplement Dulbecco’s Modified Eagle Medium containing 4.5 
g/L glucose, L-glutamine and sodium pyruvate with 10% (v/v) Fetal Bovine Serum, 1% 
(v/v) Penicillin/Streptomycin, and 1% (v/v) L-glutamine to make GM. Medium should be 
stored in the fridge and warmed in a water bath at 37 ºC before use. 
• Differentiation medium (DM): Mix Dulbecco’s Modified Eagle Medium with 4.5 g/L 
glucose, L-glutamine and sodium pyruvate with 10% Horse Serum, 1% 
Penicillin/Streptomycin, and 1% L-glutamine to make DM. Medium should be stored in 
the fridge and warmed in a water bath at 37 ºC before use. 
• Aminocaproic acid (ACA): Prepare a stock solution of 50 mg mL-1 by dissolving ACA in 
distilled sterile water. This solution may be stored at 4 ºC until use. 
• Insulin-like growth factor stock solution (IGF-1): Prepare a stock solution of 1 mg mL-1 
by dissolving IGF-1 in 10mM HCl with 1 mg mL-1 BSA as a carrier protein. This 
solution should be stored in aliquots at -20 ºC until use. 
• Supplemented growth medium (GM+): Add 1 mL ACA to 49 mL GM solution to make 
GM+ containing 1 mg mL-1ACA. This solution may be stored at 4 ºC before use.  
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• Supplemented differentiation medium (DM++): Add 1 mL ACA and 2.5 µL IGF-1 to 49 
mL DM solution to make DM++ containing 1 mg mL-1ACA and 50 ng mL-1 IGF-1. This 
solution may be stored at 4 ºC before use. 
• Thrombin stock solution: Dissolve thrombin lyophilized powder in a 0.1% (w/v) BSA 
solution to yield a final concentration of 100 units mL-1 thrombin. This solution should be 
stored in aliquots at -20 ºC until use. 
• Fibrinogen stock solution: Dissolve 8 mg fibrinogen in 1 mL of GM+ to make a solution 
of final concentration 8 mg mL-1 fibrinogen. This solution should be made fresh for each 
experiment for best results. 
• MTS working solution: Make a 20% (v/v) solution of MTS by mixing 200 µL of 
CellTiter 96® AQueous One Solution Reagent with 1 mL of DMEM containing 4.5 g/L 
glucose, no glutamine, and no phenol red. This solution should be made fresh and stored 
in the dark until use. 
• Paraformaldehyde working solution: Mix 5 mL of 16% paraformaldehyde stock with 15 
mL of PBS, yielding a final concentration of 4% (v/v). This solution can be made fresh or 
stored at -20ºC until use. 
• Triton X-100 working solution: Mix 50 µL of Triton X-100 with 25 mL of PBS, yielding 
a final concentration of 0.2% (v/v). This solution should be made fresh and stored at 
room temperature until use. 
• Primary and secondary antibody working solution: Add antibody to PBS or blocking 
solution in a ratio of 1:400 (0.25%). Store secondary antibodies in the dark before use. 
• DAPI working solution:  Mix 10 µL DAPI with 25 mL distilled water. This solution can 
be made fresh or stored at -20ºC until use. Prepare in the dark. 
• Agarose stock solution: Make a 1% (w/v) solution by dissolving agarose powder in 
distilled water. The solution will solidify and may be stored at room temperature until 
use. Warm to liquefy agarose before use. 
 
7.3.1.4 Equipment Setup 
7.3.1.4.1 Cell Culture and Manufacture of Muscle Ring Bioactuators 
• Sterile tweezers: Immerse tweezers in solution of 70% ethanol for 5 min and allow to air 






7.3.1.4.2 Optical Stimulation of Muscle Contraction 
• Sterile spatula: Immerse tweezers in solution of 70% ethanol for 5 min and allow to air 
dry completely before use. Stimulation setup: Use alligator clip wires to connect the LED 
to the function generator’s output signal as shown in Figure 7.9A. Set the function 
generator output to a square-wave pulse signal of 20 V amplitude, 50 ms pulse width, and 
the desired frequency (1-4Hz recommended). The output should resemble the signal 
shown in Figure 7.9B. 
 
7.3.1.4.3 Electrical Stimulation of Muscle Contraction 
• Sterile spatula: Immerse tweezers in solution of 70% ethanol for 5 min and allow to air 
dry completely before use. Stimulation setup: Using the resistors, capacitor, and 
operational amplifier, build the circuit design shown in Figure 7.9C on the breadboard. 
Clean the platinum electrodes by immersing in 70% ethanol for 2 min, then rinsing in 
PBS for 2 min. Set the function generator output to a square-wave pulse signal of 20 V 
amplitude, 50 ms pulse width, and the desired frequency (1-4Hz recommended). The 
output should resemble the signal shown in Figure 7.9D. 
 
7.3.2 Procedure 
7.3.2.1 CAD file preparation for 3D printing, Timing 1 h 
1| Generate a 3D digital design of the muscle ring injection mold and bio-bot skeletons using 
CAD software (e.g. SOLIDWORKS) and save the design as an STL file. Exact dimensions used 
in our studies are presented in Chapter 5. 
2| Slice the digital design into 2D printable layers (200 µm in our studies) using 3D Lightyear 
software (3D systems) so that it is readable by a stereolithographic 3D printer. Export the 
generated files to the computer operating the 3D printer.  
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Critical Step: Parts should be oriented in a manner that avoids the formation of dead volumes or 
overhangs, as these types of 3D structures are difficult to fabricate using stereolithographic 
printing. 
Critical Step: The total thickness of the part should be divisible by the layer thickness specified 
in 3D Lightyear. This will allow the software to accurately calculate the number of layers to be 
printed. 
Pause Point: The files can be prepared and loaded onto the computer operating the SLA at any 
time prior to fabrication. 
 
7.3.2.2 3D printing injection molds and bio-bot skeletons 
3| To functionalize glass coverslips with acrylate groups, pour 10 mL of 3-TPM working solution 
into large glass petri dish containing 8-10 22 mm square glass coverslips and incubate for 5 min. 
Caution: 3-TPM is flammable. Consult the 3-TPM safety data sheet and perform this step using 
appropriate engineering controls, such as a chemical fume hood and proper personal protective 
equipment (PPE). 
4| Pour used 3-TPM working solution into a solvent waste container and add 10 mL of 100% 
ethanol to the petri dish containing the cover slips. Incubate for 5 min and then pour ethanol into 
solvent waste container. 
5| Hard bake the slides in the petri dish on a hot plate at 110 °C until the coverslips are 
completely dry. 
Critical Step: The coverslips should take no longer than 5 min to dry at this temperature. Over-
baking the coverslips could result in poor stability of functionalized acrylate groups. 
Pause Point: The methacrylated slides can be stored for up to 24 h at room temperature.  
6| Using small pieces of double sided tape, attach the methacrylated glass coverslips to the center 
of 35 mm plastic petri dishes (one coverslip per dish) with the functionalized side facing up. 
7| Add 1200 µL of pre-prepared polymer resin to each 35 mm petri dish, making sure the 
coverslip is immersed in resin. Use 20% w/v PEGDMA 1000 g mol-1 for injection molds and 
20% v/v PEGDA 700 g mol-1 for bio-bot skeletons (See troubleshooting information in Table 
7.13).  
8| Place the petri dish on the build platform of the SLA and start building the part on the center 
of the glass coverslip using an energy dose setting of 138 mJ cm-2. Add 250 µL of resin every 
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time the program prompts you to recoat.  
Critical Step: The laser should be turned on at least 30 minutes prior to the start of fabrication to 
ensure uniformity of light intensity.   
Caution: Eyewear protecting against the wavelength of the laser in use should be worn while 
operating the SLA. 
9| Once the part has been fabricated, gently release the glass coverslip from the petri dishes and 
wash the part in phosphate buffered saline (PBS). 
10| Following the wash step, sterilize the parts by first immersing fabricated structures in a 
solution of 70% ethanol for 1 h, and then immersing in PBS for 1 h.    
Pause Point: Fabricated parts can be stored in PBS at room temperature or 4 °C until ready for 
use. For best results, use parts within a week of fabrication. 
 
7.3.2.3 Manufacturing modular muscle ring bioactuators, Timing 2 h 
11| Place fabricated ring injection molds in a sterile 35 mm petri dish and carefully aspirate the 
PBS from the structure to prepare it for injection of the cell/gel solution.  
Critical Step: Aspirate as much of the PBS from the molds as possible, without damaging the 
molds, to ensure that the concentration of reagents within the cell/gel solution are not diluted 
during the injection molding process. 
12| Release cells from culture flasks using trypsin, count them, and aliquot them into vials 
containing 3E6 cells each (each aliquot corresponds to two muscle rings). Note: C2C12 murine 
skeletal muscle cells should be expanded in culture prior to experimental use, passaging 1:10 
when cells reach 80% confluency. Critical Step: Cells should not be allowed to reach 100% 
confluency and start differentiating in 2D culture prior to experimental use.  
13| Centrifuge the aliquots at 200 x g at room temperature for 5 minutes, aspirate remaining 
media, and resuspend each aliquot in 59.4 µL of GM+, which corresponds to a final 
concentration of 1E7 cells mL-1 in the final cell/gel solution volume.  
14| Add 0.6 µL of thrombin stock solution and 90 µL of Matrigel® to each aliquot of cells. Then 
add 150 µL of fibrinogen stock solution to each aliquot of cells and mix thoroughly. These 
correspond to final concentrations of 4 mg mL-1 fibrinogen, 30% v/v Matrigel®, and 0.5 U mg-
fibrinogen-1 thrombin in the final cell/gel solution volume. Inject 120 µL of the completed 
cell/gel solution into each of the two wells of the injection molds.  
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Critical Step: Thrombin, Matrigel®, and fibrinogen stock solutions should be kept on ice during 
cell preparation process. Matrigel® stock solution, which is stored at -20 °C, should be thawed 
overnight at 4 °C prior to experimental use to minimize solution viscosity and ensure ease of 
pipetting. Fibrinogen stock solution can be pre-prepared and stored at -20 °C prior to 
experimental use or prepared fresh for each experiment. 
Critical Step: The cell/gel solution gels very quickly following the addition of fibrinogen. After 
centrifugation, prepare each aliquot individually and seed one injection mold (two muscle rings) 
at a time for best results (See troubleshooting information in Table 7.13). 
15| Cover the petri dish and incubate the muscle rings for 1 h inside a mammalian cell culture 
incubator at 37 °C to allow the cell/gel solution to crosslink into a stable structure. Gently add 4 
mL of warm GM+ following this incubation period and incubate for 24 h. 
 
7.3.2.4 Coupling of muscle ring bioactuators to bio-bot skeletons, Timing 5 min 
16| Following this 24 h incubation, transfer muscle rings to 3D printed bio-bot skeletons using 
sterile tweezers and refresh GM+. Change media daily. Critical Step: The transfer procedure 
must be completed prior to the muscle differentiation process, to avoid damage to formed 
myotubes that may occur during transfer (See troubleshooting information in Table 7.13). 
 
7.3.2.5 Maturation and functional optimization of modular muscle rings, Timing 7 days 
17| Three days after seeding, change media to DM++ to begin the differentiation process. 
Refresh media daily. Muscle rings should demonstrate controlled twitch response to external 
electrical or optical stimulus within 7-10 days after seeding (See troubleshooting information in 
Table 7.13). 
18| To maximize force production by providing both a static mechanical stretch stimulus and a 
dynamic optical pulse stimulus throughout differentiation, stimulate bio-bots using the exercise 
training regimen detailed in Figure 7.10. The mechanical stretch stimulus is provided by keeping 
bio-bots tethered to the underlying glass slide from Day 1-12 of differentiation. The optical pulse 
stimulus is provided by daily stimulation (between Days 4-12) at 1, 2, and 4 Hz for 5 min each, 
with a 2 min rest period between each 5 min round. Optical stimulation (detailed in Step 19A) 
should be carried out at 37 °C. 
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7.3.2.6 External stimulation of muscle contraction 
19| At this stage, muscle contraction can be triggered via either optical (Option A) or electrical 
(Option B) stimulation. The active tension force produced by the engineered muscle will be the 
same in both cases, but optical stimulation allows for a higher degree of spatiotemporal control 
over stimulation. That is, while the electrical stimulation protocol outlined here will stimulate the 
muscle actuator in its entirety, the optical stimulation protocol allows for isolated stimulation of 
specific muscle regions. 
 
7.3.2.6.1 Optical stimulation of muscle contraction TIMING 5 min 
• Using a sterile spatula, gently release the bio-bots from the underlying glass coverslips 
and place directly beneath a 470 nm LED. Connect the LED to a function generator to 
produce pulses of controlled frequency (1-10 Hz) and pulse width (50 ms) (Figure 7.9A-
B). Note that muscle rings should display tetanus behavior above 10 Hz (See 
troubleshooting information in Table 7.13). Critical Step: Use fresh media at 37 °C to 
make sure glucose content has not been depleted. Critical Step: Standard cell culture 
media is not optimal for long-term experiments at room temperature and atmosphere, as it 
requires CO2 gas for pH buffering. While we have not observed significant changes in 
tissue viability or functionality over a relatively short stimulation period (5 min), longer 
stimulation regimens at room temperature and atmosphere will require modifying the 
composition of the culture media.  
• Image using a microscope objective with a field of view large enough to capture at least 
one pillar of the bio-bot skeleton (Figure 7.11C). Record videos at a frame rate suitable to 
the frequency of stimulation (10 frames per second in our studies) and return bio-bots to 
petri dishes containing fresh DM++ after stimulation. 
 
7.3.2.6.2 Electrical stimulation of muscle contraction TIMING 5 min 
• Using a sterile spatula, gently release the bio-bots from the underlying glass 
coverslips and transfer bio-bots to a sterile petri dish containing fresh plain DMEM 
without serum (to reduce the presence of bubbles, i.e. electrolysis, during electrical 
pulse stimulation). Critical Step: Use fresh media at 37 °C to make sure glucose 
content has not been depleted and bio-bots are tested at conditions suited to 
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mammalian cell culture. Critical Step: Standard cell culture media is not optimal for 
long-term experiments at room temperature and atmosphere, as it requires CO2 gas 
for pH buffering. While we have not observed significant changes in tissue viability 
or functionality over a relatively short stimulation period (5 min), longer stimulation 
regimens at room temperature and atmosphere will require modifying the 
composition of the culture media.  
• Align bio-bots parallel to the platinum electrodes of the electrical stimulation setup, 
making sure to avoid physical contact between the muscle actuators and the 
electrodes (Figure 7.9C-D). Stimulate with pulses of controlled frequency (1-10 Hz) 
and pulse width (50 ms). Note that muscle rings should display tetanus behavior 
above 10 Hz. 
• Image using a microscope objective with a field of view large enough to capture the 
movement of at least one pillar of the bio-bot skeleton (Figure 4.8C). Record videos 
at a frame rate suitable to the frequency of stimulation (at least 10 fps) and return bio-
bots to petri dishes containing fresh DM++ after stimulation. 
 
7.3.2.7 Calculation and FEA verification of passive tension force, Timing 30 min 
20| Take a side view image of a bio-bot and use ImageJ software (NIH) to measure the maximum 
deflection of the skeleton’s beam and the distance between the muscle and the beam as depicted 
in Figure 7.11A.  
21| Use the equation presented below, derived from Euler-Bernoulli beam theory, to calculate the 
passive tension force produced by the muscle ring bioactuators: 
𝐹! =  
8𝐸𝐼𝛿!"#
𝑙𝐿!  
Where Fp is the passive tension force, E is the Young’s Modulus of the PEGDA hydrogel 
skeleton (319.4 kPa for an SLA energy dose setting of 138 mJ cm-2), I is the moment of inertia of 
the beam ( !
!"
𝑏ℎ! = 2.8E-14 m4), 𝛿!"# is the maximum deflection of the beam, l is the distance 
between the muscle and the beam, and L is the length of the beam (6 mm). Note that Young’s 
Modulus of the hydrogel is dependent on the polymer composition and SLA energy dose. Values 
of E for varying energy doses are presented in Figure 7.12. 
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22| To verify that the calculated force produced would generate the measured deflection of the 
beam, construct a static structural FEA model (using ANSYS software in this study) composed 
of half a bio-bot skeleton with the given geometric and material properties of 3D printed PEGDA 
(Figure 7.11B). Impose a fixed support constraint at the middle of the beam and a passive tension 
force of the calculated magnitude on the skeleton and compare the computed deflection with the 
deflection measured empirically. Note that the model can also output other parameters, such as 
the equivalent stress in the skeleton after deformation (which shows regions of large stresses and 
stress concentrations), and this additional information can be used in optimizing the bio-bot 
skeleton geometry during an iterative design process. Specifically, skeleton dimensions can be 
changed in the computational model, and the resulting deformation can be predicted prior to 
empirical testing.  
 
7.3.2.8 Calculation and FEA verification of active tension force, Timing 30 min 
23| With a manual tracking plugin in ImageJ 251, track the motion of a bio-bot (as shown in 
Figure 7.11C) in a video acquired during externally stimulated contraction. A custom-written 
software for automated tracking of bio-bot movement during contraction, using normalized 2D 
cross-correlation of a user-specified feature in each frame, could prove useful for analysis of 
long videos. 
24| Using this motion tracking data, calculate the average change in length of the bio-bot during 
each contraction and divide by the original length of the bio-bot to calculate strain. Knowing the 
acquisition frame rate of the video, calculate the strain rate. Input these values in the equation 
presented below, derived from a Kelvin-Voigt viscoelasticity model, to calculate active tension 
force: 
𝐹!








Where  𝐹! is the active tension force, A is the contact area between the muscle ring and the bio-
bot skeleton, E is the Young’s Modulus of the PEGDA hydrogel skeleton (319.4 kPa for an SLA 
energy dose setting of 138 mJ cm-2), ∆𝑦 is the change in length of the skeleton during a 
contraction, 𝑦! is the original length of the skeleton in the passive state, 𝜂 is the viscosity of the 
PEGDA hydrogel (5.1 E-3 mPa s for the polymer composition used to build bio-bot skeletons), 
∆𝜀 is the change in calculated strain between two successive frames, and ∆𝑡 is the elapsed time 
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between two successive frames. Critical Step: The second term in the active tension equation is 
negligible at small strain rates but becomes significant at high strain rates, corresponding to 
stimulation frequencies above 4 Hz. Thus, while it is appropriate to treat the bio-bot as a linear 
elastic structure at low frequency stimulation, the addition of the viscosity term is required for 
high frequency stimulation.  
25| To verify that the calculated force produced would generate the measured deflection and 
displacement of the bio-bot skeleton, construct a Static Structural FEA model (using ANSYS 
software in this study) coupled to a Rigid Dynamics model (Figure 7.11D). Assign the bio-bot 
skeleton with the given geometric and material properties of 3D printed PEGDA, and impose a 
dynamic active tension force of the calculated magnitudes on the skeleton. Compare the 
computed displacement with the displacement measured empirically. Changing geometric or 
material properties of the bio-bot skeleton can be used to computationally predict the effects of 
changing these parameters prior to verification via empirical testing.  
 
7.3.2.9 Assessment of engineered muscle rings 
26| At this stage, there are a number of options to analyze engineered muscle rings. Methods 
include quantification of muscle ring viability (Option A), immunohistochemical staining and 
imaging of muscle rings (Option B), histological staining and imaging of muscle rings (Option 
C), or quantification of total protein and DNA content of muscle rings (Option D). 
 
7.3.2.9.1 Quantification of muscle ring viability, Timing 4 h 
• Immerse muscle rings individually in a 24- well plate in MTS working solution (500 
µL per ring) for 4 h in the dark at 37 °C. Also incubate 500 µL of the working 
solution in a separate well, without immersed muscle rings, as a negative control. 
Critical Step: The reagent is sensitive to light and should be kept in the dark during 
preparation and incubation. 
• After the 4 h incubation, remove 100 µL of solution from each of the wells, including 
the negative control, and pipette each sample into a separate well of a 96 well plate. 
Critical Step: The use of a multichannel pipette in steps 30A(i-ii) will assure identical 
volumes for each sample. 
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• Read the absorbance of the media in each well at 490 nm excitation wavelength using 
a plate reader. First, compute the difference in absorbance of the solution obtained 
from sample wells as compared to the negative control. Comparing this normalized 
absorbance across different experimental groups will provide relative viability data 
for different muscle treatments, with larger absorbance values corresponding to 
increased viability. 
 
7.3.2.9.2 Immunohistochemical staining and imaging of muscle rings, Timing 2 d 
• Wash bio-bots in PBS and immerse in a solution of 4% formaldehyde dissolved in PBS 
for 30 minutes to fix the muscle tissue. Wash with PBS 3 times for 5 min each. 
• Immerse bio-bots in solution of 0.2% Triton X-100 in PBS for 15 min on a rotator or 
shaker at 4 °C to permeabilize the tissue. Wash with PBS 3 times for 5 min each. 
• Immerse bio-bots in Image-iT® FX Signal Enhancer blocking solution for at least 30 
min. Pause Point: Tissues immersed in blocking solution can be stored at 4 °C until ready 
for staining and imaging. 
• Immerse bio-bots in primary antibodies (MF-20, 1:400 dilution in blocking solution; 
Alpha-actinin, 1:400 dilution in blocking solution) overnight at 4 °C. Wash with PBS 3 
times for 5 min each. 
• Immerse bio-bots in secondary antibodies (Goat anti-Mouse IgG (H+L) Secondary 
Antibody Alexa Fluor® 488 conjugate, 1:400 dilution in blocking solution; F(ab')2-Goat 
anti-Rabbit IgG (H+L) Secondary Antibody Alexa Fluor® 568 conjugate, 1:400 dilution 
in blocking solution) overnight in the dark at 4 °C. Wash with PBS 3 times for 5 min 
each. 
• Immerse bio-bots in stock solution of DAPI (1:5000 dilution in DI water) for 10 min in 
the dark. Wash with PBS 3 times for 5 min each. 
• Add a small amount of liquid agarose to a glass-bottom petri dish, then immediately 
place a stained bio-bot onto the agarose and cover with more liquid agarose. Store in the 
dark at 4 °C until ready for imaging. 
• Image stained bio-bot muscle rings using a fluorescent microscope with excitation 
wavelengths specified by the fluorophores conjugated to the secondary antibodies. 
Critical Step: Muscle rings should be imaged as soon as possible after staining. 
	216	
 
7.3.2.9.3 Histological staining and imaging of muscle rings, Timing 2 d 
• Wash bio-bots in PBS and immerse in a solution of liquid nitrogen for 2 min to snap 
freeze the muscle tissue. Store the muscle tissues immediately at -80 ºC to preserve 
protein content. Caution: Handle liquid nitrogen with care and use proper PPE to 
avoid injury or asphyxiation. The use of an approved bench top dewar can facilitate 
the snap freezing process. Pause Point: Frozen tissues can be stored at 80 ºC until use. 
•  Embed the muscle tissue in optimal cutting temperature (OCT) compound in the 
orientation desired and cut 10-15 µm sections with a temperature controlled cryostat. 
•  Mount the tissue sections on glass slides and stain with hematoxylin and eosin 
(H&E) or other desired histological stains to detect cells and ECM proteins of 
interest. 
•  Allow the slides to dry for 24 h and image with a digital pathology system (such as a 
Nanozoomer). 
 
7.3.2.9.4 Quantification of total protein and DNA content of muscle, Timing 4 h 
• If samples are to be analyzed at a later date, wash bio-bots in PBS and immerse in a 
solution of liquid nitrogen for 2 min to snap freeze the muscle tissue. Store the muscle 
tissues immediately at -80 ºC to preserve protein content. Caution: Handle liquid 
nitrogen with care and use proper PPE to avoid injury or asphyxiation. The use of an 
approved bench top dewar can facilitate the snap freezing process. Pause Point: 
Frozen tissues can be stored at 80 ºC until use. 
• If live tissues are to be analyzed immediately, wash bio-bots in PBS to remove excess 
media. 
•  Use sterile scissors or forceps to gently cut the muscle tissue in half. Weigh each half 
using a balance scale and record the mass.  
•  Place each half into a separate microcentrifuge tube in the appropriate lysis buffer 
and gently cut the tissues into small pieces. Vortex the sample for 10 s. 
•  Use a DNeasy Blood and Tissue Kit (or equivalent) to isolate the genomic DNA 
from each muscle tissue half, according to the manufacturer’s instructions. Measure 
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the DNA concentration at 260 nm using a spectrophotometer and calculate the total 
content of DNA using the elution volume and the total mass of the muscle ring. 
•  Use a BCA Protein Assay Kit (or equivalent) to determine the total protein content in 
each muscle tissue half, according to the manufacturer’s instructions. First, add RIPA 
buffer to the tube to lyse the other half of each muscle tissue on ice for 30 min. 
Centrifuge the sample at 14,000 x g at room temperature for 15 min and collect the 
supernatant. Critical Step: Ensure that the tissue is completely lysed before 
continuing. Periodic vortexing during the lysing step may assist. If tissue pieces are 
still visible, sonicate the muscle tissues for 10 s. 
• Measure the absorbance of each sample at 562 nm using a spectrophotometer and 
compare to a standard curve of BSA protein absorbance vs. concentration to 
determine the protein concentration. Calculate the total protein content using the 
known supernatant volume and the total mass of the muscle tissue. This concentration 
may be normalized to the number of cells in the sample by dividing by the calculated 
total DNA content. 
 
7.3.3 Anticipated Results 
Using the formulations presented in this protocol, muscle rings are expected to contain 
elongated, aligned, and multinucleated myotubes with sarcomeric striations, visible by a range of 
immunohistochemical staining and imaging methods (Figure 7.13). Functionally, muscle rings 
should produce passive tension forces on the order of 1710 ± 230 µN (n = 3). This corresponds 
to 3.2 ± 0.4 kPa when divided by the average cross-sectional area of 0.54 ± 0.06 mm2 (n = 3), as 
measured by confocal microscopy. Muscle rings are anticipated to produce active tension forces 
of 195 ± 7.3, 114 ± 8.1, and 110 ± 16 µN (n = 3) in response to optical stimulation at 1, 2, and 4 
Hz respectively (Figure 7.14A). These correspond to active tension stresses of 0.36 ± 0.01, 0.21 
± 0.02, and 0.20 ± 0.03 kPa. Stimulation with electrical pulses should produce active tension 
forces similar to those produced by optical stimulation (Figure 7.14B). The active tension strain 
produced by the muscle rings in response to stimulation at 1 Hz is on the order of 1%. 
Unconstrained muscle rings (uncoupled to bio-bot skeletons) can produce strains on the order of 
3% for short periods of time, but myotubes within the muscle rings do not retain their alignment 
without the mechanical strain provided by the bio-bot skeleton.  
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An exercise training regimen combining a static mechanical stretch stimulus and a 
dynamic optical pulse stimulus during differentiation should produce significantly increased 
active tension forces on the order of 283 ± 32 µN (0.52 ± 0.06 kPa) (P < 0.05, n = 3, one- way 
ANOVA, post hoc Tukey test) in response to optical stimulation at 1 Hz. Exercised bio-bots are 
expected to produce directional locomotive speeds on the order of 312 ± 63 µm s-1 (n = 6) and 
2D rotation steering speeds on the order of 2.1 ± 0.5 ° s-1 (n = 6).. Locomotive speed is expected 
to increase in response to exercise training, with an average increase in speed of approximately 
300% in response to a regimen combining static mechanical stretch and dynamic optical pulse 
stimuli. Locomotive speed is also expected to change in response to changing frequencies of 
stimulation, with an average increase in speed of approximately 80% when the stimulation 
frequency is increased from 1 to 4 Hz. On average, the useful life span of muscle ring actuators 
is on the order of 2-3 weeks. 
 
7.4 Supplemental Methods 
7.4.1 Passive tension FEA analysis of bio-bot skeletons 
1| Make a SolidWorks model of one half of a symmetric one-leg bio-bot skeleton. Upload the 
CAD file in the “Geometry” tab of a Static Structural model in ANSYS finite element analysis 
software.  
2| Right click on the “Engineering Data” tab of the Static Structural model and click Edit to add 
the appropriate values for material properties of PEGDA 700 (Young’s Modulus  = 3.194E+05 
Pa, Poisson’s Ratio = 0.45) are listed. Return to the main Project Schematic menu. 
3| Right click on the “Model” tab of the Static Structural model and click Edit to open the Model 
page.  Click on the CAD file under “Geometry” to verify that the Material Assignment is 
PEGDA 700. Click on “Fixed Support” under “Static Structural” to apply a support to the middle 
of the beam. 
4|  Right click on the “Static Structural” menu and click Insert -> Force. Apply a static force of 
the calculated passive tension magnitude on the pillar of the bio-bot skeleton. Click the “Solve” 
button at the top of the menu on the Model page. 
5| Right click on “Solution” and click Insert -> Deformation -> Total. You can also choose to 
add other forms of solution, such as equivalent stress, to show regions or large stresses and stress 
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concentrations. To do so, right click on “Solution” and click Insert -> Stress -> Equivalent (von 
Mises). 
6| Click on “Total Deformation” under “Solution” to see the computed deflection of the model 
and compare it to the deflection measured empirically. If the computed deflection varies greatly 
from experimental values, re-visit your passive tension measurements and calculations. 
7| Once computed deflections match those observed empirically, change geometric and material 
properties of the bio-bot skeleton in the FEA model to predict the effects of changing these 
parameters in an experiment.  
 
7.4.2 Active tension FEA analysis of bio-bot skeletons 
1| Make a SolidWorks model of a symmetric two-leg bio-bot skeleton. Upload the CAD file in 
the “Geometry” tab of a Static Structural model in ANSYS finite element analysis software.  
2| Couple the Static Structural model to a Rigid Dynamics model by linking the “Engineering 
Data”, “Geometry”, and “Model” tabs in the two modules. To link, select the three tabs and 
move the mouse to link them. 
3| Right click on the “Engineering Data” tab of the Rigid Dynamics model and click Edit to add 
the appropriate values for material properties of PEGDA 700 (Young’s Modulus  = 3.194E+05 
Pa, Poisson’s Ratio = 0.45) are listed. Return to the main Project Schematic menu. 
4| Right click on the “Model” tab of the Rigid Dynamics model and click Edit to open the Model 
page.  Click on  the CAD file under “Geometry” to verify that the Material Assignment is 
PEGDA 700. Click on “Frictionless Support” and “Frictionless Support 2” under “Static 
Structural” to apply the supports to the bottom of the two ends of the bio-bot skeleton. 
5| Right click on the “Static Structural” menu and click Insert -> Force. Apply a time-varying 
force of the calculated active tension magnitude on the pillar of the bio-bot skeleton. Click the 
“Solve” button at the top of the menu on the Model page. 
6| Click on “Solution” and click Insert -> Deformation -> Total. You can also choose to add 
other forms of solution, such as equivalent stress, to show regions or large stresses and stress 
concentrations. To do so, right click on “Solution” and click Insert -> Stress -> Equivalent (von 
Mises). 
	220	
7| Click on “Total Deformation” under “Solution” to see the computed deflection of the model 
and compare it to the deflection measured empirically. If the computed deflection varies greatly 
from experimental values, re-visit your active tension measurements and calculations. 
8| Once computed deflections match those observed empirically, change geometric and material 
properties of the bio-bot skeleton in the FEA model to predict the effects of changing these 
parameters in an experiment. 
 
7.4.3 Image processing for analysis of cellular orientation and morphology 
1| Using the protocol outlined in step 26B from the main protocol, stain and image the muscle 
tissue, including a nuclear stain such as DAPI. Pause Point: Images should be saved after 
staining and imaging. 
2| Open the file containing the fluorescently-labeled nuclei in ImageJ and convert to 8-bit. By 
comparison to the original image, adjust the brightness and contrast to ensure that only (and all 
of) the nuclei are visible (Figure D.4). 
3| (A) Quantification of cellular alignment in muscle rings 
(i) Rotate the image 90º (Image à Transform à Rotate 90 Degrees Right). 
(ii) Perform a Fast Fourier Transform on the binary image (Process à FFT à FFT). 
(iii) Use the oval tool to draw a circle around the image. Critical Step: Ensure that the 
circle is centered on the image. 
(iv) Compute the radial sum using the Oval Profile plug-in for ImageJ. Select “360” 
for number of points and “Radial Sums” for analysis mode. This will output a plot 
of summed intensity around the circle. 
(v) Click “List” to view the x-y values. 
(vi) Repeat Steps 3 (A) (i-v) above for each image. Alternatively, a fluorescently 
labeled image of myotubes (as shown in Figure 3b) may be used for FFT 
alignment analysis. 
4| (A) Quantification of circularity of nuclei 
(i) Using the binary image from Step 2 above, apply a threshold (Image à Adjust à 
Threshold) to highlight the nuclei (Figure D.4). 
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(ii) Apply the Watershed algorithm to segment nuclei that are touching (Process à 
Binary à Watershed). If necessary, further separate touching particles by 
applying Erode or Open operations.  
(iii) Analyze the selected nuclei (Analyze à Analyze Particles). If a range of sizes or 
circularity values is desired, input those parameters here. Select “Overlay Masks” 
to label the analyzed nuclei. Select “Exclude Egdes”, “Include Holes,” and 
“Display Results”. Critical Step: Inspect the resultant image to ensure that the 
particles were appropriately separated for analysis from Step 4 (B)(ii). Critical 
Step: Make sure that the “Shape descriptors” option is selected (Results à Set 
Measurements) to view circularity values. 




Figure 7.1 3D Printing Biological Machines. (A) Schematic of 3D printing apparatus used to 
fabricate bio-bot skeletons using a biocompatible polymer. (B) Image of 3D printed bio-bot  
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Figure 7.1 (cont.) 
coupled to tissue engineered skeletal muscle. (C) Electrical and optical signals are used to drive 
contraction of the tissue engineered muscle, with each contraction corresponding to a “step” 
forward. External signals can thus be used to control bio-bots to walk on 2D substrates. The 
direction of walking can be dictated by either the geometry of the skeleton or the region of 
muscle stimulated. (D) Future work on bio-bots could involve incorporating multiple tissue types 
(such as muscle, vasculature, neurons) to create robots that can sense, process, and respond to 
dynamic environmental signals in real-time. Shown in this schematic is a bio-bot that senses a 
harmful chemical gradient, walks toward it, and secretes biological factors to neutralize the 




Figure 7.2 Biological Design Process for Capstone Project. Using the skills of 3D printing and 
3D cell culture taught in the first four labs, students iteratively designed and built biological 
machines for specific target applications in the final project 252. 
 
 
Figure 7.3 Comparison of Mid- and End-Course Survey Results. Student responses to questions 
listed in Table 3. Data is represented as mean ± standard deviation. Statistical significance is 




Figure 7.4 End-Course Survey Results. Student responses to first five questions listed in Table 4 
specifically pertaining to class format 252. 
 
 
Figure 7.5 Bio-bot design process overview. (A) Bio-bot design is inspired by biological design 
in the body. Bio-bot skeletons and muscle bioactuator injection molds are designed using 
computer aided design (CAD) software (B) (Procedural Steps 1-2), tested using finite element 
analysis (FEA) software (C) (Procedural Steps 26,29), and manufactured via stereolithographic 
3D printing (D) (Procedural Steps 3-10). Muscle rings are tissue engineered and coupled to bio-
bot skeletons (E) (Procedural Steps 11-16), and assessed via immunohistochemical staining  
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Figure 7.5 (cont.) 
(F) (Procedural Step 30) and externally stimulated force production (G) (Procedural Steps 19-
29). Each step of the design process (A-G) is iterative, and feedback from each step is used to 
improve the functionality of the bio-bot with every iteration. Figures adapted from Cvetkovic et 




Figure 7.6 Cellular orientation and morphology in muscle rings versus strips. (A) A comparison 
of muscle strip and ring designs and the effect on cellular orientation. (B) Analysis of overall 
nuclear alignment (representative of myofiber orientation) was performed with FFT analysis of 
DAPI-stained regions of both tissue designs at day 12.  While both curves have peaks at 90º and 
270º (the common longitudinal axis of the bio-bot), muscle rings display a wider average 
distribution (and increased area under the curve) around these axes, indicating a higher degree of 
local and global alignment compared to muscle strips. FFT curves represent averages of 
individual FFT analyses (n=8 regions analyzed for muscle rings, n=5 for muscle strips, with 2 
samples per design; individual curves are shown in Figure D.1).  (C) The circularity significantly 
decreased in muscle rings compared to muscle strips, revealing a more elongated nuclear profile 
and higher degree of alignment along the length of the ring (n=16 total regions analyzed for 
muscle rings, n=8 for muscle strips, containing images from 2 different z-planes; both from 2 
samples each). Data from normal distributions represent mean values ± standard deviations; 
individual data points are shown in Figure D.1; * = p < 0.05. (D) Cellular viability, determined 
by a MTS assay, was statistically increased on day 12 for muscle rings versus strips. Columns 




Figure 7.7 Cellular alignment and circularity analysis. Starting with a fluorescent image of 
cellular nuclei, convert the image to binary. To calculate circularity, apply a threshold to the 
binary image and use the Analyze Particles feature in ImageJ to bin and plot the circularity (1 = 
circular; 0 = linear) for each data set. To compute alignment, perform FFT analysis on similarly-
oriented images and plot the results (radial sums) as a function of degrees. Circularity plots 
represent all data points from Figure 4.6C (n=2312 total nuclei for muscle rings; n=2702 for 
muscle strips). Data from normal distributions represent mean values ± standard deviations; * 
= p < 0.05.  FFT Alignment plots represent individual curves for muscle ring and strip samples; 







Figure 7.8 Muscle differentiation protocol. (A) Timeline of muscle maturation, indicating the 
effect of biochemical and mechanical exercise signals on muscle functionality. Functionality is 
assessed via comparison of muscle active tension force production in response to optical 
stimulation at 1 Hz. (B) Immunohistochemical and scanning electron microscopy (SEM) images 
of mature myotubes within differentiated muscle rings, showing a dense population of contractile 
myotubes with a high degree of local alignment. (C) Schematic of optimal exercise stimulation 
protocol, which combines both a static mechanical stimulus (imposed by tethering the bio-bot to 







Figure 7.9 External stimulation of muscle rings. (A) Stimulation setup for optical pulse 
stimulation of bio-bots. (B) Representative optical pulse train signal. (C) Stimulation setup for 












Figure 7.10 Muscle ring exercise training regimen. Protocol for stimulating bio-bots using a 
static mechanical stimulus (imposed by tethering the bio-bot to an underlying glass coverslip) 
starting Day 1, immediately after ring transfer, and a dynamic optical stimulus (imposed by the 





Figure 7.11 Calculation and FEA verification of passive and active tension force production. (A) 
Side-view images of bio-bots (left) and geometric parameters of bio-bot skeletons (right) are 
used to derive the passive tension force produced by muscle ring bioactuators. (B) The calculated 
value of passive tension force produced can be verified via finite element analysis (FEA) 
simulations. (C) Top-view videos of bio-bots stimulated via electrical or optical pulse signals are 
used to derive the active tension force produced by muscle ring bioactuators. (D) The calculated 




Figure 7.12 Modulus as a function of Energy Dose. Plot of Young’s Modulus for PEGDA 700 g 
mol-1 as a function of the UV energy dose imposed by the laser of the SLA during fabrication. 
 
 
Figure 7.13 Immunohistochemistry of engineered muscle tissues. (A) A confocal z-stack reveals 
the 3D nature of the muscle tissue, which contains elongated and multinucleated myotubes. 
Tissues were stained for mature myosin, Channelrhodopsin-2 (optogenetic ion channel), and 
DAPI (nuclei) (B) Confocal imaging of muscle tissue slices highlights sarcomeric striations 
characteristic of mature myofibers, visualized with an antibody against a-actinin protein. (C) 




Figure 7.14 Muscle ring force production. (A) Passive and active tension force produced by 
representative muscle ring in response to optical stimulation at 1 Hz. (B) Passive and active 
tension force produced by representative muscle ring in response to optical stimulation at 4 Hz. 
The passive tension baseline increases at higher frequency stimulation, as the muscle ring is not 
allowed to reach a fully relaxed state before the next pulse stimulus. (C) Comparison of active 
tension force produced by representative muscle ring in response to optical and electrical 
stimulation at 1 Hz, showing no significant difference between force produced using either 














outlines a modular and inquiry-based approach to teach-
ing the fundamental principles of the burgeoning field of
biofabrication, or “building with biology”, at the under-
graduate level. Furthermore, we provide details regarding
the semester-long course schedule and lab funding struc-
ture to enable other educators to adapt this course design
for their needs. We hypothesize that this curriculum
structure will effectively teach upper-level undergraduate
students to design and execute experiments, preparing




This study employed four teams of two students each,
all senior undergraduates in the bioengineering program
at the University of Illinois at Urbana-Champaign
(UIUC) and enrolled in “BioE 306: Biofabrication Lab”.
Since proficiency in aseptic mammalian cell culture
technique is a pre-requisite to the labs in this course, en-
rollment was limited to students who had previously
completed a cell culture lab course required of sopho-
mores in the bioengineering program. Enrolled students
were also required to complete online safety training as
required by the Division of Research Safety (IBC-3923)
and undergo a practical laboratory test on aseptic cell
culture technique during the first week of class.
The course (BioE 306: Biofabrication) was structured
as a series of four labs, each addressing a distinct aspect
of biofabrication and tissue engineering, leading up to
the final capstone project that required students to
draw on skills learned in the prior labs (Tables 1 and 2;
Additional file 1: Table S1). Students attended weekly
lectures (50 min) and labs twice a week (2 h per ses-
sion), and were expected to maintain their experiments
during the week outside the regularly scheduled lab
sessions. This course structure thus required a fully
functional cell culture lab well-equipped with the sup-
plies and reagents necessary for biofabrication experi-
ments. A list of required lab supplies, as well as estimated
total cost, is provided in Additional file 2: Table S2.
The lectures for the first two labs were led by the
course instructor, Prof. Pablo Perez-Pinera. The lec-
tures for the third lab were led by the teaching assist-
ant, Colin Castleberry. The lectures for the fourth lab
and the final project were led by guest lecturer, Ritu
Raman. Students also participated in an hour-long eth-
ics discussion focused on building biological machines,
led by Ritu Raman.
Capstone design project
The capstone final project required students to design,
3D print, and build a biological machine for any applica-
tion of their choice. Such machines, which are composed
of biological materials as well as synthetic materials, can
utilize the dynamic sensing, processing, and actuation
capabilities of biological tissues to perform controlled
robotic functions (Figs. 1 and 2). Unlike traditional ro-
bots made of synthetic materials, such bio-integrated ro-
bots (bio-bots) could demonstrate the real-time adaptive
behavior typical of biological systems and potentially
be tuned to suit a variety of applications in health,
security, and the environment [13–15]. The idea of
forward engineering living tissues and using these tis-
sues to power novel machines and systems has gained
much attention in recent years, enabled by emerging
Table 1 Course schedule
Lab 1 (3 weeks) Biocompatibility Test the effect of different types of commonly used chemical
compounds in 3D printers on cell viability
Lab 2 (3 weeks) Lentiviral Transduction Learn standard methods for delivering genes to cell lines and
assessing transduction efficiency
Lab 3 (3 weeks) 3D Cell Culture in Hydrogel Scaffold Culture muscle cells in 3D hydrogel scaffolds and quantify cellular
adhesion, morphology, proliferation, and differentiation in 3D
Lab 4 (3 weeks) Build a Walker Bio-Bot 3D print walking bio-bot powered by tissue engineered skeletal
muscle and compute muscle force generation and bio-bot speed
Final Project (3 weeks) Design and Build Your Own Bio-Bot Design and build muscle-powered bio-bot to achieve a functional
behavior relevant to an application in biomedical engineering
Table 2 Course objectives
Learning objective Lab
Quantify cell viability of any type of tissue in culture 1, 2, 3, 4, 5
Deliver heterologous genes to cells in culture by
infection using lentiviruses while understanding
the safety concerns associated with viral transduction.
2, 3, 4
Grow mammalian cells in 3D environments and
evaluation of phenotypic changes that occur as a
result of modifications in the composition of the
extracellular matrix
3,4
Design, build, and test skeletal muscle-powered
biological machines
4,5
Evaluate professional and ethical concerns associated
with the construction of synthetic biological machines
Ethics Discussion
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Week M Lecture Lab W Lab 
1 8/24 Course Overview  Cell Culture Review + Aseptic 
Technique 
8/26 Cell Culture Review + Aseptic 
Technique 
2 8/31 Lab 1: Cell Culture Review. Imaging and 
Microscopy 
Lab 1: Start Cultures in 12-Well Plates 
and Treatment 
9/2 Lab 1: Live/Dead Staining 
3 9/7 No Class Labor Day 9/9 LAB PRACTICAL 
3 9/14 Lab 1: Biocompatibility, Cell Death and Cell 
Proliferation. Viability Assays 
Lab 1: MTS Assay Part 1 9/16 Lab 1: MTS Assay Part 2  
4 9/21 Lab 2: Gene Delivery  Lab 2: Transfections 9/23 Lab 2: Collect Viruses 
6 9/28 Lab 2: Muscle Biology Lab 2: Transduction 9/30 Lab 2: Viability and Imaging 
7 10/5 Lab 3: Muscle Differentiation Lab 3: Making MyoD virus 10/7 Lab 3: Transduction 
8 10/12 Lab 3: 3D Microenvironments  Lab 3: Preparation of 3D gels 10/14 Lab 3: Analysis of Differentiation 
9 10/19 Lab 4: BioBots Lectu  on St reolithographic 
3D Printing 
Lab 4: CAD Design and 3D Lightyear 
Preparation 
10/21 Lab 4: Making ChR2 virus 
10 10/26 Lab 4: Design and Fabrication of BioBot 
Muscle Ring Actuators 
Lab 4: Seed Muscle Rings 10/28 Lab 4: Transfer Muscle Rings to 
BioBots 
11 11/2 Lab 4: Optogenetics, Exercise Conditioning, 
Effect of External Factors (IGF, ACA) 
Lab 4: Exercise Conditioning. 
Stereolithographic Fabrication of BioBot 
skeleton. 
11/4 Lab 4: Exercise Conditioning 
12 11/9 Lab 4: Mechanics and Movement, Viscoelastic 
Models 
Lab 4: Optical Stimulation/Electrical 
Stimulation 
11/11 Lab 4: Quantification of 
Performance 
13 11/16 Lab 5: Group Ethics Discussion Lab 5: Fabrication of Skeleton + 
Seeding 
11/18 Lab 5: Transfer to BioBot 
13 11/23 No class Thanksgiving Break 11/25 Thanksgiving Break 
14 11/30 Lab 5: Different Types of Bioactuators, Group 
Brainstorm new designs! 
Lab 5: Exercise Training/Caretaking 12/2 Lab 5: Test BioBots, Clean Up 
16 12/7 Dry Runs Lab 5: Collect Data, Prepare 
Presentation 
12/9 Student Presentations  
 
LAB 1 Biocompatibility Students will test the effects of two different types and concentrations of commonly used stereolithography 
photoinitiators (I2959 - biocompatible in low concentrations, I651 - cytotoxic) on cell viability. They will assess 
viability via live/dead staining and MTS assay. 
LAB 2 Lentiviral Transduction Students will learn standard methods for delivering genes with high efficiency to cell lines typically considered "hard 
to transfect." The students will transduce cells with the master transcription factor MyoD and ChR2 to achieve a 
myogenic phenotype that is light inducible. 
LAB 3 3D Cell Culture in Natural 
Hydrogel 
Students will learn standard methods of culturing cells in 3D hydrogel matrices. They will assess the effect of culture 
in a 3D environment that mimics native ECM on differentiation, proliferation, and morphology. 
LAB 4 Build a Walker BioBot 
  
  
Students will learn how to design and fabricate living biological machines powered by engineered skeletal muscle 
that are capable of controlled directional locomotion in response to optical and electrical signaling. They will test the 
effects of "exercise" training on BioBot functional response and learn how to quantify force production using 






Lab Supplies 5- 25 mL serological pipettes 4 cases 
 
6, 96 well plates 1 case 
 
15 & 50 mL conical tubes 2 cases 
 
10, 200, 1000 uL pipette tips 4 cases 
 
Forceps 2 sets 
Reagents Dulbecco's Modified Eagle Medium 10 500 mL bottles 
 
Fetal Bovine Serum 1 500 mL bottle 
 
Horse Serum 1 500 mL bottle 
 
Penicillin/Streptomycin 1 100 mL bottle 
 
L-Glutamine 1 100 mL bottle 
 
Trypsin-EDTA 4 50 mL bottles 
 
PBS w/o Ca, Mg 10 500 mL bottles 
 
Long(R) R3 IGF 0.1 mg 
 
6-Aminocaproic Acid 25 g 
 
Collagen 30 mg 
 
Fibrinogen 1 g 
 
Thrombin 1 KU  
 
Matrigel 2 50 mL bottles 
 
Ethanol  1 1L bottle 
 
2-propanol 1 4L bottle 
 
Poly (ethylene glycol) diacrylate 1 100 mL bottle 
 
Poly-L LysineHBr 5 mg 
 
Lipofectamine 3000 0.1 mL 
 
LDH Cytotoxicity kit 2 
 
CellTiter 96 Viability Assay 2 
 
Live/Dead Viability Stain Kit 1 
 
DAPI 1 mL 
 
Texas Red Phalloidin 1 
 
NIH C2C12 murine myoblasts 1E6 cells 
Total Cost of approximately $5000 for class size of 8 students, not including fixed costs such as 


















manufacturing technologies such as 3D printing [16, 17].
This is the primary focus of the National Science Foun-
dation Science and Technology Center EBICS (Emer-
gent Behavior of Integrated Cellular Systems, NSF
Grant CBET-0939511) [18]. Transitioning research in
this pioneering field from the lab bench to the real
world requires equipping the next generation of engi-
neers and scientists with specific skills in biofabrication.
Teaching the fundamental design principles and prac-
tices of “building with biology” is thus an important ob-
jective in training biomedical engineers for future
careers in industry and academia. With this goal in
mind, student teams were given 3 weeks to build
muscle-powered bio-bots to target a specific challenge
in biomedical engineering. Teams consulted with the
course instructors during individual meetings in the
first week to test and iterate the proposed bio-bot de-
sign for feasibility and functionality. After these initial
design meetings, the instructors and teaching assistant
assumed facilitator roles while students led their pro-
jects independently.
Student assessment
The parameters considered for grading student perform-
ance were effort in the lab and participation (30 %),
computer-aided design (CAD) project (10 %), team la-
boratory reports (four reports: 1.5, 4.5, 6, and 18 %) and a
final presentation on the capstone design project (30 %) to
course instructors, fellow students, and professors and
graduate student researchers in related fields.
Course evaluation
Students were assessed on the metrics listed in Table 3
in mid-course and end-of-course surveys. Additional
metrics analyzed in the end-of-course survey are listed
in Table 4. Students were also assessed on their re-
sponses to the open-ended questions listed in Table 5
(mid-course survey) and Table 6 (end-course survey). All
raw data is presented in Additional file 3: Table S3,
Additional file 4: Table S4, Additional file 5: Table S5
and Additional file 6: Table S6. Significance tests were
conducted using Mann-Whitney U tests with p values
signified in figure captions. This study was approved by
the Institutional Review Board (Reference #12224). All
students in the course signed consent forms before
participating in this study.
Results and discussion
The quantitative survey metrics assessed over the course
of the class all increased from the mid- to end-course
time points, indicating an overall positive trend in the
students’ course experience (Fig. 3, Additional file 3:
Table S3).
When assessed during the mid-course time point,
100 % of students in the class confirmed that the course
was being taught at an appropriate level. Additionally,
100 % of students in the class noted that they did not
need the biology explained more explicitly in the context
of the material being taught. These percentages did not
change when assessed again at the end of the course,
indicating they already had a strong grounding in the
fundamentals of the biological concepts used in the
class, and that the instructors thoroughly explained new
terminology. Students stated that “Everything we didn’t
know was explained very well” and that, more than
learning new terminology, they valued learning “about
new applications of the knowledge most of us had
already been taught which introduced new viewpoints.”
Considering 83 % of student indicated that the final pro-
ject was the aspect of the course they were most looking
forward to, it is not surprising that the metric assessing
introduction to new topics and concepts showed a dem-
onstrable increase over the semester between the mid-
and end-course surveys. Some students indicated that
learning new skills that are not a part of standard bio-
engineering curriculum, such as CAD design and 3D
printing, was an important motivator driving enthusiasm
regarding the final project. Students also cited the ability
to “use some creativity with our designs” as a source of
excitement, indicating that the open-ended and ill-
structured nature of the final design problem was a
source of motivation for the students.
The metric that showed the most significant increase
between the mid- and end-course time points concerned
assessing whether the format of the course was appro-
priately suited to the material being taught. Responses to
specific questions regarding the format of the class,
listed in Table 4, are presented in Fig. 4 and Additional
file 4: Table S4. The results indicate that the students
Table 3 Metrics assessed in mid- and end-course surveys
Metrics 1 2 3 4 5
Strongly Disagree Disagree Neutral Agree Strongly Agree
I expect/expected the course to introduce me to new topics and concepts
The format of the course seems to be/was appropriate
The lab reports are/were helpful for understanding the course material
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were already quite familiar with the main theoretical
concepts underlying the field of tissue engineering. Since
tissue engineering is a well-developed sub-field of the
broader discipline of biomedical engineering, it is unsur-
prising that a group of senior undergraduates pursuing
bioengineering majors would report familiarity with the
field. However, student responses also show that the labs
helped strengthen understanding of tissue engineering
concepts by teaching practical lab techniques applicable
to this field. Students stated that core concepts are
“much easier to understand when the class is structure
more hands on, where we can discuss the concepts and
then actually implement them ourselves.” Furthermore,
100 % of the students indicated that the labs leading up
to the final project helped them understand the goals of
the capstone and main course objectives better, stating
“I’m enjoying how each experiment we do on a weekly
basis is building up to ultimately building a bio-bot”.
The first four labs thus served as practice in versatile
experimental techniques, and the cumulative nature of
the final project proved to be a fair assessment of the
training they received.
During the mid-course survey, the students reported
lowest satisfaction with the process of writing lab reports
as a method of developing a deeper understanding of
course material. Students expressed specifically that they
would “like more help with the data analysis”. An im-
portant objective of this class, in addition to teaching
the design principles of biofabrication, was to establish a
solid foundation in practicing the experimental method,
as students specifically expressed a desire to “have a
much stronger ability to design experiments for cell-
culture applications in the future” and expected to “learn
both lab techniques as well as the best way to plan out
experiments and all the variables necessary to take into
account”. To address these concerns, the course format
was altered to include 20 min of lab discussion time the
week before the due date for each lab report. Student
teams presented their results to all the instructors, as
well as the other teams, and were given the opportunity
to discuss their results prior to writing the lab report.
Portions of the lab sessions were also allotted to
instructor-led data analysis on practice data sets,
followed by guided team-based analysis of data gener-
ated during the labs. This led to an increase in the level
of satisfaction students reported with the lab reports by
the end of course survey, with students specifically stat-
ing that the in-class presentations “helped clear up any
misunderstandings and forced me to think about why
we were doing what we did in lab” and were valuable
because of their “informal, discussion-based format”. By
Table 4 Metrics assessed in end-course survey
Metrics 1 2 3 4 5
Strongly Disagree Disagree Neutral Agree Strongly Agree
Labs leading up to the final project helped me understand the final project better
I felt well prepared for the final project presentation
I feel that this course contributed greatly to my training in tissue engineering
I believe the lab based format helped me learn tissue engineering (TE) concepts
better than lecture based format
I found value in working in teams on the labs and final project
I would recommend this course to other students
I enjoyed my experience in this course
The course fulfilled my expectations
Table 5 Open-ended questions in mid-course survey
Metrics Please explain/expand
here
What aspects of the course are you most
looking forward to?
Do you want the biology to be explained
more explicitly in the context of the material
being taught?
What are your thoughts about the level at
which this course is being taught? (too
advanced, just right, other)
Table 6 Open-ended questions in end-course survey
Metrics Please explain/expand here.
Which aspect of the course helped you
learn most efficiently?
What aspects of the course did you find
most useful?
Was the biology explained explicitly
enough to assist you with the other
material being taught?
Provide your thoughts about the level
at which this course was taught (too
advanced, just right, other)
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   Strongly Disagree -> Neutral -> Strongly Agree 
I expect/expected the course to introduce me to 
new topics and concepts 
MID: 4,4,4,4,5,5,5 
END: 4,4,5,5,5 




The lab reports are/were helpful for 







                   1          2           3          4          5 
   Strongly Disagree -> Neutral -> Strongly Agree 
Labs leading up to the final project helped me 
understand the final project better 
5,5,5,5,5 
I felt well prepared for the final project 
presentation 
5,5,5,5,5 
I feel that this course contributed greatly to my 
training in tissue engineering 
2,4,4,4,5 
I believe the lab based format helped me learn 
tissue engineering (TE) concepts better than 
lecture based format 
3,5,5,5,5 
I found value in working in teams on the labs 
and final project 
3,5,5,5,5 
I would recommend this course to other students 4,5,5,5,5 
I enjoyed my experience in this course 4,5,5,5,5 








Please explain/expand here. 
What aspects of the course are you most looking 
forward to? 
• I am excited for the final project. 
• I’m enjoying how each experiment we do on a weekly 
basis is building up to ultimately building a biobot. 
• Learning how to do CAD to design out biobot 
skeletons. 
• I’m excited about the final project because we’ll get to 
use some creativity with our designs. 
• Making a bio-bot! This will be exciting. 
• I’m most looking forward to when we place the muscle 
cells and create the biobot. 
Do you want the biology to be explained more 
explicitly in the context of the material being 
taught?  
• No, I feel as though I already understand the biology 
referenced. 
• No, Pablo explains everything we don’t know, and 
understands that we know other things enough. 
• No, I think the amount that each subject covered is 
good – we have heard a lot of this material already but 
it’s good to get a refresher as well as discuss how it 
applies to what we’re doing. 
• No, much of the biology we have already had (or had 
multiple times). It is good to do a review in lectures, 
but the level of detail has been fine. 
• I think the biology presented to us is adequate for 
understanding what we’re doing in the lab; we have a 
really strong biology background to start with so not a 
ton of explanation is always necessary. 
• No, we have learned all the biology before. Just a brief 
review is enough. 
• I understand the basic biology. The only thing is 
sometimes I am not sure what each reagent does on the 
molecular level. 
What are your thoughts about the level at which 
this course is being taught? (too advanced, just 
right, other) 
• Just right 
• Just right 
• Just right – we are getting an overview in class and 
then meeting twice in lab which is not too much. 
• Not advanced/just right. Lab reports should be graded 
fairly stringently, we are all graduation and should be 
able to write well at this point. 
• This is a good age level for this lab, although I think it 
might be a better class for juniors because you would 
be able to transition more easily from our BIOE 202 
cell culture class that we take as a sophomore. I 
haven’t had any issues transitioning because I do alot 
[sic] of this stuff in my research lab on campus, but I 
think others struggled at the beginning of the class due 
to that gap between sophomore and senior year. 
• I don’t know in lab techniques are extremely simple, 
but I would like more help with the data analysis 
parts… 









Please explain/expand here. 
Which aspect of the course helped you learn 
most efficiently?  
• Lab Reports 
• Lab Work 
• Lab Work 
• Lab Work  
• Presentations 
What aspects of the course did you find most 
useful?  
• The lab reports and weekly presentations were very 
useful. They helped clear up any misunderstandings 
and forced me to think about why we were doing 
what we did in lab. 
• Working in the lab was most helpful. The concepts 
were explained in class but it’s much easier to 
understand when the class is structure more hands 
on where we can discuss the concepts and then 
actually implement them ourselves. 
• Writing the lab reports was probably the most 
useful. There’s where you really have to know your 
stuff to write it well. 
• Reviewing results in class in a more informal, 
discussion-based format. 
Was the biology explained explicitly enough to 
assist you with the other material being taught? 
• Yes 
• Yes. Everything we didn’t already know was 
explained very well. 
• Yes, the biology refreshers were explained well 
although none of the biology discussed was new 
information to me. It was more about new 
applications with the knowledge that most of us had 
already been taught which introduced new 
viewpoints. 
• Yes. We have had all the biology before. 
• Yes, built upon concepts presented in other courses. 
Provide your thoughts about the level at which 
this course was taught (too advanced, just right, 
other) 
• Just right 
• Just right 
• Just right – it wasn’t too difficult and if we were 
having trouble with anything then we could always 
reach out for help and get extensions if other things 
were going on. The course was flexible so it was 
able to be at our pace. 
• I think that the level of work and reports etc was 
good. However, if you are extremely experience 
[sic] in cell culture already, it didn’t teach you all 
that much by being in lab. 





Step Problem Possible Reason Possible Solution 
7 Layers of 3D printed parts 
are of inconsistent 
thicknesses 
Resin solution surface is uneven 
during fabrication  
Subject petri dish to 
oxygen plasma 
treatment to render inner 
surface of dish 
hydrophilic 
14 Cell/gel solution volume 
contains several bubbles, 
resulting in inconsistent 
volumes pipetted into 
injection mold wells 
This solution is viscous and bubbles 
can be introduced during quick 
pipetting and mixing  
Make a larger volume of 
cell/gel solution than 
that required for two 
wells of an injection 
mold (The volumes 
provided in this protocol 
generate 25% extra 
cell/gel solution than 
required) 
16 Muscle rings break during 
transfer from injection 
molds to skeleton 
Muscle rings have limited elasticity 




rings with larger inner 
diameters, rendering 
transferring to smaller 
skeletons easier 
17 Muscle rings thin and 
rupture during culture 
Myoblasts produce fibrinolytic 
compounds that break down the 
nature fibrin hydrogel matrix that 
compose the muscle ring 
Increase the 
concentration of ACA, 
the anti-fibrinolytic 
compound already 
present in the culture 
medium to 2-3 mg mL-1 
19 Muscle rings do not 
generate significant active 
tension forces in response to 
optical stimulation 
The optical light stimulus is not 
penetrating the depth of the muscle 
tissue and exciting all the myotubes 
within 
Increase light intensity 
and reduce muscle ring 
thickness until optical 
stimulation produces 
similar active tension 
forces as electrical 
stimulation 
19 Muscle ring force 
production varies 
significantly from batch to 
batch 
The concentration of Matrigel® can 
vary from lot to lot, yielding 
different protein concentrations in 
each batch of muscle rings 
Consult the certificates 
of analysis provided by 
the manufacturer for 
information regarding 
protein concentration in 
the lot used, and use the 
same lot across 
experiments to attain 
consistent results. In our 
experiments, the total 
protein concentration 





CHAPTER 8: CONCLUSION 
The enabling technology of 3D printing has provided engineers and scientists with the 
ability to manufacture complex 3D systems with biological materials. This has facilitated 
applications in both reverse engineering native tissue and forward engineering bio-hybrid 
machines. This dissertation presents an approach for using 3D printing to uncover the 
fundamental design rules and principles of building with biology, specifically as it relates to 
building bio-hybrid robots, or bio-bots, for a range of functional applications. Furthermore, it 
presents a robust optimized protocol for manufacturing 3D printed muscle-powered biological 
machines, and a mechanism to incorporate biological “building blocks” into the toolbox of the 
next generation of engineers and scientists. 
Bio-bots that can dynamically sense and adaptively respond to a range of environmental 
signals have broad applicability in healthcare applications such as dynamic implants or targeted 
drug delivery. Advanced research in exoskeletons and hyper-natural functionality could even 
extend the useful application of such machines to national defense and environmental cleanup. 
We have developed a modular skeletal muscle bioactuator that can serve as a fundamental 
building block for such machines, setting the stage for future generations of bio-hybrid machines 
that can self-assemble, self-heal, and perhaps even self-replicate to target grand engineering 
challenges. By harnessing the dynamic adaptive functional capabilities of biological materials, 
and training the next generation of engineers to build with biology, we can set the stage for a 
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This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or
one of its group companies (each a"Wiley Company") or handled on behalf of a society with
which a Wiley Company has exclusive publishing rights in relation to a particular work
(collectively "WILEY"). By clicking "accept" in connection with completing this licensing
transaction, you agree that the following terms and conditions apply to this transaction
(along with the billing and payment terms and conditions established by the Copyright
Clearance Center Inc., ("CCC's Billing and Payment terms and conditions"), at the time that
you opened your RightsLink account (these are available at any time at
http://myaccount.copyright.com).
Terms and Conditions
The materials you have requested permission to reproduce or reuse (the "Wiley
Materials") are protected by copyright. 
You are hereby granted a personal, non-exclusive, non-sub licensable (on a stand-
alone basis), non-transferable, worldwide, limited license to reproduce the Wiley
Materials for the purpose specified in the licensing process. This license, and any
CONTENT (PDF or image file) purchased as part of your order, is for a one-time
use only and limited to any maximum distribution number specified in the license. The
first instance of republication or reuse granted by this license must be completed
within two years of the date of the grant of this license (although copies prepared
before the end date may be distributed thereafter). The Wiley Materials shall not be
used in any other manner or for any other purpose, beyond what is granted in the
license. Permission is granted subject to an appropriate acknowledgement given to the
author, title of the material/book/journal and the publisher. You shall also duplicate the
copyright notice that appears in the Wiley publication in your use of the Wiley
Material. Permission is also granted on the understanding that nowhere in the text is a
previously published source acknowledged for all or part of this Wiley Material. Any
third party content is expressly excluded from this permission.
With respect to the Wiley Materials, all rights are reserved. Except as expressly
granted by the terms of the license, no part of the Wiley Materials may be copied,
modified, adapted (except for minor reformatting required by the new Publication),
translated, reproduced, transferred or distributed, in any form or by any means, and no
derivative works may be made based on the Wiley Materials without the prior
permission of the respective copyright owner.For STM Signatory Publishers
clearing permission under the terms of the STM Permissions Guidelines only, the
terms of the license are extended to include subsequent editions and for editions
in other languages, provided such editions are for the work as a whole in situ and
does not involve the separate exploitation of the permitted figures or extracts,
You may not alter, remove or suppress in any manner any copyright, trademark or
other notices displayed by the Wiley Materials. You may not license, rent, sell, loan,
lease, pledge, offer as security, transfer or assign the Wiley Materials on a stand-alone
basis, or any of the rights granted to you hereunder to any other person.
The Wiley Materials and all of the intellectual property rights therein shall at all times
remain the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or
their respective licensors, and your interest therein is only that of having possession of
and the right to reproduce the Wiley Materials pursuant to Section 2 herein during the
continuance of this Agreement. You agree that you own no right, title or interest in or
to the Wiley Materials or any of the intellectual property rights therein. You shall have
no rights hereunder other than the license as provided for above in Section 2. No right,
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license or interest to any trademark, trade name, service mark or other branding
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you
shall not assert any such right, license or interest with respect thereto
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY,
EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE
MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED
WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY
QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY,
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES
ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED
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WILEY shall have the right to terminate this Agreement immediately upon breach of
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You shall indemnify, defend and hold harmless WILEY, its Licensors and their
respective directors, officers, agents and employees, from and against any actual or
threatened claims, demands, causes of action or proceedings arising from any breach
of this Agreement by you.
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR
ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY
SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR
PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN
CONNECTION WITH THE DOWNLOADING, PROVISIONING, VIEWING OR
USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION,
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT,
NEGLIGENCE, INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT
LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE,
BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND WHETHER
OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY
FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED
HEREIN. 
Should any provision of this Agreement be held by a court of competent jurisdiction
to be illegal, invalid, or unenforceable, that provision shall be deemed amended to
achieve as nearly as possible the same economic effect as the original provision, and
the legality, validity and enforceability of the remaining provisions of this Agreement
shall not be affected or impaired thereby. 
The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition
of this Agreement. No breach under this agreement shall be deemed waived or
excused by either party unless such waiver or consent is in writing signed by the party
granting such waiver or consent. The waiver by or consent of a party to a breach of
any provision of this Agreement shall not operate or be construed as a waiver of or
consent to any other or subsequent breach by such other party. 
This Agreement may not be assigned (including by operation of law or otherwise) by




Any fee required for this permission shall be non-refundable after thirty (30) days
from receipt by the CCC.
These terms and conditions together with CCC's Billing and Payment terms and
conditions (which are incorporated herein) form the entire agreement between you and
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes
all prior agreements and representations of the parties, oral or written. This Agreement
may not be amended except in writing signed by both parties. This Agreement shall be
binding upon and inure to the benefit of the parties' successors, legal representatives,
and authorized assigns. 
In the event of any conflict between your obligations established by these terms and
conditions and those established by CCC's Billing and Payment terms and conditions,
these terms and conditions shall prevail.
WILEY expressly reserves all rights not specifically granted in the combination of (i)
the license details provided by you and accepted in the course of this licensing
transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment terms
and conditions.
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor
Type was misrepresented during the licensing process.
This Agreement shall be governed by and construed in accordance with the laws of
the State of New York, USA, without regards to such state's conflict of law rules. Any
legal action, suit or proceeding arising out of or relating to these Terms and Conditions
or the breach thereof shall be instituted in a court of competent jurisdiction in New
York County in the State of New York in the United States of America and each party
hereby consents and submits to the personal jurisdiction of such court, waives any
objection to venue in such court and consents to service of process by registered or
certified mail, return receipt requested, at the last known address of such party.
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription
journals offering Online Open. Although most of the fully Open Access journals publish
open access articles under the terms of the Creative Commons Attribution (CC BY) License
only, the subscription journals and a few of the Open Access Journals offer a choice of
Creative Commons Licenses. The license type is clearly identified on the article.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and
transmit an article, adapt the article and make commercial use of the article. The CC-BY
license permits commercial and non-
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC)License permits use,
distribution and reproduction in any medium, provided the original work is properly cited
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Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND)
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Use by commercial "for-profit" organizations
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes
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Further details can be found on Wiley Online Library
http://olabout.wiley.com/WileyCDA/Section/id-410895.html
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The publisher for this copyrighted material is Springer. By clicking "accept" in connection
with completing this licensing transaction, you agree that the following terms and conditions
apply to this transaction (along with the Billing and Payment terms and conditions
established by Copyright Clearance Center, Inc. ("CCC"), at the time that you opened your
Rightslink account and that are available at any time at http://myaccount.copyright.com).
Limited License
With reference to your request to reuse material on which Springer controls the copyright,
permission is granted for the use indicated in your enquiry under the following conditions:
- Licenses are for one-time use only with a maximum distribution equal to the number stated
in your request.
- Springer material represents original material which does not carry references to other
sources. If the material in question appears with a credit to another source, this permission is
not valid and authorization has to be obtained from the original copyright holder.
- This permission
• is non-exclusive
• is only valid if no personal rights, trademarks, or competitive products are infringed.
• explicitly excludes the right for derivatives.
- Springer does not supply original artwork or content.
- According to the format which you have selected, the following conditions apply
accordingly:
• Print and Electronic: This License include use in electronic form provided it is password
protected, on intranet, or CD-Rom/DVD or E-book/E-journal. It may not be republished in
electronic open access.
• Print: This License excludes use in electronic form.
• Electronic: This License only pertains to use in electronic form provided it is password
protected, on intranet, or CD-Rom/DVD or E-book/E-journal. It may not be republished in
electronic open access.
For any electronic use not mentioned, please contact Springer at permissions.springer@spi-
global.com.
- Although Springer controls the copyright to the material and is entitled to negotiate on
rights, this license is only valid subject to courtesy information to the author (address is
given in the article/chapter).
- If you are an STM Signatory or your work will be published by an STM Signatory and you
are requesting to reuse figures/tables/illustrations or single text extracts, permission is
granted according to STM Permissions Guidelines: http://www.stm-assoc.org/permissions-
guidelines/
For any electronic use not mentioned in the Guidelines, please contact Springer at
permissions.springer@spi-global.com. If you request to reuse more content than stipulated
in the STM Permissions Guidelines, you will be charged a permission fee for the excess
content.
Permission is valid upon payment of the fee as indicated in the licensing process. If
permission is granted free of charge on this occasion, that does not prejudice any rights we
might have to charge for reproduction of our copyrighted material in the future.
-If your request is for reuse in a Thesis, permission is granted free of charge under the
following conditions:
This license is valid for one-time use only for the purpose of defending your thesis and with
a maximum of 100 extra copies in paper. If the thesis is going to be published, permission
needs to be reobtained.
- includes use in an electronic form, provided it is an author-created version of the thesis on
his/her own website and his/her university’s repository, including UMI (according to the
definition on the Sherpa website: http://www.sherpa.ac.uk/romeo/);




Licenses may be exercised anywhere in the world.
Altering/Modifying Material: Not Permitted
Figures, tables, and illustrations may be altered minimally to serve your work. You may not
alter or modify text in any manner. Abbreviations, additions, deletions and/or any other
alterations shall be made only with prior written authorization of the author(s).
Reservation of Rights
Springer reserves all rights not specifically granted in the combination of (i) the license
details provided by you and accepted in the course of this licensing transaction and (ii) these
terms and conditions and (iii) CCC's Billing and Payment terms and conditions.
License Contingent on Payment
While you may exercise the rights licensed immediately upon issuance of the license at the
end of the licensing process for the transaction, provided that you have disclosed complete
and accurate details of your proposed use, no license is finally effective unless and until full
payment is received from you (either by Springer or by CCC) as provided in CCC's Billing
and Payment terms and conditions. If full payment is not received by the date due, then any
license preliminarily granted shall be deemed automatically revoked and shall be void as if
never granted. Further, in the event that you breach any of these terms and conditions or any
of CCC's Billing and Payment terms and conditions, the license is automatically revoked and
shall be void as if never granted. Use of materials as described in a revoked license, as well
as any use of the materials beyond the scope of an unrevoked license, may constitute
copyright infringement and Springer reserves the right to take any and all action to protect
its copyright in the materials.
Copyright Notice: Disclaimer
You must include the following copyright and permission notice in connection with any
reproduction of the licensed material:
"Springer book/journal title, chapter/article title, volume, year of publication, page, name(s)
of author(s), (original copyright notice as given in the publication in which the material was
originally published) "With permission of Springer"
In case of use of a graph or illustration, the caption of the graph or illustration must be
included, as it is indicated in the original publication.
Warranties: None
Springer makes no representations or warranties with respect to the licensed material and
adopts on its own behalf the limitations and disclaimers established by CCC on its behalf in
its Billing and Payment terms and conditions for this licensing transaction.
Indemnity
You hereby indemnify and agree to hold harmless Springer and CCC, and their respective
officers, directors, employees and agents, from and against any and all claims arising out of
your use of the licensed material other than as specifically authorized pursuant to this
license.
No Transfer of License
This license is personal to you and may not be sublicensed, assigned, or transferred by you
without Springer's written permission.
No Amendment Except in Writing
This license may not be amended except in a writing signed by both parties (or, in the case
of Springer, by CCC on Springer's behalf).
Objection to Contrary Terms
Springer hereby objects to any terms contained in any purchase order, acknowledgment,
check endorsement or other writing prepared by you, which terms are inconsistent with these
terms and conditions or CCC's Billing and Payment terms and conditions. These terms and
conditions, together with CCC's Billing and Payment terms and conditions (which are
incorporated herein), comprise the entire agreement between you and Springer (and CCC)




established by these terms and conditions and those established by CCC's Billing and
Payment terms and conditions, these terms and conditions shall control.
Jurisdiction
All disputes that may arise in connection with this present License, or the breach thereof,
shall be settled exclusively by arbitration, to be held in the Federal Republic of Germany, in
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This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or
one of its group companies (each a"Wiley Company") or handled on behalf of a society with
which a Wiley Company has exclusive publishing rights in relation to a particular work
(collectively "WILEY"). By clicking "accept" in connection with completing this licensing
transaction, you agree that the following terms and conditions apply to this transaction
(along with the billing and payment terms and conditions established by the Copyright
Clearance Center Inc., ("CCC's Billing and Payment terms and conditions"), at the time that
you opened your RightsLink account (these are available at any time at
http://myaccount.copyright.com).
Terms and Conditions
The materials you have requested permission to reproduce or reuse (the "Wiley
Materials") are protected by copyright. 
You are hereby granted a personal, non-exclusive, non-sub licensable (on a stand-
alone basis), non-transferable, worldwide, limited license to reproduce the Wiley
Materials for the purpose specified in the licensing process. This license, and any
CONTENT (PDF or image file) purchased as part of your order, is for a one-time
use only and limited to any maximum distribution number specified in the license. The
first instance of republication or reuse granted by this license must be completed
within two years of the date of the grant of this license (although copies prepared
before the end date may be distributed thereafter). The Wiley Materials shall not be
used in any other manner or for any other purpose, beyond what is granted in the
license. Permission is granted subject to an appropriate acknowledgement given to the
author, title of the material/book/journal and the publisher. You shall also duplicate the
copyright notice that appears in the Wiley publication in your use of the Wiley
Material. Permission is also granted on the understanding that nowhere in the text is a
previously published source acknowledged for all or part of this Wiley Material. Any
third party content is expressly excluded from this permission.
With respect to the Wiley Materials, all rights are reserved. Except as expressly
granted by the terms of the license, no part of the Wiley Materials may be copied,
modified, adapted (except for minor reformatting required by the new Publication),
translated, reproduced, transferred or distributed, in any form or by any means, and no
derivative works may be made based on the Wiley Materials without the prior
permission of the respective copyright owner.For STM Signatory Publishers
clearing permission under the terms of the STM Permissions Guidelines only, the
terms of the license are extended to include subsequent editions and for editions
in other languages, provided such editions are for the work as a whole in situ and
does not involve the separate exploitation of the permitted figures or extracts,
You may not alter, remove or suppress in any manner any copyright, trademark or
other notices displayed by the Wiley Materials. You may not license, rent, sell, loan,
lease, pledge, offer as security, transfer or assign the Wiley Materials on a stand-alone
basis, or any of the rights granted to you hereunder to any other person.
The Wiley Materials and all of the intellectual property rights therein shall at all times
remain the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or
their respective licensors, and your interest therein is only that of having possession of
and the right to reproduce the Wiley Materials pursuant to Section 2 herein during the
continuance of this Agreement. You agree that you own no right, title or interest in or
to the Wiley Materials or any of the intellectual property rights therein. You shall have
no rights hereunder other than the license as provided for above in Section 2. No right,
license or interest to any trademark, trade name, service mark or other branding
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("Marks") of WILEY or its licensors is granted hereunder, and you agree that you
shall not assert any such right, license or interest with respect thereto
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY,
EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE
MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED
WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY
QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY,
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES
ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED
BY YOU. 
WILEY shall have the right to terminate this Agreement immediately upon breach of
this Agreement by you.
You shall indemnify, defend and hold harmless WILEY, its Licensors and their
respective directors, officers, agents and employees, from and against any actual or
threatened claims, demands, causes of action or proceedings arising from any breach
of this Agreement by you.
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR
ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY
SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR
PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN
CONNECTION WITH THE DOWNLOADING, PROVISIONING, VIEWING OR
USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION,
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT,
NEGLIGENCE, INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT
LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE,
BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND WHETHER
OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY
FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED
HEREIN. 
Should any provision of this Agreement be held by a court of competent jurisdiction
to be illegal, invalid, or unenforceable, that provision shall be deemed amended to
achieve as nearly as possible the same economic effect as the original provision, and
the legality, validity and enforceability of the remaining provisions of this Agreement
shall not be affected or impaired thereby. 
The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition
of this Agreement. No breach under this agreement shall be deemed waived or
excused by either party unless such waiver or consent is in writing signed by the party
granting such waiver or consent. The waiver by or consent of a party to a breach of
any provision of this Agreement shall not operate or be construed as a waiver of or
consent to any other or subsequent breach by such other party. 
This Agreement may not be assigned (including by operation of law or otherwise) by
you without WILEY's prior written consent.
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and conditions.
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor
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objection to venue in such court and consents to service of process by registered or
certified mail, return receipt requested, at the last known address of such party.
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open access articles under the terms of the Creative Commons Attribution (CC BY) License
only, the subscription journals and a few of the Open Access Journals offer a choice of
Creative Commons Licenses. The license type is clearly identified on the article.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and
transmit an article, adapt the article and make commercial use of the article. The CC-BY
license permits commercial and non-
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC)License permits use,
distribution and reproduction in any medium, provided the original work is properly cited
and is not used for commercial purposes.(see below)
Creative Commons Attribution-Non-Commercial-NoDerivs License
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Use of Wiley Open Access articles for commercial, promotional, or marketing purposes
requires further explicit permission from Wiley and will be subject to a fee.
Further details can be found on Wiley Online Library
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APPENDIX B: IRB LETTER 
 
B.1 IRB approval for data gathered and presented in “Design and integration of a problem-based 







Office of the Vice Chancellor for Research 
 
Office for the Protection of Research Subjects 
528 East Green Street 
Suite 203 
Champaign, IL 61820 
U of Illinois at Urbana-Champaign • IORG0000014 • FWA #00008584
 
August 19, 2015 
 
Lizanne Destefano 
I-STEM Education Initiative 
704 S Sixth St 
Champaign IL 61820 
 
RE: The evaluation of the NSF Science Technology Center: Emergent Behaviors of Integrated 
Cellular Systems (EBICS) 
IRB Protocol Number: 12224 
EXPIRATION DATE: August 18, 2018 
Dear Dr. DeStefano and Mr. Mitchell: 
Thank you for submitting a research amendment along with a request for a three year exempt extension 
for your project entitled The evaluation of the NSF Science Technology Center: Emergent Behaviors of 
Integrated Cellular Systems (EBICS). Your project is assigned Institutional Review Board (IRB) Protocol 
Number 12224 and has been reviewed. It has been determined that the research activities described in this 
application continue to meet the criteria for exemption at 45CFR46.101(b)(1).  In addition this letter 
approves the following modifications: a) changing the co-investigator from Ayesha Tillman to Marlon 
Mitchell and b) supplying Biol 306 questionnaires and consent letter. 
This determination of exemption only applies to the research study as submitted. Please note that 
additional modifications to your project need to be submitted to the IRB for review and exemption 
determination or approval before the modifications are initiated.  
We appreciate your conscientious adherence to the requirements of human subjects research. If you have 
any questions about the IRB process, or if you need assistance at any time, please feel free to contact me 
at the OPRS office, or visit our website at http://www.irb.illinois.edu. 
Sincerely, 
 
Ronald Banks, MS, CIP 
Human Subjects Research Coordinator, Office for the Protection of Research Subjects 
 
 
